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ABSTRACT 
The onset of Next-generation sequencing (NGS) invoked the development of a large 
number of quality control (QC), assembly, annotation, and alignment tools. Bacterial 
genome data when processed with NGS tools have individual outputs. This effects 
further analysis and research related to host-pathogen studies. A defined set of bacterial 
genomes along with Vibrio parahaemolyticus PCV08-7 (VPPCV08-7) (an important 
bacterial isolate from prawn (Macrobrachium rosenbergii) in the current thesis) were 
selected for further bioinformatic analysis and experimentation. Strategies of High 
quality filtering, Trimming, Adaptor filtering and N’s removal based on which seven 
different pipelines (Pipeline 1, 2, 3, 4, 5, 6 & Trim-Adaptor-Highquality (TAH) 
pipeline) made, were used. Pre-existing QC tools have been utilized in the current 
study. The TAH pipeline had been used on VPPCV08-7 genome data to complete the 
draft genome constituting of two chromosomes. The genome adaptation of Vibrio 
parahaemolyticus strains to prawn could lead to host requisition towards pathogenic 
infections which can be further understood by gleaning into the organization of 
pathogenicity islands, virulence genes and the evolution of house-keeping genes among 
the different strains of the bacteria. V. parahaemolyticus phylogeny with gbpA in 
comparison to the 16S rRNA gene as well as the house-keeping dnaB, deaD genes has 
been done. The interesting factor of gbpA (N-acetylglucosamine-binding protein A) 
gene, of its interaction with the epithelial chitin surfaces was observed in the present 
study in response to magnesium sulphate (MgSO4.7H2O) environment in the presence 
of carapace and commercial chitin flakes. Our results showed the importance of the QC 
strategy “Trimming” with a cut-off value ≥30 phred score, applying it as the first QC 
tool followed by adaptor and high quality filtering could help use maximum percentage 
of raw read data. On application to different NGS data of VPPCV08-7 showed a good 
percentage of usage of read data. This helped analyse the draft genome which adds to an 
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important gastro-intestinal pathogen repertoire. Followed by the phylogenetic relations 
between the 52 different V. parahaemolyticus strains with 16S rRNA, deaD, dnaB and 
gbpA which portray how randomly phylogenetic branches are formed. This showed 
selecting a house-keeping gene to relate to the evolutionary past of any strain specific to 
a country or location could play a major role in phylogeny. Lastly, our in vitro 
experiment and RT-PCR findings showed an increase in expression of gbpA in the 
presence of magnesium compound while significantly lower expression on addition 
with chitin and carapace. This explains that during the “molting” of prawn the gbpA 
expression could increase, therefore increasing the chances of bacterial interactions with 
the host epithelial chitin. Our study supports the use of phred quality ≥30, QC’s 
significance in dealing with sequencing data and how the roles of host-pathogen-
environment together need to be dealt to elucidate any further possibility of entry of the 
pathogen into the host. The data could give insights to the scientific community about 
precautious handling of NGS data for precision towards host-pathogen-environment 
studies.  
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ABSTRAK 
Permulaan penjujukan generasi-seterusnya (NGS) telah menggunakan pembangunan 
sebilangan besar kawalan mutu (QC), perhimpunan, penamaan dan alat-alat penjajaran. 
Pelbagai jenis data genom bakteria apabila diproses menggunakan alat-alat NGS 
menghasilkan output individu pada peringkat pemprosesan yang berbeza. Oleh itu, 
genom bakteria daripada pelbagai jenis kandungan genom dan Vibrio parahaemolyticus 
PCV08-7 (VPPCV08-7), bakteria yang membawa dua kromosom, satu bakteria penting 
yang diambil daripada udang (Macrobrachium rosenbergii) telah dipilih untuk analisis 
bioinformatik selanjutnya dan eksperiment. Strategi penapisan kualiti tinggi, perapian, 
penapisan adaptor dan penyingkiran N berdasarkan tujuh aliran berbeza (Aliran 1, 2, 3, 
4, 5, 6 & aliran Trim-Adaptor-Highquality (TAH)) telah digunakan. Alat-alat QC yang 
sedia ada telah digunakan dalam kajian semasa. Saluran paip TAH telah digunakan pada 
data genom VPPCV08 7 untuk menyempurnakan draf genom yang mengandungi dua 
kromosom. Penyesuaian genom dari strain Vibrio parahaemolyticus terhadap udang 
boleh membawa kepada permintaan tuan rumah terhadap jangkitan patogenik yang 
boleh difahami selanjutnya dengan memasuki ke dalam organisasi kepulauan 
kepatogenan, gen-gen kebisaan dan evolusi gen-gen housekeeping diantara jenis 
bakteria berbeza. Filogeni V. parahaemolyticus dengan gbpA berbanding gen 16S 
rRNA serta gen housekeeping dnaB dan deaD telah dilakukan. Satu faktor menarik 
daripada gen gbpA (N- asetil glukosamin A) ialah interaksi gen gbpA dengan 
permukaan epitelium kitin telah diperhatikan dalam kajian ini dengan tindak balas 
terhadap persekitaran magnesium sulfat (MgSO4.7H2O) dengan kehadiran karapas dan 
chitin emping komersil. Keputusan kami menunjukkan kepentingan strategi QC 
"Trimming" dengan satu nilai pemotongan ≥ 30 mata phred. Penggunaannya sebagai 
alat QC yang pertama diikuti dengan adaptor dan penapisan berkualiti tinggi boleh 
membantu menggunakan peratusan maksimum bacaan data mentah. Penggunaan data 
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NGS yang berbeza VPPCV08-7 telah menunjukkan peratusan penggunaan bacaan data 
yang baik. Ini membantu menganalisis draf genome yang menambah kepada koleksi 
patogen gastro-intestinal penting. Diikuti dengan hubungan-hubungan filogenetik antara 
52 V. parahaemolyticus yang berbeza dengan 16S rRNA, deaD, dnaB dan gbpA telah 
mengambarkan betapa rawaknya cabang filogenetik ini terbentuk. Ini menunjukkan 
pemilihan gen housekeeping yang berkaitan dengan evolusi masa lalu pelbagai jenis 
strain yang spesifik kepada negara atau lokasi boleh memainkan peranan utama dalam 
filogeni. Akhir sekali, eksperimen in vitro dan penemuan RT-PCR menunjukkan 
peningkatan ekspresi gbpA dengan kehadiran sebatian magnesium manakala penurunan 
ekspresi yang ketara apabila ditambah dengan kitin dan karapas. Ini menjelaskan 
bahawa semasa ekdisis berlaku, ekspresi gbpA udang boleh meningkat, lalu 
meningkatkan peluang interaksi bakteria dengan kitin epitelium tuan rumah. Kajian 
kami menyokong penggunaan kualiti phred ≥ 30, kepentingan QC dalam menangani 
data penjujukan dan bagaimana peranan tuan rumah-patogen-alam sekitar bersama perlu 
ditangani untuk menjelaskan apa-apa kemungkinan selanjutnya kemasukan patogen ke 
dalam tuan rumah. Data ini boleh memberi wawasan kepada masyarakat saintifik 
mengenai pengendalian mengenai langkah berjaga-jaga mengendalikan data NGS demi 
ketepatan terhadap kajian host- patogen - persekitaran. 
 
 
 
 
 
 
vii 
 
ACKNOWLEDGEMENTS 
God I thank you from the bottom of my heart for always being with me. I would like to 
express my heartfelt gratitude and thanks to my supervisor Assoc Prof. Dr. Subha 
Bhassu for her continuous guidance, encouragement and appreciation. I would like to 
express my sincere gratitude and thanks to my co-supervisor Dr. Niyaz Ahmed for his 
all-time motivation and support. I would like to thank Prof. Thong Kwai Lin for 
providing me with the bacteria. Thanks to Genotypic Pvt. Ltd for helping me receive the 
data related to my work on time and for their services. Special thanks to Mr. Ng, Ms. Li 
Nah, Mr. KC and Mr. Foo for helping me receive chemicals and kits on time. Thank 
you so much “Bright Spark Unit” team for the support provided under Bright spark 
fellowship. Thanks to Postgraduate Research Fund (PPP). I would like to thank UM for 
giving me PhD opportunity and each and every faculty and staff who has assisted me in 
helping with my queries at every stage of my PhD tenure. Thanks to each and every one 
of my lab mates (AGAGEL members) who have built a friendly environment in the lab 
and have made research a wonderful experience. Thank you very much one and all. 
Special thanks to my sis and family for always making me feel positive. I would like to 
even thank PBL lab members for having been an encouragement whenever I have been 
in India. Thanks to each and every friend of mine in Malaysia and India for boosting up 
my confidence whenever I needed it. Thanks to my roommate Shaz who always was 
excited to listen to my research which helped my thinking process. From the bottom of 
my heart I express my fullest gratitude to my Dad, Mamma, Potti, Sushu for being my 
confidence, strength, and believing in me always. Thank you very much for all the love 
and support. I thank all my family members especially my father-in-law and mother-in-
law for being a constant support at the time I most need. Last but not least thank you 
Deen Bava for installing in me positivity, zeal in being my strong pillar of happiness & 
support in my life. DEDICATED TO MY HUSBAND, DAD, MOM & BROTHER. 
viii 
 
TABLE OF CONTENTS 
                                         Page Number 
ABSTRACT              iii - iv 
ABSTRAK               v - vi 
ACKNOWLEDGEMENTS             vii 
TABLE OF CONTENTS          viii - xii 
LIST OF FIGURES           xiii - xix 
LIST OF TABLES            xx - xxi 
LIST OF SYMBOLS & ABBREVIATIONS      xxii - xxv 
LIST OF APPENDICES        xxvi - xxvii 
 
CHAPTER 1                   
INTRODUCTION         1-3 
 
CHAPTER 2 
LITERATURE REVIEW        4-18 
 2.1 Next Generation Sequencing      4-5 
 2.2 Bacterial evolution and their survival in aquatic    6-8 
environments 
 2.3 Vibrio – As an aquatic micro-organism    8-10 
 2.4 Vibrio parahaemolyticus and its significance   10-16 
  Temperatures & growth      10-11 
  Salinity        11 
  Metals         11-12 
  Virulence factors       12-15 
  Serotyping        15-16 
ix 
 
  Food effect        16 
  Symptoms        16 
 2.5 Macrobrachium rosenbergii      17-18 
 
CHAPTER 3 – UNDERSTANDING A DEFINED SET OF BACTERIAL 
GENOMES & OPTIMIZING A STANDARD QUALITY CONTROL 
PROTOCOL FOR BACTERIA USING NEXT-GENERATION SEQUENCING 
RAW READS 
3.1 Introduction                19-20 
3.2 Review of the literature              21-22 
3.3 Materials & Methods               23-31 
 3.3.1 Next-generation sequencing raw reads of bacterial           23 
  genomes 
 3.3.2 Quality control              23-24 
 3.3.3  High Quality filtering              24 
 3.3.4 Read Trimming              24-25 
 3.3.5 Adaptor file               25-26 
 3.3.6 N’s removal               26 
 3.3.7 Adaptor removal              26 
 3.3.8 Assembly               26 
 3.3.9 Alignment               26 
 3.3.10  rRNA and GC content            26 
 3.3.11  Customized pipelines             27-31 
3.4 Results & Discussion               32-55 
 3.4.1 Next-generation sequencing & finishing bacterial genomes          32-46 
 3.4.2 Quality control protocol             46-55 
x 
 
3.5 Conclusion                56-57 
  Achievement               57
                         
CHAPTER 4 – GENOME ANATOMY OF THE GASTROINTESTINAL 
PATHOGEN, VIBRIO PARAHAEMOLYTICUS OF CRUSTACEAN ORIGIN 
4.1 Introduction                58-59 
4.2 Review of the literature              60-62 
4.3 Materials and Methods/Methodology             63-66 
 4.3.1 Source, isolation and culture of V. parahaemolyticus          63 
PCV08-7  
 4.3.2 Genomic DNA isolation and Next-Generation sequencing         63  
 4.3.3 Assembly and alignment              64 
  Velvet                64 
  OSLAY               64-65 
  SSPACE               65 
  Mauve                65-66 
4.4 Results & Discussion               67-75 
 4.4.1 Genome assembly               67-68 
 4.4.2 Genome statistics and annotation            68-70 
 4.4.3 Identification of novel gene content and comparative         70-75 
  analysis 
4.5 Conclusion                76-77 
Achievement               77 
 
xi 
 
CHAPTER 5 – VIBRIO PARAHAEMOLYTICUS PCV08-7 PHYLOGENETIC 
RELATIONSHIPS WITH CO-EVOLVED STRAINS AND ITS STUDY ON 
SYMBIOSIS WITH HOST AND ENVIRONMENT 
5.1 Introduction                78-79 
5.2 Review of the literature              80-85 
5.3 Materials and Methods              86-94 
 5.3.1 Next-generation sequencing             86 
 5.3.2 Quality control and Assembly of V. parahaemolyticus          86-87 
PCV08-7 NGS data 
 5.3.3 Alignment and Annotation of VPPCV08-7 contigs          87 
 5.3.4 Protein-protein and Protein-chemical interactions          87 
 5.3.5 Alignment and Phylogenetic analysis of             88 
V. parahaemolyticus gbpA gene 
 5.3.6 Polymerase chain reaction             88-90 
 5.3.7 Cloning of gbpA gene              90-91 
 5.3.8 V. parahaemolyticus PCV08-7 culture and bacterial          91 
  plate count 
 5.3.9 RNA isolation and cDNA synthesis            92 
 5.3.10 Real Time Polymerase chain reaction using SYBR green         92-94 
  Absolute quantification             92-94 
  Relative quantification             94 
5.4 Results & Discussion               95-112      
 5.4.1 Vibrio parahaemolyticus PCV08-7 draft genome           95-99 
completion 
 5.4.2 Bioinformatic analysis of host-pathogen genes          99-101 
 5.4.3 Phylogenetic analysis of VPPCV08-7            101-107 
xii 
 
 5.4.4 Host-Pathogen-Environment interaction studies          107-112 
5.5 Conclusion                113-115 
Achievement                115 
 
CHAPTER 6  
CONCLUSION                116-119 
  INNOVATION                          119 
  SIGNIFICANCE              119 
 
REFERENCES                120-136 
 
SUPPLEMENTARY DATA 
LIST OF PUBLICATIONS & PAPERS PRESENTED           138-205 
APPENDIX A                206-232 
APPENDIX B                233-235 
APPENDIX C                236-305 
 
   
 
 
 
 
 
 
xiii 
 
LIST OF FIGURES 
CHAPTER 2                  Page Number 
Figure 2.1 FASTQ format                 5 
CHAPTER 3 
Figure 3.3.1 Strategies of quality control used for QC of bacterial             24 
genomes 
Figure 3.3.2 Flowchart showing the process of Pipeline 1              27 
Figure 3.3.3 Flowchart showing the process of Pipeline 2              28 
Figure 3.3.4 Flowchart showing the process of Pipeline 3              28 
Figure 3.3.5 Flowchart showing the process of Pipeline 4              29 
Figure 3.3.6 Flowchart showing the process of Pipeline 5              30 
Figure 3.3.7 Flowchart showing the process of Pipeline 6              30 
Figure 3.3.8 Flowchart showing the process of TAH pipeline             31 
Figure 3.4.1 SeqQC quality graph representing average phred quality             32 
score per base position (A) Read 1 of H. pylori  
908 (B) Read 2 of H. pylori 908 
Figure 3.4.2 SeqQC quality graph representing average phred quality             33 
score per base position (A) Read 1 of E. coli  
NA114  (B) Read 2 of E. coli NA114 
Figure 3.4.3 SeqQC quality graph representing average phred quality             33 
score per base position (A) Read 1 of P. denitrificans  
SD1 (B) Read 2 of P. denitrificans SD1 
Figure 3.4.4 SeqQC quality graph representing average phred quality             34 
score per base position (A) Read 1 of M. tuberculosis  
NA-A0008 (B) Read 2 of M. tuberculosis NA-A0008 
Figure 3.4.5 SeqQC quality graph representing average phred quality             34 
xiv 
 
score per base position (A) Read 1 of V. parahaemolyticus 
PCV08-7 (B) Read 2 of V. parahaemolyticus PCV08-7 
Figure 3.4.6 SolexaQA heatplots showing average per base quality of            35 
  HP908 (wherein, white represents an error rate of 0 ranging  
  through yellow and orange to pure black representing an  
  error rate of 0.75) (A) Read 1 (B) Read 2 
Figure 3.4.7 SolexaQA heatplots showing average per base quality of            36 
  ECNA114 (wherein, white represents an error rate of 0 ranging  
  through yellow and orange to pure black representing an  
  error rate of 0.75) (A) Read 1 (B) Read 2  
Figure 3.4.8 SolexaQA heatplots showing average per base quality of            37 
  PDSD1 (wherein, white represents an error rate of 0 ranging  
  through yellow and orange to pure black representing an  
  error rate of 0.75) (A) Read 1 (B) Read 2 
Figure 3.4.9 SolexaQA heatplots showing average per base quality of            38 
  MTBNA-A0008 (wherein, white represents an error rate  
of 0 ranging through yellow and orange to pure black 
representing an error rate of 0.75) (A) Read 1 (B) Read 2 
Figure 3.4.10 SolexaQA heatplots showing average per base quality of            39 
  VPPCV08-7 (wherein, white represents an error rate of 0  
ranging through yellow and orange to pure black representing  
an error rate of 0.75) (A) Read 1 (B) Read 2 
Figure 3.4.11 RNAmmer 1.2 Server results for rRNA genes of HP908 in            41 
(A) Contig assembly by Velvet (B) Contig assembly by Edena 
Figure 3.4.12 RNAmmer 1.2 Server results for rRNA genes of ECNA114            41 
in (A) Contig assembly by Velvet (B) Contig assembly by Edena 
xv 
 
Figure 3.4.13 RNAmmer 1.2 Server results for rRNA genes of PDSD1 in            42 
(A) Contig assembly by Velvet (B) Contig assembly by Edena 
Figure 3.4.14  RNAmmer 1.2 Server results for rRNA genes of              42 
MTBNA-A0008 in (A) Contig assembly by Velvet (B)  
Contig assembly by Edena 
Figure 3.4.15 RNAmmer 1.2 Server results for rRNA genes of              43 
VPPCV08-7 in (A) Contig assembly by Velvet (B) Contig  
assembly by Edena 
Figure 3.4.16 M-GCAT alignment showing similarity between velvet and            44 
edena assembled contigs of HP908 
Figure 3.4.17 M-GCAT alignment showing similarity between velvet and  44 
edena assembled contigs of ECNA114 
Figure 3.4.18 M-GCAT alignment showing similarity between velvet and  45 
edena assembled contigs of PDSD1 
Figure 3.4.19 M-GCAT alignment showing similarity between velvet and  45 
edena assembled contigs of MTBNA-A0008 
Figure 3.4.20 M-GCAT alignment showing similarity between velvet and  45 
edena assembled contigs of VPPCV08-7 
Figure 3.4.21 Graphs representing effect of QC strategies on percentage of  47 
reads produced in (A) PDSD1, (B) VPPCV08-7 and  
(C) MTBNA-A0008 data (with phred quality < 30) 
Figure 3.4.22 Graphs representing effect of QC strategies on percentage of  48 
reads produced with (A) HP908, (B) ECNA114 data  
(with phred score > 30) 
Figure 3.4.23 Result of QC strategies on (A) MAX contig length, (B) Total  49 
number of contigs and (C) Percentage of reads used in HP908  
xvi 
 
raw read data 
Figure 3.4.24 Result of QC strategies on (A) MAX contig length, (B) Total  50 
number of contigs and (C) Percentage of reads used in  
ECNA114 raw read data 
Figure 3.4.25 Result of QC strategies on (A) MAX contig length, (B) Total 51 
number of contigs and (C) Percentage of reads used in PDSD1  
raw read data 
Figure 3.4.26 Result of QC strategies on (A) MAX contig length, (B) Total 52 
number of contigs and (C) Percentage of reads used in  
MTBNA-A0008 raw read data 
Figure 3.4.27 Result of QC strategies on (A) MAX contig length, (B) Total  53 
number of contigs and (C) Percentage of reads used in  
VPPCV08-7 raw read data 
Figure 3.4.28 Comparison of the percentage of reads used by the customized 54 
pipelines in PSD1,MTBNA-A0008, VPPCV08-7, HP908 and  
ECNA114 (P1-P6, TAH pipeline) 
Figure 3.4.29 Graphical representation of patterns of output data (total number  55 
of contigs, percentage of reads used and MAX length of contig)  
across pipelines (1,2,3,4,5,6,7(TAH)) corresponding to PDSD1,  
MTBNAA-0008, HP908, ECNA114 and VPPCV08-7 raw read  
data respectively. 
CHAPTER 4 
Figure 4.4.1 Circular view of V. parahaemolyticus PCV08-7 draft   68 
genome. Diagrammatic representation of major genes carried  
by the two chromosomes of V. parahaemolyticus PCV08-7  
genome using CGview  
xvii 
 
Figure 4.4.2 Alignment of the genome of strain RIMD2210633 against that of    69 
isolate PCV08-7 and strain O1:K33. (a) Comparison of  
chromosomes of strain RIMD2210633 (VPRIMD2210633 chr1,  
VPRIMD2210633 chr2) with the draft chromosomes of PCV08-7  
(VPPCV08-7 draft chr1, VPPCV08-7 draft chr2) using M-GCAT.  
(b) Comparison of chromosomes of strain O1:K33 (VPO1:K33  
chr1, VPO1:K33 chr2) with the draft chromosomes of PCV08-7 
 (VPPCV08-7 draft chr1, VPPCV08-7 draft chr2) using M-GCAT 
Figure 4.4.3 Alignment of a unique PCV08-7 protein sequence similar to  71 
 Photobacterium damselae subsps. damselae. A unique sequence  
from PCV08-7 genome showed similarity with putative  
uncharacterized proteins of V. anguillarum 775 (F7YI77),  
V. cholera MJ-1236 (C3NPG0) and Vibrio sp. RC586  
(D0IJW6) and similarity to a phage integrase of  
Photobacterium damselae subsps. damselae (H1A9J8) 
Figure 4.4.4 (a) V. parahaemolyticus AQ3810 alignment against PCV08-7         74 
genome: Concatenated chromosome 1 and chromosome 2 of  
V. parahaemolyticus AQ3810 (AQ3810.fasta) against  
V. parahaemolyticus PCV08-7 (PCV08-7.fasta) (b)  
V. parahaemolyticus O1:K33 alignment against PCV08-7.  
Concatenated chromosome 1 and chromosome 2 of  
V. parahaemolyticus O1:K33 (O1_K33.fasta) against V.  
parahaemolyticus PCV08-7 (PCV08-7.fasta). 
Figure 4.4.5 Comparison of whole genome sequences of strains               74 
RIMD2210633, PCV08-7 and O1:K33. Alignment of complete  
genomes of V. parahaemolyticus RIMD2210633,  
xviii 
 
V. parahaemolyticus PCV08-7 and V. parahaemolyticus  
O1:K33, showing PCV08-7 being more similar to RIMD2210633. 
CHAPTER 5 
Figure 5.2.1 Minimum spanning tree of 174 global strains   81 
Figure 5.2.2 Hypothetical representation of the possible host-pathogen-  85 
environment interaction 
Figure 5.3.1 Agarose gel electrophoresis (1% w/v) showing the PCR products 89  
dnaB, deaD and gbpA genes at their corresponding gene lengths 
Figure 5.3.2 Agarose gel electrophoresis (1% w/v) showing the PCR product 90  
with the  gbpA real time primers on the 16 isolated colonies  
after transformation of the gbpA clone 
Figure 5.3.3 Absolute quantitative standard curve for DNA concentrations  93 
(0.005µg, 0.05µg, 0.5µg, 5µg and 50µg) vs Average Ct values  
for (A) primer concentration of 0.15nm (B) primer concentration  
of 0.3nm and (C) primer concentration of 0.6nm respectively 
Figure 5.4.1 Subsystem category distribution of the parsed draft                   96 
chromosome 1 of   VPPCV08-7 
Figure 5.4.2 Subsystem category distribution of the parsed draft    97 
chromosome 2  of   VPPCV08-7 
Figure 5.4.3 Subsystem category distribution of the parsed probable             97 
plasmid of   VPPCV08-7 
Figure 5.4.4 STRING v9.1 protein-protein interactions of gbpA protein of 100 
V. parahaemolyticus. 
Figure 5.4.5 STITCH 3 protein-chemical interactions of gbpA protein of        101   
V. parahaemolyticus 
 
xix 
 
Figure 5.4.6 Phylogenetic tree representing the selected 52    103 
V. parahaemolyticus genomes in relation with the 16srRNA gene  
Figure 5.4.7 Phylogenetic tree representing the selected 52    104 
V. parahaemolyticus genomes in relation with the house-keeping  
dnaB (DNA helicase) gene  
Figure 5.4.8 Phylogenetic tree representing the selected 52    105 
V. parahaemolyticus genomes in relation with the deaD  
(RNA helicase) gene 
Figure 5.4.9 Phylogenetic tree representing the selected 52    106 
V. parahaemolyticus genomes in relation with the gbpA gene 
Figure 5.4.10 Graphs representing gbpA gene expression (2-delta delta Ct  108 
values) against (A) the concentrations of Mg2SO4.7H2O (B) presence  
of Chitin with Mg2SO4.7H2O and (C) presence of carapace  
with Mg2SO4.7H2O 
Figure 5.4.11 Graphs showing gbpA gene expression (2-delta delta Ct values)      109 
against the concentrations of Mg2SO4.7H2O and presence of  
chitin and carapace 
 
 
 
 
 
 
 
 
 
xx 
 
LIST OF TABLES 
CHAPTER 3                  Page Number 
Table 3.3.1 Next-generation sequencing data of selected bacterial   23 
Genomes 
Table 3.3.2 Trimming values of reads based on phred quality scores of   25 
bacterial genomes 
CHAPTER 4 
Table 4.4.1 Table representing pathogenicity related clusters and other   73  
VP clusters in V. parahaemolyticus PCV08-7 
CHAPTER 5 
Table 5.3.1 Details of the Next-generation sequencing output raw   86 
read data  
Table 5.3.2 Table with details of the PCR and Real time PCR primers  89 
Table 5.4.1 Number of ORFs distributed into subsystems in the draft   96  
of chromosome 1, chromosome 2 and plasmid of VPPCV08-7 
Table 5.4.2 Important genes of VPRIMD2210633 and EMS strain and    98 
their presence in VPPCV08-7 
Table 5.4.3 Analysis of Variance to identify the level of significance    110 
for gene expression with the presence of Mg2SO4.7H2O 
Table 5.4.4 Analysis of Variance to identify the level of significance   110 
for gene expression with the presence of Mg2SO4.7H2O 
and chitin 
Table 5.4.5 Analysis of Variance to identify the level of significance    111 
for gene expression with the presence of Mg2SO4.7H2O 
and carapace 
Table 5.4.6 Student two tail paired t-test of equal variance across    111 
xxi 
 
gene expression samples of samples treated with only  
Mg2SO4.7H2O, with Mg2SO4.7H2O and Chitin, with  
Mg2SO4.7H2O and carapace 
Table 5.4.7 Table represents the bacterial count in the presence of only   112  
 Mg2SO4.7H2O (NONE). In the presence of Mg2SO4.7H2O 
with Chitin and in the presence of Mg2SO4.7H2O with  
carapace (concentrations represented in ppm) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xxii 
 
LIST OF SYMBOLS AND ABBREVIATIONS 
API - Analytical Profile index 
AT - adenine thymine 
bp - base pairs 
BWA - Burrow Wheeler’s alignment 
cDNA - complementary deoxy ribonucleic acid 
clpB - caseinolytic peptidase B homolog  
CHR1 - Chromosome 1 
CHR2 - Chromosome 2 
dATP - deoxy adenosine triphosphate 
dCTP - deoxy cytidine triphosphate 
dGTP - deoxy guanosine triphosphate 
deaD - RNAhelicase 
dnaB - DNAhelicase 
dTTP - thymidine triphosphate 
DNA - Deoxy ribonucleic acid 
EC - Escherichia coli 
FPs - Fingerprint patterns 
g - gram 
gbpA - N-acetylglucosamine-binding protein A 
GC - guanine cytosine 
HGT - Horizontal gene transfer 
HP - Helicobacter pylori 
HP908 - Helicobacter pylori 908 
KCl - Potassium chloride 
LB - Luria-Bertani 
xxiii 
 
min - minutes 
ml - millilitre 
mM - millimolar 
Mg++ - Magnesium ion 
Mg - Magnesium 
MgCl2 - Magnesium chloride 
MR - Macrobrachium rosenbergii 
MTB - Mycobacterium tuberculosis 
ng - nanogram 
NaCl - Sodium Chloride 
NGS - Next-generation sequencing 
ORFs - Open reading frames 
ppm - parts per million 
ppt - parts per thousand 
PCR - Polymerase chain reaction 
PD - Paracoccus denitrificans 
QC - Quality control 
RACE - Random amplification of cDNA ends 
RAST - Rapid Annotation using Subsystem Technology 
rRNA - Ribosomal Ribonucleic acid 
sec - seconds 
STEC - Shiga-toxin producing Escherichia coli 
STs - Sequence types 
tdh+ - TDH positive 
tdh- - TDH negative 
trh+ - TRH positive 
xxiv 
 
trh- - TRH negative 
tRNA - Transfer Ribonucleic acid 
TAH - Trimming-Adaptor-Highquality 
TCBS - Thiosulfate-citrate-bile salts sucrose 
TDH - Thermostable direct hemolysin 
TRH - TDH related hemolysin 
TTSS - Type III secretion system 
T3SS1 - Type III secretion system 1 
T3SS2 - Type III secretion system 2 
ure - Urease 
VP - Vibrio parahaemolyticus  
VPaI - Vibrio pathogenicity island-like element 
VPI - Vibrio pathogenicity island 
µg - microgram  
µl - microliter 
µM - micromolar 
0C - degree centigrade 
AP-PCR - arbitrary primer PCR 
BLAST - Basic local alignment search tool 
ECNA114 - Escherichia coli NA114 
GS-PCR - group specific PCR 
M-GCAT - Multiple genome comparative analysis tool 
MgSO4 - Magnesium sulfate 
MgSO4.7H20 - Magnesium sulfate hepta hydrate 
NGSQC - Next-generation sequencing quality control 
OSLAY - Optimal syntenic layout of unfinished assemblies 
xxv 
 
PDSD1 - Paracoccus denitrificans SD1 
qRT-PCR - Quantitative real time polymerase chain reaction 
VPPCV08-7 - Vibrio parahaemolyticus PCV08-7 
β – hemolysis - beta hemolysis 
MTBNA-A0008 - Mycobacterium tuberculosis NA-A0008 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xxvi 
 
LIST OF APPENDICES 
SUPPLEMENTARY DATA               Page Number 
Paper/ Poster presentation       138 
Publications         145-205 
APPENDICES 
Appendix A 
(a) Adaptor file       206-214 
(b) Quality control data      215-232 
Appendix B 
(a)       Genomic DNA isolation     233-235 
Appendix C 
(a)       Plasmid DNA isolation     236-237 
(b)       Data corresponding to assembly of  
Vibrio parahaemolyticus PCV08-7 sequencing data  238-240 
(c)       Heatmap       241-250 
(d)  Vibrio parahaemolyticus_Genomes               251-252 
(e)  ClustalW command-line parameters    253-254 
(f)  PCR sequencing results      255-262 
(g)       pGEM T-easy vector system     263 
(h)      Plasmid isolation sequencing results from 16 selected 264-288 
     colonies 
(i)      Vibrio parahaemolyticus PCV08-7 bacterial plate count 289-291 
(j)      Vibrio parahaemolyticus PCV08-7 RNA isolation and  292-294 
cDNA synthesis concentrations and Nanodrop quality  
readings 
(k)       Absolute quantification      295 
xxvii 
 
(l)       Relative quantification     296-300 
(m) Phylogenetic tree       301-305 
 
 
1 
 
CHAPTER 1 
 
INTRODUCTION 
It was in the year 2005 that the Next generation sequencing (NGS) was introduced into 
genomic research. Until now there has been terra bytes of data generated for the 
scientific community to deal with. During the onset of NGS, it was compared to Sanger 
sequencing in being cost-effective, producing high throughput data and less time 
consuming in the process of generating sequencing reads. By the new sequencing 
technologies such as the Illumina, it has become really easy to generate large amounts 
of sequencing data with higher depths and coverage (Baker, 2010). Ion torrent 
sequencing followed by the upgraded Ion proton sequencing have shown up as 
advanced technologies which take as less as two hours to generate gigabytes of data. 
Apart from these, there have been various third generation sequencing technologies 
which have emerged such as the 454 pyrosequencing, PacBio, Helicos, etc (Metzker, 
2005). Further technologies which are currently not on the run publicly such as the 
newest Oxford Nanopore (Maitra, Kim, & Dunbar, 2012) could compete in the near 
future in generating more accurate sequencing data from the sequencers.  
With higher amounts of data, it becomes very tedious to handle, incorporate data 
and extract valuable information from any particular sequence without losing sensitive 
information related to the DNA/RNA. This primarily is applicable to smaller genomes 
such as those of bacteria. Among any sequencing theories bacterial genome sequencing 
is the need of the hour, as there have been many multi drug resistant, extremely multi 
drug resistant cases being identified (Mellmann et al., 2011; Rohde et al., 2011). Apart 
from such bacterial genomes, specifically enterobacteria are one of the most important 
lower organisms to deal with, as they reside within the human gut flora, which not only 
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play an important role in maintaining human health but, also can affect the human 
system as zoonotic pathogens. 
There are several lower organisms which can be categorized based on the 
number of chromosomes they carry, high AT content, high GC content, bearing 
numerous resistant genes, etc. Based on the aspects of assembly, alignment and 
annotation, sometimes dealing with these bacteria could differ in order of avoiding loss 
of key information related to the bacterial sequence. There have been many tools which 
developed to identify and retain maximum sequence to further annotate bacterial whole 
genomes. The critical detail lies in how to deal with all these kind of data and complete 
a bacterial genome in a single viewpoint. For this there is an utmost need to prepare a 
reliable stepwise pipeline at the level of quality control of raw sequencing reads and 
deal with a unique and reliable identifier for PCR amplification in bacterial genomes. 
This pipeline could be applied to our genome Vibrio parahaemolyticus PCV08-7 
(VPPCV08-7) also to retain and use as many percent of reads as possible for further 
bioinformatics analysis. The need for a reference dataset including the usage of 
assemblers, aligners and annotation tools has its importance so as to avoid the scientific 
community from working on these aspects to obtain false positive or negative results.   
Apart from using the above reliable pipeline for the VPPCV08-7 genome 
completion, it is needed to extract out important genes without losing any crucial 
information in the bacterial genome. Such crucial information could lead to information 
related to host-pathogen interactions studies. V. parahaemolyticus is one such bacteria 
which invades the gut or rather the hepatopancreas of the prawn, Macrobrachium 
rosenbergii. Selecting an important gene from the genome information of VPPCV08-7 
which might participate in the interactions with the host component, and this gene in 
correlation with the house-keeping genes as well as the 16S rRNA to check the closely 
related species based on phylogeny could help us understand the evolutionary origin of 
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a range of V. parahaemolyticus genomes.  It has been reported that this pathogen stays 
with the host during its life cycle, but causes infection during the older stages.  
Applying all the data and information retrieved from a next-generation 
sequenced bacterial genome to host-pathogen studies is the aim of our study. The need 
to tackle a pathogen in response to the surrounding environment while at the same time 
considering the host and pathogen interactions is an important aspect involved in our 
study.  
Based on the above description the three primary objectives of our study are as follows. 
1. Understanding a defined set of bacterial genomes and optimizing a standard 
quality control protocol for bacteria using next-generation sequencing raw reads. 
2. To glean into the genome anatomy of the gastrointestinal pathogen, V. 
parahaemolyticus of crustacean origin. 
3. To elucidate V. parahaemolyticus PCV08-7 phylogenetic relationships with co-
evolved strains and study its symbiosis with host and environment.  
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CHAPTER 2 
 
LITERATURE REVIEW 
2.1 Next Generation Sequencing 
The genomic era in bacteriology started in 1995 when Sanger sequencing was applied 
for the first time on a bacterial genome. In 2005, the first of high-throughput (next-
generation) sequencing technologies started off with a significant cost-effective 
advancement in sequencing. A variety of approaches have been introduced based on the 
conventional Sanger sequencing which includes sequencing based on template 
amplification technologies, based on difference in sequencing chemistry and single-
molecule sequencing (Loman, Constantinidou, et al., 2012; Metzker, 2005). Apart from 
this, choosing a specific platform for high-throughput bacterial genome sequencing has 
become a challenge not only to the sequencing market, but also to microbiologists. With 
the availability of high-end instruments there has been an increased amount of 
sequencing data generated. Bench top instruments (Loman, Misra, et al., 2012) come 
with an advantage of sequencing bacterial genomes within a very limited span of time, 
lower running costs and lower set-ups. The most recent example is the Ion PGM 
launched in 2011 which has shown its immediate effect in the crowd-sourcing of the 
outbreak of the Shiga-toxin producing Escherichia coli (STEC) in Germany (Mellmann 
et al., 2011; Rohde et al., 2011). The presence of such sophisticated high-end 
sequencers (Quail et al., 2012) appear to make bacteriology closer to explore for 
microbiologists by making it cost effective and making genomic epidemiology a reality 
by keeping a track on the infections caused by pathogens worldwide. The challenge 
comes in coping with huge amounts of raw read data generated by next-generation 
sequencers every year. 
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The major task in NGS revolves around the following format which the primary user 
information is given, that is the FASTQ file (Figure 2.1) constituting of the following 
format. 
 
Figure 2.1: FASTQ format 
Whole genome bacterial sequencing has been identified as one reliable way to 
analyse the pathogenicity, virulence and evolutionary history of the pathogens. While 
the need for high-quality sequencing has been introduced as more approachable for 
bioinformatic analysis than high-throughput sequencing (Alkan, Sajjadian, & Eichler, 
2011). The need for tools which improve the quality of the raw reads and help interpret 
sequencing data of bacterial genomes play an important role in the current scenario. The 
analysis pipeline of a bacterial genome sequenced data constitutes of mainly quality 
control, assembly, alignment and annotation. There are several quality control tools 
which have been used widely. These have even been tested on different sets of bacterial 
data to develop and improve the already existing methods. The assembly, alignment and 
annotation processes follow the same kind of trial and error testing for proper execution 
of tools and generation of reliable and accurate data of bacterial genomes. While there 
are pipelines for de novo assembly of microbial genomes, there are studies on 
automated finishing of bacterial genomes utilizing hybrid approach (Jiang et al., 2012). 
 
 
 
 
6 
 
2.2 Bacterial evolution and their survival in aquatic environments 
A largely complicated open question till today in bacteria is the gene content and the 
patterns of its genome evolution. There are various processes such as the loss of genes, 
gene genesis, duplication of genes and horizontal gene transfer which have reasonable 
quantitative importance to reconstruct a specific aspect of ancestral genome apart from 
specific aspects of genome evolution (Aravind, Watanabe, Lipman, & Koonin, 2000; 
Bruccoleri, Dougherty, & Davison, 1998; Kyrpides, Overbeek, & Ouzounis, 1999; 
Ochman & Jones, 2000) 
Many studies on the presence, absence and shared genes of bacterial genomes 
show that the variation in the size of genomes effect the number of shared genes 
between genomes (Snel, Bork, & Huynen, 1999) and their evolutionary distance 
(Gaasterland & Ragan, 1998; Tekaia, Lazcano, & Dujon, 1999). Functional interactions 
between genes (Huynen & Snel, 2000; Pellegrini, Marcotte, Thompson, Eisenberg, & 
Yeates, 1999) were predicted by the technique of correlation in the presence of genes. 
From all the above we can understand that the genome size, evolutionary 
history and functional selection together help determine the gene content. Some studies 
have even emphasized on the role of important processes which show involvement in 
the evolution of gene content of genomes such as in the ancestor strains of Escherichia 
coli K12 and E. coli 0157:H7 through horizontal gene transfer (Perna et al., 2001), gene 
loss in the ancestor of Buchnera (Shigenobu, Watanabe, Hattori, Sakaki, & Ishikawa, 
2000) and the postulated gene duplication in the ancestor of Vibrio cholerae (Perna et 
al., 2001). Compared to the bacteria Helicobacter pylori and Chlamydia, horizontal 
gene transfer appear to be much more in E. coli genomes as per some studies (Perna et 
al., 2001). 
Studies show that horizontal gene transfer (HGT) occurs mainly through 
biased gene transfer that is gene transfer which rarely occurs between distant relatives 
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and which occurs more frequently between closely related species and individuals. Such 
as, certain genes derived from Chlamydia species found in red and green algae and in 
plants (Becker, Hoef-Emden, & Melkonian, 2008; Horn et al., 2004; Huang & 
Gogarten, 2007; Moustafa, Reyes-Prieto, & Bhattacharya, 2008), the marine 
gammaproteobacteria constituting a threonyl-tRNA synthetase to which the enzymes 
from cyanobacterium genus Prochlorococcus show a close relation (Zhaxybayeva, 
Gogarten, Charlebois, Doolittle, & Papke, 2006). Hence, the ancestry of bacteria and 
the Archea can be well studied using both cladistics and phenetics (Andam, Williams, 
& Gogarten, 2010) in the form of a pluralistic approach (Bapteste et al., 2009). 
The several other processes on which gene content of bacteria depend on other 
than HGT are duplication, gene fusion and vertical inheritance, though gene genesis and 
ancestral genome size do depend on HGT (Snel et al., 1999). 
Every bacterial genome has its own pattern of gene loss and gene gain through 
evolution which could even be niche specific as some bacteria are well known to thrive 
in extreme conditions of acid, heat, brine water, chemicals and aquatic environments. 
This is followed by their individual adaptation to the living organisms in those 
environments. Among all the above environments prokaryotic adaptation to aquatic 
organisms is one of the primary interest of research in seafood consuming countries. 
Whereby, diseases caused in humans and aquatic organisms observed presently are 
caused even due to consumption of contaminated seafood.  
There have been a wide range of bacteria reported from contaminated lake 
water such as V. cholerae, E. coli 0157:H7, Shigella, Campylobacter jejuni, 
Leptospirosis, Salmonella and Typhoid fever, H. pylori, Legionella, Mycobacterium 
avium complex (http://www.cdc.gov/healthyswimming/) ("Centers for Disease Control. 
Vaccines for selected use in international travel: cholera vaccine," 1978; Craun, Craun, 
Calderon, & Beach, 2006) 
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The major factors affecting bacterial survival in sea water are: absence of 
required nutrients, presence of toxic substances in sea water, presence of 
bacteriophages, adsorption of bacteria and their sedimentation, the harmful action of 
sunlight, utilization of bacteria as food by not only protozoa but other predators and 
competitive and antagonistic effects of the microorganism (Carlucci & Pramer, 1959). 
 
2.3 Vibrio – As an aquatic microorganism 
16S rRNA sequence is the basis on which the Vibrio species is largely classified within 
the Vibrionaceae family, the V. cholerae, V. parahaemolyticus and Vibrio vulnificus are 
closely related in terms of their clades and distant from Photobacteriaceae and 
Eterovibrionaceae families encompassed by the Vibrio fischeri group. This has been 
demonstrated by the phylogenetic analysis of gene sequences of recA, rpoA and the 16S 
rRNA as one concatenated sequence. V. cholerae gene content has been shown to be 
more closely related to that of Vibrio mimicus and slightly distant from all other species 
(F. L. Thompson, Iida, & Swings, 2004) based on DNA-DNA hybridization studies. 
To establish the patterns of epidemiological interest which are associated with 
the pathogenicity of the strain and to record correlation of diseases with specific strains, 
serotyping has been identified as one of the useful markers. The cause for the recent 
marked emergence of pathogenic bacterial strains and prediction of events (Faruque et 
al., 2005; Reen, Almagro-Moreno, Ussery, & Boyd, 2006) through construction of 
models and identification of evolutionary relationships were done by using multi-locus 
sequence typing/analysis, serogroup association and comparative genomics. With the 
potential pathogenicity of V. cholerae, V. parahaemolyticus, and association of their 
serogroups, the specificity of the serogroups has been correlated. However, a wide 
range of species of Vibrio are pathogenic to marine organisms. Among the vast number 
of Vibrio species the pathogenicity effects on population of fish and other marine 
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organisms such as eel are due to Vibrio anguillarum, Vibrio anginolyticus, Vibrio 
panaeicida, V. vulnificus, Vibrio harveyi and Vibrio salmonicida and those associated 
with coral reef bleaching are Vibrio campbellii, Vibrio shiloi, V. harveyi and Vibrio 
fortis which can have a severe effect on the aquaculture industry. 
Medicinal relevance to humans of some species of Vibrio has also been shown  
(Igbinosa & Okoh, 2008). Vibrios associated with infections which are extra-intestinal 
such as meningitis, wound infections and with gastroenteritis are V. mimicus, Vibrio 
fernissi, Vibrio metehnikovii, Vibrio caincinnatiensis and V. alginolyticus. Vibrio 
fluvialis is also associated with infections in the gastrointestinal region in a majority of 
countries. In terms of food borne diseases various factors highlight V. vulnificus, V. 
parahaemolyticus and V. cholerae as considerable importance. While V. 
parahaemolyticus and V. cholerae are mostly related to oysters, causing gastroenteritis. 
V. vunificus has been observed to be a causative of primary septicemia not only in 
marine populations (Gulig, Bourdage, & Starks, 2005) but also in humans. 
V. cholerae O1 causes cholera. Most cases of infection with these bacteria 
were reported through eating seafood (Shigenobu et al., 2000) and especially 
consumption of shellfish (Besser, Feikin, Eberhart-Phillips, Mascola, & Griffin, 1994; 
Finelli, Swerdlow, Mertz, Ragazzoni, & Spitalny, 1992; Hayat et al., 1993; Hollis, 
Weaver, Baker, & Thornsberry, 1976; Klontz, Tauxe, Cook, Riley, & Wachsmuth, 
1987; Lowry et al., 1989; Pavia et al., 1987). 
Non-O1 V. cholerae are strains of V. cholerae which do not show agglutination 
in O1 antiserum, infection through this bacterium is said to be caused due to 
consumption of shellfish. V. vulnificus has been reported to have caused high fatality 
rates due to its invasiveness associated with infections. This species has been reported 
an encapsulated form which most commonly occurs in clinical isolates rather than 
environmental isolates (Hollis et al., 1976). 
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Other species such as V. fluvialis, V. mimicus, V. alginolyticus, 
Photobacterium damsel (Vibrio damsela), V. metschnikovii, Vibrio cincimnatiensis, 
Vibrio fuenisii and Vibrio hollisae are also known to be pathogenic which can cause 
severe infections among which  are environmental  as well as human specimens. V. 
parahaemolyticus was identified as a causative of food-borne illness and associated 
with consumption of crab (Dadisman, Nelson, Molenda, & Garber, 1972). It has also 
been very well defined as being associated with seafood ranging from crustacean, 
molluscan shellfish to even giant water prawn. In comparison to other species of the 
Vibrio genus, V. parahaemolyticus has emerged from a pre-pandemic to a pandemic 
clone which will be dealt later on. Its emergence has shown a drastic change in the 
presence and absence of certain pathogenicity islands which define these clones. The 
interesting factor about this V. parahaemolyticus is whether all bacteria cause infection 
or live symbiotically within the prawn. 
 
2.4 V. parahaemolyticus and its significance 
Temperatures & growth 
Gram-negative bacterium, V. parahaemolyticus is curved rod-shaped and non-spore 
forming bacterium whose high motility is due to a polar flagellum. By a mechanism 
called swarming these microorganisms migrate across semi-solid surfaces (Barrow & 
Miller, 1974a) with the help of their lateral flagella. Throughout the world inshore 
marine waters are the primary area where distribution of V. parahaemolyticus is in 
abundance as it is said to be an inhabitant mostly of estuarine marine water. The effect 
of seasons on V. parahaemolyticus has reported (Colwell et al., 1984) that V. 
parahaemolyticus in a small number has been isolated from among sediment samples of 
marine water and was not detected during the period of winter (November - March) in 
Chesapeake Bay seawater. V. parahaemolyticus is proposed to multiply when there is 
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an increase in temperature that is by re-introduction of the microorganism into the sea 
water and to live in the marine sediments throughout the winter. 
The temperature ranging from 350C to 390C (Jackson, 1974) are the optimal 
conditions for the growth of V. parahaemolyticus. Though the doubling time of V. 
parahaemolyticus is as little as 5 min (Barrow & Miller, 1974b) in certain conditions, 
under optimal conditions this organism has a generation time of less than 20 min. 
Hence, V. parahaemolyticus is most prevalently observed to be in a suitable 
environment in the course of the warm season in summer being a mesophillic bacterium 
and cause food borne outbreaks which peaks in summer (Daniels, MacKinnon, et al., 
2000; Daniels, Ray, et al., 2000). Though the range of V. parahaemolyticus in seafood 
which is freshly harvested are rather lower than the dose of infection which has been 
predicted (Sanyal & Sen, 1974) the rapid multiplying ability of this bacteria at suitable 
temperatures shows its presence in food enough to cause a disease. 
Salinity 
V. parahaemolyticus has an important requirement for its multiplication and living 
conditions that is salinity. V. parahaemolyticus encounter salinity concentrations in 
marine environment typically ranging between 0.8% and 3% (DePaola, Kaysner, 
Bowers, & Cook, 2000). With optimal levels ranging between 1% and 3%, V. 
parahaemolyticus can thrive very well in a range of concentrations of sodium chloride 
that is, between 0.5% and 10% based on laboratory studies. 
Metals 
Apart from salinity, the capacity of the organism to utilize, tolerate and thrive in marine 
conditions is affected by various concentrations of metal ions present. V. 
parahaemolyticus isolates are found to survive in 300 mM magnesium a condition 
which is considered as toxic to various other microorganisms which is one of the 
example from severely polluted coastal waters in some parts of India (Bhattacharya, 
12 
 
Roy, Biswas, & Kumar, 2000). V. parahaemolyticus survival under several conditions 
can be improved by the increase in the ability to utilize magnesium. A 5.5 kb plasmid is 
said to carry the genes responsible for high resistance to increased magnesium 
concentrations (Bhattacharya et al., 2000). Injured or thermally treated V. 
parahaemolyticus cells show increased uptake of magnesium which indicates a possible 
increased requirement for magnesium not only for the stability and repair (Heinis, 
Beuchat, & Boswell, 1978) of ribosome, but also the membrane. 
V. parahaemolyticus capability to survive magnesium or any metal ion at high 
concentrations out-competes other basic flora of seawater for its own survival and 
growth in the presence of the ions.  
Virulence factors 
The mechanisms specific to mount an infection which contribute to the V. 
parahaemolyticus strain's ability which lack the virulence factors, well recognized as 
the TRH (TDH related hemolysin) and the TDH (Thermostable direct hemolysin) are 
still unknown. The following factors described below show association with virulence 
properties exhibited in V. parahaemolyticus. Clinically V. parahaemolyticus exhibits 
beta hemolysis (β-hemolysis) on Wagatsuma agar through TDH production (Yeung & 
Boor, 2004) and is characterized as “Kanagawa phenomenon” positive with only less 
than 5% of isolates from the environment producing TDH (Miyamoto et al., 1969), it 
has been shown to be associated with clinical isolates, describing TDH production as a 
virulence factor. When compared to TDH positive (tdh+) wildtype V. 
parahaemolyticus, a tdh mutant was observed in a model of a ligated rabbit ileal loop 
with nil fluid accumulation (Nishibuchi, Fasano, Russell, & Kaper, 1992) hence 
describing TDH to be a virulence factor of considerable importance in strains which are 
tdh+. Resulting in altered ion flux TRH induces calcium activated chloride channels. 
Showing a decreased accumulation of fluid in rabbit ileal loops (Xu, Yamamoto, 
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Honda, & Ming, 1994) is a genetically modified TRH in a KP-negative strain which 
gives support to TRH’s role in V. parahaemolyticus. As gastroenteritis is mostly being 
linked to the involvement of trh and tdh genes (Shirai et al., 1990), both these genes 
have enough background to qualify as virulence factors of V. parahaemolyticus. Neither 
of these hemolysin genes has been possessed by most environmental isolates though 
their presence in few clinical isolates has been studied (Shirai et al., 1990). This shows 
that a bacterial strain’s capacity to elicit an infection does not depend only on the 
presence of the tdh gene (Hoashi et al., 1990) and suggest that expression of TDH may 
vary among different strains. Hence, results suggest that TDH is not the one and only 
factor contributing to the pathogenicity of V. parahaemolyticus, but there are many 
additional virulence factors which could be contributing to the pathogenesis of the 
bacteria. 
The pathogenic strains of V. parahaemolyticus constituting the chromosome of 
its subset (Iida et al., 1995) carries the trh and ure (Urease) genes in close proximity 
which can be correlated to the urea hydrolysis being shown as a decent marker for the 
strains V. parahaemolyticus in the Pacific Northwest (Kaysner et al., 1994) associated 
with sporadiac illness. From a number of patients as urease negative strains have also 
been isolated including the new O3:K6 strains, its specific role in the pathogenesis of V. 
parahaemolyticus is still not clear and the urease activity cannot be defined as a 
universal marker for its virulence.  
Bacteria are well known to carry with them iron storage proteins (Andrews, 
1998) that are heme free ferritins and heme-containing bacterioferritins. A novel 
siderophore called vibrioferrin (Yamamoto et al., 1994) is produced by V. 
parahaemolyticus under iron limiting conditions. For example, in the human host with 
conditions where it is iron-limiting environments, strains could be provided with an 
advantage of surviving with an increase in the production of vibrioferrin. Increased 
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haemolytic activities, higher adherence and greater proliferation rate was demonstrated 
through culture of V. parahaemolyticus in iron limiting conditions. The possible relation 
between the concentration of iron present in the growth media of bacteria and the V. 
parahaemolyticus virulence was observed in previous studies (H. C. Wong & Lee, 
1994). Hence, contribution towards the pathogenesis of V. parahaemolyticus may also 
be due to the production of vibrioferrin. The emergence of unique variety of strains with 
enhanced virulence among the existing strains of V. parahaemolyticus is due to the 
incorporation of new genetic elements within its genome. In V. parahaemolyticus, while 
the rest of the genome has 45.4% as an average GC content, the pathogenicity island 
carries a GC content of 39.8%. It is the smaller chromosome where this pathogenicity 
island is located which suggests the island as being acquired due to horizontal transfer. 
Two genes of tdh and some other genes are borne by the pathogenicity island 
which has association with the virulence properties of other organisms which include 
the genes encoding the Pseudomonasexoenzyme T and the cytotoxic necrotizing factor 
of E. coli homologues. As the secretion mechanism is triggered on the movement of a 
bacterium into close contact with the host cells the Type III secretion system (TTSS) is 
also known as a contact-dependent secretion. V. cholerae does not show the presence of 
TTSS. While V. cholerae causes non-inflammatory secretory diarrhoea, inflammatory 
diarrhoea is considered to be shown by V. parahaemolyticus even though some clinical 
manifestations could be common between the infections caused due to V. 
parahaemolyticus and V. cholerae. 
V. parahaemolyticus with the presence of TTSS brings out the major 
differences in the pathogenicity between closely related organisms. The tdh and the trh 
genes are suggested to be important related to V. parahaemolyticus in terms of virulence 
factors based on epidemiological studies, but these would be well supported by further 
research studies. 
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Serotyping 
It is based on the antigens defined as O and K that the strains of the V. 
parahaemolyticus are typically serotyped. 13 O groups and 71 K types of strains can be 
marked as identified by the use of commercially available antisera. Since 1996 it is the 
serovar O3:K6 (tdh+ and TRH negative (trh-)) which is highly predominant. It is to this 
serovar that the outbreaks related to the bacteria V. parahaemolyticus are linked to (H. 
Han et al., 2008). There has been a recent emergence of a new O3:K6 serovar which has 
been studied (Chowdhury, Stine, Morris, & Nair, 2004; H. C. Wong et al., 2007). The 
derivatives of this new O3:K6 serovar that are O1:KUT, O4:K68 and the O1:K65 
isolated since the same year 1996 have similarity in terms of sequence types (STs) or 
fingerprint patterns (FPs) constituting a clonal complex collectively together defined as 
the “pandemic group”. These pandemic groups are said to possess a number of unique 
DNA markers such as ORF8 in phage f237, toxRS/new sequence (GS-PCR), an ORF 
VP2905, AP-PCR fragment of 932bp and a sequence of insertion within the gene Hu-
alpha (Hu alpha-insertion) (Okura et al., 2003; Okura et al., 2004). Two genome 
sequences that is, one complete sequence of non-pandemic strain of O3:K6 AQ3810 
and that of a pandemic strain O3:K6 RIMD2210633 (Boyd et al., 2008; Makino et al., 
2003) were determined. Studies showed that none of the ORF8, Hu-alpha insertion and 
toxRS/new sequence were suitable to identify strains as being pandemic by PCR 
(Meador et al., 2007). Further work showed that the cluster VP2900, VP2910 with 
genomic island VPaI-5 and GS-PCR sequence were shown to be specific genomic 
features to the pandemic group of strains. Studies (H. Han et al., 2008) show that the 
present pandemic clone (trh-, GS-PCR+ and tdh+) has emerged from that of its 
previous O3:K6 clone (TRH positive (trh+), GS-PCR and TDH negative (tdh-)). The 
pandemic clone has been shown to consist of five serovars, O:KUT (1strain), O1:K25(3 
strains), O6:K18 (1 strain), O4:K68 (5 strains) and O3:K6 (29 strains). Apart from 
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arising from old O3:K6, it has been recently reported that the pandemic clone acquired 
genomic regions including type IV secretion system and VPaI-1 to VpI-7. The 
pandemic clone microevolution has been hence not only an acquisition of new genomic 
islands, but also differentiation in genes of O/K antigen providing us with the pandemic 
group's evolutionary history. 
Food effect 
The concentration of V. parahaemolyticus goes to higher levels in shellfish than those in 
the surrounding water as they obtain food by filter feeding. The raw and under-cooked 
sea-food consumption such as the molluscan shellfish that are clams, mussels and 
oysters therefore cause illness due to V. parahaemolyticus. Cooked products being 
contaminated or improper cooking could show the presence of V. parahaemolyticus as 
it is extremely sensitive to heat. 
Symptoms 
The consumption of raw seafood causes major infections of V. parahaemolyticus 
infections and are considerably important in countries like Japan, but in countries 
wherein seafood is consumed after being well-cooked, V. parahaemolyticus associated 
diseases occur less frequently. In general, reports of dosage of infection are considered 
to be approximately 10 to the power of 5 per organism (Zhaxybayeva et al., 2006). V. 
parahaemolyticus linked to watery diarrhoea causes gastroenteritis and is very often 
followed by nausea, fever, vomiting and even abdominal cramps. These symptoms 
appear within a day after consuming under-cooked or raw seafood such as fish and 
shellfish. It usually resolves in 3-7 days in case it is a self-limiting infection. The 
presence of blood and mucus are observed in the watery stool in cases of severity. 
2.5 Macrobrachium rosenbergii  
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The farming in modern times of M. rosenbergii started in early 1960’s. It was proposed 
to require brackish conditions for its survival though found even in freshwater (New, 
2004). 
M. rosenbergii is one freshwater prawn species of which there is considerable 
production compared to that of Macrobrachium nipponense which appears less in 
official details of prawn production. Though it is influenced by the areas of brackish 
water this species resides in tropical environments of freshwater. The female body bears 
a gelatinous mass underneath between the fourth pair of its walking legs. It is here that 
the male deposits the sperm. After a few hours of mating, eggs are laid and fertilized by 
the sperm. “Berried Females” is the terminology used for females carrying the eggs 
(D'Abramo & Brunson, 1996).  During the course of embryo development the eggs 
remain constantly adhered to the female. It is during this time that the females migrate 
towards estuaries as the larvae cannot survive in freshwater for more than two days. The 
eggs hatch in brackish water whose salinity ranges from approximately 9 parts per 
thousand (ppt) to 19 ppt (D'Abramo & Brunson, 1996). They exist as free-swimming 
larvae at this stage.  
The change in phase from a larval to a post larval stage is very crucial in a 
prawn’s life cycle as it grows through a process of moulting (Saravanan, Biju Sam 
Kamalam, Stephen, & Kumar, 2008). It undergoes around almost 11 molts to transform 
into post larvae. These molts represent a process of metamorphosis. This stage can be 
explained as a critical part of a prawn’s life cycle as the old exoskeleton is replaced by a 
new soft exoskeleton underneath. It is here that the M. rosenbergii absorbs water into 
the tissue to increase in size. Hence, the environmental condition to which the M. 
rosenbergii is exposed to, further enhances its ability to grow into a healthy adult or 
decreases its chances of survival. These physiological traits of both V. 
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parahaemolyticus and M. rosenbergii could be used to further study the host-pathogen 
interactions. 
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CHAPTER 3 
 
UNDERSTANDING BACTERIAL GENOMES & OPTIMIZING A STANDARD 
QUALITY CONTROL PROTOCOL FOR BACTERIA USING NEXT-
GENERATION SEQUENCING RAW READ DATA 
3.1 Introduction 
Bacterial whole genome sequencing requires a number of quality controls entailing the 
assembly, annotation and alignment processes to herald a bacterial genome from the test 
tube on to the computer. The primary issues with next-generation sequencing data is the 
raw read data constituting contamination in terms of sequencing adaptors and low 
quality reads in terms of per base quality. Any bacterial genome raw read sequencing 
data processed without a proper quality control procedure could affect further steps that 
are assembly, annotation and alignment. There are several bacterial genomes that differ 
from each other in a number of ways such as bearing a small genome size, presence of 
two chromosomes, a completely new genome/ a de-novo assembled genome, etc. Such 
as these a number of genomes have been quality filtered, assembled and analysed till 
date with various different approaches to finish bacterial genomes. In our present work 
we have concentrated upon the contigs obtained by one simple assembly process and 
validated backwards to define the importance of reads and the data which we obtain 
from the contigs. Quality control (QC) tools were developed previously on the basis of 
four main strategies that are: high quality filtering, adaptor filtering, N’s removal and 
trimming. The arrangement of these strategies while processing raw reads under quality 
control could have an effect on the resulting output read data. A several number of QC 
tools have been made since the start of Next-generation sequencing which had made its 
entry in 2005 (Cox, Peterson, & Biggs, 2010; Dai et al., 2010; Dodt, Roehr, Ahmed, & 
Dieterich, 2012; Lassmann, Hayashizaki, & Daub, 2009; Patel & Jain, 2012; Schmieder 
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& Edwards, 2011; Yang et al., 2013). Usage of the pre-existing tools with application to 
the above defined strategy is the aim of our study. The validation results obtained for 
the selected five bacterial genome data while processing for GC content, RNA 
information, QC and assembly hybrid data could serve as a reference to have one 
common protocol to deal with bacterial genomes. Hence, the problems faced can 
therefore be prevented by the first step of bioinformatics in Next-generation sequencing 
analysis that is the Quality control.    
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3.2 Review of the literature 
With the generation of high amounts of next-generation sequencing data the need to 
develop reliable tools for every step of analysing data has been very important. Apart 
from each tool for analysis, there has been much difference in handling data generated 
from several different sequencing platforms (Kircher & Kelso, 2010). The value of 
sequencing a new bacterial genome has been increasing as a rapid rise in the number of 
sequencing datasets of genomes could affect the loss of important biological 
information (Barbosa et al., 2014). There have been various studies on how to comply 
with the usage of the best possible information from the sequencing reads. These were 
studied in detail as applications of next generation sequencing to bacterial genetics 
(Hall, 2007; MacLean, Jones, & Studholme, 2009; Mardis, 2008; Morozova & Marra, 
2008; Shendure & Ji, 2008). A guide to selecting appropriate read lengths across 
prokaryotic genomes as an algorithm has also been reported (Cahill, Koser, Ross, & 
Archer, 2010). A fixed assembly strategy regardless of the emergence of the sequencing 
reads has been reported recently which involved the stages of pre-filtering processes 
(El-Metwally, Hamza, Zakaria, & Helmy, 2013). Quality control for non-model 
organisms such as those without a defined reference so as to carry ahead for assembly 
process have also been built (Trivedi et al., 2014). Several quality control tools have 
been developed which are directed towards high quality read filtering, trimming of 
sequencing read data, adaptor removal, in short cleaning up of artefacts. These tools 
were developed based on both depending on graphic user interface as well as command-
line usage. SeqQC (http://genotypic.co.in/SeqQC.html) has been available for both 
windows and Linux operating systems to process high quality filtering, inbuilt adaptor 
filtering as well as trimming. Tools such as FASTX (Taylor, Schenck, Blankenberg, & 
Nekrutenko, 2007), NGStoolkit (Patel & Jain, 2012) , PRINSEQ (Schmieder & 
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Edwards, 2011), SolexaQA (Cox et al., 2010) are highly used in recent times for quality 
control.  
Out of all the strategies mentioned above a study has shown that across different 
types of NGS data, trimming quality with a cut off of thirty could help increase the 
quality and reliability of the analysis (Del Fabbro, Scalabrin, Morgante, & Giorgi, 
2013). Few tools were made to specifically target the sequencing data of Illumina read 
information (Bolger, Lohse, & Usadel, 2014; Yang et al., 2013). Few others show 
quality control pipelines constituting simulated data and real time metagenomics 
datasets which reported lesser processing time as well as the identification of 
contamination identification ability (Zhou, Su, & Ning, 2014). NGSQC has been one 
cross-platform analysis pipeline which has utilized read data regardless of the assay 
technologies which shows that it can help researchers to understand the quality issues 
with sequencing (Dai et al., 2010). A study based on three stage quality control strategy 
was also reported considering the raw data, alignment and variant calling which 
explains the importance of control strategies at three different levels of DNA 
sequencing analysis (Guo, Ye, Sheng, Clark, & Samuels, 2014).  
The primary aim of this objective is to identify the best strategy among the 
quality control steps and create a pipeline with the order of these strategies so as to 
utilize maximum percentage of reads. With the increase in the number of tools for 
quality control and data generation from next generation sequencers, it could be 
important to utilize the pre-existing tools. Utilizing these routinely used tools to 
facilitate access to reliable data generation could be currently very significant in the 
next-generation sequencing market. 
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3.3 Materials and Methods  
3.3.1 Next – generation sequencing raw reads of bacterial genomes 
Five different bacterial genome next – generation sequencing data were selected for our 
studies (Avasthi, Kumar, et al., 2011; Devi et al., 2010; Majid et al., 2014; Siddavattam 
et al., 2011; Tiruvayipati et al., 2013). The genomes selected were namely Helicobacter 
pylori 908 (HP), Escherichia coli NA114 (EC), Mycobacterium tuberculosis NA1 
(MTB), Vibrio parahaemolyticus PCV08-7 (VP) and Paracoccus denitrificans SD (PD) 
corresponding to sequencing data as mentioned in Table 3.3.1. Among which HP, EC, 
VP and PD correspond to Illumina sequencing data, while MTB correspond to ion 
torrent data, respectively. These bacterial genomes were selected based on their 
differences entailing high GC content, de-novo assembly, high AT content, presence of 
two chromosomes and ion torrent data. 
Table 3.3.1: Next-generation sequencing data of selected bacterial genomes 
 
3.3.2 Quality control 
The next – generation quality control tools in our study were SeqQC, FASTX, 
NGStoolkit, PRINSEQ, SolexaQA, Flexbar_v2.33 (Dodt et al., 2012) and Tagdust 
(Lassmann et al., 2009). Among these the SeqQC tool has been used to plot the phred 
quality scores of the raw read data and Solexa QA to generate heatmap to identify the 
quality level per base.  
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The tools were used based on different quality control categories: High quality 
filtering, Read trimming, N’s removal and Adaptor removal as in Figure 3.3.1 to 
validate sequencing data. The quality control parameters were made in reference to our 
filtering protocols which were published (Baddam, Kumar, et al., 2012; Baddam, 
Thong, et al., 2012; Kumar et al., 2012) 
 
Figure 3.3.1: Strategies of quality control used for QC of bacterial genomes 
3.3.3 High Quality filtering  
SeqQC, FASTX and NGStoolkit were utilized directly on the raw sequencing data of 
the five selected bacterial genomes HP, EC, VP, PD, MTB. The cut-off value for high 
quality filtering of raw sequencing reads was set to greater than equal to 20 (>=20) to 
remove all low quality reads.  
3.3.4 Read Trimming  
As mentioned in the previous studies that trimming with a quality score cutoff of 30 has 
been good in filtering data (Del Fabbro et al., 2013), we have used three different tools 
that are FASTX trim, PRINSEQ trim and SolexaQA trim for checking the effects of 
trimming utilizing a common quality trimming cutoff of 30. Obtained from the quality 
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graph of SeqQC we have input values for phred score cutoff of greater than equal to 30 
for all the bacterial sequencing reads as shown in Table 3.3.2. 
Table 3.3.2: Trimming values of reads based on phred quality scores of bacterial 
genomes 
 
 
3.3.5 Adaptor File 
The adaptor file had been made with a combination of two files which were taken from 
the Flexbar_v2.33 as well as Tagdust quality control tools constituting of the following 
sequences Illumina Single end adapter 1, Illumina Single end adapter 2, Illumina Single 
end PCR primer 1, Illumina Single end PCR primer 2, Illumina Paired end adapter 1, 
Illumina Paired end adapter 2, Illumina Paired end PCR primer 1, Illumina Paired end 
PCR primer 2, Illumina multiplexing adapter 1, Illumina multiplexing adapter 2, 
Illumina multiplexing PCR primer 1.01, Illumina multiplexing PCR primer 2.01, 
Illumina multiplexing read1 primer, Illumina multiplexing index primer, Illumina 
multiplexing read2 primer, Illumina PCR primer index (1 – 12), TruSeq universal 
adapter, TruSeq Adapter Index (1 – 12), Solexa 5’ adapter, Solexa 3’ adapter, PE 
adapters1, PE adapters1_1, PE PCR primers1, PE PCR primers1_1, PE sequencing 
primer, PE sequencing primer 1, Gex adapter 1, Gex adapter 1_2, Gex adapter 2, Gex 
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adapter 2_2, Gex PCR primer 1, Gex PCR primer 2, Gex sequencing primer, adapters1, 
adapters1_1, PCR primers1, PCR primers1_1, Genomic  DNA sequencing primer.  
All mentioned adapter sequences were maintained at a uniform minimum length of 12 
following length maintained in Tagdust adaptor file. The adaptor file is as mentioned in 
Appendix A (a). 
3.3.6 N’s removal  
To remove all the raw sequencing reads containing at least one “N” instead of bases A, 
T, G, C, FASTX clipper has been used.  
3.3.7 Adaptor removal  
Adaptor filtering has been done with two different methods combining High quality and 
adaptor filtering as well as only adaptor filtering using the tools FASTX and SeqQC. 
3.3.8 Assembly  
The results of the quality control tools were validated using one step assembly that is by 
Velvet version 1.0.12a (Zerbino & Birney, 2008) assembly tool. Apart from this the 
bacterial genomes were compared of their contig information with two assembly tools: 
one based on the principle of overlapping reads of assembly “Edena” (Hernandez, 
Francois, Farinelli, Osteras, & Schrenzel, 2008) and the second based on the de-bruijn 
method “Velvet” version 1.0.12a. 
3.3.9 Alignment  
The contigs generated by Edena were re-aligned according to the contig arrangement of 
contigs generated by Velvet for individual bacterial genomes using Mauve (Darling, 
Mau, & Perna, 2010) alignment tool. The alignments of Edena re-arranged contigs with 
Velvet contigs were plotted using M-GCAT (Treangen & Messeguer, 2006) multiple 
genome alignment tool. 
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3.3.10 rRNA and GC content 
 rRNA copies in the contigs were determined using RNAmmer 1.2 Server (Lagesen et 
al., 2007). GC content has been determined using the Artemis tool (Rutherford et al., 
2000). 
3.3.11 Customized pipelines 
Based on the usage of quality control strategies as mentioned above, 7 pipelines of 
difference in order of usage of the tools were formed to process the bacterial data for 
any difference in total percent of raw reads used. The last step of all these pipelines was 
assembly by the Velvet tool. The Pipeline 1 begins with N’s removal with FASTX with 
adaptor removal by FLEXBAR followed by SeqQC to generate quality control graph, 
trimming by PRINSEQ and lastly High quality filtering by SeqQC and assembly by 
Velvet. (Figure 3.3.2) 
 
Figure 3.3.2: Flowchart showing the process of Pipeline 1 
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The Pipeline 2 follows trimming by PRINSEQ firstly then followed by adaptor removal 
by FLEXBAR by generating quality control graph through SeqQC with assembly by 
Velvet (Figure 3.3.3). 
 
Figure 3.3.3: Flowchart showing the process of Pipeline 2 
Pipeline 3 consists of trimming with PRINSEQ followed by adaptor removal by 
FLEXBAR and high quality filtering by SeqQC and finally assembly by Velvet (Figure 
3.3.4). 
 
Figure 3.3.4: Flowchart showing the process of Pipeline 3 
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Pipeline 4 involves adaptor removal by FLEXBAR followed by quality control graph 
generation with trimming by PRINSEQ and high quality filtering by SeqQC followed 
with assembly by Velvet (Figure 3.3.5). 
 
Figure 3.3.5: Flowchart showing the process of Pipeline 4 
Pipeline 5 is ordered to filter adaptors by FLEXBAR followed by high quality filtering 
using SeqQC and trimming by PRINSEQ with assembly by Velvet (Figure 3.3.6). 
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Figure 3.3.6: Flowchart showing the process of Pipeline 5 
Adaptor removal with FASTX followed by high quality filtering SeqQC and assembly 
by Velvet has been the Pipeline 6 strategy as used for checking the best pipeline to use 
(Figure 3.3.7). 
 
Figure 3.3.7: Flowchart showing the process of Pipeline 6 
The 7th pipeline named as the Trimming-Adaptor-High quality (TAH) pipeline made 
was with trimming by NGStoolkit followed by adaptor removal using FLEXBAR with 
FASTX for high quality filtering and assembly by Velvet (Figure 3.3.8). 
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Figure 3.3.8: Flowchart showing the process of Pipeline 7 (TAH pipeline) 
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3.4 Results and Discussion 
3.4.1 Next-generation sequencing & finishing bacterial genomes 
The first step of processing raw read sequencing information has been the QC to avoid 
possible contamination by sequencing primers and adaptors. To evaluate the probable 
erroneous information which any bacterial raw read data could provide us with, we have 
performed a set of experiments. Five bacterial genomes HP908, ECNA114, PDSD1, 
MTBNA-A0008 and VPPV08-7 were selected which differ in their physiology and 
occurrence in the environment for this study. The analysis include checking raw reads 
of their phred quality scores and running heat plots to check the probable error rate per 
average base of any read length. The quality control graphs generated by SeqQC 
(Figures 3.4.1, 3.4.2, 3.4.3, 3.4.4 and 3.4.5) show how different any sequencing data 
could be which needs a standard protocol to be dealt with as a single moiety which in 
the present study as a “bacterial dataset”.  
 
Figure 3.4.1: SeqQC quality graph representing average phred quality score per base 
position (A) Read 1 of H. pylori 908 (B) Read 2 of H. pylori 908 
The above plot shows that the average phred quality score for total number of reads 
generated per base position in the H. pylori 908 genome sequencing in Read 1 
(Run22_so_518_s_1_1_sequence.txt) is greater than 35.5 and in Read 2 
(Run22_so_518_s_1_2_sequence.txt) is greater than 35. 
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Figure 3.4.2: SeqQC quality graph representing average phred quality score per base 
position (A) Read 1 of E. coli NA114 (B) Read 2 of E. coli NA114 
The above plot shows that the average phred quality score for total number of reads 
generated per base position in the E. coli NA114 genome sequencing in Read 1 
(Run22_so_519_s_1_1_sequence.txt) is greater than 34 and in Read 2 
(Run22_so_519_s_1_2_sequence.txt) is greater than 33. 
 
 
Figure 3.4.3: SeqQC quality graph representing average phred quality score per base 
position (A) Read 1 of P. denitrificans SD1 (B) Read 2 of P. denitrificans SD1 
The above plot shows that the average phred quality score for total number of reads 
generated per base position in the P. denitrificans SD1 genome sequencing in Read 1 
(Run33_SO_736_s_7_1_sequence.txt) is greater than 25 and in Read 2 
(Run33_SO_736_s_7_2_sequence.txt) is greater than 20. 
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Figure 3.4.4: SeqQC quality graph representing average phred quality score per base 
position (A) Read 1 of M. tuberculosis NA-A0008 (B) Read 2 of M. tuberculosis NA-
A0008 
The above plot shows that the average phred quality score for total number of reads 
generated per base position in the M. tuberculosis NA-A0008 genome sequencing in 
Read 1 (Run13_SO_1222_MTBNA1_s_7_1_sequence.txt) is greater than 20 and in 
Read 2 (Run13_SO_1222_MTBNA1_s_7_2_sequence.txt) is greater than 20. 
 
 
Figure 3.4.5: SeqQC quality graph representing average phred quality score per base 
position (A) Read 1 of V. parahaemolyticus PCV08-7 (B) Read 2 of V. 
parahaemolyticus PCV08-7 
The above plot shows that the average phred quality score for total number of reads 
generated per base position in the V. parahaemolyticus PCV08-7 genome sequencing in 
Read 1 (Run21_SO_1222_HPVB8_s_8_1_sequence.txt) is greater than 25 and in Read 
2 (Run21_SO_1222_HPVB8_s_8_2_sequence.txt) is greater than 25. 
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The heat plots generated by SolexaQA shows the average quality of a base of various 
read lengths (Figures 3.4.6, 3.4.7, 3.4.8, 3.4.9 and 3.4.10) in terms of 120 tiles in a 
flowcell.  
 
Figure 3.4.6: SolexaQA heatplots showing average per base quality of HP908 
(wherein, white represents an error rate of 0 ranging through yellow and orange to pure 
black representing an error rate of 0.75) (A) Read 1 (B) Read 2 
 
The above heat plot represents the average per base quality of HP908 sequencing reads 
of both Read 1 (Run22_so_518_s_1_1_sequence.txt) and Read 2 
(Run22_so_518_s_1_2_sequence.txt) in terms of color coded error rates. The heat maps 
show a wide range of difference in the distribution of quality scores through the 120 
tiles of a flow cell within the reads. 
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Figure 3.4.7: SolexaQA heatplots showing average per base quality of ECNA114 
(wherein, white represents an error rate of 0 ranging through yellow and orange to pure 
black representing an error rate of 0.75) (A) Read 1 (B) Read 2 
 
The above heat plot represents the average per base quality of ECNA114 sequencing 
reads of both Read 1 (Run22_so_519_s_1_1_sequence.txt) and Read 2 
(Run22_so_519_s_1_2_sequence.txt) in terms of color coded error rates. The heat maps 
show a wide range of difference in the distribution of quality scores through the 120 
tiles of a flow cell within the reads. 
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Figure 3.4.8: SolexaQA heatplots showing average per base quality of PDSD1 
(wherein, white represents an error rate of 0 ranging through yellow and orange to pure 
black representing an error rate of 0.75) (A) Read 1 (B) Read 2 
 
The above heat plot represents the average per base quality of PDSD1 sequencing reads 
of both Read 1 (Run33_SO_736_s_7_1_sequence.txt) and Read 2 
(Run33_SO_736_s_7_2_sequence.txt) in terms of color coded error rates. The heat 
maps show a wide range of difference in the distribution of quality scores through the 
120 tiles of a flow cell within the reads. 
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Figure 3.4.9: SolexaQA heatplots showing average per base quality of MTBNA-A0008 
(wherein, white represents an error rate of 0 ranging through yellow and orange to pure 
black representing an error rate of 0.75) (A) Read 1 (B) Read 2 
 
The above heat plot represents the average per base quality of MTBNA-A0008 
sequencing reads of both Read 1 (Run13_SO_1222_MTBNA1_s_7_1_sequence.txt) 
and Read 2 (Run13_SO_1222_MTBNA1_s_7_2_sequence.txt) in terms of color coded 
error rates. The heat maps show a wide range of difference in the distribution of quality 
scores through the 120 tiles of a flow cell within the reads. 
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Fig 3.4.10: SolexaQA heatplots showing average per base quality of VPPCV08-7 
(wherein, white represents an error rate of 0 ranging through yellow and orange to pure 
black representing an error rate of 0.75) (A) Read 1 (B) Read 2 
 
The above heat plot represents the average per base quality of VPPCV08-7 sequencing 
reads of both Read 1 (Run21_SO_1222_HPVB8_s_8_1_sequence.txt) and Read 2 
(Run21_SO_1222_HPVB8_s_8_2_sequence.txt) in terms of color coded error rates. 
The heat maps show a wide range of difference in the distribution of quality scores 
through the 120 tiles of a flow cell within the reads. 
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The plots represent a range of different read lengths of bacterial genomes consisting of 
randomly different qualities ranging from white, explaining the occurrence of an error 
to be zero to black, being the highest error prone base. This when checked along all the 
selected genomes show how the plots differ completely having a zero error to possibly 
highly error prone bases in sequencing data. This could give us an insight on how these 
slightly error prone bases could also incorporate change in the actual genome assembly 
of a bacteria with newer gene information altogether.  
In continuation we have concentrated on the primary information which a 
bacterial genome can give the user. That is in terms of uniqueness of the 16S rRNA 
genes which are well known to be conserved hence, the rRNA genes (5S, 16S, and 23S) 
were selected. Along with this two different strategies of assemblies were employed: 
one being the de-brujin method (Velvet) and the overlapping method (Edena) to obtain 
contigs. The contigs generated were checked for alignments among data of these two 
assemblers a method that we would like to name “Self-assembly alignment” which 
differs from previous studies which were performed among different next – generation 
sequencing platform data to obtain a hybrid assembly (Koren et al., 2012; Utturkar et 
al., 2014). We have used the Velvet and Edena contig information to scan the number of 
rRNA in the individual genomes (Figures 3.4.11, 3.4.12, 3.4.13, 3.4.14 and 3.4.15) 
which had shown different number of copies in each bacteria.  
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Figure 3.4.11: RNAmmer 1.2 Server results for rRNA genes of HP908 in (A) Contig 
assembly by Velvet (B) Contig assembly by Edena 
 
RNA prediction results for HP908 from RNAmmer prediction server showing the 
detection of one copy of 5S rRNA, 23S rRNA, 16S rRNA each respectively in Velvet 
assembled contigs and one copy of 5S rRNA, 23S rRNA, 16S rRNA each respectively 
in Edena assembled contigs. 
 
 
 
Figure 3.4.12: RNAmmer 1.2 Server results for rRNA genes of ECNA114 in (A) 
Contig assembly by Velvet (B) Contig assembly by Edena 
 
RNA prediction results for ECNA114 from RNAmmer prediction server showing the 
detection of two copies of 5S rRNA, one copy of 23S rRNA and 16S rRNA respectively 
in Velvet assembled contigs and one copy of 23S rRNA in Edena assembled contigs. 
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Figure 3.4.13: RNAmmer 1.2 Server results for rRNA genes of PDSD1 in (A) Contig 
assembly by Velvet (B) Contig assembly by Edena 
 
RNA prediction results for PDSD1 from RNAmmer prediction server showing the 
detection of one copy of 5S rRNA, 23S rRNA, 16S rRNA each respectively in Velvet 
assembled contigs and one copy of 5S rRNA, 23S rRNA, 16S rRNA each respectively 
in Edena assembled contigs. 
 
 
Figure 3.4.14: RNAmmer 1.2 Server results for rRNA genes of MTBNA-A0008 in (A) 
Contig assembly by Velvet (B) Contig assembly by Edena 
 
RNA prediction results for MTBNA-A0008 from RNAmmer prediction server showing 
the detection of one copy of 5S rRNA and 16S rRNA respectively in Velvet assembled 
contigs and one copy of 5S rRNA, 23S rRNA, 16S rRNA each respectively in Edena 
assembled contigs. 
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Figure 3.4.15: RNAmmer 1.2 Server results for rRNA genes of VPPCV08-7 in (A) 
Contig assembly by Velvet (B) Contig assembly by Edena 
 
RNA prediction results for VPPCV08-7 from RNAmmer prediction server showing the 
detection of one copy of 5S rRNA, 23S rRNA, 16S rRNA respectively in Velvet 
assembled contigs and one copy of 5S rRNA in Edena assembled contigs. 
 
While the Velvet contigs showed 3, 4, 3, 2, 3 number of rRNA genes in HP908, 
ECNA114, PDSD1, MTBNA-A0008 and VPPCV08-7 respectively (Figures 3.4.11A, 
3.4.12A, 3.4.13A, 3.4.14A and 3.4.15A). The Edena contig information showed 3, 1, 3, 
3, 1 rRNA genes in HP908, ECNA114, PDSD1, MTBNA-A0008 and VPPCV08-7 
(Figures 3.4.11B, 3.4.12B, 3.4.13B, 3.4.14B and 3.4.15B). The GC content of these 
genomes were as follows HP908 – 39.39 %, ECNA114 – 51.15%, PDSD1 – 65.24%, 
MTBNA-A0008 – 64.13% and VPPCV08-7 – 45.3% respectively. While some studies 
report the high GC bias in sequencing could probably effect the read information 
lacking the lower GC regions, some explained that the GC bias and assembly obtained 
could depend on the organism (Y. C. Chen, Liu, Yu, Chiang, & Hwang, 2013). The 
above information shows that not only the genomes PDSD1 and MTBNA-A0008 with 
higher GC content have been detected of their 5S, 16S and 23S when compared among 
the dual assembly contigs but, the genomes HP908, ECNA114 and VPPCV08-7 have 
shown the copies of the rRNA genes too. This shows not only that a combination of 
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these two assemblers could solve the problem of detection of rRNA genes but, these 
genes could be of utmost importance in obtaining genome information. It can be 
explained as that when the contigs from both the assemblies were aligned (Figures 
3.4.16, 3.4.17, 3.4.18, 3.4.19 and 3.4.20) by M-GCAT, there was a proper alignment of 
genome information in both assembled contigs.  
 
 
Figure 3.4.16: M-GCAT alignment showing similarity between Velvet and Edena 
assembled contigs of HP908 
 
Alignment of HP908 Velvet and Edena assembled contigs show high similarity among 
both de-bruijn generated and overlap based assemblies with Velvet contigs amounting 
to a total of 1543 kb and Edena contigs to a total of 1564 kb, respectively. 
 
 
 
Figure 3.4.17: M-GCAT alignment showing similarity between Velvet and Edena 
assembled contigs of ECNA114 
 
Alignment of ECNA114 Velvet and Edena assembled contigs show high similarity 
among both de-bruijn generated and overlap based assemblies with Velvet contigs 
amounting to a total of 4907 kb and Edena contigs to a total of 4340 kb, respectively. 
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Figure 3.4.18: M-GCAT alignment showing similarity between Velvet and Edena 
assembled contigs of PDSD1 
 
Alignment of PDSD1 Velvet and Edena assembled contigs show high similarity among 
both de-bruijn generated and overlap based assemblies with Velvet contigs amounting 
to a total of 2949 kb and Edena contigs to a total of 2808 kb, respectively. 
 
 
 
Figure 3.4.19: M-GCAT alignment showing similarity between Velvet and Edena 
assembled contigs of MTBNA-A0008 
 
Alignment of MTBNA-A0008 Velvet and Edena assembled contigs show high 
similarity among both de-bruijn generated and overlap based assemblies with Velvet 
contigs amounting to a total of 3360 kb and Edena contigs to a total of 3442 kb, 
respectively. 
 
 
 
Figure 3.4.20: M-GCAT alignment showing similarity between Velvet and Edena 
assembled contigs of VPPCV08-7 
 
Alignment of VPPCV08-7 Velvet and Edena assembled contigs show high similarity 
among both de-bruijn generated and overlap based assemblies with Velvet contigs 
amounting to a total of 5173 kb and Edena contigs to a total of 5067 kb, respectively. 
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The interesting factor could be that utilizing the rRNA gene information we 
could further perform Inverse polymerase chain reaction (Inverse PCR) for each rRNA 
gene as in 5S, 16S and 23S rRNA. As these exist in multiple copies throughout the 
bacterial genome it could help us obtain the sequence information of probable flanking 
regions and check the overlapping sequences among the contigs to incorporate the 
correct sequence among the assembly.   
 
3.4.2 Quality control protocol 
Trimming has been one of the best method used on NGS data at phred score 30 as 
reported in an earlier study (Del Fabbro et al., 2013). We have used a range of QC tools 
to check which strategy could give the best possible data in terms of maximum 
percentage of usage of raw read data. This had not been reported yet in recent years. 
The data we generated from all five different bacteria datasets with the QC tools (Figure 
3.4.21) show that trimming was one QC strategy which retains 100% of raw reads and 
could be maintained as the first step of QC.  
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Figure 3.4.21: Graphs representing effect of QC strategies on percentage of reads 
produced in (A) PDSD1, (B) VPPCV08-7 and (C) MTBNA-A0008 data (with phred 
quality < 30) 
 
The above graph explains the effect of trimming as the first QC process which has no 
drastic change in retaining the total number of reads for further QC processing. This can 
be observed as percentage of reads retained by usage of FASTX_trim, PRINSEQ_trim, 
Solexa_trim as 92.5%, 100%, 100%, respectively in PDSD1, 100%, 100%, 100%, 
respectively in VPPCV08-7 and 100%, 100%, 100%, respectively in MTBNA-A0008. 
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The genomes PDSD1, MTBNA-A0008 and VPPCV08-7 have lower phred scores 
(Figures 3.4.3, 3.4.4 and 3.4.5) for which trimming had to be run (Figure 3.4.21) while, 
HP908 and ECNA114 have phred scores greater than 30 for which no trimming has 
been represented on the graph (Figure 3.4.22) as by default it showed the usage of 
100% of raw reads.  
 
Figure 3.4.22: Graphs representing effect of QC strategies on percentage of reads 
produced with (A) HP908, (B) ECNA114 data (with phred score > 30) 
 
The above graph explains the effect of using raw read sequencing data with high phred 
quality scores which do not require trimming in retaining the total number of reads for 
further QC processing. This can be observed as percentage of reads retained by usage of 
raw reads as 100% in HP908 and 100% in ECNA114. 
The best QC strategy among the four (Figure 3.3.1) High quality, Trimming, Adaptor 
filtering and N’s removal seems to be trimming as it shows a good MAX length of 
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contig, good percentage of reads used as well as fewer contigs as possible (which makes 
it easier to handle genome information) (Figures 3.4.23, 3.4.24, 3.4.25, 3.4.26 and 
3.4.27) (Appendix A (b)).  
 
 
Figure 3.4.23: Result of QC strategies on (A) MAX contig length, (B) Total number of 
contigs and (C) Percentage of reads used in HP908 raw read data 
 
In HP908 by QC processing utilizing various QC tools it has been observed that due to 
high phred quality scores of HP908 raw reads the process of assembly directly from the 
raw reads, “Normal” shows comparatively good MAX contig length, lower number of 
contigs and good percentage of reads which is considered precise in assembly of 
bacterial genomes. 
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Figure 3.4.24: Result of QC strategies on (A) MAX contig length, (B) Total number of 
contigs and (C) Percentage of reads used in ECNA114 raw read data 
 
In ECNA114 by QC processing utilizing various QC tools it has been observed that due 
to high phred quality scores of ECNA114 raw reads the process of assembly directly 
from the raw reads, “Normal” shows comparatively good MAX contig length, lower 
number of contigs and good percentage of reads which is considered precise in 
assembly of bacterial genomes. 
 
 
 
51 
 
 
 
 
 
Figure 3.4.25: Result of QC strategies on (A) MAX contig length, (B) Total number of 
contigs and (C) Percentage of reads used in PDSD1 raw read data 
 
In PDSD1 by QC processing utilizing various QC tools it has been observed that the 
process of assembly from “Trimming” shows comparatively good MAX contig length, 
lower number of contigs and good percentage of reads which is considered precise in 
assembly of bacterial genomes. 
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Figure 3.4.26: Result of QC strategies on (A) MAX contig length, (B) Total number of 
contigs and (C) Percentage of reads used in MTBNA-A0008 raw read data 
 
In MTBNA-A0008 by QC processing utilizing various QC tools it has been observed 
that the process of assembly from “Trimming” shows comparatively good MAX contig 
length, lower number of contigs and good percentage of reads which is considered 
precise is considered good in assembly of bacterial genomes. 
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Figure 3.4.27: Result of QC strategies on (A) MAX contig length, (B) Total number of 
contigs and (C) Percentage of reads used in VPPCV08-7 raw read data 
 
In VPPCV08-7 by QC processing utilizing various QC tools it has been observed that 
the process of assembly from “Trimming” shows comparatively good MAX contig 
length, lower number of contigs and good percentage of reads which is considered 
precise in assembly of bacterial genomes. 
 
A number of pipelines were reported previously which dealt with NGS 
information in order to QC as well as assemble (Dai et al., 2010; Tritt, Eisen, Facciotti, 
& Darling, 2012). Here we have dealt a newer approach to QC of NGS data that is, we 
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have constructed seven different pipelines with difference in order of strategies to select 
the one which utilizes the best percentage of read data in all bacterial genomes in 
common. We have observed and named one TAH pipeline [Trimming by NGStoolkit, 
Adaptor filtering (with FLEXBAR and customized adap.txt file (Appendix A (a)) and 
High quality filtering by FASTX] which has shown to utilize the best percentage of 
reads among all bacterial genomes (Figure 3.4.28).  
 
Figure 3.4.28: Comparison of the percentage of reads used by the customized pipelines 
in PDSD1, MTBNA-A0008, VPPCV08-7, HP908 and ECNA114 (P1-P6, TAH 
pipeline) 
 
The graphs represent the output of the 7 pipelines in the PDSD1, MTBNA-A0008, 
VPPCV08-7, HP908 and ECNA114 bacterial genomes in terms of usage of total 
percentage of reads. The yellow highlighted bar represents the Trim – Adaptor – High 
Quality pipeline (TAH) based on the usage of reads which has a uniformly occurring 
higher value among the 6 pipelines in all the graphs from A to E corresponding to 
PDSD1, MTBNA-A0008, VPPCV08-7, HP908 and ECNA114 respectively. 
 
Meanwhile, the HP908 and ECNA114 were omitted from trimming as they already had 
higher phred quality score that was above 30. Figure 3.4.29 shows the patterns of output 
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data for are MAX length of contig, total number of contigs and percentage of reads used 
for all the bacterial genomes where the TAH pipeline shows comparatively good 
statistics of data output. 
 
 
Figure 3.4.29: Graphical representation of patterns of output data (total number of 
contigs, percentage of reads used and MAX length of contig) across pipelines (1, 2, 3, 4, 
5, 6, 7 (TAH)) corresponding to PDSD1, MTBNAA-0008, HP908, ECNA114 and 
VPPCV08-7 raw read data, respectively 
 
The patterns represented under (A) Total number of contigs show a comparison of the 
effect of the TAH pipeline “P7” exhibiting uniformly less number of contigs being 
produced after the assembly. (B) Percentage of reads used shows a comparison of effect 
of TAH pipeline to the other pipelines exhibiting uniformly good usage of reads (C) 
MAX length of contig shows significantly good max length of contig among all the 
genomes with the application of TAH pipeline. 
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3.5 Conclusion 
For each and every base produced through NGS the quality factor is of great 
significance as any error in any base could alter the genome information completely. 
While concentrating on the bacterial genome as a whole, considering each and every 
gene would create a huge amount of data for analysis and completion of a bacterial 
genome. Targeting in particular the basic machinery such as the rRNA genes by 
performing Inverse PCR could help fix the completion of a bacterial genome. This 
could be furthered to tRNA too as there would be multiple copies. Hence, the presence 
of multiple copies of these RNA genes could help simplify the experimental time and 
could help set up Inverse PCR more efficiently.  
Trimming appears to be best as the first step of QC as it does not allow us to 
lose any information in terms of raw reads. An adaptor file modified according to the 
necessity of the NGS platforms could help resolve at least few problems concerned with 
primer and adaptor filtering. The TAH pipeline has been the best compared to all the 
pipelines and in common at the level of working as a QC step among all the bacterial 
data.  
Our work could help researchers understand that NGS raw read data need to be 
dealt carefully with their quality scores which probably could be one of the reasons 
behind altered genome information and could even further lead to erroneous outputs. 
Such data could cause problems at the level of assembling a drug resistant, virulent or a 
highly pathogenic bacteria as per the case in the current study. To finish a bacterial 
genome, studies showed PCR filling between contigs (Chibana et al., 2005), but the 
most basic genes of importance that are rRNA could possibly be targeted for finishing a 
bacterial genome followed by the tRNA genes too. 
While trimming reads has been applied in most NGS reads to obtain best data 
for further genome analysis. Our study shows that trimming could be applied as the first 
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step of QC followed by adaptor filtering and high quality filtering. The TAH pipeline 
has been formed using the pre-existing tools which make it even more unique as using 
the best quality of a tool could provide us with accurate data. 
These details could help researchers not only to understand the importance of 
dealing with NGS data but, the problems which could be encountered with even one 
base change due to a low quality base. The actual genome in the bacterial cell can never 
be viewed microscopically hence, caution in dealing NGS data is indeed very important 
with drastic rise in data generation each hour. 
 
Achievement 
The four quality control strategies selected as follows: N’s removal, high quality 
filtering, adaptor filtering and trimming were successfully applied on the selected 
bacterial genome raw read data. The various QC tools were employed and a standard 
quality control TAH pipeline was successfully established from the data generated. 
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CHAPTER 4 
 
GENOME ANATOMY OF THE GASTROINTESTINAL PATHOGEN, VIBRIO 
PARAHAEMOLYTICUS OF CRUSTACEAN ORIGIN 
4.1 Introduction 
The assembly of draft genomes of bacteria had been of utmost importance with the 
increase in next-generation sequencing data per hour. While working with draft 
bacterial genomes has been a challenge, dealing with bacteria consisting of two 
chromosomes has been a tedious task to accomplish. Every bacterial genome has its role 
to play in the environment among which Vibrio parahaemolyticus has been known to 
cause infection in aquatic organisms. The need to glean into the statistics of the 
bacterial genome of aquatic origin is of utmost importance due to the increase in 
seafood consumption countries. Previously studied V. parahaemolyticus genomes were 
studied of their virulence factors and their possible pathogenic roles in zoonotic 
infection spreading through undercooked or raw seafood to humans. Annotation for 
only one genome (Vibrio parahaemolyticus RIMD2210633) was available on Genbank 
during the beginning of our study which has been selected as our reference genome for 
our study. There were cases reported of pathogenic as well as non-pathogenic strains 
worldwide in North America, South East Asia, Japan and in some parts of East Asia. 
These genomes consisted of pathogenic islands which differ among serovar and from 
genome to genome. The presence, absence and co-existence of two genes TDH 
(thermostable direct haemolysin) and TRH (TDH - related haemolysin) have also been 
considered to be a reference for the evolution of V. parahaemolyticus. Herein we deal 
with one Vibrio parahaemolyticus PCV08-71 strain isolated from Macrobrachium 
rosenbergii, a freshwater prawn in Malaysia whose whole genome study could give us 
                                                          
1 This chapter was published as (Tiruvayipati et al., 2013) in Gut Pathogens. 
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interesting information about whether this bacteria causes infection or survives within 
the prawn. 
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4.2 Review of the literature 
V. parahaemolyticus inhabits the estuarine, marine and brackish water ecosystems. It is 
an important human pathogen associated with gastroenteritis linked to contaminated 
seafood consumption. Since this species is abundant in marine products, it has become a 
significant concern in the production and trade of seafood worldwide (DePaola et al., 
2003). In Southeast Asian countries, including Malaysia, virulent V. parahaemolyticus 
in raw seafood have been reported (Paydar, Teh, & Thong, 2013; Sujeewa, Norrakiah, 
& Laina, 2009). Numerous cases of V. parahaemolyticus infection were reported in 
North America, South East Asia and Japan including some places in East Asia (Bag et 
al., 1999; "Guidelines for national human immunodeficiency virus case surveillance, 
including monitoring for human immunodeficiency virus infection and acquired 
immunodeficiency syndrome. Centers for Disease Control and Prevention," 1999; H. 
Han et al., 2008; Nair & Hormazabal, 2005; Nair et al., 2007; Nishibuchi & Kaper, 
1995; Okuda et al., 1997) giving the illness a pandemic status affecting thousands of 
people. Thus, the prevalence of pathogenic Vibrios in seafood is of public health 
concern and is an open ended issue. The pathogenic V. parahaemolyticus strains are 
differentiated from non-pathogenic ones by their ability to cause β-hemolysis on 
Wagatsuma agar, an activity known as ‘Kanagawa phenomenon’. This effect is 
mediated by the activity of thermostable direct hemolysin (TDH) encoded by the tdh 
genes (Nishibuchi & Kaper, 1995). A pandemic clone of V. parahaemolyticus can 
broadly be defined as the one that is positive for TDH and exhibits the Kanagawa 
phenomenon (H. Han et al., 2008). V. parahaemolyticus strains are classified based on 
the types and variants of their O antigen and flagellar antigen (K). There are 13 O-
serogroups and 71 K antigens and various combinations of these give rise to a wide 
variety of serovars which have been recognized as the causative agents of the disease. A 
clone of serovar O3:K6 has recently emerged and was associated with outbreaks in 
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India and Japan (Nair et al., 2007). Frequent recombination events that promote clonal 
diversification suggest a scenario whereby a subset of O3:K6 strains might continue to 
evolve (Gonzalez-Escalona et al., 2008). Consequently, different groups of related 
O3:K6 clonal strains have now been globally disseminated in Asia, North and South 
America, Africa and Europe (Nair et al., 2007). The genomes of V. parahaemolyticus 
strains are said to have undergone a number of recombination events that could have 
been the reason for serotype conversion from O3:K6 to O4:K68 (Y. Chen et al., 2011). 
Regions of recombination likely involve a genetic element larger than the gene clusters 
encoding O and K-antigens. More than 20 serovariants which include O3:K6, O4:K68, 
O1:K25, O6:K18 and O1: KUT (Chowdhury et al., 2000; Chowdhury et al., 2004) 
emerged from an original pandemic strain, O3:K6. The pandemic group of these 
bacteria has evolved through a number of deletions, substitutions and acquisitions of 
regions primarily corresponding to TDH or a TDH-related hemolysin (TRH). It is the 
presence of either of these two virulence factors that confer potential to cause 
gastroenteritis in human populations. The pandemic clone is said to have emerged from 
a pre-pandemic clone which was positive for TRH and negative for TDH genes and 
harboured a new sequence of toxR (GS-PCR). The intermediate clone is described as 
being negative for both TRH and TDH, but positive for GS-PCR. It has been observed 
that V. parahaemolyticus contains two chromosomes; V. parahaemolyticus 
RIMD2210633 has 3.2 Mb and 1.8 Mb of genome sizes for chromosome1 and 2 
respectively (Makino et al., 2003). There are several V. parahaemolyticus genomes 
which were sequenced and deposited in Genbank as whole genomes or shotgun 
submissions (WGS) and sequence read archives (SRA). The only fully annotated 
submissions entail V. parahaemolyticus RIMD2210633 and V. parahaemolyticus 
BB220P. The V. parahaemolyticus RIMD2210633 genome harbors a Type III secretion 
system as a central virulence factor which is found in most diarrhea-causing bacteria 
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(Makino et al., 2003). As mentioned above, many studies link to the evolutionary 
aspects of the present pandemic clone formed from a pre- pandemic clone with a drastic 
change in its gene content that is, the evolution from a TDH negative (tdh-)/TRH 
positive (trh+) to a TDH positive (tdh+)/TRH negative (trh-) strain and the occurrence 
of several serovariants in the V. parahaemolyticus species. The present isolate (V. 
parahaemolyticus PCV08-7) has been recovered from seafood (prawn) in 2008 which 
were purchased from a wet market in Selangor, Malaysia. The main purpose of this 
study was to analyse the PCV08-7 genome that originates from Malaysia, a large 
peninsular as well as archipelagic country having a thriving seafood business and that it 
experiences several food borne outbreaks each season. Unfortunately, there are no 
markers based on native genome(s) to guide detection of V. parahaemolyticus in wet 
market, in the aquaculture farms and from human excreta and blood. We hope that this 
genome sequence will be helpful in identifying markers relevant in diagnostic 
development and molecular epidemiology/transmission dynamics of this significant 
bacterium in Malaysia and elsewhere. 
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4.3 Materials and Methods/ Methodology  
4.3.1 Source, isolation and culture of V. parahaemolyticus PCV08-7 
The V. parahaemolyticus PCV08-7 (VPPCV08-7) isolate was identified and 
characterized by obtaining pure cultures on selective media followed by analysis 
through biochemical tests, Analytical Profile Index (API) tests and genetic confirmation 
by polymerase chain reaction (PCR). The bacterial culture was maintained by streak 
plate on Thiosulfate-Citrate- Bile-Sucrose (Difco, France) agar plates. After incubation 
at 37°C for 21 – 24 hr, characteristic bacterial colonies appeared with blue-green 
colored boundaries. An isolated bacterial colony was cultured in Luria-Bertani (LB) 
broth with 2% Sodium Chloride (NaCl) and incubated overnight at 37°C for 16 – 18 hr. 
This bacterial culture was further maintained as glycerol stocks at −80°C in 20% 
glycerol. The genomic DNA was isolated from a pure, single colony. The bacterial 
identity was confirmed by sequence analysis of the 16S rRNA.  
4.3.2 Genomic DNA isolation and Next-Generation Sequencing  
The genomic DNA was isolated using Qiagen DNeasy Blood & Tissue kit (Qiagen, 
Germany) (Appendix B) and the genome sequence was determined by Illumina genome 
analyzer at the Genotypic Technology Pvt. Ltd. Bengaluru, India (GA2x, pipeline 
version 1.6). The sequencing data comprised of 100 bp paired-end reads with an insert 
size corresponding to approximately 240 bp. The genome coverage obtained was 
approximately about 80X with per base quality of reads in the range of 25 – 40. A total 
of 3.8 million reads were generated. Bioinformatic analysis was carried out with the 
help of protocols, algorithms and scripts developed previously (Avasthi & Ahmed, 
2011; Avasthi, Devi, et al., 2011; Avasthi, Kumar, et al., 2011; Baddam, Kumar, et al., 
2012; Baddam, Thong, et al., 2012; Kumar et al., 2012; Tiruvayipati et al., 2013)  
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4.3.3 Assembly and alignment 
Various strategies were applied to resolve the difficulties in dealing with the two 
chromosomes to be assembled from the sequence reads. The following main approaches 
were adopted:  
Velvet (Zerbino & Birney, 2008): Contigs were generated using the sequence reads 
which consisted of information from both the chromosomes of the isolate PCV08-7. 
This was checked by manually comparing contigs against the NCBI database by 
BLAST to check the highest similarity hit. V. parahaemolyticus RIMD2210633 was 
found to be the closest match in each search. The contigs showed unique hits to 
chromosome 1 (CHR1) and chromosome 2 (CHR2) as well as few common hits in both 
the chromosomes. The strategy of using the contigs together representing a whole 
genome (CHR1 and CHR2 together) or using the contigs separately as CHR1 and 
CHR2 was found to be challenging for further analysis to assemble them separately into 
two chromosomal sequences.  
 
OSLAY (Richter, Schuster, & Huson, 2007): All the contigs were compared against both 
the chromosomes of the genome of RIMD2210633 individually and were then used to 
form supercontigs for both the chromosomes separately. This procedure was found to 
be problematic as the supercontig files generated from CHR1 and CHR2 (separately) 
revealed that the preliminary contigs mapped to sequences in both the supercontig files. 
This was perhaps due to the input file comprising assembled whole genome contigs 
used against CHR1 and CHR2. The second strategy under OSLAY was to attach CHR1 
and CHR2 of the reference genome RIMD2210633 as follows: CHR1 and CHR2 were 
concatenated (as a ‘whole genome stretch’) and then further used as one full length 
single sequence. Using this whole genome stretch for BLAST analysis, supercontigs 
were generated using Velvet contigs and the BLAST results. This also eventually 
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proved inefficient since the supercontigs contained some sequences with several “N” 
representing a gap in this case and such supercontigs had to be sorted to their own 
positions on the genome. 
 
SSPACE (Boetzer, Henkel, Jansen, Butler, & Pirovano, 2011): Scaffolding was 
performed on Velvet assembled contigs. As explained above, scaffolds were obtained 
separately from both CHR1 and CHR2 as well as with the whole genome stretch. All 
the scaffolds were then BLAST analysed against both CHR1 and CHR2 of the reference 
genome individually, as well as at the level of the whole genome stretch. The difficulty 
faced with scaffolding was similar to that of OSLAY. Hence, the option of separately 
identifying the scaffolds with respect to CHR1 and CHR2 and dealing with them 
separately remained a problem.  
 
Mauve (Darling et al., 2010): Velvet assembled contigs were used at this step and 
exported as sorted contigs by performing an alignment against the whole genome 
stretch. The results obtained as aligned sorted contigs were taken through a stand-alone 
BLAST protocol against the whole genome of RIMD2210633. Then the BLAST results 
were carefully checked for their positions corresponding to both CHR1 and CHR2. The 
contigs were carefully divided as belonging to CHR1 and CHR2 sequences of PCV08-7 
draft genome. The issues faced here were limited to identifying and dealing with the 
sequences other than those present in the contigs, but which were common to both 
RIMD2210633 and PCV08-7 genomes. While working on the above strategies, BWA 
alignment (Li & Durbin, 2010) was performed using sequence reads against the whole 
genome stretch of VPRIMD2210633. Using SAMTOOLS (Li et al., 2009) a .sam file 
was generated with which the whole genome of RIMD2210633/FASTA sequence was 
loaded on Tablet viewer (Milne et al., 2010) to manually inspect the presence of 
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common genes and to position the draft genome of PCV08-7. The sequencing reads 
obtained by us were primarily passed through a quality control step using FASTX 
toolkit (Taylor et al., 2007) to obtain high quality reads free from adaptor and primer 
contamination which was further standardized to an optimal parameter p value of 70. 
High quality reads thus obtained were assembled de-novo (Milne et al., 2010; Taylor et 
al., 2007) using the Velvet assembly tool which produced 83 contigs with a hash length 
optimized to 71. These contigs were used to run OSLAY to form supercontigs with the 
reference genome RIMD2210633. Alignment of the reads against the reference genome 
was performed using BWA. The preassembled reads were also formed into scaffolds 
using SSPACE. Perl scripts written in house and modified after Baddam et al. (Baddam, 
Kumar, et al., 2012) were used to re-order the contigs, supercontigs and scaffolds into 
their individual files. These approaches were put together to finalize the draft genome of 
V. parahaemolyticus PCV08-7.  
 
The V. parahaemolyticus PCV08-7 whole genome shotgun project was deposited in 
Genbank under the accession AOCL00000000. The version described in this paper is 
the first version, AOCL01000000. This consists of sequences from AOCL01000000 –  
AOCL01000083 (http://www.ncbi.nlm.nih.gov/nuccore/AOCL00000000). 
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4.4 Results and Discussion  
4.4.1 Genome assembly 
The 100 bp paired end reads were assembled using Velvet assembly tool that effectively 
utilized approximately 3.7 million reads. The N50 value observed was 261989 bp. The 
contig with the maximum length was 704232 bp and the total number of bases in the 
genome were 5184164 bp. The genome was artificially closed. The genomes with 
multiple chromosomes pose technical difficulties during assembly. It is a known fact 
that Vibrios – V. cholerae, V. parahaemolyticus and V. vulnificus contain two circular 
chromosomes (Yamaichi, Iida, Park, Yamamoto, & Honda, 1999). The reference 
genome used in this study, V. parahaemolyticus RIMD2210633 also consists of two 
chromosomes (Chowdhury et al., 2000). As studied previously (Chowdhury et al., 
2000), the origin of replication in chromosome 1 with the presence of dnaA gene shows 
its similarity to many genomes of prokaryotic origin and the origin of replication of 
chromosome 2 shows homology with that present on V. cholerae chromosome 2. The 
identification of distinct replication sites is of utmost importance for assembling 
bacterial genomes with two chromosomes which in the case of V. cholerae were studied 
earlier (Egan & Waldor, 2003). Previous studies explain need for a more accurate 
procedure to handle data to correctly assemble two chromosomes and assign gene 
locations. The reads were assembled into a total of 83 contigs which were separated 
based on the assembly strategy as explained in the materials and methods section. 
Dealing with the present data, we observed that many of the genes of significant 
virulence or fitness importance were located on the chromosomes rather than showing 
any significant homology to the Vibrio plasmids. The presence of the Phd-Doc toxin 
antitoxin gene in our genome (Figure 4.4.1) makes it interesting as the antitoxin gene 
has been previously reported related to plasmids (McKinley & Magnuson, 2005) while 
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a recent study (Guerout et al., 2013) described its occurrence on the chromosome of 
Vibrio species.  
 
 
Figure 4.4.1: Circular view of V. parahaemolyticus PCV08-7 draft genome. 
Diagrammatic representation of major genes carried by the two chromosomes of V. 
parahaemolyticus PCV08-7 genome using CGview (Stothard & Wishart, 2005). 
 
However, we agree that the exact source of these genes can be mapped only when the 
plasmids will be sequenced and or analysed separately.  
4.4.2 Genome statistics and annotation  
The draft assembled genome was annotated using the RAST server (Aziz et al., 2008). 
Statistics of the V. parahaemolyticus PCV08-7 draft genome were derived using 
Artemis (Rutherford et al., 2000), RNAmmer (Lagesen et al., 2007) and tRNAscanSE 
(Schattner, Brooks, & Lowe, 2005): the sizes of chromosome 1 and chromosome 2 of 
the isolate were 3471185 bp and 1867355 bp respectively with G + C content of 
45.35%. The number of tRNA and rRNA genes were 102 and 31 for chromosome 1, 
and 13 and 3 for chromosome 2, respectively. The chromosome 1 revealed a coding 
percentage of 85 with an average gene length of 943 bp while the chromosome 2 had a 
coding percentage of 86.2 with an average gene length of 950 bp. The alignment of V. 
parahaemolyticus PCV08-7 genome with that of the V. parahaemolyticus 
RIMD2210633 genome using M-GCAT (Treangen & Messeguer, 2006) showed visible 
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rearrangements in the sequences of the two chromosomes of PCV08-7 isolate (Figure 
4.4.2).  
 
Figure 4.4.2: Alignment of the genome of strain RIMD2210633 against that of isolate 
PCV08-7 and strain O1:K33. (a) Comparison of chromosomes of strain RIMD2210633 
(VPRIMD2210633 chr1, VPRIMD2210633 chr2) with the draft chromosomes of 
PCV08-7 (VPPCV08-7 draft chr1, VPPCV08-7 draft chr2) using M-GCAT. (b) 
Comparison of chromosomes of strain O1:K33 (VPO1:K33 chr1, VPO1:K33 chr2) with 
the draft chromosomes of PCV08-7 (VPPCV08-7 draft chr1, VPPCV08-7 draft chr2) 
using M-GCAT. 
 
The chromosome 1 of the draft genome carried phage shock proteins A, B and C, and 
bacteriophage f237 ORF8. It contained an integrated tmRNA gene with the closest 
element encoding the ribonuclease H. A site-specific recombinase IntI4 and a gene 
encoding beta-lactamase were present. The draft genome also revealed genes 
responsible for fatty acid and amino acid metabolism. An important outer membrane 
protein OmpU was also identified. Genes coding for gyrase B (gyrB), HU-alpha 
insertion and putative sigma factors such as rpoD, rpoE, rpoS, rpoN and rpoH were also 
found in our analysis. The chromosome 2 carried a TDH pathogenicity island with 
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many deletions and substitutions and displayed a malG gene on one of the flanking 
regions of the pathogenicity island. This region also contained genes coding for nutrient 
uptake and metabolism. We documented the presence of vibrioferrin receptor pvuA and 
ferrichrome ABC transport pvuB, pvuC, pvuD and pvuE encoding genes, and the related 
pvsA, pvsB, pvsC, pvsD and pvsE genes. The analysis of the genome further revealed 
presence of a cobalt-zinc-cadmium resistance protein and a Rhodanese related sulfur 
transferase (as also present in RIMD2210633 genome) and a lead-cadmium-zinc-
mercury transporting ATPase enzyme (as seen in the V. parahaemolyticus BB220P 
genome). Phd antitoxin and Doc toxin (McKinley & Magnuson, 2005) which fall under 
the programmed cell death systems were also uniquely identified. Studies in E. coli 
have shown the presence of a stress related protein clpB (caseinolytic peptidase B 
homolog) along with rpoS and a few other genes (Wang & Wood, 2011) which help 
cope with stress conditions and help in survival. Our analysis detected the presence of 
clpB, rpoS and hipA genes in the present genome as was also seen in the reference 
genome of RIMD2210633. There were two types of Type III secretion systems 
observed in V. parahaemolyticus RIMD2210633 (Park et al., 2004); T3SS1 and T3SS2. 
Our genome analysis remains open ended with respect to the presence of such type III 
secretion systems.  
 4.4.3 Identification of novel gene content and comparative analysis 
Our genome analysis revealed some unique sequences which have good similarity to 
hypothetical proteins of other Vibrio species such as Vibrio anguillarum and Vibrio 
cholerae. A 6315 bp nucleotide sequence showed identity to a V. anguillarum 
hypothetical protein and a V. cholerae hypothetical protein on NCBI-BLASTN. One of 
the coding proteins in this stretch revealed similarity to the annotated phage integrase 
encoding gene of Photobacterium damselae subsp. damselae plasmid pAQU1 DNA 
(Figure 4.4.3).  
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Figure 4.4.3: Alignment of a unique PCV08-7 protein sequence similar to 
Photobacterium damselae subsps. damselae. A unique sequence from PCV08-7 
genome showed similarity with putative uncharacterized proteins of V. anguillarum 775 
(F7YI77), V. cholerae MJ-1236 (C3NPG0) and Vibrio sp. RC586 (D0IJW6) and 
similarity to a phage integrase of Photobacterium damselae subsps. damselae 
(H1A9J8). 
 
A parD gene (antitoxin to parE) was also found which showed closer identity to other 
Vibrio species such as Vibrio vulnificus, Vibrio mimicus and Vibrio orientalis. parD 
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when aligned against V. vulnificus and V. mimicus revealed an identity of 76 bp out of 
80 bp (95%) (e-value 2e-48) and with V. orientalis an identity of 72 bp out of 80 bp 
(90%) (e-value 2e-45) on NCBI-BLASTN. A few newer hypothetical proteins with no 
reported annotation were identified. The genome also contained a gene relevant to 
arsenic resistance, possibly important in the adaptation of the bacterium to a high 
arsenic environment. Our analysis of the genome revealed presence of a partially 
similar sequence of TDH Pathogenicity Island, as compared to V. parahaemolyticus 
RIMD2210633. This island revealed genetic instability due to various insertion/ 
deletion and substitution events which were documented. The presence of toxS and toxR 
genes was also observed. 
The old pandemic O3:K6 strain of V. parahaemolyticus is said to have gained 
gene clusters VPaI1-VPaI7 (Hurley, Quirke, Reen, & Boyd, 2006) to develop into a 
new pandemic clone of which VPaI4-VPaI6 are said to be putative virulence factors and 
may be potential pathogenicity islands. These regions are said to carry along with them 
a type VI secretion system (VP1386-1420). Our PCV08-7 genome analysis revealed 
that only one cluster, VPaI2, was detected completely, whereas VPaI3 and VPaI7 were 
partially present (Table 4.1).  
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Table 4.4.1: Table representing pathogenicity related clusters and other VP clusters in 
V. parahaemolyticus PCV08-7: (1) pathogenicity related clusters (VPaI1-VPaI7) in the 
genome of strain RIMD2210633 that signify it to be a pandemic O3:K6 strain and their 
presence or absence in the genome of PCV08-7 isolate, (2) various other VP clusters 
and their occurrence in the genome of PCV08-7. 
 
 
This perhaps shows that our strain could be possibly a new serovariant of a non-
pandemic O3:K6 strain like the V. parahaemolyticus AQ3810 (Nishibuchi & Kaper, 
1995). While variability of different gene clusters (Table 4.4.1) portrays a probably 
novel serovariant of V. parahaemolyticus with the presence of ribonuclease H encoding 
element (previously thought to be present only in V. parahaemolyticus RIMD2210633 
and absent in V. parahaemolyticus AQ3810 (Y. Chen et al., 2011). A further 
comparative study between the V. parahaemolyticus PCV08-7 and the non-pandemic V. 
parahaemolyticus AQ3810 (O3:K6 strain) and the newest V. parahaemolyticus O1:K33 
(trh+/ tdh+ genotype) strain showed that V. parahaemolyticus PCV08-7 has more 
genetic relatedness towards a trh+/ tdh+ strain (Figure 4.4.4).  
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Figure 4.4.4: (a) V. parahaemolyticus AQ3810 alignment against PCV08-7 genome: 
Concatenated chromosome 1 and chromosome 2 of V. parahaemolyticus AQ3810 
(AQ3810.fasta) against V. parahaemolyticus PCV08-7 (PCV08-7.fasta) (b) V. 
parahaemolyticus O1:K33 alignment against PCV08-7. Concatenated chromosome 1 
and chromosome 2 of V. parahaemolyticus O1:K33 (O1_K33.fasta) against V. 
parahaemolyticus PCV08-7 (PCV08-7.fasta). 
 
But, alignments of the V. parahaemolyticus PCV08-7 contig data against the V. 
parahaemolyticus O1:K33 and V. parahaemolyticus RIMD2210633 (Figure 4.4.2) 
strains show that it is closer to O3:K6 serotype (Figure 4.4.5).  
 
Figure 4.4.5: Comparison of whole genome sequences of strains RIMD2210633, 
PCV08-7 and O1:K33. Alignment of complete genomes of V. parahaemolyticus 
RIMD2210633, V. parahaemolyticus PCV08-7 and V. parahaemolyticus O1:K33, 
showing PCV08-7 being more similar to RIMD2210633. 
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From the above data, it becomes probably apparent that the genome of V. 
parahaemolyticus PCV08-7 meaningfully adds to the battery of important genomic 
sequences representing enteropathogenic bacteria. The genome of an arthropod derived, 
foodborne Vibrio should be important to understand adaptation to a crustacean host and 
a human host. 
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4.5 Conclusion 
A first account of the genome of V. parahaemolyticus PCV08-7 has been presented. 
The draft genome and its annotation as described would be able to explain the lifestyle 
of pathogenic Vibrio species. The experience of assembling this genome and the 
difficulties associated with separating the data with respect to two chromosomes would 
certainly be helpful to the community in the follow-up studies. Further, a host of new 
molecular markers as gleaned by our analysis would be relevant in the diagnostic 
development and molecular epidemiology. 
The present genome and the ensuing comparative genomics would be able to 
rekindle our thoughts on the survival and virulence as well as transmission potentials of 
V. parahaemolyticus and also on their adaptation to different hosts and the niches 
thereof. Our results clearly reveal a significantly novel gene content which could 
presumably have been acquired through a horizontal gene transfer mechanism. Our 
analysis revealed the presence of not only the conserved genomic regions among 
different V. parahaemolyticus bacteria, but also dissects some of the unique sets of 
genes that hold relevance to virulence. We propose to finish and polish the genome in 
the near future also with the help of further coverage using alternative sequencing 
platforms and by employing a hybrid assembly approach. Also, it will be possible to 
determine the true extent of the diversity of V. parahaemolyticus strains obtained from 
seafood as compared to those isolated from human cases. Such a diversity analysis 
would focus on 1) genomic coordinates relevant to colonization of and adaptation to 
different hosts in different ecosystems; 2) genome dynamics relative to bacterial fitness 
shaping over time and with transmission across different hosts; and 3) profile of 
genomic rearrangements including additive and reductive genome evolution and their 
significance in the evolution of pathogenic Vibrio species. Presently, the epidemiology 
of V. parahaemolyticus infection in resource-poor countries largely entails a classical 
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serology concocted with guess work as to the type of strain involved and its source. Our 
genomic data would hopefully contribute to this situation also.  
 
Achievement 
The draft genome of VPPCV08-7 was completed using the Illumina sequencing raw 
read data. A customized assembly strategy was employed in our work utilizing 
SSPACE, OSLAY, Velvet together. The draft genome was successfully gleaned of its 
various important genes and compared to other closely related Vibrio parahaemolyticus 
genomes for meaningful comparative data. 
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CHAPTER 5 
 
VIBRIO PARAHAEMOLYTICUS PCV08-7 PHYLOGENETIC 
RELATIONSHIPS WITH CO-EVOLVED STRAINS AND ITS STUDY ON 
SYMBIOSIS WITH HOST AND ENVIRONMENT 
5.1 Introduction 
Draft genome of bacteria helps extract information from sequencing raw reads which 
further guides in annotation and genome analysis. Apart from this, the huge data 
generated can be used in a wide range of studies such as designing experiments for 
completion of a genome and to study the evolution within the species. If the bacteria is 
pathogenic the data could be quite useful in studying the host-pathogen interactions. 
Our study deals with bacteria with two chromosomes. There are numerous studies on 
bacteria containing multiple chromosomes and the presence of plasmids, for the 
integration of assembled data into individual components. The foremost issue with 
multiple chromosomes is the placement of genomic information into individual 
chromosomes in comparison to a reference genome. Herein retaining the uniqueness of 
a bacterial genome could be lost as we use the order of a reference and construct a 
synteny among the genomes. As the order would be more similar to the reference than 
that of the new genome, the data generated as above has chances of affecting further 
analysis. Any evolutionary studies conducted with data following the above aligned 
data could make the genomes lie more closer or distant depending upon the alignment 
and completion. Further, such data can even affect any host-pathogen interaction studies 
as researchers tend to select the data which contains sequences arranged according to 
the reference genome data. V. parahaemolyticus PCV08-7 (VPPCV08-7) as mentioned 
in Chapter 4 was isolated from Macrobrachium rosenbergii (MR), a freshwater aquatic 
organism. The presence of an external environment, in this case freshwater and its 
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constituents as the environment cannot be ruled out from host-pathogen interaction 
studies.  
In our study, as dealt earlier in Chapter 4 we deal with a bacterial genome with 
two chromosomes. Our primary aim in the current chapter is to deal with separation of 
contig information into two chromosomes and a plasmid. To deal with the genome 
information at the contig level as it provides with maximum information related to 
virulence, pathogenicity and survival. Further, we would apply this extracted 
information to choose a few important genes one-by-one while tracing back their 
evolution. These genes would contain the house-keeping gene, 16S rRNA (Janda & 
Abbott, 2007) and the host-pathogen related genes corresponding to interactions with 
the component of the host (M. rosenbergii). The genes related to interactions with the 
host would be selected bioinformatically. This gene will be checked with Real Time 
Polymerase chain reaction studies for their responses in levels of gene expression 
through an in vitro stimulated experiment. The experiment would be setup based on the 
gbpA gene from V. parahaemolyticus PCV08-7 in relation to the host component under 
specific external environment conditions that is in the presence of varied magnesium 
concentrations. This study could give us an insight on how undoubtedly it is more 
advisable to use contig data for completing a bacterial genome with the discussion as 
mentioned in Chapter 3. Apart from this the tracing back of a number of strains of a 
bacteria genome with the house-keeping gene and the 16S rRNA as a reference for 
phylogeny, would help us identify the effects on host-pathogen interaction related 
genes. Real time studies of gene expression could even help us understand possible 
activation mechanism the environment follows to keep the host-pathogen intact. Further 
studies could help in identifying the core responsible factor to control any possible entry 
conditions of pathogen into the host.  
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5.2 Review of the literature  
V. parahaemolyticus PCV08-7 draft genome has been reported in December 2013 
(Tiruvayipati et al., 2013), as a partial Thermostable direct hemolysin pathogenicity 
island carrying V. parahaemolyticus strain. Chromosome 1 and chromosome 2 bear a 
size of 3471185 bp and 1867355 bp respectively in the V. parahaemolyticus PCV08-7 
draft genome with G + C content of 45.35%. The number of tRNA and rRNA genes 
were 102 and 31 in chromosome 1, and 13 and 3 in chromosome 2, respectively. A 
number of annotation tools were developed among which Genemark (Besemer, 
Lomsadze, & Borodovsky, 2001), Glimmer (Delcher, Harmon, Kasif, White, & 
Salzberg, 1999), Easygene (Larsen & Krogh, 2003) are widely used. Rapid Annotation 
using Subsystem Technology (RAST) (Aziz et al., 2008) is an online GUI based server 
which provides with high quality annotations for prokaryotic genomes. It provides the 
user with downloadable annotated formats such as genbank, fasta, embl, etc files for 
further gleaning into the statistics of the bacterial genomes. Open Reading Frames 
(ORFs) both present in the subsystem as well as not present within the subsystem with 
both hypothetical as well non-hypothetical categories are also represented as subsystem 
figures by RAST. Important genes obtained from the annotations with their possible 
roles in interaction with any particular host components can be determined through the 
protein-protein interactions and protein-chemical interactions. STITCH (Kuhn, von 
Mering, Campillos, Jensen, & Bork, 2008) database for protein-chemical interactions 
and STRING (von Mering et al., 2003) database for protein-protein interactions are 
used widely for predicting information among chemicals and protein.  
 The V. parahaemolyticus has undergone a number of evolutionary changes, of 
which few strains have even been labelled as a pandemic clone. Based on different 
pathogenicity islands of the bacteria a haplotyping study has been done to study the 
grouping of the different existing strains of V. parahaemolyticus. The pathogenicity 
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islands mainly considered as being VPA1322-1369, VPaI5, TDH Pathogenicity Island, 
TRH Pathogenicity Island, GS-PCR, toxS and toxR genes. It has been shown how the 
old-pandemic clone has formed a completely new strain through microevolution over 
time. The genome plasticity and the “microevolution” of this bacteria has been 
explained in previous publications as serovariants due to their acquisition or loss of 
gene regions (Figure 5.2.1). 
 
 
Figure 5.2.1: Minimum spanning tree of 174 global strains: each circle indicates a 
haplotype (node), and a larger size of the circle corresponds to a larger number of 
strains included. The number along each edge reflects the phylogenic distance between 
each two neighbouring nodes. In addition, a thicker edge corresponds to a shorter 
phylogenic distance. 165 (98 nodes) of the 174 strains are assigned into five complexes, 
C1 to C5, while the remaining nine strains are assigned into five sub-groups, SG1 to 
SG5 (different SGs distribute in different nodes). The presence or absence of trh, tdh, 
toxRS/new sequence and VpaI-5 in various groups of strain are shown as well (H. Han 
et al., 2008). 
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Studies have shown how a selected number of V. parahaemolyticus strains can acquire 
completely new genes over a period of time and which could be by horizontal gene 
transfer (Y. Chen et al., 2011). Previous reports have compared six different strains that 
are V. parahaemolyticus RIMD2210633, V. parahaemolyticus Peru466, V. 
parahaemolyticus AQ4037, V. parahaemolyticus AQ3810, V. parahaemolyticus 
AN5034 and V. parahaemolyticus K5030 for the presence of common and unique 
number of genes. Other genes related to the interaction of pathogen with the host which 
have not been studied evolutionarily could help us understand the specific niche to 
which the strains could belong to worldwide. 
M. rosenbergii is a freshwater aquatic organism. The optimal range for M. 
rosenbergii larvae to survive is 280C – 310C. It has been observed that a salinity of 
<10% parts per thousand (ppt) would be ideal for hatcheries for freshwater prawn 
(New, 2002). Though calcium shows its importance in the formation of exoskeleton 
(Saravanan et al., 2008) it is the conditions which are favourable for the “survival” of 
larvae which stands of primary importance. There are previous reports which describe 
Magnesium as an important component in the environment for prawn survival. One 
such previous literature explains the requirement of the magnesium in juvenile prawns 
(Akio, Teshima, & Sasaki, 1984). A recent article (Hangsapreurke et al., 2008) 
describes the study of effects of salinity with the use of artificial sea water. Here it 
clearly explains the role of magnesium (Mg) in the survival rates of post larvae. Taking 
an example of the effect of an acidic environment with the presence of aluminium, 
magnesium ion (Mg++) in increased levels has been observed of importance in survival 
stages of the post larvae (Rejeki, 2003). The characteristics of water which are good for 
prawn hatcheries are said to be 10-27 parts per million (ppm) Mg in freshwater, 1250-
1345 ppm Mg in seawater and 460-540ppm Mg in brackish water (New, 2002). These 
features and conditions show how important is the Magnesium ion for the survival of 
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larvae which undergo a very critical “Molting stage” before reaching the post-larval 
stage. 
Most Vibrio as shown are adapted to aquatic organisms and cause severe 
infections on consumption by humans. The V. parahaemolyticus has several virulence, 
pathogenicity and antibiotic resistance factors with which it can survive aquatic 
organisms especially the giant fresh water prawn, M. rosenbergii (Hameed, Rahaman, 
Alagan, & Yoganandhan, 2003).  
The growth conditions of M. rosenbergii in the environment can be studied in 
depth to understand the adaptation correlation of V. parahaemolyticus to M. 
rosenbergii. Studies show that M. rosenbergii survival in different media compositions 
has been observed with variations in NaCl, KCl and MgCl2 + MgSO4 (Daniels, 
MacKinnon, et al., 2000). The fertilization envelope of shrimp eggs has been observed 
to thin when there is depletion of calcium and magnesium contents (Clark & Lynn, 
1977). Embryos at early stages has been shown to require optimum levels of medium 
including MgCl2 + MgSO4 for their proper development (Damrongphol, 
Jaroensastraraks, & Poolsanguan, 2001). 
The role of magnesium ion in the normal hatching rate or the newly hatched 
larvae is not shown to be significant (Damrongphol et al., 2001). The importance of 
Magnesium in survival mechanism has been observed (Hangsapreurke et al., 2008). 
There are various resistance factors which V. parahaemolyticus carry such as the 
Cobalt, Zinc, Cadmium and Chromium resistance genes which can also explain the 
possible link to M. rosenbergii which could have been exposed to toxic substances 
during its life cycle. During the course of evolution the bacteria must have acquired 
these resistance genes on prolonged exposure while surviving together with the host that 
is M. rosenbergii. Antitoxin genes such as the Phd antitoxin and the Doc antitoxin 
genes (Guerout et al., 2013) have also been identified in V. parahaemolyticus PCV08-7 
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isolated from prawn which strengthens the explanation on host-pathogen co-existence. 
The most interesting factor is the tolerance of V. parahaemolyticus unlike other bacteria 
to higher concentrations of Magnesium as mentioned in Chapter 2 and growth under 
iron-limiting conditions directly proportional to conditions of prawn larval survival.  
Apart from this, another important factor is the N-acetylglucosamine-binding protein 
(gbpA) that has been studied in one Vibrio species, Vibrio cholerae (Jude, Martinez, 
Skorupski, & Taylor, 2009; E. Wong et al., 2012) to have the property to bind to 
epithelial cell surfaces and chitin on the host surface (Bhowmick et al., 2008). There are 
no reports yet on previous studies of host-pathogen interactions on gbpA gene of V. 
parahaemolyticus with M. rosenbergii as the host bearing chitin as a component in its 
carapace.  
The evolutionary strength of this bacteria having acquired virulence could 
make the V. parahaemolyticus a strong host-pathogen partner to M. rosenbergii and 
therefore explain the host-pathogen co-existence and the presence of Magnesium ion in 
the environment to be hypothesized as one of the important link between V. 
parahaemolyticus and M. rosenbergii. 
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Figure 5.2.2: Hypothetical representation of the possible check point where the host-
pathogen interaction of V. parahaemolyticus and M. rosenbergii can be targeted to deal 
with bacteria infecting seafood. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
86 
 
5.3 Materials and Methods 
5.3.1 Next-generation sequencing  
V. parahaemolyticus PCV08-7 genome has been sequenced by Illumina GAIIX 
analyzer as well as Ion Proton technology by Genotypic Pvt. Ltd, Bangalore, India. The 
plasmid has been isolated by the Hi Yield plasmid extraction kit (BioAmerica) 
(Appendix C (a)). The plasmid has been sent for sequencing through Illumina (GA2x, 
pipeline version 1.6). The genomic DNA was isolated using Qiagen DNeasy Blood & 
Tissue kit (Qiagen, Germany) and the genome sequence was determined by Ion proton. 
The details of the sequencing are shown in Table 5.3.1. 
Table 5.3.1: Details of the Next-generation sequencing output raw read data 
 
5.3.2 Quality control and Assembly of V. parahaemolyticus PCV08-7 NGS data 
The Trimming-Adaptor-High quality (TAH) pipeline customized quality control 
pipeline has been used for the filtering of raw sequencing read data of VPPCV08-7. The 
high quality step has been tweaked so as to compliment the quality score format in the 
plasmid Illumina and Ion torrent sequencing reads as per the syntax mentioned below. 
The Illumina sequencing reads were high quality filtered using the FASTX toolkit while 
the Ion torrent sequencing reads were processed using PRINSEQ. 
VPPCV08-7 Illumina sequencing data high quality filtering step 
./fastq_quality_filter -t 21 -l 100 -i /PATH/xx.fastq -o /path/outputVPPCV08-7 plasmid 
Illumina sequencing high quality filtering step 
./fastq_quality_filter -t 10 -l 100 –i /PATH/xx.fastq -o /path/output 
87 
 
VPPCV08-7 Ion torrent sequencing data high quality filtering step 
perl prinseq-lite.pl -verbose -fastq /PATH/xx.fastq -out_good null -out_bad null -
min_len 54 -trim_to_len 54 -out_format 3 
All the three datasets corresponding to Illumina and Ion proton sequenced genomic 
DNA as well as the Illumina sequenced plasmid DNA were assembled by Velvet-
1.0.12a and Edena (Appendix C (b)). 
5.3.3 Alignment and Annotation of VPPCV08-7 contigs 
The contigs produced from the VPPCV08-7 plasmid Illumina sequencing data using 
Edena assembler were used for alignment against the reference genome V. 
parahaemolyticus RIMD2210633 as in Chapter 4. The methodology as in Chapter 4 has 
been followed to re-order contigs aligning with Mauve to the concatenated reference 
genome. The re-ordered contigs (Appendix C (c)) were once again aligned against the 
reference to label the contigs to their respective chromosomes, represented as a 
heatmap. The contigs which show match in both the chromosomes were retained in a 
separate file. The contigs with no match were checked against the Genbank database 
and then placed into a file named plasmid.fa. Contigs matching with only RNA and 
with match in both the chromosomes were separated into two different files. The 
annotation of the parsed components was done using the online Rapid Annotation using 
Subsystems Technology (RAST). tRNA-scanSE (Lowe & Eddy, 1997) has been used 
for analysing the tRNA genes. 
5.3.4 Protein-protein and Protein-chemical interactions 
Databases STITCH v1.9 for protein-protein interactions and STRING 3 for protein-
chemical interactions were used to check the interactions of the gbpA gene of the 
VPPCV08-7 with other proteins and chemical molecules. 
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5.3.5 Alignment and Phylogenetic analysis of V. parahaemolyticus gbpA gene 
With publicly available annotated V. parahaemolyticus genomes as well as Sequence 
Read Archive data on Genbank, 52 different genomes (Appendix C (d)) were selected 
to check the evolutionary relationship of each genome with reference to our selected 
gene of interest gbpA, two house-keeping genes of V. parahaemolyticus, dnaB (DNA 
helicase), deaD (RNA helicase) and 16S rRNA sequences. Chitinase gene isoforms 
found in the genome of V. parahaemolyticus have also been used for the study. 
Standalone BLASTN has been used to obtain sequences from all the 52 individual 
genome files. ClustalW (J. D. Thompson, Higgins, & Gibson, 1994) has been used on 
the command-line to produce multiple alignments (Appendix C (e)). Splitstree (Huson, 
1998) has been used to run Neighbour-joining with a bootstrap value of 1000 and 
Figtree v1.4.2 (http://tree.bio.ed.ac.uk/software/figtree/) for plotting the phylogenetic 
tree in order of increasing clades with a scalebar of 2.0. 
5.3.6 Polymerase chain reaction 
Polymerase chain reaction has been performed on the gbpA (N-acetylglucosamine-
binding protein) gene for the whole length of 1464 bp gene. The tools used for primer 
designing were AmliFX  , DNA star (Burland, 2000), Primer3 (Untergasser et al., 2012; 
Untergasser et al., 2007) and NCBI primer Blast (Ye et al., 2012). The house keeping 
genes that are dnaB (DNA helicase) and deaD (RNA helicase) have also been selected 
to perform PCR for the whole length of the genes (Table 5.3.2) and for their selected 
domain lengths (Figure 5.3.1).  
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Table 5.3.2: Table with details of the PCR and Real time PCR primers. 
 
 
 
Figure 5.3.1: Agarose gel electrophoresis (1% w/v) showing the PCR products dnaB, 
deaD and gbpA genes at their corresponding gene lengths 
 
The gel picture shows 100 bp ladder (Vivantis) in Lane 6 with 1464 bp amplified gbpA 
gene product in Lane 7, 196 bp amplified dnaB gene product (corresponding to its 
domain region) in Lane 2 and 181 bp amplified deaD gene product (corresponding to its 
domain region) in Lane 4. The negative control or blank can be observed in Lane1, 
Lane3 and Lane8 for dnaB, deaD and gbpA respectively. 
 
The domains of the three genes were selected for amplifying (Table 5.3.2). The PCR 
working concentrations for all the three genes deaD, dnaB and gbpA were standardized 
as follows: 1X Gotaq green buffer, 1.5 mM Magnesium chloride (MgCl2), 0.2 mM 
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dATP, 0.2 mM dCTP, 0.2 mM dTTP, 0.2 mM dGTP, 0.25 µM forward primer, 0.25 
µM reverse primer, 0.025 u/ul Taq polymerase, 5 µg/ul genomic DNA template and 
made up to 10 µl reaction using ultrapure water. 
The PCR reactions were run on Biorad Thermal C1000 machine with the standardized 
reaction as follows: Initial denaturation of 950C/5 min, Denaturation 950C, Annealing 
600C and Extension 720C for 1 min and 40 cycles, Final extension 720C/5 min and 400C 
forever. PCR amplified products were sent to First Base Laboratories (Malaysia) for 
confirming the gene (Appendix C (f)). 
5.3.7 Cloning of gbpA gene 
gbpA gene has been cloned into pGEM vector and has been transformed into JM109 
Escherichia coli bacterial cells for isolation of cloned plasmid DNA. After 
transformation by the standard pGEM T-easy vector system I kit protocol (Promega), 
colony PCR for 190 bp product length of gbpA gene with real time PCR primers (Table 
5.4) has been done. Plasmid isolation (Appendix C (g)) was performed to check the 
presence of the gene by PCR (Figure 5.3.2).  
 
Figure 5.3.2: Agarose gel electrophoresis (1% w/v) showing the PCR product with the 
gbpA real time primers (190 bp length corresponding to its domain region) on the 16 
isolated colonies after transformation of the gbpA clone. 
 
Selected number of plasmid isolations were sent for DNA sequencing to FirstBase 
Laboratories (Malaysia) to confirm the clone (Appendix C (h)). The concentration of 
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the gbpA gene was obtained after PCR amplification which as per the Nanodrop 
2000/2000c Spectrophotomer readings (Thermo-Scientific) was 37.9 ng/µl. 
5.3.8 V. parahaemolyticus PCV08-7 culture and bacterial plate count 
Luria-Bertani Broth with 2% NaCl (Sodium chloride) was prepared for culturing 
VPPCV08-7 with Magnesium as the environment and in the presence of carapace of 
prawn and commercial grade chitin (chitin from shrimp shells, SIGMA). Six 
concentrations of Magnesium sulphate hepta hydrate (MgSO4.7H2O) had been used 
(Stock prepared was 500 mM). The three sets of experiments were performed as 
follows. Six different concentrations of MgSO4.7H2O were selected corresponding to 0 
ppm (0 mM), 300 ppm (1 mM), 18500 ppm (75 mM), 34000 ppm (137 mM), 55500 
ppm (225 mM), 73941 ppm (300 mM) respectively for each set. The first set was added 
with varied concentrations of MgSO4.7H2O. 0.05 g/3 ml by dry weight of carapace of 
the prawn was added per tube to all the six concentrations of MgSO4.7H2O in the 
second set. While the third set of six concentrations of MgSO4.7H2O were added with 
0.05 g/3 ml of chitin flakes (Sigma). 
1. (Without carapace)  
0 ppm, 300 ppm, 18500 ppm ,34000 ppm , 55500 ppm ,73941 ppm 
2. (With carapace)  
0 ppm, 300 ppm, 18500 ppm ,34000 ppm , 55500 ppm ,73941 ppm  
3. (With chitin flakes (Sigma))  
0 ppm, 300 ppm, 18500 ppm ,34000 ppm , 55500 ppm ,73941 ppm 
The bacterial plate count has been done in triplicates by counting on Difco TCBS agar 
by incubating the spread plates overnight at 370C for 16-20 hours (Appendix C (i)). 
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5.3.9 RNA isolation and cDNA synthesis  
RNA has been isolated from the triplicates of each of the samples above using Promega 
Total RNA isolation kit and converted to cDNA using the reverse transcription PCR 
protocol (Appendix C (j)). 4 µl of each isolated RNA sample from each of the 
triplicates was added with 1 µl Random primer to make a reaction mixture of 5 µl for an 
initial incubation at 700C/5 mins followed by 40C/5 mins in Biorad PCR machine. A 
reverse transcription mix of 15 µl each (6.1 µl Nuclease free water, 4 µl of 5X reaction 
buffer, 2.4 µl MgCl2, 1 µl dNTPs, 0.5 µl ribonuclease inhibitor and 1 µl reverse 
transcriptase) has been added to the former mixture for annealing at 250C/5 min, 
extension at 420C/60min and heat inactivation of reverse transcriptase at 700C/15 min 
for cDNA synthesis. 
 5.3.10 Real Time Polymerase chain reaction using SYBR green 
Absolute quantification 
The standardization of absolute quantification of cDNA was performed on the Applied 
Biosystems 7500 Real time PCR system with varied DNA concentrations of 0.005 µg, 
0.05 µg, 0.5 µg, 5 µg and 50 µg. While the forward primer and the reverse primers were 
standardized with 0.6 nm, 0.3 nm and 0.15 nm concentrations, respectively (Figure 
5.3.3)  
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Figure 5.3.3: Absolute quantitative standard curve for DNA concentrations (0.005µg, 
0.05µg, 0.5µg, 5µg and 50µg) vs Average Ct values for (A) primer concentration of 
0.15nm (B) primer concentration of 0.3nm and (C) primer concentration of 0.6nm 
respectively 
 
R2 values for primer concentrations of 0.15nm, 0.3nm and 0.6nm are 0.9573, 0.867 and 
0.9131 respectively. 
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The default thermal cycling conditions were used for the run with stage 1 of 500C/2 min 
and stage 2 950C/10 min for one cycle, stage 3 with 40 repetitions with 950C/15 sec 
followed by 600C/1 min (Appendix C (k)). 
Relative quantification 
Relative quantification of the cDNA samples was performed on an Applied Biosystems 
7500 Real Time PCR system with each qRT-PCR reaction amounting to 10 µl Power 
SYBR green PCR master mix, 0.6 µl forward primer, 0.6 µl reverse primer 1 µl DNA 
template and 7.8 µl ultrapure water.  The default thermal cycling conditions are used for 
the run with stage 1 of 500C/2 min and stage 2 950C/10 min for one cycle, stage3 with 
40 repetitions with 950C/15 sec followed by 600C/1 min (Appendix C (l)).  
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5.4 Results and Discussion 
5.4.1 Vibrio parahaemolyticus PCV08-7 draft genome completion 
Applying the TAH pipeline as in the discussion from Chapter 3 showed reasonably 
good usage of reads corresponding to the VPPCV08-7 sequencing reads. Using the pre-
existing tools the data from all sequencing data has been brought to one common format 
to deal with the accuracy of the TAH pipeline (Appendix C (b)). The VPPCV08-7 
plasmid Illumina sequencing generated contigs were aligned against the concatenated 
reference genome of VPRIMD2210633. The contigs were separated into chromosome 
1, chromosome 2 and the plasmid depending on the alignment hits obtained (Appendix 
C (c)). The presence of RNA genes in all these files hence, support the fact that PCR 
reactions for rRNA and tRNA can help support the completion of a bacterial genome as 
it could be one common factor among all bacterial genomes. Previously, there were 
studies reported on optically mapping bacterial genomes for completion of genomes 
experimentally (Riley, Lee, Lesho, & Kirkup, 2011). 
The individual files were annotated on the RAST annotation system which 
showed a total of 1676, 546 and 1 ORFs in the subsystem in VPPCV08-7 chr1, 
VPPCV08-7 chr2 and VPPCV08-7 plasmid, respectively (Table 5.4.1).  
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Table 5.4.1: Number of ORFs distributed into subsystems in the draft of chromosome 
1, chromosome 2 and plasmid of VPPCV08-7 
 
Table shows ORF’s distributed under subsytems annotated by RAST server as 1676, 
546, 1 for VPPCV08-7 chr1, VPPCV08-7 chr2 and VPPCV08-7 plasmid, respectively. 
The number of ORF’s not present within the subsystem were 1382, 1066, 12 for 
VPPCV08-7 chr1, VPPCV08-7 chr2 and VPPCV08-7 plasmid, respectively. 
 
Among the above, 1569, 510 and 1 number of ORFs were non-hypothetical and 107, 36 
and 0 were hypothetical corresponding to the individual components. A total of 1382, 
1066 and 12 ORFs were found in chr1, chr2 and the plasmid respectively which are not 
present within the subsystem (Figures 5.4.1, 5.4.2 and 5.4.3). 
 
Figure 5.4.1: Subsystem category distribution of the parsed draft chromosome 1 of 
VPPCV08-7 
 
The RAST subsystem category distribution shows highest number of feature counts 
under Amino acids and derivatives with observable counts under phages, prophages, 
transposable elements and plasmids. 
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Figure 5.4.2: Subsystem category distribution of the parsed draft chromosome 2 of 
VPPCV08-7 
 
The RAST subsystem category distribution shows highest number of feature counts 
under Carbohydrates with observable counts under phages, prophages, transposable 
elements and plasmids. 
 
 
 
 
Figure 5.4.3: Subsystem category distribution of the parsed probable plasmid of 
VPPCV08-7 
 
The RAST subsystem category distribution shows feature counts in sulphur metabolism 
and carbohydrates. 
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The VPPCV08-7 chr1, chr2 and plasmid data has been used to glean into the 
important genes in similarity with the VPRIMD2210633 genome. Alignments matching 
chromosome 1 of VPRIMD2210633 were genes coding for lipopolysaccharides, 
phagef37 like genes type 3 secretion system 1 and the integron class 1 which are 
partially present. While the hypothetical proteins and osmotolerance genes are 
completely present. Alignments against chromosome 2 of VPRIMD2210633 showed 
partial presence of genes responsible for degradation processes, phagef37 like genes, 
biofilm formation and multidrug efflux systems. The genes coding for gametolysin 
(peptidases, amylases, lipases), osmotolerance, capsule lipopolysaccharide, type 1 
secretion, type 1 pilus, ferric uptake system and a 140kb region not found in Early 
Mortality syndrome (EMS) strains were present (Table 5.4.2).  
Table 5.4.2: Important genes of VPRIMD2210633 and EMS strain and their presence 
in VPPCV08-7 
 
The list of genes in the table represent important selected genes of VPRIMD2210633 
chr1 (Lipopolysaccharides, Phagef37, T3SS-1, Osmotolerance and Integronclass-1), 
VPRIMD2210633 chr2 (Genes in degradation processes, Phagef37-like genes, Biofilm, 
Gametolysin, Osmotolerance, Capsule lipopolysaccharide, Type 1 secretion, Type 1 
pilus, Multidrug efflux system, Ferrics uptake system) and VPTUMSATD06_S3 (63kb 
gene stretch in EMS strain) and their presence or absence in VPPCV08-7. 
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The 140kb region constitutes thermostable direct hemolysin A and S, transposases, 
cytotoxic necrotizing factor, transcriptional regulator, putative type III secretion 
proteins, membrane proteins and hypothetical proteins. A 63kb stretch of sequence 
present in Vibrio parahaemolyticus TUMSATD06_03, a recently reported EMS strain 
from Thailand was not present in our genome. The 63kb stretch constitutes conjugal 
transfer proteins (Trb C, D, E, F, G, H, I, L), Type II and III secretion proteins and 
matches a Vibrio parahaemolyticus strain 13-028/A3 plasmid pVPA3-1 containing 
Photorhabdus insect-related (Pir) genes (J. E. Han, Tang, Tran, & Lightner, 2015). This 
explains that the current genome has no common features with that of the EMS strain 
ruling out the fact that our genome could be fatal for prawn. The online BLASTN 
analysis with the contigs separated into the plasmid file against the Genbank database 
corresponded to genes from Vibrio parahaemolyticus strain vp plasmid pVP1 and 
Vibrio parahaemolyticus UCM-V493 chr1 which correspond to conjugative transfer 
protein Tra1, relaxase and mobile elements.  
The above data extracted from the draft completion of genome showed that 
though the number of contigs generated might be comparatively more during assembly, 
it indeed helps not to lose important gene information. It supports in identifying the 
undetectable gene features which might as well would have been lost existing within 
huge contigs during the assembly process. 
5.4.2 Bioinformatic analysis of host-pathogen genes 
Previous studies have shown that the gbpA gene product of Vibrio cholerae interacts 
with the intestinal epithelial chitinous membrane (Bhowmick et al., 2008). As M. 
rosenbergii is known to be infected by V. parahaemolyticus we have selected this gene 
for probable interactions with any other proteins or chemicals (Frederiksen et al., 2013). 
The results of protein-protein interactions and protein-chemical interactions of gbpA of 
Vibrio parahaemolyticus showed interactions with various genes and carbohydrates. 
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Among which the chitinase and chitin were observed to be closer to our research area. 
The results obtained from the STRING v9.1 interactions show the interaction of gbpA 
with various other gene products of VPRIMD2210633 and also its possible interaction 
with chitinase (Figure 5.4.4).  
 
Figure 5.4.4: STRING v9.1 protein-protein interactions of gbpA protein of V. 
parahaemolyticus 
 
Protein-protein interactions of gbpA (N-acetylglucosamine-binding protein A) on 
STRING v9.1 database shows interactions primarily with gene proteins of Vibrio 
parahaemolyticus (VPA0714 – putative collagenase, VPA0832 - chitodextrinase, 
VP2338 - chitinase, VPA1177 – putative chitinase A, VPA0092 – spindolin-related 
protein, VP1340 - collagenase, VP0619 – putative chitinase, VPA1016 – multidrug 
resistance protein D, prt - collagenase, Chi1 - chitinase). 
 
Figure 5.4.5 obtained from STITCH 3 shows the probable interaction with chitin which 
explains that the gbpA protein could participate in epithelial cell surface binding whose 
component could be chitin, a major complex carbohydrate constituent of the prawn 
shell. 
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Figure 5.4.5: STITCH 3 protein-chemical interactions of gbpA protein of V. 
parahaemolyticus 
 
Protein – chemical interactions of gbpA (N-acetylglucosamine-binding protein A) on 
STITCH 3 database shows interactions primarily with proteins of V. parahaemolyticus 
(VPA1016 – multidrug resistance protein D, VPA1017 – AraC/XylS family 
transcriptional regulator, VP2338 – chitinase, VPA1177 – putative chitinase A, 
VPA0092 – spindolin-related protein, VPA0832 – chitodextrinase, VPA0714 – putative 
collagenase, prt – collagenase, Chi1 – chitinase) and chitin (one of the main constituents 
of the shell of prawn (M. rosenbergii)). 
 
5.4.3 Phylogenetic analysis of VPPCV08-7  
Phylogenetic analysis has been performed on 52 genomes of V. parahaemolyticus 
selected from Genbank (Appendix C (d)). Among which the VPPCV08-7, 
VPRIMD2210633, VPO1:K33 strains and recent EMS strains (VPBAVF, VPBAHG, 
VPBAHH) were of our interest. The genes selected for phylogenetic analysis were 
DNA helicase (dnaB) and RNA helicase (deaD) which represent the basic machinery of 
any bacterial genome, the 16S rRNA which has been used as the blueprint for 
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identifying the genus of bacterial genomes and the gbpA gene which has been used in 
our study as a possible interacting agent with the host from the V. parahaemolyticus. 
Among all the phylogenetic trees the genome VPPCV08-7 lies closer to the Thailand 
EMS strains over the phylogenies plotted for 16S rRNA (Figure 5.4.6), DNA helicase 
(Figure 5.4.7), RNA helicase (Figure 5.4.8) and gbpA (Figure 5.4.9) genes representing 
a closer proximity in relation to the basic machinery of V. parahaemolyticus.  
 
 
 
 
103 
 
 
Figure 5.4.6: Phylogenetic tree representing the selected 52 V. parahaemolyticus 
genomes in relation with the 16S rRNA gene. Marked in RED are the three genomes 
VPPCV08-7, VPRIMD2210633 and VP01:K33 genomes. In GREEN are the three 
EMS strains from Thailand VPBAVF (V. parahaemolyticus TUMST_DE1_S1), 
VPBAVG (V. parahaemolyticus TUMSAT_DE2_S2) and VPBAVH (V. 
parahaemolyticus TUMSAT_D06_S3) 
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Figure 5.4.7: Phylogenetic tree representing the selected 52 V. parahaemolyticus 
genomes in relation with the house-keeping dnaB (DNA helicase) gene. Marked in 
RED are the three genomes VPPCV08-7, VPRIMD2210633 and VP01:K33 genomes. 
In GREEN are the three EMS strains from Thailand VPBAVF (V. parahaemolyticus 
TUMST_DE1_S1), VPBAVG (V. parahaemolyticus TUMSAT_DE2_S2) and 
VPBAVH (V. parahaemolyticus TUMSAT_D06_S3) 
 
105 
 
 
Figure 5.4.8: Phylogenetic tree representing the selected 52 V. parahaemolyticus 
genomes in relation with the deaD (RNA helicase) gene. Marked in RED are the three 
genomes VPPCV08-7, VPRIMD2210633 and VP01:K33 genomes. In GREEN are the 
three EMS strains from Thailand VPBAVF (V. parahaemolyticus TUMST_DE1_S1), 
VPBAVG (V. parahaemolyticus TUMSAT_DE2_S2) and VPBAVH (V. 
parahaemolyticus TUMSAT_D06_S3) 
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Figure 5.4.9: Phylogenetic tree representing the selected 52 V. parahaemolyticus 
genomes in relation with the gbpA gene. Marked in RED are the three genomes 
VPPCV08-7, VPRIMD2210633 and VP01:K33 genomes. In GREEN are the three 
EMS strains from Thailand VPBAVF (V. parahaemolyticus TUMST_DE1_S1), 
VPBAVG (V. parahaemolyticus TUMSAT_DE2_S2) and VPBAVH (V. 
parahaemolyticus TUMSAT_D06_S3) 
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VPRIMD2210633 taken as the reference genome for VPPCV08-7 is observed to have a 
distant relation in terms of dnaB, deaD and gbpA genes from VPPCV08-7. The results 
showed that though VPRIMD2210633 being a pandemic strain could not possibly 
evolve into a newer pathogenic or virulent strain in the present scenario that is the Early 
Mortality Syndrome strain. On the other hand, the phylogenetic tree of all the genes 
considered together explain that the difference in the genomic content of the V. 
parahaemolyticus might be expanded worldwide with lesser chances to identify closer 
strains among countries based only upon 16S rRNA genes. The five different chitinase 
genes present in genome have also been aligned by ClustalW to plot the phylogeny 
(Appendix C (m)). The phylogeny patterns of chitinase 1 and 3 genes as shown in the 
Appendix C (m (i) & (iii)) show more similarity in the arrangements closer to the 
house-keeping genes dnaA (Figure 5.4.7) and deaD (Figure 5.4.8).  
5.4.4 Host-Pathogen-Environment interaction studies 
In the presence of MgSO4.7H2O, a uniform increase in the gene expression of gbpA was 
observed (Figures 5.4.10 and 5.4.11).  
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Figure 5.4.10: Graphs representing gbpA gene expression (2-delta delta Ct values) 
against (A) the concentrations of MgSO4.7H2O (B) presence of chitin with 
MgSO4.7H2O and (C) presence of carapace with MgSO4.7H2O 
 
Increased gene expression can be observed in the presence of MgSO4.7H2O in (A) 
while a decrease in gbpA gene expression can be observed in the presence of chitin (B) 
and carapace (C). The graphical representation has been made using the Livak method 
for real time PCR calculations. The statistical highly significant values (p<0.05) are 
represented with an asterisk. 
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Figure 5.4.11: Graphs showing gbpA gene expression (2-delta delta Ct values) against 
the concentrations of Magnesium sulphate and with presence of chitin and carapace 
 
Graph representing comparative gbpA expression among the three treatment groups of 
V. parahaemolyticus PCV08-7 culture. The graphical representation has been made 
using the Livak method for real time PCR calculations. The statistical highly significant 
values (p<0.05) are represented with an asterisk. 
 
MgSO4.7H2O with the presence of chitin showed a gradual increase in gene expression 
of gbpA. MgSO4.7H2O with carapace showed an increase and then a slow decrease in 
the expression of the gbpA gene. In common to all the three experiments in the presence 
of 0 ppm MgSO4.7H2O, a standard level of expression was observed among all the three 
experiments.  The results of the experiment checking the host-pathogen-environment 
interaction was significant in the V. parahaemolyticus culture treated with MgSO4.7H2O 
only with a P-value of 0.0154 (Table 5.4.3) and also in the presence of MgSO4.7H2O 
with chitin, P-value of 0.000441 (Table 5.4.4).  
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Table 5.4.3: Analysis of Variance to identify the level of significance for gene 
expression with the presence of MgSO4.7H2O 
 
 
Table 5.4.4: Analysis of Variance to identify the level of significance for gene 
expression with the presence of MgSO4.7H2O and chitin 
 
 
There was no significant effect in treating V. parahaemolyticus culture with 
MgSO4.7H2O with the presence of carapace (Table 5.4.5).  
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Table 5.4.5: Analysis of Variance to identify the level of significance for gene 
expression with the presence of MgSO4.7H2O and carapace 
 
Concentrations of 300 mM (P-value = 0.02744) and 75 mM (P-value = 0.00132) were 
highly significant values in MgSO4.7H2O treated and MgSO4.7H2O with chitin treated 
sample respectively (Table 5.4.6).  
Table 5.4.6: Student two tail paired t-test of equal variance across gene expression 
samples of samples treated with only MgSO4.7H2O, with MgSO4.7H2O and chitin, with 
MgSO4.7H2O and carapace 
 
The colony count of VPPCV08-7 in the presence of MgSO4.7H2O, MgSO4.7H2O with 
chitin and MgSO4.7H2O with carapace has been observed to show a significant decrease 
in fold change with increase in the treatment of concentrated MgSO4.7H2O (Table 
5.4.7). 
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Table 5.4.7: Table represents the bacterial count in the presence of only MgSO4.7H2O 
(NONE). In the presence of MgSO4.7H2O with chitin and in the presence of 
MgSO4.7H2O with carapace (concentrations represented in ppm). 
 
Table shows colony forming units at different concentrations of 0 ppm, 300 ppm, 18500 
ppm, 34000 ppm, 55000 ppm and 73941 ppm in the presence of chitin (0.05 gm/3 ml) 
carapace (0.05 gm/3 ml) and in the presence of only MgSO4.7H2O 
 
Hence, this explains that in the presence of chitin and carapace, the levels of gbpA 
expression has been lowered significantly when compared to the absence of chitin and 
carapace. This shows that the gbpA expression has been regulated both by the host 
component (chitin/ carapace) as well as by the presence of an external source 
magnesium.  
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5.5 Conclusion 
The TAH pipeline shows comparatively good usage of percentage of reads for 
assembly. The need to get all the sequencing read data into a similar format had been 
important to process the next annotation process. This shows that any sequencing data 
has to be dealt with post processing to one common format of FASTQ file. The 
presence of more number of contigs can help in identifying unique sequences as less 
number of contigs could increase the probability of occurrence of a gene inside a huge 
contig. This could interfere with the probable alignments against genes on databases 
such a Genbank. The usage of two assembly tools Velvet and Edena could give a better 
result as two different algorithms based on de-bruijn graphs and overlaps were used. 
This procedure could probably help in filling the gaps between contigs which has not 
been covered by the other assembly tool. Our genomes do not show any similarity to 
EMS strain in terms of its specific sequences but, shows similarity to VPRIMD2210633 
and VPO1:K33.  
 The bioinformatics analysis on the gbpA gene shows probable interactions with 
chitin which is an important component of the outer carapace content of the prawn or 
shrimp. The 16S rRNA has been used to categorize bacteria into the niche specific 
regions worldwide. This has been critical in the case of V. parahaemolyticus as it is an 
aquatic organism which has a probability of being exported and imported across the 
world with its presence in the prawn/ shrimp. Hence, it could be of utmost importance 
in such conditions to trace back the similarity among the strains based on the basic 
machinery while utilizing 16S rRNA and the functional gene of interest as the reference 
in any phylogenetic analysis. Therefore, the importance of utilizing genes such as dnaB, 
deaD cannot be ruled out from phylogenetic analysis as these could probably help us 
understand the ancestral strains of the current V. parahaemolyticus strain. Meanwhile, 
in comparison to these basic machinery understanding the evolution of individual genes 
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such as gbpA and chitinase in the current scenario which are related to the interactions 
with the host is significant. This significance is in terms of extracting information of the 
evolutionary trend followed by these host related genes within the pathogen to overlay 
and understand its relationship with the already existing patterns of V. parahaemolyticus 
principle gene features through phylogeny. 
 The in vitro experiment on the gbpA expression of V. parahaemolyticus in the 
presence of M. rosenbergii component (chitin/ carapace) and presence of an external 
environment (Magnesium) has shown how gbpA gene expression has been regulated. 
Our results show no definite change in levels of gbpA expression in the absence of 
magnesium as well as absence of chitin and carapace but, showed an increase in gbpA 
expression of magnesium and decreased gbpA expression in presence of both 
magnesium as well as with chitin and carapace. Hence this explains the importance of 
the presence of an environment (Magnesium) in regulating the gene expression of the 
bacterial gbpA. The patterns of gene expression of gbpA observed could possibly help 
understand the roles of magnesium as the environment and the chitin as the component 
of the host which are indeed necessary for a pathogenic gene to respond. In reference to 
molting phase of prawn wherein thick or mature carapace of the prawn is lost and the 
new carapace replaces as a thin chitinous layer, our study could support that an 
increased gbpA expression could be observed when compared to the stage in the 
presence of the mature carapace before molting. Hence, this supports the fact that it 
could be probably during the molting stage that the pathogen shows higher gbpA 
expression. This could further be studied with introduction of various pathogen related 
genes and carried ahead for research on possible interaction studies between gbpA and 
chitin (pathogen and host) with magnesium as one of the very important component in 
the environment.  
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Achievement 
The genome of VPPCV08-7 was once again assembled using Ion proton and Illumina 
raw read data successfully applying our TAH pipeline from objective 1. 52genes of 
Vibrio parahaemolyticus were downloaded as Sequence Read Archives (SRA) from 
Genbank, assembled preceded by phylogenetic analysis. Phylogenetic analysis was 
performed with house-keeping genes in view and 16srRNA and gbpA gene. Real time 
PCR was performed for gbpA gene expression and successfully an expression pattern 
was observed in the presence and absence of Mg2SO4.7H2O, chitin and carapace. 
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CHAPTER 6 
 
CONCLUSION 
A defined set of bacterial next-generation sequencing raw read data was used in the 
current research for establishing an accurate quality control pipeline which was 
successfully achieved. Followed by the usage of retrieved sequencing data of various V. 
parahaemolyticus genomes for analysis of the sequenced V. parahaemolyticus PCV08-7 
genome. This was further targeted at studying not only the host-pathogen-environment 
interactions but, even the phylogenetic relationships with the co-evolved strains in terms 
of house-keeping genes and basic machinery genes. These ultimate goals are 
summarized below in order of the successfully achieved objectives and challenging 
innovative goals for further research. 
“Trimming” has shown to retain maximum percentage of reads for further 
assembly processing among high quality filtering, adaptor filtering, N’s removal and 
trimming strategies in quality control (QC) of next-generation sequencing of bacterial 
data. Keeping this “Trimming” strategy as the first step of QC pipeline in common 
among the five different bacterial genomes showed a constancy in maintaining the total 
percentage of used reads. Apart from trimming, strategies of high quality filtering and 
adaptor filtering among these genomes was observed to be quite important to remove 
artefacts from sequencing raw read data. Hence, the QC pipeline has been assembled 
with “trimming – adaptor filtering – high quality filtering” as a good application to the 
QC flow to refine the output data which further will be used in bioinformatic analysis. 
Our pipeline named TAH pipeline includes the usage of pre-existing QC control tools 
by improvising and tweaking their parameters in order to make the best use of and 
produce as output the best QC filtered data for more reliable and accurate NGS genome 
analysis. 
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Finishing a draft genome of bacteria is quite necessary as it is important to keep 
the genome information intact. Dealing with a genome with two chromosomes is quite 
tedious with assembled sequencing data being a challenge lying in separating the 
genome data into two chromosomes. The challenge is two sided: One, to separate data 
into two chromosomes based on a reference genome already present in Genbank. Two, 
is working with data which belongs to a de-novo assembled genome. In the present 
work we dealt with the availability of a reference genome VPRIMD2210633 but, for 
this we have completely dealt unmatched sequences between both chromosomes as 
separate sequences during the process of annotation. Our study mentions that dealing 
with bacterial genomes needs utmost support and evidence through completing the 
bacterial genome with amplifications by PCR reactions. Inverse PCR could possibly be 
one such strategy which can be used on rRNA’s which exist in multiple copies in 
bacteria to fill up the gaps between the assembled contigs. Applying a similar procedure 
to tRNA’s could be an added advantage. 
In addition to this, we have worked on the current genome V. parahaemolyticus 
PCV08-7 and have worked on assembly-assembly (Overlap-De-bruijn) hybrid approach 
with two different assembly (Edena and Velvet) tools which does indeed explain the 
importance of the generation of more number of contigs in comparison to larger contigs 
in the assembly process. Herein, we have shown that this strategy helps the user to 
identify few important gene features of the bacteria as they exist separately within short 
contigs, while their existence in larger contigs blurs the identification of short genes 
which could be of significant importance in microbiology research. 
 Apart from this, we have used VPPCV08-7 to focus on using one single gene 
for phylogenetic analysis with reference to the house-keeping genes as well as 16S 
rRNA which could give more in depth information about the existence and evolutionary 
trace back of bacterial strains. This can be explained as that the basic machinery genes 
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are the preliminary processed genes of any bacterial genome. Avoiding these genes of 
bacteria could be critical in our understanding of a bacterial pathogen, especially to 
identify the evolution of a certain virulence trait of a bacteria. Hence, our work shows 
how distantly a phylogenetic relationship exists among genomes when compared 
between pathogenic gene traits (gbpA, chitinase) and basic machinery (deaD, dnaB) and 
16S rRNA genes. Considering these genes together could help understand bacterial 
genomes with in-depth understanding towards evolutionary emergence of bacterial 
genomes based on location or region of origin. The application of a gbpA gene to study 
its response in the presence of a host component (chitin/ carapace) and environmental 
factor (magnesium) with an in vitro experiment showed how the gene was regulated in 
their presence and absence. It even could probably support the fact of higher expression 
of pathogenic gene gbpA during the sensitive phase of prawn during molting with a 
declined chitinous layer of its carapace and vice versa. This data could help us 
understand host-pathogen-environment play a role together and cannot be neglected in 
order to further studies in understanding the mechanisms of interactions between the 
host-pathogen components of V. parahaemolyticus in M. rosenbergii. Along with this 
our research shows how important is an external environment factor (Magnesium) is in 
regulating gene expression of the pathogen in accordance with the presence of host 
component. 
 
Our research on the whole deals with data that supports further work on making one 
markedly significant tool based on the strategies applied to the QC pipeline. The current 
work could help gradually lessen the difficulty in dealing with erroneous raw read 
sequencing data, to deal with bacterial genome assembly hybrid data as well as 
concentrate on rRNA’s and tRNA’s for completion of a draft bacterial genome. Apart 
from this, further work could be held on dealing with the M. rosenbergii itself and 
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checking its infection with V. parahaemolyticus with the source of magnesium as an 
external environment in-vitro. This could help us understand possible roles of 
interactions between the host and the pathogen and the probable phase of entry of the 
pathogen into the host. 
 
INNOVATION  
1. Establishing the importance of trimming short reads in bacterial genome datasets 
generated by next-generation sequencing technique. 
2. Developing and evaluating several novel next-generation sequencing data 
analysis pipelines with TAH pipeline identified as best suited to the problem at 
hand.  
3. Successfully applying the TAH pipeline to the VPPCV08-7 bacterial draft 
genome. 
4. The data analysis performed was used to identify a single gene to track the host-
pathogen response under different environmental conditions. 
 
SINGIFICANCE 
The findings reported in the current research thesis are significant, with the defined 
objectives set out being achieved. More importantly, mechanism by which the 
bacterium infects prawns has been proposed, which is essential for developing strategies 
to prevent infection by V. parahaemolyticus. 
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RNA-seq analysis of Macrobrachium rosenbergii
hepatopancreas in response to Vibrio
parahaemolyticus infection
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Abstract
Background: The Malaysian giant freshwater prawn, Macrobrachium rosenbergii, is an economically important
crustacean worldwide. However, production of this prawn is facing a serious threat from Vibriosis disease caused by
Vibrio species such as Vibrio parahaemolyticus. Unfortunately, the mechanisms involved in the immune response of
this species to bacterial infection are not fully understood. We therefore used a high-throughput deep sequencing
technology to investigate the transcriptome and comparative expression profiles of the hepatopancreas from this
freshwater prawn infected with V. parahaemolyticus to gain an increased understanding of the molecular
mechanisms underlying the species’ immune response to this pathogenic bacteria.
Result: A total of 59,122,940 raw reads were obtained from the control group, and 58,385,094 reads from the
Vibrio-infected group. Via de novo assembly by Trinity assembler, 59,050 control unigenes and 73,946 Vibrio-infected
group unigenes were obtained. By clustering unigenes from both libraries, a total of 64,411 standard unigenes were
produced. The standard unigenes were annotated against the NCBI non-redundant, Swiss-Prot, Kyoto Encyclopaedia
of Genes and Genome pathway (KEGG) and Orthologous Groups of Proteins (COG) databases, with 19,799 (30.73%),
16,832 (26.13%), 14,706 (22.83%) and 7,856 (12.19%) hits respectively, giving a final total of 22,455 significant hits
(34.86% of all unigenes). A Gene Ontology (GO) analysis search using the Blast2GO program resulted in 6,007
unigenes (9.32%) being categorized into 55 functional groups. A differential gene expression analysis produced a
total of 14,569 unigenes aberrantly expressed, with 11,446 unigenes significantly up-regulated and 3,103 unigenes
significantly down-regulated. The differentially expressed immune genes fall under various processes of the animal
immune system.
Conclusion: This study provided an insight into the antibacterial mechanism in M. rosenbergii and the role of
differentially expressed immune genes in response to V. parahaemolyticus infection. Furthermore, this study has
generated an abundant list of transcript from M.rosenbergii which will provide a fundamental basis for future
genomics research in this field.
Keywords: Transcriptomics, Macrobrachium rosenbergii, Vibrio parahaemolyticus, de novo assembly, Immune genes,
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Background
The Malaysian giant freshwater prawn, Macrobrachium
rosenbergii (locally known as ‘udang galah’), belongs to
the genus Macrobrachium, which is the largest genus of
the family Palaemonidae [1]. They are found in most in-
land freshwater areas, including lakes, rivers, swamps,
estuarine areas, ponds, canals as well as in irrigation ducts
[2]. M. rosenbergii spends its adult life in fresh water, but
requires brackish water during the initial stages of its life
cycle [3]. High demand from the aquaculture industry has
led to large-scale farming of this prawn in many countries;
the major producers being Bangladesh, Brazil, China,
Ecuador, India, Thailand, Taiwan Province of China, and
Malaysia [4].
The global production of this prawn had increased to
over 200 000 tonnes/year by 2002, and income in Asia
alone is now worth US$1 billion per annum [5,6]. In
Malaysia, the production of cultured M. rosenbergii
reached 281 metric tonnes by 1998 [4]. Generally, M.
rosenbergii is assumed to be less resistant towards dis-
eases than penaeid shrimp [7]. However, with the rise of
large-scale high density prawn aquaculture techniques,
production of this prawn worldwide is facing a serious
threat from fatal diseases caused by nodaviruses and
bacteria, particularly from the Vibrio species [8,9]. The
emergence of these pathogens has had a detrimental im-
pact on the M. rosenbergii farming industry, causing
considerable economic losses.
Vibrio is a Gram-negative halophilic bacterium found
abundantly in marine and estuarine environments [10,11].
Among the different species, Vibrio parahaemolyticus has
emerged as an important pathogen for M. rosenbergii [12].
Several other marine shrimps such as Penaeus monodon,
Penaeus japonicas and Litopenaeus vannamei have also
been found to be susceptible to Vibrio infection [13]. Severe
V. parahaemolyticus infection in prawns leads to a disease
known as ‘Vibriosis’ [14,15]. M. rosenbergii suffering from
vibriosis may appear black in colour on the carapace, with
red discolouration of the exoskeleton and loss of append-
ages within six days, leading to an 80% mortality rate [12].
Acquiring and establishing knowledge regarding host
pathogen interactions is necessary to unlock the patho-
genesis of a particular disease. Host pathogen interac-
tions can result in acute and adaptive immune responses
against an invader; however, this has been lacking in M.
rosenbergii [16]. The species defends itself against patho-
gen invasion using an innate immune system involving
the cellular and humoral mechanisms [17,18]. Recently,
some progress has been made in analysing the molecular
mechanisms of shrimp-pathogen interactions, and sev-
eral immune genes from shrimp have been discovered
such as lectins, antimicrobial peptides, prophenoloxidase
and manganese superoxide dismutase, using methods
such as suppression subtractive hybridization (SSH) and
expressed sequence tags (EST) [19-21]. However, these
two methods have been found to be laborious and costly,
which limits their use for the production of large-scale
transcripts [22].
A cutting edge technology has emerged recently, known
as Next Generation Sequencing technology (NGS). Cur-
rently, there are four established platforms which uses
NGS technology: the Illumina Genome Analyzer, the
Roche/454 Genome Sequencer FLX Instrument, and the
ABI SOLiD System [23,24]. These platforms have proven
versatile and cost-effective tools for advanced research in
various genomic areas, such as genome sequencing and
re-sequencing, DNA methylation analysis, miRNA expres-
sion profiling, and also in non-model organisms as the de
novo transcriptome sequencing [25]. By using the NGS
platform, transcriptome analysis can be performed faster
and more easily, because it does not require any bacterial
cloning of cDNAs [26]. NGS sequencing has the further ad-
vantage of generating greater depth of short reads with
minimum error rates [27]. Moreover, it is more reliable and
efficient than previous methods in measuring transcrip-
tome composition, revealing RNA expression patterns,
and discovering new genes on a larger scale [28]. The su-
periority of this technology also lies in its sensitivity, which
allows the detection of low-abundance transcripts [29].
Previous studies have been performed on whole tran-
scriptome sequencing of the hepatopancreas, gill and
muscle tissues of M. rosenbergii using the Illumina
Genome Analyzer IIx platform (Illumina). They suc-
cessfully produced a comprehensive transcript data for
this freshwater prawn, leading to the discovery of new
genes [30]. This present study utilised a similar ap-
proach to analyse transcriptome data obtained from
the hepatopancreas of M. rosenbergii experimentally
infected with V. parahaemolyticus. The aim was to dis-
cover, and determine the role of, immune genes in M.
rosenbergii involved in V. parahaemolyticus infection,
which in turn could provide insights into the host-
pathogen interactions between these two organisms.
Material and methods
M. rosenbergii and V. parahaemolyticus PCV08-7 challenge
M. rosenbergii prawns (5-8 g body weight) purchased
from a local hatchery (Kuala Kangsar, Perak, Malaysia)
were acclimatized at 28 ± 1°C in aerated and filtered fresh-
water for one week prior to challenge with V. parahaemo-
lyticus. During the challenge experiment, the prawns (n =
10) were intramuscularly injected with 100 μl 1X105 cfu
cultured V. parahaemolyticus [31] whereas another batch
of prawns (n = 10) were injected with 100 μl 2% NaCl
(1:10, w/v) solution which serves as negative control
group. The hepatopancreas tissues of the prawns were dis-
sected at 12 hours post-infection. The tissues were rapidly
frozen in liquid nitrogen and stored at −80°C until total
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RNA extraction. The 12 hour time point was chosen based
on our previous work regarding immune related genes
from M. rosenbergii in response to pathogen such as vi-
ruses showing significant gene expression at this time
point [32-35].
Total RNA extraction and next-generation sequencing
Total RNA (~20 mg) was isolated from both the V.
parahaemolyticus-challenged and negative control group
hepatopancreases. The RNA extraction process was per-
formed by using the Macherey-Nagel NucleoSpin RNA
II extraction kit in accordance with the manufacturer’s
protocols and stored at −80°C prior to RNA sequencing.
The purity and integrity of the RNA was assessed by
using the Bioanalyzer 2100 (Agilent technologies, USA).
In each group, the total RNA samples were pooled from
10 prawns after which cDNA was synthesized followed
by sequencing. The sequencing run was conducted on
an Illumina HiSeq™ 2000 platform at the Beijing Gen-
ome Institute, Shenzhen, China. The sequencing data
constituted 90 bp paired end read data, with ~117 mil-
lion raw reads.
Assembly and functional annotation
The raw reads were primarily quality filtered to remove
adaptor sequences followed by removal of ambiguous
‘N’ nucleotides (with a ratio of ‘N’ more than 10%) and se-
quences with a phred quality score of less than 20 before
proceeding to de novo assembly by using the Trinity soft-
ware [36]. The Trinity programme assembles the reads
into contigs and these contigs were assembled to unigenes.
Finally, the TIGR Gene Indices clustering tools (TGICL)
[37] with default parameters was applied to cluster the
unigenes from both groups which produces non-
redundant unigenes.
The non-redundant unigene sequences were aligned to
databases which included NCBI non-redundant (Nr),
Swissprot [38], Cluster of Orthologous Groups (COG)
[39] and Kyoto Encyclopaedia of Genes and Genome
(KEGG) [40] using BLASTX [41] with an E-value cut-off
of 10−5. Gene Ontology (GO) was conducted utilizing de-
fault parameters using the BLAST2GO software [42,43]. It
was from the above mentioned databases that the gene
direction of the unigenes which were annotated and the
coding sequence were determined from the BLAST re-
sults. The prediction for the coding sequence and the gene
direction was performed by ESTscan [44] for those se-
quences with no defined annotation by using BLAST pre-
dicted coding sequence data as the training set.
Identification of differentially expressed unigenes
The FPKM method (Fragments Per kb per Million frag-
ments) was used to calculate the transcript expression
levels [45]. An FDR (false discovery rate) of <0.001 was
used as the threshold p-value in multiple tests to judge
the degree of differences in gene expression [46]. In a
given library when the p-value was less than 0.001 and
when the expression level showed greater than two-fold
change between two groups genes were considered as
differentially expressed.
Quantitative RT-PCR analysis
We selected seven differentially expressed M. rosenbergii
unigenes (arginine kinase 1, anti-lipopolysaccharide factor,
inhibitor of apoptosis protein, caspase, heat shock protein
21, lectin 1, and NF-kappa B inhibitor alpha) for quantita-
tive RT-PCR analysis (qRT-PCR) to evaluate our Illumina
sequencing result. The primer design for the seven
unigenes was performed by using Primer3 software http://
www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi/
and listed in Additional file 1. Using 1 μg of RNA, first
strand cDNA synthesis was carried out (similar to the
sample used for transcriptome sequencing) by using the
ImProm-II™ Reverse Transcription System (Promega). The
qRT-PCR reaction (20 μl) consisted of a 10 μl TaqMan
Universal RT-PCR Master Mix (Applied Biosystems, Foster
City, CA, USA), a 1 μl of primers/probe set containing 900
nM of forward reverse primers, a 300 nM probe and 2 μl of
template cDNA. The qRT-PCR program was set with an
incubation step at 50°C for 2 min, 40 cycles at 95°C for
10 min, 95°C for 15 sec, and 60°C for 1 min, carried out by
using Step One Plus Real-Time PCR System® (Applied
Biosystems). Similar qRT-PCR cycle profile was applied
for the internal control gene, Elongation factor 1-alpha
(primer sequences are listed in Additional file 1). The
expression level of the seven immune genes were ana-
lysed by using the comparative CT method (2 -ΔΔCT
method) [47].
Results
Illumina sequencing and assembly
The task of profiling all the immune-related genes in-
volved in V .parahaemolyticus infection began with se-
quencing the two cDNA libraries prepared from pooled
mRNAs obtained from the hepatopancreases of the con-
trol and infected groups using the Illumina HiSeq™ 2000
platform. A total of 59,122,940 raw reads were obtained
from the control group, and 58,385,094 reads from the
Vibrio-infected group. The raw reads were further fil-
tered to remove adaptor sequences, ambiguous reads
and low quality reads, thereby generating 90-bp of
54,708,014 and 54,295,342 clean reads for the control
and infected groups respectively ( Q20 ~ 98% and per-
centage of unknown nucleotide is 0%). All sequencing
reads were deposited into the Short Read Archive (SRA)
of the National Centre for Biotechnology Information
(NCBI), and can be accessed under the accession number
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SRR1424572 for control and SRR1424574 for Vibrio-in-
fected ones.
All the clean reads were subjected to de novo assembly
using the Trinity program which uses three independent
software modules – Inchworm, Chrysalis, and Butterfly
– applied sequentially to process the huge sequencing
data of RNA-seq reads. The assembly of the reads pro-
duced 95,645 contigs (with an N50 of 467 bp and mean
length of 313 bp) for the control group and 123,141 con-
tigs (with an N50 of 482 bp and mean length of 318 bp)
for Vibrio-infected group. These contigs were further as-
sembled into unigenes, producing 59,050 control uni-
genes (with an N50 of 685 bp and mean length of
479 bp) and 73,946 infected group unigenes (with an
N50 of 829 bp and mean length of 532 bp). The length
distribution of control and Vibrio-infected contigs and
unigenes are shown in Additional file 2. By clustering
unigenes from both libraries, a total of 64,411 standard
unigenes were produced, with a mean size of 698 bp and
an N50 of 1137 bp. An overview of the sequencing and
assembly is shown in Table 1.
The standard unigenes were annotated by searching
the sequences using BLASTX against the NCBI non-
redundant, Swiss-Prot, Kyoto Encyclopaedia of Genes
and Genome pathway (KEGG) and Orthologous Groups
of Proteins (COG) databases, which produced 19,799
(30.73%), 16,832 (26.13%), 14,706 (22.83%) and 7,856
(12.19%) hits respectively, giving a final total of 22,455
significant hits (34.86% of all unigenes). The size distri-
bution profile for the coding sequences (CDS) and iden-
tified proteins are shown in Additional file 2. A Gene
Ontology (GO) analysis search using the Blast2GO pro-
gram resulted in 6,007 unigenes (9.32%) being catego-
rized into 55 functional groups. The unigenes without
hits using the BLASTX analysis were subjected to an
ESTScan, producing 4,977 unigenes (7.82%) predicted to
contain coding sequences. The size distribution of the
ESTs and proteins are shown in Additional file 2.
The species distribution of the unigenes using the
BLASTX results is shown in Figure 1. The M. rosenbergii
unigenes were matched against Daphnia pulex sequences
(10.3%),Tribolium castaneum (6.1%) and Pediculus huma-
nus corporis (4.2%). The unigenes showed a match with
those of D. pulex and T. castaneum probably because of
their closer phylogenetic relationship and the availability
of vast genomic information. The remaining unigenes
(66.5%) which matched were similar to other species due
to limited genome information in crustaceans.
Functional annotation
The standard unigenes were analysed using the COG
database to classify them and predict their functions. A
total of 7,856 unigenes were assigned to COG classifica-
tions and functionally classified into 25 protein families
which mainly were involved in cellular structure, bio-
chemistry metabolism, molecular processing, and signal
transduction (Figure 2). The cluster predicted for general
function (3,431, 43.67%) emerged as the largest group,
followed by translation, ribosomal structure, biogenesis
cluster (1,760, 22.40%) and the replication, recombin-
ation, repair clusters (1,413, 17.98%). The clusters with
the lowest number of unigenes were nuclear structure
and extracellular structures (<1% in each cluster).
The standard unigenes with Nr annotations were sub-
jected to Gene Ontology (GO) analysis, which provides a
dynamic controlled vocabulary and hierarchical relation-
ship for the representation of information on molecular
functions, cellular components and biological processes,
allowing a coherent annotation of gene products. The
GO annotations produced 6,007 unigenes (biological
process: 2,177 unigenes; cellular component: 1,563 uni-
genes; and molecular function: 2,267 unigenes) which
were assigned to 55 GO ontology sub-categories (Figure 3).
In the molecular function category, most of the genes fell
into the ‘binding’ and ‘catalytic activity’ groups, whereas in
the biological process category, the majority of the genes
fell into the categories of ‘cellular processes’, ‘metabolic
processes’ and ‘single-organism processes’. Finally, in the
cellular component category, a high percentage of the
genes fell into the ‘cell’, ‘cell part’ and ‘organelle’ sub-
categories.
The Kyoto Encyclopaedia of Genes and Genomes
(KEGG) Pathway is a collection of manually drawn path-
way maps representing knowledge on molecular interac-
tions and reaction networks. Pathway-based analysis are
helpful in identifying biological functions and gene inter-
actions in the pathway. Using the KEGG database, 14,706
unigenes were grouped into 253 pathways. The majority
of the unigenes fell into the categories of “metabolic
Table 1 Summary of the control and V. parahaemolyticus
infected transcriptome sequencing
Control V. parahaemolyticus
infected
Total number of clean reads 54,708,014 54,295,342
Total base pairs (bp) 4,923,721,260 4,886,580,780
Q20 value 97.73% 97.77%
Total number of contigs 95,645 123,141
Mean length of contigs (bp) 313 318
Total number of unigenes 59,050 73,946
Mean length of unigenes (bp) 479 532
NCBI Nr annotated 19,799
Swiss-Prot annotated 16,832
KEGG annotated 14,706
COG annotated 7,856
GO annotated 6,007
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10.4%
6.1%
4.2%
3.7%
3.3%
3.0%
2.9%
66.5%
Figure 1 Species distribution of the BLASTX matches of the transcriptome unigenes. This figure shows the species distribution of unigene
BLASTX matches against the nr protein database (cutoff value E<10−5) and the proportions for each species.
Figure 2 Histogram presentation of Cluster of Orthologus Groups (COG) classification of 7,856 known protein annotated unigenes.
Each bar represents the number of unigenes classified into each of the 25 COG functional categories.
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pathways” (2192 members, 14.91%), “regulation of actin
cytoskeleton” (557 members, 3.79%), “spliceosome” (509
members, 3.46%), “RNA transport” (498 members, 3.38%)
and “focal adhesion” (475 members, 3.22% each). The least
represented pathways, with less than 10 unigenes catego-
rized in each pathway, were “biotin metabolism”, “phenyl-
alanine, tyrosine and tryptophan biosynthesis”, “vitamin
B6 metabolism”, “lipoic acid metabolism” and “thiamine
metabolism”. The top twenty of these KEGG biological
pathway classifications are shown in Figure 4.
Identification of aberrantly expressed genes
We identified differentially expressed genes between these
two groups by comparing the relative transcript abundance
in each unigene by using the FPKM method (Fragments
Per kb per Million fragments). A total of 14,569 unigenes
were found to be aberrantly expressed; 11,446 of these
were significantly up-regulated, whereas 3,103 uni-
genes were significantly down-regulated (Figure 5).
The differentially expressed genes were annotated
against the NR, Swiss-Prot, GO, COG and KEGG data-
bases by BLASTX with a cut-off E-value of 10−5. The
annotation analysis is presented in Additional file 3.
The 9,469 (65%) unigenes containing low sequence
homology to known sequences in public databases
could represent non-coding RNA, misassembled uni-
genes or unknown genes of M. rosenbergii which
responded to V. parahaemolyticus-infection.
For validation of the Illumina sequencing result,
seven unigenes were chosen randomly for quantitative
real time-PCR (qRT-PCR) analysis. The qRT-PCR
results showed similar trends for all the genes to the
sequencing data (Figure 6). For example, based on the
Illumina sequencing analysis, arginine kinase 1, anti-
lipopolysaccharide factor, inhibitor of apoptosis
protein, caspase, heat shock protein 21, lectin 1 and
NF-kappa B inhibitor alpha were up-regulated 4.67,
4.13, 1.02, 3.08, 4.61, 4.4 and 3.11 log2-fold respect-
ively; and the same elements showed 2.5, 4.4, 1.5, 2.1,
4.8, 3.6 and 2.7 log2-fold change respectively in the
qRT-PCR analysis. While the results from these two
analyses did not match perfectly, perhaps due to
sequencing biases, the qRT-PCR analysis broadly
confirmed the direction of change obtained from the
Illumina sequencing analysis.
Potential immune-related genes involved in M. rosenbergii
immune response
Many of the aberrantly expressed genes found in the
V. parahaemolyticus-infected groups compared to the
control group are known to belong to various
processes clustered under the animal immune system
(Table 2). These immune genes are grouped into 11
functions, including antimicrobial proteins, proteases
and proteinases, signal transduction, blood clotting
system, cell death, cytoskeletal, heat shock proteins,
oxidative stress, pathogen recognition immune recep-
tors, prophenoloxidase system and other immune
genes. The role of these groups is described in more
detail in the next (Discussion) section.
Figure 3 Gene ontology (GO) classification of the 6,007 protein annotated unigenes. Unigenes sequences were systematically classified
into GO sub-categories under the biological process, cellular component and molecular function gene ontology catalogue system. Each bar
represents the relative abundance of unigenes classified under each sub-category.
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Figure 4 Top 20 KEGG biological pathway classification histograms for annotated unigenes.
Figure 5 Digital gene expression between control group and V. parahaemolyticus infected group. Each point represents a unigene. The
x- and y-axis are the log10 of the normalized expression level (FPKM) of unigene between the two groups. Red and green points indicate significant
change at the absolute value of log2 (FPKM ratio in two groups) ≥1 and fdr =0.001. Red points indicate up-regulated unigenes and green points
indicate down-regulated unigenes in the two groups which its expression level is represented by the y-axis. Blue points indicate insignificant
differentially expressed unigenes.
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Discussion
Apart from viral diseases,Vibrio infections causing Vibriosis
is another factor hindering the shrimp aquaculture in-
dustry worldwide [9]. This fatal disease has contributed
to mass mortality and severe economic losses in India,
Thailand, Philippines, Japan, Ecuador, Peru, Colombia
and Central America [13]. Knowledge about the inter-
action between M. rosenbergii and Vibrio species is in
its infancy, and in-depth study is urgently needed to ad-
dress this issue. Discovery of the molecular mechanisms
surrounding the innate immune system against Vibrio
infection in freshwater prawns should be beneficial to both
scientific research and the aquaculture industry. Identify-
ing and quantifying immune-related gene expression on a
large scale is a promising method to investigate the host
response against pathogens and provide a platform for fur-
ther studies in this area.
Microarray and EST analyses have long been used to
study the molecular mechanisms underlying the innate
immune system and to identify genes aberrantly expressed
during infection [48-50]. However, the most recent NGS
platforms such as the Illumina HiSeq™ 2000 appear much
better at quantifying transcripts expressed at low levels
than microarrays or EST analysis [29]. This is because this
revolutionary technique verifies direct transcript profiling
without compromise or bias, unlike previous methods
[27]. Furthermore, this technology has been successfully
used in transcriptome profiling studies on non-model or-
ganisms where there is no complete genome database
[51-53]. The introduction of NGS technology has led to
various studies on host-viral interactions in shrimps to
identify potential immune-related genes [54-56] – but not
so far on the interaction between the freshwater prawn
and Vibrio species. To our knowledge, this study could be
the very first to use the Illumina HiSeq™ 2000 platform to
explore the immune-related gene response in M. rosenber-
gii against V. parahaemolyticus.
Taking advantage of the Illumina HiSeq™ 2000 plat-
form’s capability to sequence with a high throughput
data providing more candidate genes, the total RNA ex-
tracted at the 12th hour time point from a pool of con-
trol and infected hepatopancreases was sequenced and
assembled using the Trinity assembler. The overall ana-
lysis yielded 14,549 differentially expressed unigenes,
with 11,446 unigenes significantly up-regulated and
3,103 unigenes significantly down-regulated. The se-
quencing data analyses obtained clearly showed a signifi-
cant impact of V. parahaemolyticus infection on the M.
rosenbergii transcriptome.
M. rosenbergii possesses an innate immune system,
consisting of cellular and humoral components which
work individually or cooperatively to protect the species
from invading pathogens such as V. parahaemolyticus
[17,18]. This immune response is activated when the ani-
mal detects the invading pathogen through pattern recog-
nition proteins (PRPs) [57]. Two important PRPs
molecules identified in shrimp are lectins and the beta-
1,3- glucan binding protein (LGBP) [58-61]. Besides
pathogen recognition, lectins are also involved in phago-
cytosis through opsonisation in crustaceans [62]. Our data
Figure 6 Comparison of the expression profiles of selected genes as determined by Illumina Hiseq TM 2000 sequencing (green) and
qRT-PCR (blue). Target gene abbreviations are as follows: AK1 - arginine kinase, ALF- anti-lipopolysaccharide factor, IAPs- apoptosis inhibitor,
Casp- caspase, HSP21- heat shock protein 21, LT1- lectin 1, NFκBI-α - NF-kappa B inhibitor alpha. Error bars indicated standard deviations of
averages from three replicates.
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Table 2 Candidate genes involved in M. rosenbergii immune response against V. parahaemolyticus
Category or gene id Homologues function Species FC*
Antimicrobial
Unigene4120_all Anti-lipopolysaccharide factor Macrobrachium rosenbergii 4.13
Unigene23546_all Anti-lipopolysaccharide factor 2 Macrobrachium rosenbergii 2.84
CL1276.Contig1_all Anti-lipopolysaccharide factor 3 Macrobrachium rosenbergii 2.15
Unigene37309_all Crustin Macrobrachium rosenbergii 5.13
Unigene26338_all Lysozyme Portunus trituberculatus 1.92
Unigene13073_all NF-kappa B inhibitor alpha Macrobrachium rosenbergii 3.11
Blood clotting system
Unigene13048_all Clottable protein Marsupenaeus japonicus 1.42
Unigene34308_all Transglutaminase Macrobrachium rosenbergii 11.34
Unigene36567_all Proclotting enzyme Harpegnathos saltator 11.22
Unigene41253_all Coagulation factor XII Hageman factor 10.61
PRPs
Unigene10978_all Lectin 1 Macrobrachium rosenbergii 4.4
CL4516.Contig1_all Lectin 2 Macrobrachium rosenbergii 1.05
Unigene7825_all Lectin 3 Macrobrachium rosenbergii 2.54
CL3039.Contig4_all Lectin 4 Macrobrachium rosenbergii 4.55
Unigene9635_all C-type lectin Penaeus monodon 1.14
CL1600.Contig1_all C-type lectin-2 Litopenaeus vannamei 1.69
CL5230.Contig3_all C-type lectin 5 Fenneropenaeus chinensis 2
Unigene1391_all Hemolectin Papilio xuthus 5.81
Unigene25701_all M-type lectin Marsupenaeus japonicus 1.69
Unigene23215_all Perlucin-like protein Mytilus galloprovincialis −1.92
CL1075.Contig4_all Tachylectin Macrobrachium rosenbergii −1.71
Unigene28944_all Ficolin Branchiostoma floridae 1.31
Unigene19793_all Lectin B isoform 2 Marsupenaeus japonicus 3.55
Unigene37041_all Mannose-binding protein Procambarus clarkii 11.69
CL1124.Contig1_all Glucan pattern-recognition lipoprotein Fenneropenaeus chinensis 1.12
Unigene23671_all lipopolysaccharide and beta-1,3-glucan binding protein Macrobrachium rosenbergii 1.71
Proteinases and proteinases inhibitors
Unigene1509_all Cathepsin B Pandalus borealis 1.87
Unigene22859_all Cathepsin C Fenneropenaeus chinensis 2.33
CL1587.Contig2_all Cathepsin D Penaeus monodon −1.56
Unigene26111_all Cathepsin L Pandalus borealis 1.41
CL5824.Contig1_all Serpin serine protease inhibitor Fenneropenaeus chinensis 12.24
CL6038.Contig1_all 26S protease regulatory Nasonia vitripennis 1.44
Unigene12869_all Alpha-2-macroglobulin Macrobrachium rosenbergii 5.09
CL2365.Contig1_all Caspase Marsupenaeus japonicus 1.04
Unigene13293_all Astacin Strongylocentrotus purpuratus 1.64
Unigene13633_all Serine protease Fenneropenaeus chinensis 3.08
Unigene17259_all Caspase 8 Ictalurus punctatus 2.41
CL2565.Contig1_all Serine proteinase inhibitor 6 Penaeus monodon 4.51
CL1118.Contig1_all Serpin B Marsupenaeus japonicus 7.02
Unigene26757_all Hemocyte kazal-type proteinase inhibitor Penaeus monodon 3.87
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Table 2 Candidate genes involved in M. rosenbergii immune response against V. parahaemolyticus (Continued)
CL1127.Contig2_all Kazal-type serine proteinase inhibitor 4 Procambarus clarkii −6.01
CL5487.Contig2_all Aminopeptidase N Camponotus floridanus 1.4
Unigene5621_all Masquerade-like serine proteinase-like protein 2 Penaeus monodon 5.39
Unigene21512_all Serine proteinase inhibitor Macrobrachium rosenbergii 6.91
Unigene28987_all CUB-serine protease Panulirus argus 2.92
Heat shock proteins
Unigene3736_all Heat shock protein 21 Macrobrachium rosenbergii 4.61
Unigene23034_all Heat shock protein 40 Frankliniella occidentalis 1.8
Unigene14757_all Heat shock protein 70 Portunus trituberculatus 2.26
CL4309.Contig3_all Heat shock protein 90 Scylla paramamosain 1.93
Unigene16858_all Small heat shock protein Fenneropenaeus chinensis 2.41
Oxidative stress
CL353.Contig2_all Glutathione S transferase Procambarus clarkii 1.01
Unigene19405_all Cu/Zn superoxide dismutase Bombyx mori 1.61
CL5590.Contig3_all Glutamine synthetase Panulirus argus −3.03
CL559.Contig1_all Farnesoic acid O-methyltransferase Nilaparvata lugens 1.81
CL2477.Contig1 Catalase Litopenaeus vannamei 1.6
CL2787.Contig2 Thioredoxin reductase Branchiostoma floridae 1.09
Cytoskeletal
Unigene10471 Chitinase Trichomonas vaginalis 6.16
CL6026.Contig5_all Actin Marsupenaeus japonicus 2.92
Unigene13021_all Calponin Chironomus riparius 2.32
CL5710.Contig1_all Profilin Fenneropenaeus chinensis 1.45
CL461.Contig8_all Tubulin Homarus americanus 1.39
Unigene19173_all Beta-integrin Fenneropenaeus chinensis 2.78
CL2046.Contig1_all Integrin Litopenaeus vannamei 3.03
Signal transduction
Toll pathway
CL1915.Contig5_all Toll interacting protein Marsupenaeus japonicus 1.73
CL5402.Contig1_all Toll receptor 2 Marsupenaeus japonicus −2.46
Unigene25507_all Toll-like receptor 3 Daphnia pulex 2.59
CL2421.Contig1_all Toll-like receptor 8 Ixodes scapulari 1.48
Unigene25799_all Myd88 protein Artemia sinica 3.25
Unigene9776_all Caspase Fenneropenaeus merguiensis 3.08
Unigene14481_all Dorsal Fenneropenaeus chinensis 3.19
Wnt signaling pathway
Unigene36938_all Lipoprotein receptor Callinectes sapidus 10.94
Unigene15960_all Prickle Saccoglossus kowalevskii 1.71
Unigene15970_all Low-density lipoprotein receptor-related protein 6 Daphnia pulex 2.05
Unigene12737_all Glypican 4 Daphnia pulex 1.14
Unigene25938_all Secreted frizzled-related protein 5 Daphnia pulex 1.82
MAPK signaling pathway
Unigene26817_all Mitogen-activated protein kinase kinase kinase 1 Oryctolagus cuniculus 2.79
Unigene110_all Mitogen-activated protein kinase 8 interacting protein 3 Bombus terrestris 2.94
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Table 2 Candidate genes involved in M. rosenbergii immune response against V. parahaemolyticus (Continued)
CL726.Contig3_all Mitogen-activated protein kinase kinase kinase kinase 4 Bombus terrestris 1.65
CL3174.Contig1_all Mitogen-activated protein kinase kinase kinase 7 Danaus plexippus 1.41
Unigene29569_all Mitogen-activated protein kinase kinase kinase 13 Bombus terrestris 4.03
CL4432.Contig2_all Max protein Daphnia pulex −3.11
Unigene14757_all Heat shock protein 70 Portunus trituberculatus 2.26
Unigene3873_all Protein phosphatase 5 Bombus terrestris 1.21
Unigene102_all Map kinase-interacting serine/threonine Scylla paramamosain 2.48
Unigene11596_all Raf homolog serine/threonine-protein kinase phl-like Nasonia vitripennis 2.41
JAK/STAT pathway
Unigene25562_all STAT long form Penaeus monodon 2.84
Unigene25762_all Signal transducing adaptor molecule Megachile rotundata 1.98
Unigene16474_all Tumor susceptibility gene 101 protein Harpegnathos saltator 2.46
CL1133.Contig6_all Domeless Tribolium castaneum 2.94
Unigene28876_all Thyroid peroxidase Pediculus humanus corporis 3.66
Other signal transduction genes
CL1409.Contig1_all Innexin 3 Cancer borealis 10.29
Unigene30035_all cAMP-dependent protein kinase type II regulatory subunit Camponotus floridanus 1.05
CL3406.Contig2_all Casein kinase II subunit alpha Danaus plexippus 1.75
CL4247.Contig1_all Rab-protein 14 Tribolium castaneum 1.85
Unigene37520_all Afadin Pediculus humanus corporis 2.89
Unigene34256_all TBC1 domain family member 10B Crassostrea gigas 11.52
Unigene33128_all REM2- and Rab-like small GTPase 1-like Cavia porcellus 3.21
ProPO system
Unigene12734_all Prophenoloxidase Macrobrachium rosenbergii 3.15
Unigene7353_all Prophenoloxidase activating factor Fenneropenaeus chinensis 3.79
Unigene18337_all Prophenoloxide activating enzyme III Macrobrachium rosenbergii 4.99
Cell death
Unigene2555_all Beclin 1 Megachile rotundata 11.89
CL1843.Contig2_all ALG-2 interacting protein x Penaeus monodon Penaeus monodon 3.2
Unigene14045_all Program cell death 5-like Penaeus monodon 1.61
CL2477.Contig1_all Catalase Litopenaeus vannamei 1.6
Unigene3163_all inhibitor of apoptosis protein Litopenaeus vannamei 1.02
Unigene9776_all Caspase Fenneropenaeus merguiensis 3.08
Unigene36052_all DNA fragmentation factor subunit beta Danio rerio 3.26
Other immune genes
CL4920.Contig1_all Calmodulin Procambarus clarkii 1.92
CL1939.Contig4_all Ferritin Litopenaeus vannamei −2.87
CL4071.Contig2_all Peritrophin Macrobrachium nipponense −2.18
Unigene10835_all Selenoprotein W Cricetulus griseus −1.98
Unigene26739_all Metallothionein I Macrobrachium rosenbergii −2.75
Unigene29279_all Selenoprotein L Ciona intestinalis 1.06
CL6324.Contig2_all Arginine kinase 1 Macrobrachium rosenbergii 4.67
CL5294.Contig2_all Hemocyanin Macrobrachium nipponense 1.21
Unigene26326_all Tetraspanin-like protein CD9 Fenneropenaeus chinensis 1.02
CL4316.Contig1_all Crustacyanin-like lipocalin Macrobrachium rosenbergii −4.12
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showed that challenge by V. parahaemolyticus greatly af-
fects the expression of PRPs, as observed in previous stud-
ies using different Vibrio strains [63-67]. The activation of
LGBP molecules triggers the melanisation process, a
prophenoloxidase-activating system (proPO-AS) which is
an enzymatic cascade involving several enzymes, including
the key enzyme phenoloxidase (PO) [68-70]. The active
PO converts phenols into quinones. These build a non-
specific crosslink between neighbouring molecules to form
melanin, which provides defence against invading micro-
organisms [71]. Increased activity of prophenoloxidase
against Vibrio species has also been noted in Fennerope-
naeus indicus [72], L. vannamei [73] and P. monodon [74].
Antimicrobial peptides (AMPs) play a pivotal role in
killing or clearing infected pathogens, especially Vibrio
species [75]. Notable shrimp AMPs, such as penaeidins,
lysozymes, crustins, anti-lipopolysaccharide factors
(ALFs) and stylicins have been identified and character-
ized previously in shrimps [76-80]. However, only four
types of AMPs – lysozyme, crustin, NF-kappa B inhibi-
tor alpha and ALF (3 isoforms) – were detected in our
transcriptome data and found to be highly expressed.
The up-regulation of these AMPs correlated with previ-
ous studies showing their antimicrobial properties
against Vibrio species and other bacteria [81-84]. Blood
clotting is vital in crustaceans to prevent excess blood
loss from a wound and prevent micro-organisms from
invading the wound [85]. We found four molecules of
the blood clotting system – transglutaminase, clottable
protein, proclotting enzyme and coagulation factor XII –
to be highly induced in our transcriptome data after
challenge by V. parahaemolyticus. A similar expression
of these molecules after bacterial challenge has been re-
ported in previous studies [72,86,87].
Stress conditions such as bacterial infections lead to an
accumulation of reactive oxygen species (ROS) in a cell
[88]. Increased levels of ROS causes oxidative damage to
important cellular macromolecules (lipids, proteins, car-
bohydrates and nucleotides) which are components of the
membranes, cellular enzymes and DNA [89]. In order to
restrict the production of ROS, antioxidant genes are acti-
vated to produce antioxidant enzymes which eliminate
ROS. Several antioxidant enzymes have been isolated and
characterised in the penaeid shrimp in previous studies
[90-92]. In this study, we found six antioxidant unigenes
to be over-expressed after V. parahaemolyticus challenge
– the exception being glutamine synthetase. High expres-
sion levels of these genes have similarly been observed in
other shrimps and scallops after Vibrio challenge [93-96].
The up-regulation of actin and tubulin genes play a crucial
role in a wide range of cellular functions such as nodule
formation, phagocytosis, encapsulation, as well as cell
shape change, cell motility and adhesion, all of which may
aid in clearing the pathogen [97].
Heat shock proteins (HSPs) are highly generated when
induced by stress. They are known to play a major role
in protein folding, the protection of proteins from de-
naturation or aggregation, and aiding protein transport
through membrane channels [98,99]. In addition to mo-
lecular chaperones, HSPs have been reported to play
important roles in innate immune responses, and have
been well studied in crustaceans [100-102]. In this
study, we noted higher levels of expression of all heat
shock proteins in M. rosenbergii when challenged by V.
parahaemolyticus. The increased expression of these
HSPs is in line with previous reports, which tends to
confirm the important role of these proteins in pro-
tecting this species from the stress induced by Vibrio
challenge [97,103,104]. The general higher expression
of proteinases and their inhibitors was to be expected
in our data, as these are known to modulate elements
of the innate immune system such as haemolymph co-
agulation, antimicrobial peptide synthesis, cell adhe-
sion, and melanisation [105].
Bacteria like Vibrio are known to induce cell apoptosis
through a variety of mechanisms such as pore-forming
proteins, secretion of protein synthesis inhibitors, mole-
cules activating the endogenous death machinery in an
infected cell, lipopolysaccharides, and other superanti-
gens [106]. Increased levels of apoptosis contribute to
the degradation of DNA and RNA, which may contrib-
ute to shrimp mortality [107]. In our transcriptome data,
an up-regulation of genes involved in apoptosis was ob-
served, similar to the trends reported in previous studies
[74,108,109]. Apoptosis may also serve as host defence
against bacterium by allowing other healthy cells to
phagocytise apoptotic bodies containing bacteria from
target cells, effectively clearing the pathogen [110].
The signalling pathways involved in the M. rosenbergii
innate immune response against V. parahaemolyticus
Table 2 Candidate genes involved in M. rosenbergii immune response against V. parahaemolyticus (Continued)
CL6297.Contig2_all E cadherin Tenebrio molitor 3.19
CL2339.Contig2_all Adenosine deaminase Caligus rogercresseyi −1.35
CL3196.Contig2_all Calnexin Penaeus monodon 1.57
CL2701.Contig1_all Ubiquitin-conjugating enzyme Macrobrachium nipponense 1.33
*Fold changes (Log2 ratio) in gene expression. PRPs- pattern recognition proteins, ProPO- prophenoloxidase.
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were observed to be highly induced in our transcriptome
data. The Toll protein initially identified in Drosophila
had been reported to play a key role in the anti-fungal
and anti-Gram-positive bacterial responses of flies in the
Toll pathway [111]. Other Toll components have also
been found to be activated in penaeid shrimps when
challenged with Vibrio species [109,112,113]. In Caenor-
habditis elegans, the mitogen-activated protein kinase
(MAPK) pathways are transcriptionally up-regulated by
the pore-forming toxin released by Bacillus thuringien-
sis, which provide a cellular defence against this toxin
[114]. This could explain the higher expression of this
signalling pathway in our data, as V. parahaemolyticus is
known to release a thermostable direct haemolysin,
which is a pore-forming toxin [115]. The Janus kinase
(JAK) and signal transducer and activator of transcrip-
tion (STAT) pathways have been reported to be activated
when Fenneropenaeus chinensis is challenged with Vibrio
anguillarum, which suggest that these pathways are im-
portant for immune responses against bacteria [116]. In
addition, Rab-related proteins have been reported to
regulate the hemocytic phagocytosis of bacteria in
Marsupenaeus japonicas [117].
Several genes in the other immune gene group were
found to be aberrantly expressed in our transcriptome
data. Calmodulin, which plays an important role in
calcium-dependent signal transduction pathways, was
over-expressed in our data – as was the case in L. van-
namei when challenged with V. parahaemolyticus
[118]. Ferritin, an iron storage protein crucial for the
metabolism of iron and maintaining iron homeostasis
in a cell, was found to be down-regulated. The reduced
expression of this gene could possibly lead to prawn
mortality, as increased expression of this gene has been
found to protect P. monodon from Vibrio harveyi
[119]. Arginine kinase (AK), a phosphagen kinase in
the invertebrate energy metabolism, has previously
been reported to play an immune role against viral in-
fection [32]. However, we observed a higher expression
of this gene in M. rosenbergii after challenge by V.
parahaemolyticus, which could suggest that AK plays a
similar role in bacterial infection. Haemocyanin, an
important immune gene in crustaceans, is involved in
prophenoloxidase activity [120]. It has antiviral proper-
ties against WSSV [121], and its increased expression
in our transcriptome data tends to bear out its import-
ance as a defence molecule against challenge by V.
parahaemolyticus. Finally, metallothioneins, a metal-
binding protein, was found to be highly expressed in
our transcriptome data. The increased expression of
this gene was to be expected, as it is known as a scav-
enger of reactive oxygen intermediates and generally
shows higher expression levels during immune re-
sponses in invertebrates against pathogens [49].
Conclusion
We utilised the Illumina HiSeq™ 2000 platform and Trin-
ity assembler package to perform a de novo transcriptome
profiling of the hepatopancreases isolated from M. rosen-
bergii challenged with V. parahaemolyticus. The differential
expression analysis between V. parahaemolyticus-infected
and control groups revealed significant differences in the
gene expression with 11,446 unigenes found to be signifi-
cantly up-regulated and 3,103 unigenes observed to be sig-
nificantly down-regulated. This study provided a valuable
insight into antibacterial mechanisms of freshwater prawn
against V. parahaemolyticus with majority of the differ-
entially expressed unigenes were grouped into 11 animal
immune system categories. Furthermore, this study has
generated an abundant list of transcript from M.rosen-
bergii which will provide a fundamental basis for future
genomics research in this field.
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Genomes of Two Clinical Isolates of Mycobacterium tuberculosis from
Odisha, India
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We report whole-genome sequences of two clinical isolates ofMycobacterium tuberculosis isolated from patients in Odisha, In-
dia. The sequence analysis revealed that these isolates are of an ancestral type andmight represent some of the “pristine” isolates
in India that have not admixed with other lineages.
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Tuberculosis caused by Mycobacterium tuberculosis is a chronicinfectious disease that is often fatal if not effectively treated.
Every year, 8 to 9 million new infections and a death toll of 1.5
million are recorded worldwide. It is estimated that about one-
third of the human population is infected with M. tuberculosis (1).
Comparative genomic studies have provided deeper insights into
the genetic diversity and clonal architecture of M. tuberculosis (2).
Recent studies conducted on isolates from India have shown that
highly concentrated reservoirs of the ancestral M. tuberculosis lin-
eages prevail in South and Central India (3–6). Only a limited
number ofM. tuberculosis genomes from India are sequenced. The
whole-genome analysis of ancestral and modern lineages would
facilitate deciphering of the genetic variability and evolutionary
mechanisms of this obligate parasite. We describe the whole-
genome sequences of two M. tuberculosis strains, NA-A0008 and
NA-A0009, isolated in 2008 from patients in rural Odisha, India.
Genomic DNAs of both strains were isolated using the Qiagen
kit method. Whole-genome sequencing was carried out on an Ion
Torrent sequencing platform (Life Technologies). The process
generated 3 million and 2.9 million reads amounting to 89 and
93 genome coverage for NA-A0008 and NA-A0009, respec-
tively, with a mean read length of 250 bp. The reads after filtration
were assembled into 280 and 310 contigs for NA-A0008 and NA-
A0009, respectively, using the MIRA v.2 de novo assembler. These
contigs were ordered and reoriented according to the M. tubercu-
losis CCDC 5180 genome using in-house written scripts. The re-
sulting draft genomes were annotated using the RAST annotation
server (7), and CDSs were validated by comparing outputs from
EasyGene (8) and Glimmer (9), as done previously (10–13). The
number of rRNA operons were predicted in both strains using
RNAmmer (14), while tRNAscan-SE (15) was used to identify
tRNA sequences. Artemis (16) was used to glean the genome sta-
tistics of both the strains. The genome sizes of NA-A0008 and
NA-A0009 were 4,259,206 and 4,271,739 bp, with coding percent-
ages of 89.4% and 89.3%, respectively. The GC contents of both
strains were high, as usually observed for the M. tuberculosis com-
plex, 65.31% (NA-A0008) and 65.28% (NA-A0009). The two ge-
nomes, NA-A0008 and NA-A0009, were predicted to encode
4,400 and 4,453 CDSs with average lengths of 866 and 857 bp,
respectively. Both of them contained a single rRNA operon and 45
tRNA genes.
The availability of these genome sequences would definitely
complement the gene pool analysis of the Indian strains from
different parts of the country. Besides this, comparative genomic
analysis and phylogenetic study of these isolates with other M. tu-
berculosis strains might give us important insights into the biology
and molecular epidemiology of this organism.
Nucleotide sequence accession numbers. The M. tuberculosis
NA-A0008 and NA-A0009 whole-genome shotgun projects have
been deposited in the GenBank database under the accession
numbers ALYG00000000 and ALYH00000000, respectively. The
BioProject designations for these projects are PRJNA168604 and
PRJNA168605, respectively.
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Genome anatomy of the gastrointestinal
pathogen, Vibrio parahaemolyticus of
crustacean origin
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Abstract
Vibrio parahaemolyticus, an important human pathogen, is associated with gastroenteritis and transmitted through
partially cooked seafood. It has become a major concern in the production and trade of marine food products. The
prevalence of potentially virulent and pathogenic V. parahaemolyticus in raw seafood is of public health
significance. Here we describe the genome sequence of a V. parahaemolyticus isolate of crustacean origin which
was cultured from prawns in 2008 in Selangor, Malaysia (isolate PCV08-7). The next generation sequencing and
analysis revealed that the genome of isolate PCV08-7 has closest similarity to that of V. parahaemolyticus RIMD2210633.
However, there are certain unique features of the PCV08-7 genome such as the absence of TDH-related hemolysin (TRH),
and the presence of HU-alpha insertion. The genome of isolate PCV08-7 encodes a thermostable direct hemolysin
(TDH), an important virulence factor that classifies PCV08-7 isolate to be a serovariant of O3:K6 strain. Apart from these,
we observed that there is certain pattern of genetic rearrangements that makes V. parahaemolyticus PCV08-7 a
non-pandemic clone. We present detailed genome statistics and important genetic features of this bacterium and
discuss how its survival, adaptation and virulence in marine and terrestrial hosts can be understood through the genomic
blueprint and that the availability of genome sequence entailing this important Malaysian isolate would likely enhance
our understanding of the epidemiology, evolution and transmission of foodborne Vibrios in Malaysia and elsewhere.
Keywords: Vibrio parahaemolyticus, Genomics, Malaysia, Seafood, Comparative genomics
Background
Vibrio parahaemolyticus inhabits the estuarine, marine
and brackish water ecosystems. It is an important human
pathogen associated with gastroenteritis linked to contami-
nated seafood consumption. Since this species is abundant
in marine products, it has become a significant concern in
the production and trade of seafood worldwide [1]. In
Southeast Asian countries, including Malaysia, virulent V.
parahaemolyticus in raw seafood have been reported [2,3].
Numerous cases of V. parahaemolyticus infection were re-
ported in North America, South East Asia and Japan in-
cluding some places in East Asia [4-10] giving the illness a
pandemic status affecting thousands of people. Thus, the
prevalence of pathogenic Vibrios in seafood is of public
health concern and is an open ended issue.
The pathogenic V. parahaemolyticus strains are differen-
tiated from non-pathogenic ones by their ability to cause
beta-haemolysis on Wagatsuma agar, an activity known as
‘Kanagawa phenomenon’. This effect is mediated by the ac-
tivity of thermostable direct hemolysin (TDH) encoded by
the tdh genes [8]. A pandemic clone of V. parahaemolyti-
cus can broadly be defined as the one that is positive for
TDH and exhibits the Kanagawa phenomenon [10].
V. parahaemolyticus strains are classified based on the
types and variants of their O antigen and flagellar anti-
gen (K). There are 13 O-serogroups and 71 K antigens
and various combinations of these give rise to a wide
variety of serovars which have been recognized as the
causative agents of the disease. A clone of serovar O3:K6
has recently emerged and was associated with outbreaks
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in India and Japan [7]. Frequent recombination events that
promote clonal diversification suggest a scenario whereby
a subset of O3:K6 strains might continue to evolve [11].
Consequently, different groups of related O3:K6 clonal
strains have now been globally disseminated in Asia,
North and South America, Africa and Europe [7].
The genomes of V. parahaemolyticus strains are said
to have undergone a number of recombination events
that could have been the reason for serotype conversion
from O3:K6 to O4:K68 [12]. Regions of recombination
likely involve a genetic element larger than the gene
clusters encoding O and K-antigens. More than 20 sero-
variants which include O3:K6, O4:K68, O1:K25, O6:K18
and O1:KUT [13,14] emerged from an original pandemic
strain, O3:K6. The pandemic group of these bacteria has
evolved through a number of deletions, substitutions
and acquisitions of regions primarily corresponding to
TDH or a TDH-related hemolysin (TRH). It is the pres-
ence of either of these two virulence factors that confer
potential to cause gastroenteritis in human populations.
The pandemic clone is said to have emerged from a pre-
pandemic clone which was positive for TRH and nega-
tive for TDH genes and harbored a new sequence of
toxR (GS-PCR). The intermediate clone is described as
being negative for both TRH and TDH, but positive for
GS-PCR.
It has been observed that V. parahaemolyticus contains
two chromosomes; V. parahaemolyticus RIMD2210633
has 3.2 Mb and 1.8 Mb of genome sizes for chromosome1
and 2 respectively [15]. There are several V. parahaemoly-
ticus genomes which have been sequenced and deposited
in Genbank as whole genomes or shotgun submissions
(WGS) and sequence read archives (SRA). The only
fully annotated submissions entail V. parahaemolyticus
RIMD2210633 and V. parahaemolyticus BB220P. The V.
parahaemolyticus RIMD2210633 genome harbors a Type
III secretion system as a central virulence factor which is
found in most diarrhea-causing bacteria [15]. As men-
tioned above, many studies link to the evolutionary
aspects of the present pandemic clone formed from a pre-
pandemic clone with a drastic change in its gene content
i.e., the evolution from a TDH negative/TRH positive to a
TDH positive/TRH negative strain and the occurrence of
several serovariants in the V. parahaemolyticus species.
The present isolate (V. parahaemolyticus PCV08-7) has
been recovered from seafood (prawn) in 2008 which were
purchased from a wet market in Selangor, Malaysia.
The main purpose of this study was to analyze the
PCV08-7 genome that originates from Malaysia, a large
peninsular as well as archipelagic country having a thriv-
ing seafood business and that it experiences several food
borne outbreaks each season. Unfortunately, there are no
markers based on native genome(s) to guide detection of
V. parahaemolyticus in wet market, in the aquaculture
farms and from human excreta and blood. We hope
that this genome sequence will be helpful in identifying
markers relevant in diagnostic development and molecular
epidemiology/transmission dynamics of this significant
bacterium in Malaysia and elsewhere.
Methods
Source, isolation and culture of V. parahaemolyticus
PCV08-7
The V. parahaemolyticus PCV08-7 (VPPCV08-7) isolate
was identified and characterized by obtaining pure cul-
tures on selective media followed by analysis through
biochemical tests, Analytical Profile Index (API) tests
and genetic confirmation by PCR. The bacterial culture
was maintained by streak plate on a Thiosulfate-Citrate-
Bile-Sucrose (Difco, France) agar plates. After incubation
at 37°C for 21 – 24 hr, characteristic bacterial colonies
appeared with blue-green colored boundaries. An iso-
lated bacterial colony was cultured in Luria-Bertani (LB)
broth with 2% Sodium Chloride (NaCl) and incubated
overnight at 37°C for 16 – 18 hr. This bacterial culture
was further maintained as glycerol stocks at −80°C in
20% glycerol. The genomic DNA was isolated from a
pure, single colony. The bacterial identity was confirmed
by sequence analysis of the 16S rRNA.
Genomic DNA isolation and Next-Generation Sequencing
The genomic DNA was isolated using Qiagen DNeasy
Blood & Tissue kit (Qiagen, Germany) and the genome se-
quence was determined by Illumina genome analyzer at
the Genotypic Technology Pvt. Ltd. Bengaluru, India
(GA2x, pipeline version 1.6). The sequencing data com-
prised of 100 bp paired-end reads with an insert size corre-
sponding to approximately 240 bp. The genome coverage
obtained was approximately about 80X with per base qual-
ity of reads in a range of 25 – 40. A total of 3.8 million
reads were generated. Bioinformatics analysis was carried
out with the help of protocols, algorithms and scripts de-
veloped, customized and tested in Ahmed Labs.
Assembly and alignment
Various strategies were applied to resolve the difficulties
in dealing with the two chromosomes to be assembled
from the sequence reads. The following main approaches
were adopted:
1. Velvet [16]: Contigs were generated using the
sequence reads which consisted of information from
both the chromosomes of the isolate PCV08-7. This
was checked by manually comparing contigs against
the NCBI database by BLAST to check the highest
similarity hit. V. parahaemolyticus RIMD2210633
was found to be the closest match in each search.
The contigs showed unique hits to chromosome 1
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(CHR1) and chromosome 2 (CHR2) as well as few
common hits at both the chromosomes. The strat-
egy of using the contigs together representing a
whole genome (i.e., CHR1 and CHR2 together) or
using the contigs separately as CHR1 and CHR2 was
found to be challenging for further analysis to as-
semble them separately into two chromosomal
sequences.
2. OSLAY [17]: All the contigs were compared against
both the chromosomes of the genome of
RIMD2210633 individually and were then used to
form supercontigs for both the chromosomes
separately. This procedure was found to be
problematic as the supercontig files generated from
CHR1 and CHR2 (separately) revealed that the
preliminary contigs mapped to sequences in both
the supercontig files. This was perhaps due to the
input file comprising assembled whole genome
contigs used against CHR1 and CHR2. The second
strategy under OSLAY was to attach CHR1 and
CHR2 of the reference genome RIMD2210633 as
follows: CHR1 and CHR2 were concatenated (as a
‘whole genome stretch’) and then further used as
one full length single sequence. Using this whole
genome stretch for BLAST analysis, supercontigs
were generated using Velvet contigs and the BLAST
results. This also eventually proved inefficient since
the supercontigs contained some sequences with
several ‘N’ representing a gap in this case and such
supercontigs had to be sorted to their own positions
on the genome.
3. SSPACE [18]: Scaffolding was performed on velvet
assembled contigs. As explained above, scaffolds
were obtained separately from both CHR1 and
CHR2 as well as with the whole genome stretch. All
the scaffolds were then BLAST analyzed against
both CHR1 and CHR2 of the reference genome
individually, as well as at the level of the whole
genome stretch. The difficulty faced with scaffolding
was similar to that of OSLAY. Hence, the option of
separately identifying the scaffolds with respect to
CHR1 and CHR2 and dealing with them separately
remained a problem.
4. Mauve [19]: Velvet assembled contigs were used at
this step and exported as sorted contigs by performing
an alignment against the whole genome stretch. The
results obtained as aligned sorted contigs were taken
through a stand-alone BLAST protocol against the
whole genome of RIMD2210633. Then the BLAST
results were carefully checked for their positions
corresponding to both CHR1 and CHR2. The contigs
were carefully divided as belonging to CHR1 and
CHR2 sequences of PCV08-7 draft genome. The is-
sues faced here were limited to identifying and dealing
with the sequences other than those present in the
contigs, but which were common to both
RIMD2210633 and PCV08-7 genomes. While working
on the above strategies, BWA alignment [20] was
performed using sequence reads against the
whole genome stretch of VPRIMD2210633. Using
SAMTOOLS [21] a .sam file was generated with
which the whole genome of RIMD2210633/FASTA
sequence was loaded on Tablet viewer [22] to manu-
ally inspect the presence of common genes and to
position the draft genome of PCV08-7.
The sequencing reads obtained by us were primarily
passed through a quality control step using FASTX toolkit
[23] to obtain high quality reads free from adaptor and
primer contamination which was further standardized to
an optimal parameter p value of 70. High quality reads
thus obtained were assembled de-novo [22,23] using the
Velvet assembly tool which produced 83 contigs with a
hash length optimized to 71. These contigs were used to
run OSLAY to form supercontigs with the reference gen-
ome RIMD2210633. Alignment of the reads against the
reference genome was performed using BWA. The pre-
assembled reads were also formed into scaffolds using
SSPACE. Perl scripts written in house and modified after
Baddam et al. [24] were used to re-order the contigs,
supercontigs and scaffolds into their individual files. These
approaches were put together to finalize the draft genome
of V. parahaemolyticus PCV08-7 (Figure 1).
Results and discussion
Genome assembly
The 100 bp paired end reads were assembled using Velvet
assembly tool that effectively utilized approximately 3.7
million reads. The N50 value observed was 261989 bp. The
contig with the maximum length was 704232 bp and
the total number of bases in the genome were 5184164
bp. The genome was artificially closed.
The genomes with multiple chromosomes pose tech-
nical difficulties during assembly. It is a known fact that
Vibrios – V. cholerae,V. parahaemolyticus and V. vulnificus
contain two circular chromosomes [26]. The reference gen-
ome used in this study,V. parahaemolyticus RIMD2210633
also consists of two chromosomes [13]. As studied previ-
ously [13], the origin of replication in chromosome 1 with
the presence of dnaA gene shows its similarity to many ge-
nomes of prokaryotic origin and the origin of replication of
chromosome 2 shows homology with that present on V.
cholerae chromosome 2. The identification of distinct repli-
cation sites is of utmost importance for assembling bacter-
ial genomes with two chromosomes which in the case of V.
cholerae have been studied earlier [27]. Previous studies ex-
plain need for a more accurate procedure to handle data to
correctly assemble two chromosomes and assign gene
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locations. The reads were assembled into a total of 83 con-
tigs which were separated based on the assemble strategy
as explained in the materials and methods section. Dealing
with the present data, we observed that many of the genes
of significant virulence or fitness importance were located
on the chromosomes rather than showing any significant
homology to the Vibrio plasmids. The presence of the Phd-
Doc toxin antitoxin gene in our genome makes it interest-
ing as the antitoxin gene has been previously reported
related to plasmids [28] while a recent study [29] described
Figure 1 Circular view of Vibrio parahaemolyticus PCV08-7 draft genome. Diagrammatic representation of major genes carried by the two
chromosomes of Vibrio parahaemolyticus PCV08-7 genome using CGview [25].
Figure 2 Alignment of the genome of strain RIMD2210633 against that of isolate PCV08-7 and strain O1:K33. (a) Comparison of
chromosomes of strain RIMD2210633 (VPRIMD2210633 chr1, VPRIMD2210633 chr2) with the draft chromosomes of PCV08-7 (VPPCV08-7 draft
chr1, VPPCV08-7 draft chr2) using M-GCAT. (b) Comparison of chromosomes of strain O1:K33 (VPO1:K33 chr1, VPO1:K33 chr2) with the draft chro-
mosomes of PCV08-7 (VPPCV08-7 draft chr1, VPPCV08-7 draft chr2) using M-GCAT.
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its occurrence on the chromosome of Vibrio species. How-
ever, we agree that the exact source of these genes can be
mapped only when the plasmids will be sequenced and or
analyzed separately.
Genome statistics and annotation
The draft assembled genome was annotated using the
RAST server [30]. Statistics of the V. parahaemolyticus
PCV08-7 draft genome were derived using Artemis [31],
RNAmmer [32] and tRNAscanSE [33]: the sizes of
chromosome 1 and chromosome 2 of the isolate were
3471185 bp and 1867355 bp respectively with G + C
content of 45.35%. The tRNA and rRNA genes were 102
and 31 for chromosome 1, and 13 and 3 for chromo-
some 2, respectively. The chromosome 1 revealed a cod-
ing percentage of 85 with an average gene length of
943 bp while the chromosome 2 had a coding percent-
age of 86.2 with an average gene length of 950 bp.
Figure 3 Alignment of a unique PCV08-7 protein sequence similar to Photobacterium damselae subsps. damselae. A unique sequence
from PCV08-7 genome showed similarity with putative uncharacterized proteins of V. anguillarum 775 (F7YI77), V. cholera MJ-1236 (C3NPG0) and
Vibrio sp. RC586 (D0IJW6) and similarity to a phage integrase of Photobacterium damselae subsps. damselae (H1A9J8).
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The alignment of V. parahaemolyticus PCV08-7 gen-
ome with that of the V. parahaemolyticus RIMD2210633
genome using M-GCAT [34] showed visible rearrange-
ments in the sequences of the two chromosomes of
PCV08-7 isolate (Figure 2). The chromosome 1 of the
draft genome carried phage shock proteins A, B and C,
and bacteriophage f237 ORF8. It contained an integrated
tmRNA gene with the closest element encoding the ribo-
nuclease H. A site-specific recombinase IntI4 and a gene
encoding beta-lactamase were present. The draft gen-
ome also revealed genes responsible for fatty acid and
amino acid metabolism. An important outer membrane
protein OmpU was also identified. Genes coding for gyr-
ase B (gyrB), HU-alpha insertion and putative sigma fac-
tors such as rpoD, rpoE, rpoS, rpoN and rpoH were also
found in our analysis. The chromosome 2 carried a TDH
pathogenicity island with many deletions and substitu-
tions and displayed a malG gene on one of the flanking
regions of the pathogenicity island. This region also con-
tained genes coding for nutrient uptake and metabolism.
We documented the presence of vibrio ferrin receptor
pvuA and ferrichrome ABC transport pvuB, pvuC, pvuD
and pvuE encoding genes, and the related pvsA, pvsB,
pvsC, pvsD and pvsE genes. The analysis of the genome
further revealed presence of a cobalt-zinc-cadmium re-
sistance protein and a Rhodanese related sulfur transfer-
ase (as also present in RIMD2210633 genome) and a
lead-cadmium-zinc-mercury transporting ATPase en-
zyme (as seen in the V. parahaemolyticus BB220P gen-
ome). Phd antitoxin and Doc toxin [28] which fall under
the programmed cell death systems were also uniquely
identified. Studies in E. coli have shown the presence of
a stress related protein clpB along with rpoS and a few
other genes [35] which help cope with stress conditions
and help in survival. Our analysis detected the presence
of clpB, rpoS and hipA genes in the present genome as
was also seen in the reference genome of RIMD2210633.
There were two types of Type III secretion systems
observed in V. parahaemolyticus RIMD2210633 [36];
T3SS1 and T3SS2. Our genome analysis remains open
ended with respect to the presence of such type III se-
cretion systems.
Identification of novel gene content and comparative
analysis
Our genome analysis revealed some unique sequences
which have good similarity to hypothetical proteins
of other Vibrio species such as Vibrio anguillarum and
Vibrio cholerae. A 6315 bp nucleotide sequence showed
identity to a V. anguillarum hypothetical protein and a
V. cholera hypothetical protein on NCBI-BLASTN. One
of the coding proteins in this stretch revealed similarity to
the annotated phage integrase encoding gene of Photobac-
terium damselae subsp. damselae plasmid pAQU1 DNA
(Figure 3). A parD gene (antitoxin to parE) was also found
which showed closer identity to other Vibrio species such
as Vibrio vulnificus, Vibrio mimicus and Vibrio orientalis.
parD when aligned against V. vulnificus and V. mimicus
revealed an identity of 76 bp out of 80 bp (95%) (e-value
2e-48) and with V. orientalis an identity of 72 bp out of
80 bp (90%) (e-value 2e-45) on NCBI-BLASTN. A few
newer hypothetical proteins with no reported annota-
tion were identified. The genome also contained a gene
relevant to arsenic resistance, possibly important in the
adaptation of the bacterium to a high arsenic environ-
ment. Our analysis of the genome revealed presence
of a partially similar sequence of TDH Pathogenicity
Island, as compared to V. parahaemolyticus RIMD2210633.
This island revealed genetic instability due to various inser-
tion/deletion and substitution events we documented. The
presence of toxS and toxR genes was also observed.
The old pandemic O3:K6 strain of V. parahaemolyti-
cus is said to have gained gene clusters VPaI1-VPaI7
[37] to develop into a new pandemic clone of which
VPaI4-VPaI6 are said to be putative virulence factors
and may be potential pathogenicity islands. These regions
are said to carry along with them a type VI secretion
system (VP1386-1420). Our PCV08-7 genome analysis re-
vealed that only one cluster, VPaI2, was detected com-
pletely, whereas VPaI3 and VPaI7 were partially present
(Table 1). This perhaps shows that our strain could be
possibly a new serovariant of a non-pandemic O3:K6
strain like the V. parahaemolyticus AQ3810 [8]. While
Table 1 Table representing pathogenicity related clusters
and other VP clusters in V. parahaemolyticus PCV08-7: (1)
pathogenicity related clusters (VPaI1-VPaI7) in the
genome of strain RIMD2210633 that signify it to be a
pandemic O3:K6 strain and their presence or absence in
the genome of PCV08-7 isolate, (2) various other VP
clusters and their occurrence in the genome of PCV08-7
(1) Vibrio parahaemolyticus
RIMD2210633
V. parahaemolyticus
PCV08-7
VPaI1 (VP0380-0403) Absent
VpaI2 (VP0635-0643) Present
VpaI3 (VP1071-1094) Partially present
VpaI4 (VP2131-2144) Absent
VpaI5 (VP2900-2910) Absent
VpaI6 (VPA1254-1270) Absent
VpaI7 (VP1312-1398) Present
Type VI secretion system (VP1386-1420) Absent
(2) Other VP clusters V. parahaemolyticus PCV08-7
VP1355-1368 Partially present
VPA0074-0089 Present
VPA0713-0732 Present
VPA1194-1210 Present
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Figure 4 (a) V. parahaemolyticus AQ3810 alignment against PCV08-7 genome: Concatenated chromosome 1 and chromosome 2 of
V. parahaemolyticus AQ3810 (AQ3810.fasta) against V. parahaemolyticus PCV08-7 (PCV08-7.fasta) (b) V. parahaemolyticus O1:K33
alignment against PCV08-7. Concatenated chromosome 1 and chromosome 2 of V. parahaemolyticus O1:K33 (O1_K33.fasta) against
V. parahaemolyticus PCV08-7 (PCV08-7.fasta).
Figure 5 Comparison of whole genome sequences of strains RIMD2210633, PCV08-7 and O1:K33. Alignment of complete genomes of
V. parahaemolyticus RIMD2210633, V. parahaemolyticus PCV08-7 and V. parahaemolyticus O1:K33, showing PCV08-7 being more similar
to RIMD2210633.
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variability of different gene clusters (Table 1) portrays
a probably novel serovariant of V. parahaemolyticus
with the presence of ribonuclease H encoding element
(previously thought to be present only in V. parahaemoly-
ticus RIMD2210633 and absent in V. parahaemolyticus
AQ3810 [12]). A further comparative study between the
V. parahaemolyticus PCV08-7 and the non-pandemic V.
parahaemolyticus AQ3810 (O3:K6 strain) and the newest
V. parahaemolyticus O1:K33 (trh+/ tdh + genotype) strain
showed that V. parahaemolyticus PCV08-7 has more gen-
etic relatedness towards a trh+/ tdh + strain (Figure 4).
But, alignments of the V. parahaemolyticus PCV08-7 con-
tig data against the V. parahaemolyticus O1:K33 and V.
parahaemolyticus RIMD2210633 (Figure 2) strains show
that it is closer to O3:K6 serotype (Figure 5).
From the above thesis, it becomes probably apparent that
the genome of V. parahaemolyticus PCV08-7 meaningfully
adds to the battery of important genomic sequences repre-
senting enteropathogenic bacteria. The genome of an
arthropod derived, foodborne Vibrio should be important
to understand adaptation to a crustacean host and a hu-
man host.
Epilogue and future directions
A first account of the genome of V. parahaemolyticus
PCV08-7 has been presented. The draft genome and its
annotation as described would be able to explain the
lifestyle of pathogenic Vibrio species. The experience of
assembling this genome and the difficulties associated
with separating the data with respect to two chromo-
somes would certainly be helpful to the community in
the follow-up studies. Further, a host of new molecular
markers as gleaned by our analysis would be relevant in
the diagnostic development and molecular epidemiology.
The present genome and the ensuing comparative gen-
omics would be able to rekindle our thoughts on the
survival and virulence as well as transmission potentials
of V. parahaemolyticus and also on their adaptation to
different hosts and the niches thereof. Our results clearly
reveal a significantly novel gene content which could
presumably have been acquired through a horizontal
gene transfer mechanism. Our analysis revealed the
presence of not only the conserved genomic regions
among different V. parahaemolyticus bacteria, but also
dissects some of the unique sets of genes that hold rele-
vance to virulence. We propose to finish and polish the
genome in the near future also with the help of further
coverage using alternative sequencing platforms and by
employing a hybrid assembly approach. Also, it will be
possible to determine the true extent of the diversity of
V. parahaemolyticus strains obtained from seafood as
compared to those isolated from human cases. Such a
diversity analysis would focus on 1) genomic coordinates
relevant to colonization of and adaptation to different
hosts in different ecosystems; 2) genome dynamics rela-
tive to bacterial fitness shaping over time and with trans-
mission across different hosts; and 3) profile of genomic
rearrangements including additive and reductive genome
evolution and their significance in the evolution of
pathogenic Vibrio species. Presently, the epidemiology of
V. parahaemolyticus infection in resource-poor coun-
tries largely entails a classical serology concocted with
guess work as to the type of strain involved and its
source. Our genomic data would hopefully contribute to
this situation also.
Availability of supporting data
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Abstract
Salmonella Typhi is a human restricted pathogen with a significant number of individuals as asymptomatic carriers
of the bacterium. Salmonella infection can be effectively controlled if a reliable method for identification of these
carriers is developed. In this context, the availability of whole genomes of carrier strains through high- throughput
sequencing and further downstream analysis by comparative genomics approaches is very promising. Herein we
describe the genome sequence of a Salmonella Typhi isolate representing an asymptomatic carrier individual
during a prolonged outbreak of typhoid fever in Kelantan, Malaysia. Putative genomic coordinates relevant in
pathogenesis and persistence of this carrier strain are identified and discussed.
Background
Salmonella enterica serovar Typhi, the aetiologic agent
of typhoid fever is still posing a major health problem
for the developing world, as about 16 million new cases
are reported each year [1]. S. Typhi causes systemic
infections (typhoid fever) as well as chronic infections
(asymptomatic carriers) in humans, the latter serve as
the source of infection [2]. The transmission of S. Typhi
is primarily through faecal-oral route and a significant
number of infected individuals become chronic asymp-
tomatic carriers and keep shedding S. Typhi in faeces for
decades [3]. This results in endemicity of S. Typhi in
regions of the world with underdeveloped sanitation and
community hygiene [4].
Carrier identification becomes extremely important as
some of the ancestral haplotypes were observed in re-
cent isolates suggesting their persistence in these asymp-
tomatic carriers [5]. Traditional methods such as
culturing of bacteria from faecal samples are not fool
proof as the carriers shed bacteria intermittently. Sero-
logical tests to detect specific antibodies such as anti-H
and anti-O are unable to differentiate between carriers
and individuals who have recovered from the infection
[6]. Especially, in areas endemic for S. Typhi, due to high
background levels of these antibodies, serological tests
cannot be adopted for the identification of a carrier [7].
Thus, there is an urgent need for inexpensive and effi-
cient detection methods for the establishment of carrier
state, perhaps based on genomic markers.
The genetic typing tools such as PFGE, AFLP, ribotyp-
ing etc. can resolve limited genetic variation occurring
within specific sites, and therefore are incapable of dif-
ferentiating highly clonal strains such as outbreak related
strains from the ones not associated with the outbreak
(carrier isolates) [8-10]. High-throughput sequencing
technologies have already been employed as a high reso-
lution molecular epidemiologic tool to discern micro-
evolution of highly related strains [11].
In this study, we attempted to determine if whole gen-
ome sequencing of S. Typhi isolated from a carrier indi-
vidual can provide insights related to persistence and or
adaptation mechanisms. We describe the genome
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sequence of a Salmonella enterica serovar Typhi strain
(ST CR0063) isolated from a carrier individual during a
prolonged outbreak of typhoid fever in Kelantan,
Malaysia.
Results and discussion
Genome statistics
The size of the draft genome of Salmonella Typhi (ST
CR0063) is 4,585,851 bp with a coding percentage of
86.1%. The G + C content of this strain is about 51.71%.
The total number of CDS determined are 4946 with
an average length of gene about 798 nucleotides. The
genome of ST CR0063 revealed 77 tRNA and 22 rRNA
genes. The subsystems distribution of basic metabolic
machinery of this strain is represented in Figure 1. The
assembled draft genome shows high degree of similarity
and shared core genome regions with Salmonella Typhi
ST BL196 [12], the one identified as associated with a
typhoid outbreak in Kelantan during the same period
(Figure 2).
Virulence factors
The gene shdA, a key factor predicted to be involved in
persistence of the bacterium in the intestines [14] by
binding to its extracellular matrix, was identified and
annotated. This gene, by mimicking the host heparin, is
able to bind to the extracellular matrix proteins, fibro-
nectin and collagen, and probably plays an important
role in carriers by contributing to prolonged faecal shed-
ding [15]. The fim gene cluster [16] of chaperone –usher
family involved in adhesion to non-phagocytic cells was
detected along with its negative regulator fimW. Type
IV pili and agf operon [17,18] encoding curli fimbriae
which aid in attachment of the bacterium to intestinal
villi and also with each other, were found in the genome.
These adherence factors determine the sites of bacterial
colonisation and thereby adaptation and pathogenicity of
a particular strain [19,20].
The S. Typhi strain ST CR0063 genome also revealed
viaA and viaB loci, the prime regulators of Vi antigen
expression. The viaB locus contains all genes for the
biosynthesis (tviA-E) and export (vexA-E) of the Vi anti-
gen, a well-known virulence factor [21,22]. The mgtC
gene involved in Magnesium uptake and ferric uptake
regulators (fur) [23] were also identified in ST CR0063.
The PhoPQ regulon [24], which induces cytokine secre-
tion and cationic antimicrobial peptide resistance, was
also found to be conserved in our carrier strain. The
RpoS sigma factor needed to cope up with external
stress and nutrient depletion conditions [25] was also
identified and annotated. The co-ordinates of these viru-
lence factors in the genome of ST CR0063 are depicted
in Figure 3.
Phages and pathogenicity islands (PAIs)
The phages gifsy-1 and fels-2 [27] together with many
phage proteins and a few hypothetical proteins were
identified in the genome of ST CR0063 by various algo-
rithms (See Methods for details). It is expected that
these phages are acquired by horizontal gene transfer
(HGT) events as they were embedded in some of the
genomic islands recognized. The phage encoding SopE
effector protein of SPI-1 (Salmonella Pathogenicity Is-
land) was present in ST CR0063 as recognized in other
Typhi genomes [28,29].
Figure 1 Subsystem distribution of ST CR0063. The subsystem statistics of ST CR0063 based on genome annotations performed according to
RAST conventions.
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More than 15 PAIs that encode clusters of virulence
associated genes have been identified across various ser-
ovars of Salmonella enterica. Ten pathogenicity islands
have been identified by us in ST CR0063 and as
expected [30], they were characterised by different G + C
content and bounded by t-RNA genes. The SPI-1 type
III secretion system (TTSS) structural genes spaM-
NOPQRS and invABCEFGH and their regulatory pro-
teins HilA, HilC, HilD [31] were also identified and
annotated. The SPI-1 secreted effector proteins SopE,
Figure 2 Comparison of Salmonella Typhi strains ST CR0063 and ST BL196. Comparison of whole genome sequences of S. Typhi strains
using MG-CAT – one strain was isolated from a carrier individual (ST CR0063) and another from an infected individual (ST BL196) during a
prolonged outbreak of Typhoid fever in Kelantan [13].
Figure 3 Circular Genome view of ST CR063. Positions of some of the major virulence factors and their regulators identified in ST CR0063
marked in the circular genome generated using CGview [26].
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SopE2, SipA, SipB, SipC and SptP required for endothe-
lial uptake and invasion [32] are also present. The genes
SpiC, SseF, SseG, SifA, SifB secreted by SPI-2 TTSS and
that are needed for survival in macrophages and colon-
isation of host organs [33] were also recognised in the
present genome. The known regulators of SPI-2, OmpR-
EnvZ and PhoP-PhoQ [34] were present. SPI-3, identi-
fied by us, contained magnesium transport genes mgtC
and marT which are required for survival in macro-
phages [35]. Type I secretion system and its associated
proteins encoded by SPI-4, and that are involved in the
invasion of the intestinal epithelium [36], were also
located in the present genome. The SPI-1 effector pro-
teins SopB and PipB associated with enteritis and coded
by SPI-5 [37] were also detected and annotated.
The chaperone-usher fimbrial operons carried by SPI-6,
SPI-10 and bacteriocin immunity proteins carried by
SPI-8 [38] were identified. The SPI-7 and SPI-9 were
identified in the ST CR0063 genome and were found to
encode viaB locus, type IV pili formation proteins and
TISS [38,39].
Conclusions and prospective
The genomic blueprint of Salmonella Typhi isolate ST
CR0063 was elucidated in this study. The genome se-
quence information presented herein may be harnessed
to guide comparative genomics and identification of
novel and specific diagnostic markers. However, further
studies involving large scale genome sequencing of
the strains from several of the endemic countries and
especially those from carrier individuals of different
socio-economical settings is needed to develop a reliable
approach to decipher the characteristics of a carrier state.
Also, it will be required to determine the true extent of
the diversity of carrier strains as juxtaposed to their
acutely pathogenic forms in terms of 1) gene gain/loss
during colonization and adaptation; 2) dynamics of viru-
lence acquisition/attenuation; 3) possible genomic rear-
rangements; and 4) the relative preponderance of carrier
and virulent strains circulating in different endemic
regions of the world. Finally, an in-depth analysis of the
host-pathogen interactions and their influence on gut
microbiota can only explain the adaptation and persist-
ence mechanisms of the (asymptomatic) carrier strains.
Methods
Genome sequencing
DNA was isolated from the stool sample of an asymp-
tomatic carrier individual from Kelantan, Malaysia in
2007 during a prolonged outbreak. The draft genome se-
quence of this strain (STCR0063) was determined by
Illumina Genome Analyzer (GAIIx, pipe- line ver l.6).
The 100 bp paired-end sequencing was done with an
insert size of 300 bp. About 67X genome coverage was
achieved and 1.9 gigabytes of data were obtained.
Assembly and annotation
The sequence data were assembled de-novo in the same
way as described previously [40-45] into 538 contigs
using Velvet [46] at optimal hash length 39. SSPACE
[47] was used for scaffolding the pre-assembled contigs
using paired-end data. The gaps within these scaffolds
were filled using Gapfiller by aligning the reads against
already generated Scaffolds by SSPACE [48].
A reference guided assembly was generated by aligning
reads to Salmonella Typhi str. CT18 [GenBank:
AL513382.1] using bwa tools [49]. This reference guided
assembly was used to re-order the scaffolds generated in
de-novo way. In-house written Perl scripts were used for
this re-ordering process and to finalize the gaps. The de
novo and reference guided approaches were used to
finalize the consensus draft genome. The reference
guided assembly and reordered scaffolds were loaded on
to Tablet – NGS data visualisation tool, to visualise the
repeats, insertions and deletions [50].
The final draft nucleotide sequence after manual cur-
ation was annotated in our laboratory using RAST [51]
and ISGA pipeline [52]. The genome statistics were
gleaned using Artemis [53]. The data were further vali-
dated using gene prediction tools such as Glimmer [54]
and EasyGene [55]. The RNAmmer [56] and tRNAscan-
SE [57] were used to identify rRNA and tRNA
respectively.
Phages and PAIs
Prophages and putative phage like elements in the gen-
ome were identified using PhiSpy [58] and Prophage
Finder [59]. The putative HGT events were determined
using Alien Hunter tool [60]. An integrated interface Is-
land Viewer was used to predict putative genomic
islands within the genome [61].
Sequence data access
The Salmonella enterica subsp. enterica serovar Typhi
str. CR0063 whole genome shotgun (WGS) project
has been submitted to the GenBank and has the project
accession AKIC00000000. The project version entail-
ing draft assembly described herein has the accession
number AKIC01000000, and consists of sequences
AKIC01000001-AKIC01000538.
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Genome Sequence and Comparative Pathogenomics Analysis of a
Salmonella enterica Serovar Typhi Strain Associated with a Typhoid
Carrier in Malaysia
Kien-Pong Yap,a,b Han Ming Gan,c Cindy Shuan Ju Teh,a,b Ramani Baddam,d Lay-Ching Chai,a,b Narender Kumar,d
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Research Cluster, University of Malaya, Kuala Lumpur, Malaysiab; ScienceVision SB, Setia Alam, SeksyenU13, Shah Alam, Selangor, Malaysiac; and Pathogen Biology
Laboratory, Department of Biotechnology, School of Life Sciences, University of Hyderabad, Hyderabad, Indiad
Salmonella enterica serovar Typhi is a human pathogen that causes typhoid fever predominantly in developing countries. In this
article, we describe the whole genome sequence of the S. Typhi strain CR0044 isolated from a typhoid fever carrier in Kelantan,
Malaysia. These data will further enhance the understanding of its host persistence and adaptive mechanism.
Typhoid fever caused by human-specific Salmonella enterica se-rovar Typhi (S. Typhi) remains a major health problem that
affects 21.7 million people, with 217,000 deaths worldwide annu-
ally (6). S. Typhi is transmitted through the oral-fecal route and
sometimes persists in the body, establishing an asymptomatic
chronic carrier (10, 12). The risk of developing gallbladder dis-
eases, including carcinoma, is also higher among typhoid carriers
(5, 10, 21).
Although typhoid fever is endemic in many countries, includ-
ingMalaysia, little is known about the mechanism of survival and
persistence of S. Typhi in the host. Therefore, the genome se-
quence and comparative pathogenomics analysis of carrier strain
will provide in-depth understanding of its persistence and adap-
tive mechanism within its host.
S. Typhi CR0044 was isolated from stool sample of a typhoid
carrier in Kelantan, Malaysia, in 2007. This strain was subtyped as
ST1 by multilocus sequence typing (14) and was highly similar to
the outbreak strain in 2005 by pulsed field gel electrophoresis
(PFGE) (2). Genome sequencing of S. Typhi strain CR0044 was
performed using the Ilumina Genome Analyzer (GA2x, pipeline
version 1.60, insert size 300), which generated 1.0 gigabyte of data
with a 90 depth coverage and a 73-bp read length. Genome
assembly was constructed with Velvet (26) using the de novo ap-
proach, which generated 201 contigs with a minimum contig
length of more than 200 bp and an average size of 23,367 bp. The
open reading frames (ORFs) of the resultant contigs were pre-
dicted using RAST (1) and Prodigal (13) and subsequently anno-
tated using Blast2GO (4), whereas tRNA and rRNA genes were
identified with tRNAscan-SE (17) and RNAmmer (15), respec-
tively. The predicted genome size is approximately 4,769,054 bp,
with an average GC content of 52.1% and coding percentage of
85.8. The genome revealed approximately 4,884 coding sequences
(CDS)with an average length of 825 bp. The genome also contains
predicted 69 tRNA and 22 rRNA genes.
The genome revealed a type III secretion system and flagellum
subsystem as reported in S. Typhi strains Ty2 and CT18 (7, 12).
The genome contains genes reported in Ty2 andCT18, such as the
gene coding for type 4 fimbrial assembly protein, the yjbEFGH
locus, yhjD conserved clusters, andwca genes, which are related to
cell wall and biofilm formation andhost persistence (3, 8, 7, 12, 18,
25). It is noteworthy that the genome sequence also revealed the
presence of the GGDEF family protein YeaJ, which is associated
with cell surface adhesion and biofilm formation, which was not
identified in Ty2 and CT18 (9, 19). The gene encoding the rham-
nogalacturonide transporter RhiT for rhamnose utilization was
also found adjacent to a transposase gene in CR0044 (20). Inter-
estingly, the genome also revealed a zonular occludens toxin fam-
ily protein that was not previously reported in Salmonella spp.
S. Typhi in Southeast Asia is genetically diverse, with genome
variations and clonal expansion reported (2, 11, 15, 16, 21, 22, 23,
24). The dynamic nature of the S. Typhi chromosome greatly en-
hances its persistence and adaptation within the host, which al-
lows the pathogen to survive and thrive in typhoid carriers. The
genomic information obtained here could unveil the genome evo-
lution and mechanism involved in carrier-state transformation.
Nucleotide sequence accession numbers. This Whole Ge-
nome Shotgun project has been deposited in GenBank under ac-
cession no. AKZO00000000. The version described in this paper is
the first version, AKZO01000000. The Bioproject designation for
this project is PRJNA160187.
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Next-Generation Sequencing and De Novo Assembly, Genome
Organization, and Comparative Genomic Analyses of the Genomes of
Two Helicobacter pylori Isolates from Duodenal Ulcer Patients in
India
Narender Kumar,a Asish K. Mukhopadhyay,b Rajashree Patra,b Ronita De,b Ramani Baddam,a Sabiha Shaik,a Jawed Alam,b
Suma Tiruvayipati,a,c and Niyaz Ahmeda,c,d
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Malaya, Kuala Lumpur, Malaysiac; and Institute of Life Sciences, University of Hyderabad Campus, Gachibowli, Hyderabad, Indiad
The prevalence of differentH. pylori genotypes in various geographical regions indicates region-specific adaptations during the
course of evolution. Complete genomes ofH. pylori from countries with high infection burdens, such as India, have not yet been
described. Herein we present genome sequences of twoH. pylori strains, NAB47 and NAD1, from India. In this report, we briefly
mention the sequencing and finishing approaches, genome assembly with downstream statistics, and important features of the
two draft genomes, including their phylogenetic status. We believe that these genome sequences and the comparative genomics
emanating thereupon will help us to clearly understand the ancestry and biology of the IndianH. pylori genotypes, and this will
be helpful in solving the so-called Indian enigma, by which high infection rates do not corroborate the minuscule number of
serious outcomes observed, including gastric cancer.
Helicobacter pylori’s coevolution with its host (10, 11, 16) andits tight compartmentalization (13, 16, 18, 19) into several
different populations and subpopulations have delivered an excel-
lent premise to pursue the idea of geographic evolution/spread of
humans and their pathogens from Africa and to gain insights into
pathogen adaptation mechanisms (1, 3). Based partly on these
conventions, Indian H. pylori isolates have shown to have Euro-
pean origins (9) and are widely held as mostly innocuous or only
mildly pathogenic. The severity of H. pylori-induced gastro-duo-
denal diseases and their outcomes vary in different geographic
regions and populations, which may be significantly attributable
to different genetic compositions of the underlying bacterial
strains. More data based on genome sequences from many of
strains from different countries are needed to clearly establish the
genetic makeup, colonization potential, and virulence character-
istics of a particular strain or genotype. In view of this, genome
sequence-based characterizations of strains prevalent in different
locales is necessary (2).
We describe genomes of H. pylori strains NAB47 (Bangalore)
and NAD1 (Delhi) from duodenal ulcer patients. Illumina se-
quencing was performed as described previously (4, 8); briefly,
about 3 gigabytes and 1.8 gigabytes of data comprising 72-bp
paired-end reads (insert size, 300 bp) provided genome coverages
of approximately 300 and 200, respectively. The raw reads
were filtered using the FASTX tool kit (17) and assembled using
Velvet (20); the reads yielded 107 (NAB47) and 103 (NAD1) con-
tigs with a hash length set to 37. These contigs were joined into 34
(NAB47) and 48 (NAD1) scaffolds by using SSPACE (6). The
scaffolds were aligned and ordered according to their closest ref-
erence genome and confirmed using BLAST (12) and Mummer
(14). The draft genomes were submitted to RAST (5) for annota-
tion, and the output was validated by using Glimmer (7) and
EasyGene (15).
The draft genomes of H. pylori NAB47 and NAD1 had sizes of
about 1,590,862 bp and 1,588,938 bp, respectively, with GC
contents of 39.17 and 39.03%, respectively. The genomes revealed
coding percentages of 91.5% (NAB47) and 91.3% (NAD1) and
encoded 1,572 and 1,567 proteins, respectively; each of the ge-
nomes contained 36 tRNA genes and 6 rRNA genes. The average
lengths for protein-coding genes were found to be 929 bp and 922
bp, respectively. Major virulence markers, such as cagA, vacA, the
whole cag pathogenicity island, and several outer membrane pro-
teins of the Hop family, were annotated. In addition, NAD1 har-
bored two plasmids of 16 kb and 10 kb each that carried genes for
transposase, IS606, and mobilization proteins, together with rep-
lication protein A. CagA protein in both of the strains contained
EPIYA D-type motifs, which are typical of Indo-European strains.
Important plasticity region genes, such as jhp0940, jhp0947, and
dupA, were absent, and hp0986 was detected only in NAB47. Fi-
nally, whole-genome phylogeny incorporating all the available ge-
nomes reconfirmed an Indo-European ancestry (HpEurope).
We believe that the genomes described herein are likely to re-
kindle our knowledge of the genetic makeup and evolutionary
relationships of H. pylori in India. Comparative genomic analyses
extending out to other unexplored strains from the tribal and
mainstream populations will facilitate understanding of the true
pathogenic potential (amid adaptive evolution) of the Indian H.
pylori. Furthermore, they will be immensely helpful in global ep-
idemiological studies and also for the development of diagnostic
tools tailored to a particular host population.
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Nucleotide sequence accession numbers. The genome se-
quences of H. pylori NAB47 and NAD1 have been deposited with
GenBank and assigned accession numbers AJFA00000000 and
AJGJ00000000, respectively. The updated sequences/contigs are also
available for download from the International Society for Genomic
and Evolutionary Microbiology (ISOGEM) server (http://isogem.org
/HPNAB47.txt and http://isogem.org/HPNAD1.txt).
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Insights from the Genome Sequence of a Salmonella enterica Serovar
Typhi Strain Associated with a Sporadic Case of Typhoid Fever in
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Salmonella enterica serovar Typhi is the causative agent of typhoid fever, which causes nearly 21.7million illnesses and 217,000 deaths
globally.Herein, we describe thewhole-genome sequence of the SalmonellaTyphi strain ST0208, isolated froma sporadic case of ty-
phoid fever inKuala Lumpur,Malaysia. Thewhole-genome sequence and comparative genomics allow an in-depth understanding of
the genetic diversity, and its link to pathogenicity and evolutionary dynamics, of this highly clonal pathogen that is endemic to
Malaysia.
Salmonella enterica serovar Typhi (S. Typhi) is a human intra-cellular pathogen of global importance, infecting 21.7 million
people and causing 217,000 deaths annually (4). The challenges of
higher incidence of typhoid fever in developing countries have led
to an increased health burden (4).
In 2008, 201 cases of sporadic outbreaks were reported in Ma-
laysia (18). The genome sequence of this sporadically associated
strain will provide insights into possible genetic events that would
confer a fitness advantage.
S. Typhi strain ST0208 was isolated from the stool sample of a
typhoid fever patient admitted to University Malaya Medical
Centre (UMMC), Kuala Lumpur, Malaysia, in 2008. The strain
was characterized by pulsed-field gel electrophoresis (PFGE), re-
petitive extragenic palindromic (REP)-PCR, and antimicrobial
susceptibility profiling (25). The genome sequence of S. Typhi
ST0208 was determined using an Illumina genome analyzer
(GA2x, pipeline version 1.60) with an insert size of 300 bp, which
generated 1.83 gigabytes of data with an average coverage of 165
and yielded 1,499,986 paired-end reads with a 100-bp read length.
Genome assembly was constructed de novo using Velvet (26),
which generated 222 contigs. The resultant contigs were uploaded
into the RAST server (2, 17) to predict the open reading frames
(ORFs) by using Glimmer3 (5) and validated with the ISGA inte-
grated system (8). In brief, the predicted ORFs were annotated by
searching against clusters of orthologous group (21) and SEED (7)
databases, whereas tRNAand rRNAgeneswere identified by using
tRNAscan-SE (15) and RNAmmer (12), respectively. The draft
genome size is approximately 4,798,272 bp in length, with an av-
erage GC content of 52.0%, and is composed of 4,890 predicted
coding sequences with an average length of 810 bp. A mean per-
centage of 83.7% of nucleotides of the genome are predicted to
encode proteins. The genome reveals 71 tRNA and 22 rRNA pre-
dicted genes.
Thegenomecontains severalmonosaccharideandpolysaccharide
metabolism-related genes, which were not reported in S. Typhi
strains Ty2 and CT18 (6, 11, 18), such as D-galactarate permease,
gluconate permease, tagatose-6-phosphate kinase, trehalase, and ar-
abinose-proton transporter, that could be associated with host per-
sistence (20). The genome sequence revealed four multidrug resis-
tance clusters, mdtABCR and marABCR proteins (1, 3, 19), DNA
gyrase subunit A andB, and topoisomerase subunit (IV)A andB (9),
which were also identified in S. Typhi Ty2 and S. Typhi CT18 (6, 11,
19).Hypothetical proteins andpathogenicity islandswere annotated.
High genetic diversity of S. Typhi was detected among human
strains in Malaysia and Southeast Asia (10, 14, 22, 23, 24). Varia-
tion in the genome sequence revealed by the strain ST0208 is con-
sistent with the proposed key theory of persistent adaptation and
optimization of function (13, 16, 19). Genomic information from
locality-specific strains associated with clinical manifestation al-
lows genome evolution and endemicity to be studied.
Nucleotide sequence accessionnumbers.Thiswhole-genome
shotgun project has been deposited inDDBJ/EMBL/GenBank un-
der the accession number AJXA00000000. The version described
in this paper is the first version, AJXA01000000. The BioProject
designation for this project is PRJNA160181.
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enterica Serovar Typhi Isolates from Patients with Fatal and Nonfatal
Typhoid Fever in Papua New Guinea
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Many of the developing countries of the Southeast Asian region are significantly affected by endemic typhoid fever, possibly as a
result of marginal living standards. It is an important public health problem in countries such as Papua New Guinea, which is
geographically close to some of the foci of endemicity in Asia. The severity of the disease varies in different regions, and this may
be attributable to genetic diversity among the native strains. Genome sequence data on strains from different countries are
needed to clearly understand their genetic makeup and virulence potential. We describe the genomes of two Salmonella Typhi
isolates from patients with fatal and nonfatal cases of typhoid fever in Papua New Guinea. We discuss in brief the underlying
sequencing methodology, assembly, genome statistics, and important features of the two draft genomes, which form an essential
step in our functional molecular infection epidemiology program centering on typhoid fever. The comparative genomics of these
and other isolates would enable us to identify genetic rearrangements andmechanisms responsible for endemicity and the dif-
ferential severity of pathogenic salmonellae in Papua New Guinea and elsewhere.
Typhoid fever is amajor pestilence in the developingworld (20),and its prevalence is significant (1,000 cases per 100,000 indi-
viduals per year) in Papua New Guinea, which is geographically
close to Southeast Asia (15). DNA profiling, which was used pre-
viously (6, 14, 20, 21, 22), could not fully explore genome diver-
sity, as Salmonella enterica serovar Typhi isolates fromPapuaNew
Guinea showed limited heterogeneity, perhaps because of recent
clonal expansion from a single endemic/ancestral strain (the dis-
ease was rarely seen before 1985) (17, 20).Minimal selection pres-
sure and confinement to a specific geographical region might ex-
plain this limited genetic diversity (21, 22) despite horizontal gene
transfer (13).
We hypothesized that the genome sequences of Salmonella
Typhi isolates from patients with typhoid fever due a fatal strain
(UJ308A) or a nonfatal strain (UJ816A) would provide significant
insights into the association among disease phenotypes and strain
characteristics. Two such strainswere isolated fromblood samples
from patients and were found to be sensitive to common antibi-
otics. StrainUJ308A (phage typeVS1)was obtained fromapatient
who died of typhoid, while UJ816A (phage type DI) was from a
patient who recovered.
The 73-bp paired-end sequence data (insert size, 300 bp) were
determined with an Illumina Genome Analyzer (GA2x, pipeline
version l.6). About 95 and 105 coverage was achieved for
strains UJ308A and UJ816A, respectively, comprising 1.9 and 2.0
Gb of data, respectively. De novo assembly was done as described
previously (1, 2, 4, 8, 19); initial assembly generated 416 and 335
contigs for UJ308A and UJ816A, respectively, using Velvet (23)
with a hash length of 39. The scaffolds were generated from con-
tigs by using SSPACE (5) and further assembled and curated to
give a consensus draft. The following statistics were gleaned upon
analysis at RAST (3). The sizes of the chromosomes for UJ308A
and UJ816A were approximately 4,724,875 and 4,736,723 bp, re-
spectively, with a GC contents of 51.89 and 51.94%, respec-
tively. The coding percentage for both strains was 86.8%;
UJ308A and UJ816A contained approximately 4,720 and 4,710
protein coding sequences with average lengths of 869 and 873 bp,
respectively. The data were further validated by Glimmer (7) and
EasyGene (12). RNAmmer (11) revealed that the genome of
UJ308A has 78 tRNA and 21 rRNA genes and the genome of
UJ816A contains 77 tRNA and 22 rRNA genes. All of the major
virulencemarkers encoded by pathogenicity islands and the genes
relevant to the assembly of a type III secretion system (16) were
identified in both the strains. The Vi antigen (10, 18), which plays
major role in immune evasion, was present in both strains, as in
Salmonella Typhi CT18 (16). The homologues of Campylobacter
toxin cdtB and Bordetella pertussis toxin (9) were also present.
In view of this, further efforts are needed to determine the true
extent of strain diversity in terms of (i) gene gains and losses over
an evolutionary time scale, (ii) geographic gene flow, (iii) core
versus accessory genome dynamics, (iv) virulence acquisition and
attenuation, and (v) the preponderance of highly virulent versus
“docile” strains across the regions of Asia where typhoid fever is
endemic.
Nucleotide sequence accession numbers. The GenBank
accession numbers for the genomes reported here are
AJTD00000000 (UJ308A) and AJTE00000000 (UJ816A).
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Abstract
A decade since the availability of Mycobacterium tuberculosis (Mtb) genome sequence, no promising drug has seen the light
of the day. This not only indicates the challenges in discovering new drugs but also suggests a gap in our current
understanding of Mtb biology. We attempt to bridge this gap by carrying out extensive re-annotation and constructing a
systems level protein interaction map of Mtb with an objective of finding novel drug target candidates. Towards this, we
synergized crowd sourcing and social networking methods through an initiative ‘Connect to Decode’ (C2D) to generate the
first and largest manually curated interactome of Mtb termed ‘interactome pathway’ (IPW), encompassing a total of 1434
proteins connected through 2575 functional relationships. Interactions leading to gene regulation, signal transduction,
metabolism, structural complex formation have been catalogued. In the process, we have functionally annotated 87% of the
Mtb genome in context of gene products. We further combine IPW with STRING based network to report central proteins,
which may be assessed as potential drug targets for development of drugs with least possible side effects. The fact that five
of the 17 predicted drug targets are already experimentally validated either genetically or biochemically lends credence to
our unique approach.
Citation: Vashisht R, Mondal AK, Jain A, Shah A, Vishnoi P, et al. (2012) Crowd Sourcing a New Paradigm for Interactome Driven Drug Target Identification in
Mycobacterium tuberculosis. PLoS ONE 7(7): e39808. doi:10.1371/journal.pone.0039808
Editor: Manfred Jung, Albert-Ludwigs-University, Germany
Received November 4, 2011; Accepted May 30, 2012; Published July 11, 2012
Copyright:  2012 Vashisht et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Council of Scientific and Industrial Research, India, Funding (Grant No. HCP0001). The funders had no role in study
design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: Authors Dr. Ramanna, Dr. Raghavan and Dr. Subramanya are employed by Business Intelligence Technologies Pvt Ltd. This does not alter
the authors’ adherence to all the PLoS ONE policies on sharing data and materials.
* E-mail: skb@igib.res.in (SKB); nchandra@biochem.iisc.ernet.in (NC); anshu@csir.res.in (AB)
. These authors contributed equally to this work.
"Lead author for the OSDD Consortium.
PLoS ONE | www.plosone.org 1 July 2012 | Volume 7 | Issue 7 | e39808
192
Introduction
Proclaimed a global health emergency by the World Health
Organization (WHO) in 1993, Tuberculosis (TB) still remains the
leading cause of mortality and affects approximately 32% of the
world population [1]. The emergence of multi-drug-resistant
strains of Mycobacterium tuberculosis, the causative agent of TB, and
the vulnerability of the patients infected with HIV to tuberculosis
have not only fuelled the spread of the disease but also present a
challenging task of understanding the disease physiology and
discovering new drug targets. In this quest, Mtb was sequenced
and annotated in 1998 [2]. A subsequent re-annotation in 2002
successfully assigned functions to almost half of the approximately
4000 genes [3]. More recently, 20 more ORFs have been added to
this list and the annotations updated [4,5]. However a huge gap in
information exists between published literature and the genome
databases. The existing annotations in these databases are thus
insufficient to generate the protein interaction map or the
interactome, pivotal to understanding Mtb biology and identifi-
cation of novel drug targets. To this end, Open Source Drug
Discovery (OSDD) project (www.osdd.net) [6,7] launched the
Connect to Decode (C2D) program (http://c2d.osdd.net), an
innovative blend of crowd sourcing and social networking in a
virtual cloud space for a comprehensive collaborative re-
annotation of Mtb which is the primer for generating the
interactome. The ultimate objective is to identify drug targets
based on better understanding of the complex interactions of
various biological macromolecules in the pathogen.
Systems biology-based approaches have been applied to obtain
better insights into the pathogen biology [8]. This strategy may
help in identifying more than one potential drug targets and these
can be utilized as sets of targets for a polypharmacology approach.
A promising candidate in this category is bi-substrate acyl-
sulfamoyl analogues that simultaneously disrupt crucial nodes in
biosynthetic network of virulent lipid with dramatic effect on the
cell surface architecture of Mtb [9]. Also, a recent study on
genome-wide siRNA experiment has identified host factors that
regulate Mtb load in human macrophages and are crucial to
understand the dynamic interplay of molecular components of the
pathogen and the host [10]. There are many such studies that try
to capture the snapshots of the molecular interactions in Mtb in
different conditions. It is therefore imperative to capture and
curate data on experimentally validated interactions lying
scattered in diverse sources in the literature to generate a genome
scale network. This was achieved through the C2D program. The
C2D community started with initial registration of more than 800
researchers, which largely consisted of research scholars, graduate
students and under-graduate students. The participants were
trained, evaluated and filtered at various stages of online training
and assignments (https://sites.google.com/a/osdd.net/c2d-01/
pathwayannotationproject/results-of-the-exercise). More than
100 researchers were selected as curators to obtain the final
annotations (https://sites.google.com/a/osdd.net/c2d-01/
pathwayannotationproject).
Here we describe how C2D has implemented a community
annotation approach in a distributed co-creation mode for mining
literature and how the accuracies and scope of assigning functions
were enhanced using combined evidence approach. We have
enriched the annotations of the Mtb genome both in terms of
coverage and details (Table 1). Web2.0 collaborative online tools
enabled voluntary community participation for implementing this
task. An important part of the project was creating self-organized
communities to collectively learn and share the process and the
standards for reporting annotations. As per published estimates,
this innovative approach packed nearly 300 man-years into 4
months [11] and it has also established a novel way of collective
problem solving on a voluntary basis in a sustainable manner [12].
This is, to the best of our knowledge, lead to the creation of the
largest manually curated interactome of Mtb. Based on the varied
nature of interactions among proteins in vivo, we propose a new
network definition called ‘‘Protein-Protein Functional Network’’
(PPFN). This network encompasses a total of 1434 proteins
connected through 2575 functional relationships. In this paper, we
detail how the Interactome - PathWay (IPW), an open collabo-
rative platform was used to generate and analyze potential drug
targets. Using betweenness centrality [13] as a first indicator to
shortlist candidate drug targets, we zeroed into 73 proteins. We
have in the process also created a sustainable open innovation
platform.
Results and Discussion
C2D Annotation
An overview of the approach followed in ‘Connect to Decode’
(C2D) exercise is as illustrated in Figure 1. Broadly the approach
was designed based on the principles of the fourth paradigm of
science, encompassing data collation, curation and analysis [14].
Roughly ,4.4 Mbp genome of Mtb was re-annotated manually.
To streamline the annotation process and select a community of
researchers competent to implement this project, a series of online
assignments and training modules were assigned (see methods).
These steps ensured the selection of serious and dedicated
contributors thereby assuring the quality of data collation, curation
and analysis. Various standard operating protocols (SOPs) were
designed and shared with the participants for the consistency in
the steps followed for the annotation of genes (https://sites.google.
com/a/osdd.net/c2d-01/pathwayannotationproject/instructions-
for-annotation and https://sites.google.com/a/osdd.net/c2d-01/
pathwayannotationproject/example-annotation and https://sites.
google.com/a/osdd.net/c2d-01/pathwayannotationproject/steps
forproteinannotation ). Given the exponential increase in the
number of publications from about 300 per year since 1990’s to
a staggering 2000 per year in 2010, the challenging task of
collating and curating data was achieved through the formula-
tion of community editable interactive platform designed to
facilitate real time annotations and continuous updates. The
community scanned and retrieved information from nearly
10,000 published studies in addition to extracting information
from databases and transferred annotations using sequence and
structure analyses based approaches. The community has cited
more than 3000 papers in annotation process as on an average
3–4 manuscripts were referred or read in order to get the
relevant information to annotate a given protein.
The Mtb Genome Annotation and Interactome Curation
IPW has resulted in annotation of 87% of the genome in the
context of reporting gene products as compared to 52% in the re-
annotation reported in 2002. Moreover, less than 5% of the
interactions in IPW (Table S1) exist in other manually curated
interaction databases such as BIND [15], APID [16], IntAct [17],
DIP [18] and MINT [19] (Figure 2(b)). Thus, to the best of our
knowledge, Connect to Decode’s Interactome Pathway Annotation
(IPW) has generated the largest data set of manually curated
interactions in Mtb. These interactions not only include data from
large interaction databases such as IntAct, BIND, MINT, APID,
Crowd Sourcing for M. tuberculosis Interactome
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Table 1. The data structure that was used to capture the interactome data.
Field Description
GeneID The unique identifier for a given gene (Rv ID and NCBI Gene ID)
Gene Name Assigned name of the gene
Pathway Biological role of the gene
Gene function The biological function of the gene
Interacting Partners All the interacting partners for a given gene
Type of Interaction Type of interaction (protein-protein [p-p], protein-nucleotide [p-n])
Nature of Interaction This field contains nature of interaction, such as structural complex, regulatory, signaling etc.
Method of Inferring Interaction Contains information about the experimental or computational methods used for the inference of interacting partners
Type of Evidence Type of evidence, adopted from Gene Ontology (IDA, IPI, ISO, TAS, etc)
PUBMED/Link of source PubMed ID or any web based link from where the interaction and other annotation details were inferred
Email of author E-mail address of curator
There were 11 annotation fields for reporting annotations. The data is available in PSI MITAB format.
doi:10.1371/journal.pone.0039808.t001
Figure 1. From Social Network to Biological Network. The C2D annotation approach for manual annotation and curation of Mtb interactome
followed by network analysis to predict potential drug targets reported at various sequence and structural level filters. (A) Illustrates the overall
approach of crowd sourcing through social network implemented in C2D exercise (B)(a) Mtb Genome (b) Manual collation and sequence/structure
based curation for gene annotation (c) Collation of re-annotated genome into comprehensive data structure (d) Construction of protein-protein
interaction network based on the annotated data (e) Target identification using network analysis; Sequence level comparison of selected proteins
with that of human homologs, human gut flora and human oral flora; systems, sequence and structure level analysis of shortlisted proteins and
experimentally validated drug targets.
doi:10.1371/journal.pone.0039808.g001
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DIP, etc but also include a large amount of manually curated
information from literature.
Of the 1193 hypothetical proteins from TubercuList [4], the
IPW based annotations identify gene products for 770 proteins. Of
the 1480 hypothetical proteins reported in KEGG [20] database,
functional associations have been made to 1055 proteins, clearly
showing how IPW has bridged the wide gap that existed between
information captured in databases and that available in literature.
To ensure that IPW remains up to date, the data from IPW is
shared with members of the OSDD community in an ‘edit’ mode,
through which new interactions can be added using the SOP that
includes a rigorous quality check phase, specifically designed for
community contribution.
Interactome Construction: IPW and Combined Network
with STRING
Interactome as a whole constitutes various biological interac-
tions belonging to both structural and functional type of protein-
protein associations. To have an encyclopedic view of various
interactions that take place at protein functional level, we report
the construction of two types of networks. The first network,
termed IPW only (Figure 2(a)), was constructed on the basis of
the IPW curated data alone. The nodes in the network represent
the proteins whereas the edges represent the functional interac-
tions among those proteins. The nodes were scaled and color
coded in proportion to their degrees. Also, based on the common
interactions we derived a connectivity relationship between
various TubercuList functional classes [4]. Figure 2(c) shows
the connectivity among 10 broad functional classes of Tubercu-
List. The edge thickness was taken to be directly proportional to
the number of common proteins between the two TubercuList
functional classes for the given pair. Significant functional
dependencies are seen among the ‘Lipid Metabolism, Cell Wall,
Intermediary metabolism and Regulatory systems’ functional
classes, reflected in their edge thicknesses in the network.
Disruption of such linkages can lead to breakdown of crosstalk
between these biological processes and thus could be exploited to
identify new drug targets.
Secondly, in order to obtain insights on the complete functional
organization among all the possible proteins of Mtb, a combined
network termed, IPW-STRING (IPWSI), was constructed by
overlaying STRING network on the IPW network. The STRING
based network of Mtb was derived from STRING 8.0 [21]
database consisting of various interactions among proteins as
derived on the basis of extensive computational and limited
experimentally inferred interactions. Computational predictions
Figure 2. IPW interactome and comparison with existing annotation databases (a) IPW-Only protein-protein functional interaction network, (b)
Comparative analysis of IPW-Only proteins and interaction with existing manually curated databases, Ring represents all interactions and proteins in
IPW displaying the subsets which are obtained from other manually curated databases (b1) Comparative analysis of IPW-Only interactions to that of
existing manually curated databases (b2) comparative analysis of protein as curated in IPW-Only to that of proteins presents in other manually
curated databases (c) TubercuList functional class interaction relation based on the interactions as obtained from IPW-Only. The connectivity (lines)
represents the interacting proteins within these classes.
doi:10.1371/journal.pone.0039808.g002
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have been based on established methods such as phylogenetic
profiling, domain fusion, common gene neighborhood and operon
criteria. However, computational models over predicts interactions
since they do not account for spatio-temporal separation of the
interacting partners. Thus, in the combined network the accuracy
of interaction decreases whereas the coverage increases. It should
also be noted that there is an inherent bias for well-studied proteins
in IPW. A simple comparison shows that nearly 60% of IPW
interactions have experimental evidence codes as compared to 2%
existing in STRING. Also, about 29 additional proteins and 1762
new functional interactions apart from that reported by STRING
were included in the new IPW-STRING combined interactome.
The combined IPW-STRING interactome was further used to
decipher various possible drug targets using the concepts of graph
theory. The network analysis of these networks provides a means
to understand the functional organization of the organism from
the network topology point of view [22,23]. Various network
properties as computed for both the networks and their biological
relevance are discussed below.
Topological Organization of Interactome
In order to understand the functional organization of con-
structed interactome we further assessed the fundamental prop-
erties of this network from the graph theoretic point of view. Given
a vast interaction space encompassing the interactome as whole,
where the nodes represents proteins and interaction represents a
functional relation between them, it becomes imperative to
understand the functional organization of the network from its
topology. The most fundamental characteristic of a graph is the
connectivity of its constituent nodes as represented by the degree.
Degree, being a measure of interconnectedness of nodes highlight
the importance of a node (protein in this case) with respected to
other nodes in the network. A maximum degree of 44 and 289 was
observed for the IPW and IPWSI networks, respectively,
suggesting the level of maximum number of functional relation
of a given protein in both the networks.
Clustering coefficient for a node indicates the connectivity of
the neighbours of a given node to the other nodes in the network
[24]. This parameter was computed to elucidate the dependen-
cies of two or more proteins with respect to each other and to
rest of the proteins in the network. The clustering coefficient for
Figure 3. Network parameters (a) Characteristic path length of IPW-Only network and IPWSI network. In both the graphs the x-axis represents the
path length whereas the y-axis represents the frequency. 3(b) Log-Log plot of degree distribution of IPW network, the solid line was obtained by
fitting the power law for c =1.99 and Log-Log plot of degree distribution of IPWSI network, the solid line represents the power law fit with c = 2.01.
doi:10.1371/journal.pone.0039808.g003
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IPW and IPWSI networks was observed to be 0.249 and 0.377,
respectively. The high clustering coefficient of both the networks
suggests the presence of well-connected hubs within the network,
which are important from the functional crosstalk between the
proteins of Mtb. Further, the characteristic path length of both
the networks was computed in order to comprehend the extent
of functional relation between any two given proteins in the
network. The characteristic path length of both the networks is
as shown in Figure 3(a). The characteristic path length in IPW
network was observed to be 7.2 whereas for IPWSI it was
observed to be 3.13. From the network navigability point of view
the characteristic path length can be inferred as the number of
steps that one has to take traversing from one node to other,
which from biological point of view could be inferred as the
amount of communication that is possible between any two
proteins. Pertaining to the high characteristic path length of IPW
alone, the absence of functional relation between any two
proteins can be inferred; however, the functional relation
between any two proteins increase when the IPW alone was
clubbed with STRING based network. The characteristic path
length, thus, can be used to understand the functional gap that
possibly exists in the protein-protein interaction network.
Emphasizing on the network communication further, the
network diameter was computed representing the length of the
‘longest’ shortest path in the network. The network diameter of
IPW and IPWSI networks was observed to be 18 and 10,
respectively. Akin to characteristic path length, the network
diameter can be used to interpret the overall navigability of the
network, the higher the diameter, the more distantly two nodes
are related and vice versa.
As discussed, understanding the topological organization of the
network could lead to better understanding of its underlying
principles. The network topology could also be used to
understand the number of possible modules (hubs) in the
network, which may help in identifying potential drug targets.
In order to obtain such insights, we tested the existence of power
law distribution on IPW and IPWSI networks, respectively. The
power law distribution can also be used to understand the scale
free nature of a network [23]. There is extensive literature that
reports the existence of scale free nature of biological networks.
The power law distribution on the node degree distribution of
IPW and IPWSI networks is shown in Figure 3(b). The value
of c was observed to be 1.99 for IPW and 2.01 for IPW-
STRING combined node degree distribution.
Target Identification
Apart from inferring fundamental principles of network
properties the availability of an interactome also enables predic-
tion of essential proteins from the network structure point of view.
The protein lethality within a network is usually obtained from the
degree distribution of the nodes in the networks. The nodes with
high degree are considered important and hence regarded as
probable drug targets. The degree distribution alone could lead to
improper putative drug target identification as it does not capture
the alternate routes in the network. Most of the biological networks
possess large number of shortest paths [25]. The large number of
shortest paths also suggests the availability of alternate routes
within the network which could be used to achieve a certain
biological objective. Removing such nodes from the network could
lead to maximum disruption in the network. In order to capture
these properties, important nodes as well as important edges, we
used betweenness centrality [24,26] as a metric system to infer
putative drug targets. The node betweenness centrality at a
threshold of $0.2 lead to identification of 17 and 64 central
proteins from IPW and IPWSI networks, respectively (Table S2).
Analysis of Putative Drug Targets: Identifying Probable
Non-toxic Targets
To design a viable drug it is essential to ensure least probability
of off-target interactions. A sequence, structure and systems based
analysis was performed in order to predict the druggability of the
shortlisted central proteins from the two networks so as to reduce
the chances of off-target interactions.
The list of 17 and 64 proteins (73 unique proteins as eight are
common in the two lists) was first filtered against human homologs
and human oral and gut flora [27]. Of the 17 targets identified by
IPW, none had a homolog in human proteome and in human oral
and gut flora. In the combined network IPWSI, 53 such targets
were identified (Figure 4). There are 62 unique central proteins
without any significant homology to human proteome, gut and
oral flora from IPW and IPWSI. We further analyzed this list of 62
proteins for absence of small peptides (octamer) since it has been
reported that a small fraction of peptide sequences are evolution-
arily conserved and invariant across several organisms [28]. These
peptide sequences can adopt similar conformation in different
protein structures [28]. A comparative analysis shows that one
protein Rv3221A does not share any common octapeptide with
human proteome, gut or oral flora. However, a closer and detailed
analysis needs to be performed for proteins sharing octapeptide
with human proteome and human microbiome in order to
evaluate their status for off-target binding. In order to understand
the binding pockets, an independent analysis has been performed
to predict and match binding pockets of central proteins with
human proteome. Of the 73 central proteins, 57 have either PDB
or ModBase [29] structure making them amenable to structural
analysis for druggability. We analyzed these proteins as per the
targetTB [30] pipeline where the top 10 binding sites for each of
these 57 proteins were identified using PocketDepth algorithm
[31]. The binding pockets of these proteins were then compared
with human proteome using PocketMatch [32]. Of the 57
proteins, 31 proteins have high structural similarity with human
proteome at binding site level whereas 26 proteins which do not
have binding site similarity with human proteome. It is interesting
to note that seven of these are experimentally validated drug
targets.
Rv3221A (RshA) (Figure 4 List d), an anti-sigma factor to the
primary stress response sigma factor SigH, passed all filters but is
neither reported as a potential drug target in literature nor in
targetTB predictions. The gene encoding RshA lies in the same
operon as SigH and is co-expressed with the same [33]. It has a
strong affinity to bind with SigH and attenuates its ability to bind
to the RNA polymerase holoenzyme under normal growth
conditions. Under conditions of oxidative stress, phosphorylation
of RshA by Rv0014c (PknB) abolishes its binding to SigH, which
in turn leads to the cascade of expression of several stress response
proteins [34] (Figure 5). SigH causes increased expression of two
other sigma factors Rv2710 (SigB) and Rv1221 (SigE), which are
also known to be stress related sigma factors that assist Mtb in its
survival during several stress conditions and are also central
proteins. The other interacting partners of RshA include heat
shock proteins and chaperones like Rv0384c (ClpB) and Rv0350
(DnaK), enzymes for oxidative stress response Rv1471 (TrxB1),
Rv3913 (TrxB2) and Rv3914 (TrxC) which are also part of the
sigH regulon. sigH also induces enzymes involved in cysteine
biosynthesis and in the metabolism of ribose and glucose for the
production of mycothiol precursors, which assist in cellular
protection under oxidative stress. The SigB and SigE signaling
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cascade downstream interacts and regulate other central proteins
(Figure 5). RshA is at the beginning of this cascade and seems to
play in crucial role in regulating the stress response proteins,
starting with sigH.
The objective of the interactome construction and analyses
was to identify central proteins, which have significant roles in
maintaining growth and survival of the bacterial pathogen. We
identified 17 such central proteins (Table 2), five of which (PknB,
NuoG, PhoP, EccCb1, HspX) have been previously functionally
characterized and shown to be essential by gene deletion and
mutation and thus are considered as validated drug targets. The
target gets further validated if there are inhibitors which inhibit
the function of the target enzyme or protein as well. PknB
(Rv0014c) is an essential serine-threonine protein kinase in Mtb
and has role in a number of signaling pathways in cell division
and metabolism. Several inhibitors have been reported for this
kinase [35] and is also one of the targets being pursued by
Working Group on New TB Drugs (http://www.newtbdrugs.
org/project.php?id = 81). NuoG (Rv3151) is a subunit of type I
NADH dehydrogenase playing an important role in growth in
macrophage and pathogenesis in animal models [36]. PhoP
(Rv0757), a response regulator and part of the two component
system, when mutated leads to growth defects in macrophages
and in mouse models [37]. eccCb1 (Rv3871) is a part of the RD1
Figure 4. Illustrates the comprehensive analyses of central proteins as potential drug targets. The various filters include comparison with
validated drug targets, sequence and structural level comparison with Human proteome, gut and oral flora (a) The list of 73 central ORFs wherein Rv
Ids in bold represent IPW central ORFs, Rv IDs in regular font represents IPWSI central ORFs and the italicized-bold represent common Rv Ids to both
IPW and IPWSI. (b & b’) Five of the 17 IPW and six of 64 central ORFs with experimental validation as drug targets. (c) Sequence homology comparison
with human proteome and human microbiome results in 62 ORFs with no significant similarity (d) Octamer analyses against human proteome and
human microbiome results in one ORF with no hits (e) Comparative binding site analysis with human proteome results in 26 ORFs with no significant
similarity (lists b, b’, c, d and e available in Table S2).
doi:10.1371/journal.pone.0039808.g004
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region and mutation leads to attenuated growth and toxicity in
THP-1 cells. The mutants cannot export CFP-10 and are
avirulent [38]. hspX (Rv2031c) encodes for a alpha-crystallin-like
protein and plays a significant role in retaining a non-replicating
state in latency [39,40]. The fact that five of the 17 putative drug
targets from IPW are already validated drug targets, lends
credence to our approach of annotating the genome and
interactome construction of Mtb for system level understanding
towards novel drug target identification.
Despite the efforts over a number of years, discovering novel,
fast acting drugs for TB has been a major challenge. However,
recently introduced combination drug Risorine designed on the
principles of Ayurveda has been shown to cut down rifampicin use
leading to very high compliance [41]. Understanding the biology
of the pathogen through a systems level approach can help in
identifying the Achilles heel for Mtb. Towards this, Interactome
Pathway annotation has captured the updated relevant informa-
tion on Mtb genes and has tried to unravel the puzzle. We have
amalgamated crowd sourcing with social networking to compre-
hensively reannotate the Mtb genome, generated its largest ever
interactome and propose potentially efficacious drug targets. In
the process, we have set up an open collaborative platform and a
dynamic community to ensure regular updates.
Materials and Methods
Crowd Sourcing for Data Curation
Data capture. Two annotation standard operating protocols
(SOPs), in the presence of literature and in the absence of
literature, were designed in order to capture the maximum
amount of relevant data. Wherever the protein was not studied in
Mtb, the annotations were transferred from other organisms based
on conservative statistical measures in sequence and structure-
based analysis as discussed below (i and ii). To ensure consistency
and integrity of the data added to the resource, Standard
Operating Protocols (SOPs) were created and followed by the
community. These SOPs and tutorials may be accessed at (http://
c2d.osdd.net and https://sites.google.com/a/osdd.net/c2d-01/
pathwayannotationproject).
Annotation SOP in presence of literature. The first step
was to retrieve information on Mtb proteins with experimental
evidence from literature. PubMed and Google based literature
searches were carried out using suitable keywords, such as the
respective Rv number, gene name, Mycobacterium tuberculosis, along
with suitable Boolean expressions, such as AND and OR (for
example, [Rv1018c] AND [mycobacterium tuberculosis], [epox-
ide hydrolase] AND [mycobacterium tuberculosis]). While
Figure 5. Illustration of 17 putative drug target interaction from IPW interactome depicting the cascade of how the central proteins
interact with each other in a spatio-temporal manner under different conditions like growth, stress and survival in macrophages
including virulence. Under normal conditions, PknB phosphorylates RshA which inhibits SigH. However, under oxidative stress, RshA is not
phosphorylated and this abolishes its binding to SigH, rendering it free. SigH in turn upregulates expression of SigE and SigB which regulates MprA
(bacterial persistence regulator). MprA also regulates SigB and SigE. SigB plays important role in adaptation to stationary phase and nutritionally poor
conditions and SigE is upregulated in mycobacterial growth within human macrophages and is transcribed from three different promoters under
different conditions. sigB is also regulated by SigF, which regulates the expression of genes involved in the biosynthesis and structure of the
mycobacterial cell envelope, including complex polysaccharides and lipids, particularly virulence- related sulfolipids and several transcription factors.
Rv0516c is an anti-anti sigma factor and regulates anti-sigma factor SigF (upregulated during infection culture of human macrophages and in
nutrient starvation condition; regulates transcription of genes involved in cell wall biosynthesis, sulfolipid metabolism, nucleotide metabolism, energy
metabolism and several transcription factors) on getting phosphorylated by PknD which in turn is regulated by Rv0020c phosphorylated by PknB and
PknE. SigF also regulates sigC and regulates hspx that is also regulated by dosR regulon. dosR regulon in turn is again regulated by PhoP which is a
transcription factor for nuoG, eccCb1, esxb/cfp10 [48].
doi:10.1371/journal.pone.0039808.g005
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manually scanning the available literature, emphasis was placed
on the references, which dealt with Mycobacterium tuberculosis
H37Rv followed, by evidence in other mycobacterial species. If
the protein was an enzyme, the corresponding reaction, along
with the EC number, and the pathway(s) in which the protein
participates was also recorded.
SOP for annotation in the absence of direct information
from literature. In absence of direct literature information,
annotations were derived based on sequence, structure and profile
based information and analyses. To begin with, NCBI-BLAST
[42] was used to obtain homology information of the query
protein. Hits with e-value of #0.0001 and identity of $35%, with
$75% sequence coverage were considered as significant hits.
Annotations of the closest homologue were transferred and
recorded in the template against each annotation. Similarity
search in the Pfam [43] database was carried out to support
BLAST results and also to annotate in the absence of high query
coverage with BLAST analysis. If both BLAST and Pfam
similarity search failed to give a significant hit, Phyre [44], an
automatic fold recognition tool was used for predicting the
function of the Mtb proteins through high confidence fold
associations. Appropriate evidence codes have been used to
distinguish between transferred annotations and experimental
based annotations.
Data curation. Multiple rounds of collaborative data quality
checks were carried out to ensure that the data has been correctly
captured and reported. A set of instructions (SOPs) were devised
for the same (https://sites.google.com/a/osdd.net/c2d-01/
pathwayannotationproject/data-qc-guide) where the annotations
curated by the members were systematically crosschecked
iteratively by other members. It was interesting to note that high
quality curation was achieved by this approach of ‘many eyeballs
make the bug shallow’, a common phenomenon in open source
software projects.
Data organization. The collated data was organized into a
defined data structure as depicted in Table 1 with two columns,
field and description. The PSI MI (Proteomics Standards Initiative
Molecular Interactions) was used as the community standard for
reporting protein-protein interactions in MITAB format (Table
S3). This helps in improving the representation of molecular
interaction data and its accessibility to the user community.
Interactome Construction and Network Parameter
Estimation
IPW and IPWSI network. The IPW-only network was
constructed based on the annotations and curation of the data
from IPW. The combined network of IPW and STRING termed,
IPWSI, was constructed by combining the IPW network with that
from STRING. All the interactions in STRING with high and
medium level confidence score (above 400) were used to construct
STRING based protein-protein interaction network. Methods
used to compute network parameters are discussed below.
Network properties. To understand the functional organi-
zation of interacting proteins in both the networks, an analysis of
various network topologies was performed. These network
properties were computed using Boost Graph library in MATLAB
(David Gleich; http://www.stanford.edu/,dgleich/programs/
matlab_bgl/).
Connectivity or degree. The most elementary characteristic
of a node in the network is its degree k, which represents, for a
given node the number of other nodes it is connected to.
Clustering coefficient. The clustering coefficient was first
defined by Watts and Strogatz [24]. The clustering coefficient, C,
for a node is a notion of how connected the neighbours of a given
node are to the other nodes (cliquishness) [45]. The average
clustering coefficient for all nodes in a network is taken to be the
network clustering coefficient. In an undirected graph, if a vertex vi
has ki neighbors, k i (k i - 1)/2 edges could exist among the vertices
Table 2. The list of all the 17 central proteins as predicted from the betweenness centrality of .0.2 through IPW network with
their gene products.
Accession Gene Name Description (Gene Product)
Rv0014c*[35] pknB TRANSMEMBRANE SERINE/THREONINE-PROTEIN KINASE B PKNB (PROTEIN KINASE B)
Rv0020c fhaA CONSERVED HYPOTHETICAL PROTEIN WITH FHA DOMAIN, TB39.8
Rv0516c Rv0516c ANTI-ANTI SIGMA FACTOR
Rv0757*[37] phoP POSSIBLE TWO COMPONENT SYSTEM RESPONSE TRANSCRIPTIONAL POSITIVE REGULATOR
Rv0931c pknD TRANSMEMBRANE SERINE/THREONINE-PROTEIN KINASE D PKND (PROTEIN KINASE D)
Rv0981 mprA MYCOBACTERIAL PERSISTENCE REGULATOR MRPA (TWO COMPONENT RESPONSE TRANSCRIPTIONAL REGULATORY PROTEIN)
Rv1221 sigE ALTERNATIVE RNA POLYMERASE SIGMA FACTOR SIGE
Rv2031c*[39,40] hspX HEAT SHOCK PROTEIN HSPX (ALPHA-CRSTALLIN HOMOLOG) (14 kDa ANTIGEN) (HSP16.3)
Rv2069 sigC PROBABLE RNA POLYMERASE SIGMA FACTOR, ECF SUBFAMILY
Rv2710 sigB RNA POLYMERASE SIGMA FACTOR
Rv3151*[36] nuoG PROBABLE NADH DEHYDROGENASE I (CHAIN G) NUOG (NADH-UBIQUINONE OXIDOREDUCTASE CHAIN G)
Rv3221A Rv3221A POSSIBLE ANTI-SIGMA FACTOR RSHA
Rv3223c sigH ALTERNATIVE RNA POLYMERASE SIGMA-E FACTOR (SIGMA-24)
Rv3286c sigF ALTERNATE RNA POLYMERASE SIGMA FACTOR
Rv3871*[38] Rv3871 ESX CONSERVED COMPONENT ECCCB1 (ATPase activity)
Rv3874 esxB 10 KDA CULTURE FILTRATE ANTIGEN ESXB (LHP) (CFP10)
Rv3911 sigM RNA POLYMERASE SIGMA FACTOR
RvIDs superscripted with asterisk are essential proteins as evidenced by genetic and biochemical studies.
doi:10.1371/journal.pone.0039808.t002
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within the neighbourhood (Ni ). The clustering coefficient for an
undirected graph G(V, E) (where V represents the set of vertices in
the graph G and E represents the set of edges) can then be
defined as
Ci~
2D ejk
 
D
ki ki{1ð Þ ; vj ,vk[Ni,ejk[E
The average clustering coefficient characterizes the overall
tendency of nodes to form clusters or groups. C(k) is defined as the
average clustering coefficient for all nodes with k links.
Characteristic path length. The characteristic path length,
L, is defined as the number of edges in the shortest path between
two vertices, averaged over all pairs of vertices. It measures the
typical separation between two vertices in the network. Intuitively,
it represents the network’s overall navigability [45].
Network diameter. The network diameter d is the greatest
distance (shortest path, or geodesic path) between any two nodes in
a network. It can also be viewed as the length of the ‘longest’
shortest path in the network.
d~max
u,v[G
dG u, vð Þ
where dG (u, v) is the shortest path between u and v in G [45].
Power law distribution. For a given network the power law
distribution states the probability that a given node has k links,
which is given by equation p(k) , k-c, where c is degree exponent.
For smaller values of c, the role of the ‘hubs’, or highly connected
nodes, in the network becomes more important. For c .3, hubs
are not relevant, while for 2,c ,3, there is a hierarchy of hubs,
with the most connected hub being in contact with a small fraction
of all nodes. Scale-free networks have a high degree of robustness
against random node failures, although they are sensitive to the
failure of hubs [23]. The probability that a node is highly
connected is statistically more significant than in a random graph
[45].
Betweenness centrality. The betweenness centrality is the
measure of vertex within a graph. For a given graph G(V,E), with
n vertices, the betweenness CB (v) of a vertex v is defined as.
CB vð Þ~
X
s=v=t [V
sst(v)
sst
where sst is the number of shortest path from s to t, and sst (v) is
the number of shortest paths from s to t that passes from vertex v.
The betweenness centrality analysis was performed for both the
networks [45–46].
Drug Target Identification
Sequence homology with human proteome, oral and gut
flora. The complete human proteome was downloaded from
NCBI and BLAST was used to filter out the proteins, which had
homology of greater than 45% with human protein. Human gut
and oral flora constitutes the microbes that are considered to
influence the physiology, nutrition, immunity and development of
host. The complete proteome of 8-gut flora and 27 oral floras were
downloaded. CD-HIT with similarity of 60% and a word size of 4
was used to compare the predicted proteins [27].
Binding site similarity with human proteome, oral and
gut flora. We analyzed these proteins as reported in targetTB
[30] pipeline where the top 10 binding sites for each protein was
identified using PocketDepth algorithm [31]. The binding pockets
of these proteins were then compared with human proteome using
PocketMatch [32].
Peptide level conformation comparison with human
proteome, oral and gut flora. We analyzed the proteins for
absence of small peptides (octamer) [28] across human proteome,
gut or oral flora using in house PERL scripts.
Literature based target validation. The predicted targets
were further validated based on presence of existing functional
evidence in literature. Data-mining and manual curation was
performed to identify and document validated drug targets in Mtb.
In addition to this, it was also documented whether the central
protein is also reported to be essential or non-essential in context of
Mtb growth and survival.
Web Server for Accessing and Searching IPW
The IPW data has been posted on http://sysborg2.osdd.net, the
semantic web-based platform of Open Source Drug Discovery
(OSDD) project [47]. For ease of access and search, the data is
provided through a web-based server available at http://crdd.
osdd.net/servers/ipw built using PHP and Mysql. This also works
as the annotation and curation interface for the community. Any
new submission to this web servers requires http://sysborg2.osdd.
net open ID for authentication so that appropriate credits may be
given to the members submitting updated information.
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Genetic Fine Structure of a Salmonella enterica Serovar Typhi Strain
Associated with the 2005 Outbreak of Typhoid Fever in Kelantan,
Malaysia
Ramani Baddam,a Narender Kumar,a Kwai-Lin Thong,b,c Soo-Tein Ngoi,b,c Cindy Shuan Ju Teh,c Kien-Pong Yap,b,c Lay-Ching Chai,b,c
Tiruvayipati Suma Avasthi,a,b and Niyaz Ahmeda,b
Pathogen Biology Laboratory, Department of Biotechnology, School of Life Sciences, University of Hyderabad, Hyderabad, Indiaa; Institute of Biological Sciences, Faculty
of Science, University of Malaya, Kuala Lumpur, Malaysiab; and Laboratory of Biomedical Science and Molecular Microbiology, UMBIO Research Cluster, University of
Malaya, Kuala Lumpur, Malaysiac
Among enteric pathogens, Salmonella enterica serovar Typhi is responsible for the largest number of food-borne outbreaks and
fatalities. The ability of the pathogen to cause systemic infection for extended durations leads to a high cost of disease control.
Chronic carriers play important roles in the evolution of Salmonella Typhi; therefore, identification and in-depth characteriza-
tion of isolates from clinical cases and carriers, especially those from zones of endemicity where the pathogen has not been ex-
tensively studied, are necessary. Here, we describe the genome sequence of the highly virulent Salmonella Typhi strain BL196/05
isolated during the outbreak of typhoid in Kelantan, Malaysia, in 2005. The whole-genome sequence and comparative genomics
of this strain should enable us to understand the virulence mechanisms and evolutionary dynamics of this pathogen inMalaysia
and elsewhere.
Salmonella enterica serovar Typhi and other pathogenic salmo-nellae are endemic in some countries (8, 15), and outbreaks
occur due to unhygienic conditions (16), leading to alarming
morbidity and mortality figures (9, 18). This results in a huge
burden on the public health machinery. Salmonella Typhi persists
for an extended duration in its host (18) due to modulation of the
host immune responses togetherwith genetic rearrangements that
confer fitness advantages (12, 13, 17).
The incidence of typhoid in Kelantan had always been higher
than in other states of Malaysia. In the 2005 outbreak (April to
June 2005), 735 cases and 2 deaths occurred (18). We hypothe-
sized that the genome sequences of the underlying strains would
providemore insights to enhance understanding of endemicity or
persistence of typhoid in Kelantan.
SalmonellaTyphi BL196/05was isolated fromblood samples of
a severe typhoid case inKelantan during the notorious outbreak of
2005. The strain was characterized by PCR to determine the pres-
ence ofmany different virulence genes. The genome sequence was
analyzed and annotated exactly as described previously (4, 5, 11,
21). Briefly, the 73-bp paired-end Illumina sequence reads,
amounting to 1.7 gigabytes of data (insert size, 300 bp), were gen-
erated with 80 genome coverage. Velvet (26), with the hash
length set to 37, was used to assemble sequence reads into 191
contigs; these were further assembled into a draft genome and
were submitted to RAST (6) to determine the following data. The
size of the single chromosome was approximately 4,744,056 bp,
with a GC content of 53.21% and a coding percentage of 87.1.
Therewere 4,875 protein coding sequences found,with an average
length of 875 bp. The genome revealed 76 tRNA and 22 rRNA
genes. Our strain did not harbor any plasmid, and its phage typing
revealed Vi phage type B1. The genome sequence revealed two
mar regulons, marRAB and marC, as reported also in Salmonella
Typhi strains CT18 and Ty2, and these were homologous to Esch-
erichia coli mar (multiple antibiotic resistance) regulon members
(2, 3, 10, 20, 25). The genes encoding amelittin resistance protein,
PqaB, and a polymyxin resistance protein, PmrD (7), were located
in the genome as also seen in the Salmonella Typhi CT18 and Ty2
genomes. Themethyl viologen resistance gene (14) smvAwas also
identified. Several pathogenicity islands as well as a pool of hypo-
thetical proteins were annotated.
Considerable genetic diversity exists among human isolates of
Salmonella Typhi inMalaysia and Southeast Asia (22, 23), and the
heterogeneity in genome sizes (24) points to a high degree of plas-
ticity in the Salmonella pan-genome. The genome sequence of
strain BL196/05 also revealed rearrangements putatively relevant
to virulence optimization, persistence, and adaptation within the
host. Such information would be harnessed to improve under-
standing of genome evolution and adaptation dynamics of Salmo-
nella in Malaysia and to develop point-of-care diagnostics. Fur-
ther, future efforts are needed to evaluate the significance of
comparative genomics/genotypic data in juxtaposition with host
genetic polymorphisms to herald the beginning of the “functional
molecular infection epidemiology” (1) of typhoid. Finally, we rec-
ommend greater use of data determined in studies of clinical iso-
lates and strains specific to outbreaks and countries rather than
use of the reference (type) strains alone.
Nucleotide sequence accession numbers. This genome proj-
ect has been deposited at GenBank under accession no.
AJGK00000000. The version described herein is the first version,
AJGK01000000. The Bioproject designation for this project is
PRJNA85621.
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APPENDIX A 
(a) Adaptor File 
>Illumina Single End Adapter 1      
GATCGGAAGAGCTCGTATGCCGTCTTCTGCTTG 
>Illumina Single End Adapter 1      
GATCGGAAGAGCTCGTATGCCGTCTTCTGCTT 
>Illumina Single End Adapter 1      
GATCGGAAGAGCTCGTATGCCGTCTTCTGCT 
>Illumina Single End Adapter 1      
GATCGGAAGAGCTCGTATGCCGTCTTCTGC 
>Illumina Single End Adapter 1      
GATCGGAAGAGCTCGTATGCCGTCTTCTG 
>Illumina Single End Adapter 1      
GATCGGAAGAGCTCGTATGCCGTCTTCT 
>Illumina Single End Adapter 1      
GATCGGAAGAGCTCGTATGCCGTCTTC 
>Illumina Single End Adapter 1      
GATCGGAAGAGCTCGTATGCCGTCTT 
>Illumina Single End Adapter 1      
GATCGGAAGAGCTCGTATGCCGTCT 
>Illumina Single End Adapter 1      
GATCGGAAGAGCTCGTATGCCGTC 
>Illumina Single End Adapter 1      
GATCGGAAGAGCTCGTATGCCGT 
>Illumina Single End Adapter 1      
GATCGGAAGAGCTCGTATGCCG 
>Illumina Single End Adapter 1      
GATCGGAAGAGCTCGTATGCC 
>Illumina Single End Adapter 1      
GATCGGAAGAGCTCGTATGC 
>Illumina Single End Adapter 1      
GATCGGAAGAGCTCGTATG 
>Illumina Single End Adapter 1      
GATCGGAAGAGCTCGTAT 
>Illumina Single End Adapter 1      
GATCGGAAGAGCTCGTA 
>Illumina Single End Adapter 1      
GATCGGAAGAGCTCGT 
>Illumina Single End Adapter 1      
GATCGGAAGAGCTCG 
>Illumina Single End Adapter 1      
GATCGGAAGAGCTC 
>Illumina Single End Adapter 1      
GATCGGAAGAGCT 
>Illumina Single End Adapter 1      
GATCGGAAGAGC 
>Illumina Single End Adapter 2      
CAAGCAGAAGACGGCATACGAGCTCTTCCGATCT 
>Illumina Single End Adapter 2      
CAAGCAGAAGACGGCATACGAGCTCTTCCGATC 
>Illumina Single End Adapter 2      
206
CAAGCAGAAGACGGCATACGAGCTCTTCCGAT 
>Illumina Single End Adapter 2      
CAAGCAGAAGACGGCATACGAGCTCTTCCGA 
>Illumina Single End Adapter 2      
CAAGCAGAAGACGGCATACGAGCTCTTCCG 
>Illumina Single End Adapter 2      
CAAGCAGAAGACGGCATACGAGCTCTTCC 
>Illumina Single End Adapter 2      
CAAGCAGAAGACGGCATACGAGCTCTTC 
>Illumina Single End Adapter 2      
CAAGCAGAAGACGGCATACGAGCTCTT 
>Illumina Single End Adapter 2      
CAAGCAGAAGACGGCATACGAGCTCT 
>Illumina Single End Adapter 2      
CAAGCAGAAGACGGCATACGAGCTC 
>Illumina Single End Adapter 2      
CAAGCAGAAGACGGCATACGAGCT 
>Illumina Single End Adapter 2      
CAAGCAGAAGACGGCATACGAGC 
>Illumina Single End Adapter 2      
CAAGCAGAAGACGGCATACGAG 
>Illumina Single End Adapter 2      
CAAGCAGAAGACGGCATACGA 
>Illumina Single End Adapter 2      
CAAGCAGAAGACGGCATACG 
>Illumina Single End Adapter 2      
CAAGCAGAAGACGGCATAC 
>Illumina Single End Adapter 2      
CAAGCAGAAGACGGCATA 
>Illumina Single End Adapter 2      
CAAGCAGAAGACGGCAT 
>Illumina Single End Adapter 2      
CAAGCAGAAGACGGCA 
>Illumina Single End Adapter 2      
CAAGCAGAAGACGGC 
>Illumina Single End Adapter 2      
CAAGCAGAAGACGG 
>Illumina Single End Adapter 2      
CAAGCAGAAGACG 
>Illumina Single End Adapter 2      
CAAGCAGAAGAC 
>Illumina Single End PCR Primer 1     
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTC
CGATCT 
>Illumina Single End PCR Primer 2     
CAAGCAGAAGACGGCATACGAGCTCTTCCGATCT 
>Illumina Single End Sequencing Primer    
ACACTCTTTCCCTACACGACGCTCTTCCGATCT 
>Illumina Paired End Adapter 1      
ACACTCTTTCCCTACACGACGCTCTTCCGATCT 
>Illumina Paired End Adapter 1      
ACACTCTTTCCCTACACGACGCTCTTCCGATC 
207
>Illumina Paired End Adapter 1      
ACACTCTTTCCCTACACGACGCTCTTCCGAT 
>Illumina Paired End Adapter 1      
ACACTCTTTCCCTACACGACGCTCTTCCGA 
>Illumina Paired End Adapter 1      
ACACTCTTTCCCTACACGACGCTCTTCCG 
>Illumina Paired End Adapter 1      
ACACTCTTTCCCTACACGACGCTCTTCC 
>Illumina Paired End Adapter 1      
ACACTCTTTCCCTACACGACGCTCTTC 
>Illumina Paired End Adapter 1      
ACACTCTTTCCCTACACGACGCTCTT 
>Illumina Paired End Adapter 1      
ACACTCTTTCCCTACACGACGCTCT 
>Illumina Paired End Adapter 1      
ACACTCTTTCCCTACACGACGCTC 
>Illumina Paired End Adapter 1      
ACACTCTTTCCCTACACGACGCT 
>Illumina Paired End Adapter 1      
ACACTCTTTCCCTACACGACGC 
>Illumina Paired End Adapter 1      
ACACTCTTTCCCTACACGACG 
>Illumina Paired End Adapter 1      
ACACTCTTTCCCTACACGAC 
>Illumina Paired End Adapter 1      
ACACTCTTTCCCTACACGA 
>Illumina Paired End Adapter 1      
ACACTCTTTCCCTACACG 
>Illumina Paired End Adapter 1      
ACACTCTTTCCCTACAC 
>Illumina Paired End Adapter 1      
ACACTCTTTCCCTACA 
>Illumina Paired End Adapter 1      
ACACTCTTTCCCTAC 
>Illumina Paired End Adapter 1      
ACACTCTTTCCCTA 
>Illumina Paired End Adapter 1      
ACACTCTTTCCCT 
>Illumina Paired End Adapter 1      
ACACTCTTTCCC 
>Illumina Paired End Adapter 2      
GATCGGAAGAGCGGTTCAGCAGGAATGCCGAG 
>Illumina Paired End Adapter 2      
GATCGGAAGAGCGGTTCAGCAGGAATGCCGA 
>Illumina Paired End Adapter 2      
GATCGGAAGAGCGGTTCAGCAGGAATGCCG 
>Illumina Paired End Adapter 2      
GATCGGAAGAGCGGTTCAGCAGGAATGCC 
>Illumina Paired End Adapter 2      
GATCGGAAGAGCGGTTCAGCAGGAATGC 
>Illumina Paired End Adapter 2      
GATCGGAAGAGCGGTTCAGCAGGAATG 
208
>Illumina Paired End Adapter 2      
GATCGGAAGAGCGGTTCAGCAGGAAT 
>Illumina Paired End Adapter 2      
GATCGGAAGAGCGGTTCAGCAGGAA 
>Illumina Paired End Adapter 2      
GATCGGAAGAGCGGTTCAGCAGGA 
>Illumina Paired End Adapter 2      
GATCGGAAGAGCGGTTCAGCAGG 
>Illumina Paired End Adapter 2      
GATCGGAAGAGCGGTTCAGCAG 
>Illumina Paired End Adapter 2      
GATCGGAAGAGCGGTTCAGCA 
>Illumina Paired End Adapter 2      
GATCGGAAGAGCGGTTCAGC 
>Illumina Paired End Adapter 2      
GATCGGAAGAGCGGTTCAG 
>Illumina Paired End Adapter 2      
GATCGGAAGAGCGGTTCA 
>Illumina Paired End Adapter 2      
GATCGGAAGAGCGGTTC 
>Illumina Paired End Adapter 2      
GATCGGAAGAGCGGTT 
>Illumina Paired End Adapter 2      
GATCGGAAGAGCGGT 
>Illumina Paired End Adapter 2      
GATCGGAAGAGCGG 
>Illumina Paired End Adapter 2      
GATCGGAAGAGCG 
>Illumina Paired End Adapter 2      
GATCGGAAGAGC 
>Illumina Paried End PCR Primer 1     
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTC
CGATCT 
>Illumina Paired End PCR Primer 2     
CAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGCTGAACCGCT
CTTCCGATCT 
>Illumina Paried End Sequencing Primer 1    
ACACTCTTTCCCTACACGACGCTCTTCCGATCT 
>Illumina Paired End Sequencing Primer 2    
CGGTCTCGGCATTCCTGCTGAACCGCTCTTCCGATCT 
>Illumina Multiplexing Adapter 1      
GATCGGAAGAGCACACGTCT 
>Illumina Multiplexing Adapter 1      
GATCGGAAGAGCACACGTC 
>Illumina Multiplexing Adapter 1      
GATCGGAAGAGCACACGT 
>Illumina Multiplexing Adapter 1      
GATCGGAAGAGCACACG 
>Illumina Multiplexing Adapter 1      
GATCGGAAGAGCACAC 
>Illumina Multiplexing Adapter 1      
GATCGGAAGAGCACA 
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>Illumina Multiplexing Adapter 1      
GATCGGAAGAGCAC 
>Illumina Multiplexing Adapter 1      
GATCGGAAGAGCA 
>Illumina Multiplexing Adapter 1      
GATCGGAAGAGC 
>Illumina Multiplexing Adapter 2      
ACACTCTTTCCCTACACGACGCTCTTCCGATCT 
>Illumina Multiplexing PCR Primer 1.01    
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTC
CGATCT 
>Illumina Multiplexing PCR Primer 2.01    
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT 
>Illumina Multiplexing Read1 Sequencing Primer  
ACACTCTTTCCCTACACGACGCTCTTCCGATCT 
>Illumina Multiplexing Index Sequencing Primer  
GATCGGAAGAGCACACGTCTGAACTCCAGTCAC 
>Illumina Multiplexing Read2 Sequencing Primer  
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT 
>Illumina PCR Primer Index 1       
CAAGCAGAAGACGGCATACGAGATCGTGATGTGACTGGAGTTC 
>Illumina PCR Primer Index 2       
CAAGCAGAAGACGGCATACGAGATACATCGGTGACTGGAGTTC 
>Illumina PCR Primer Index 3       
CAAGCAGAAGACGGCATACGAGATGCCTAAGTGACTGGAGTTC 
>Illumina PCR Primer Index 4       
CAAGCAGAAGACGGCATACGAGATTGGTCAGTGACTGGAGTTC 
>Illumina PCR Primer Index 5       
CAAGCAGAAGACGGCATACGAGATCACTGTGTGACTGGAGTTC 
>Illumina PCR Primer Index 6       
CAAGCAGAAGACGGCATACGAGATATTGGCGTGACTGGAGTTC 
>Illumina PCR Primer Index 7       
CAAGCAGAAGACGGCATACGAGATGATCTGGTGACTGGAGTTC 
>Illumina PCR Primer Index 8       
CAAGCAGAAGACGGCATACGAGATTCAAGTGTGACTGGAGTTC 
>Illumina PCR Primer Index 9       
CAAGCAGAAGACGGCATACGAGATCTGATCGTGACTGGAGTTC 
>Illumina PCR Primer Index 10      
CAAGCAGAAGACGGCATACGAGATAAGCTAGTGACTGGAGTTC 
>Illumina PCR Primer Index 11      
CAAGCAGAAGACGGCATACGAGATGTAGCCGTGACTGGAGTTC 
>Illumina PCR Primer Index 12      
CAAGCAGAAGACGGCATACGAGATTACAAGGTGACTGGAGTTC 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTC
CGATCT 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTC
CGATC 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTC
CGAT 
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>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTC
CGA 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTC
CG 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTC
C 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTC 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTT 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCT 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTC 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCT 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGC 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACG 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGAC 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGA 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACG 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACAC 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACA 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTAC 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTA 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCT 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGATCTACACTCTTTCCC 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGATCTACACTCTTTCC 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGATCTACACTCTTTC 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGATCTACACTCTTT 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGATCTACACTCTT 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGATCTACACTCT 
>TruSeq Universal Adapter       
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AATGATACGGCGACCACCGAGATCTACACTC 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGATCTACACT 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGATCTACAC 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGATCTACA 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGATCTAC 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGATCTA 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGATCT 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGATC 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGAT 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAGA 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGAG 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCGA 
>TruSeq Universal Adapter       
AATGATACGGCGACCACCG 
>TruSeq Universal Adapter       
AATGATACGGCGACCACC 
>TruSeq Universal Adapter       
AATGATACGGCGACCAC 
>TruSeq Universal Adapter       
AATGATACGGCGACCA 
>TruSeq Universal Adapter       
AATGATACGGCGACC 
>TruSeq Universal Adapter       
AATGATACGGCGAC 
>TruSeq Universal Adapter       
AATGATACGGCG 
>TruSeq Universal Adapter       
AATGATACGGC 
>TruSeq Adapter, Index 1        
GATCGGAAGAGCACACGTCTGAACTCCAGTCACATCACGATCTCGTATGCC
GTCTTCTGCTTG 
>TruSeq Adapter, Index 2        
GATCGGAAGAGCACACGTCTGAACTCCAGTCACCGATGTATCTCGTATGCC
GTCTTCTGCTTG 
>TruSeq Adapter, Index 3        
GATCGGAAGAGCACACGTCTGAACTCCAGTCACTTAGGCATCTCGTATGCC
GTCTTCTGCTTG 
>TruSeq Adapter, Index 4        
GATCGGAAGAGCACACGTCTGAACTCCAGTCACTGACCAATCTCGTATGCC
GTCTTCTGCTTG 
>TruSeq Adapter, Index 5        
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GATCGGAAGAGCACACGTCTGAACTCCAGTCACACAGTGATCTCGTATGCC
GTCTTCTGCTTG 
>TruSeq Adapter, Index 6        
GATCGGAAGAGCACACGTCTGAACTCCAGTCACGCCAATATCTCGTATGCC
GTCTTCTGCTTG 
>TruSeq Adapter, Index 7        
GATCGGAAGAGCACACGTCTGAACTCCAGTCACCAGATCATCTCGTATGCC
GTCTTCTGCTTG 
>TruSeq Adapter, Index 8        
GATCGGAAGAGCACACGTCTGAACTCCAGTCACACTTGAATCTCGTATGCC
GTCTTCTGCTTG 
>TruSeq Adapter, Index 9        
GATCGGAAGAGCACACGTCTGAACTCCAGTCACGATCAGATCTCGTATGCC
GTCTTCTGCTTG 
>TruSeq Adapter, Index 10       
GATCGGAAGAGCACACGTCTGAACTCCAGTCACTAGCTTATCTCGTATGCC
GTCTTCTGCTTG 
>TruSeq Adapter, Index 11       
GATCGGAAGAGCACACGTCTGAACTCCAGTCACGGCTACATCTCGTATGCC
GTCTTCTGCTTG 
>TruSeq Adapter, Index 12       
GATCGGAAGAGCACACGTCTGAACTCCAGTCACCTTGTAATCTCGTATGCC
GTCTTCTGCTTG 
>Solexa 5' adapter 
AATGATACGGCGACCACCGACAGGTTCAGAGTTCTACAG 
>Solexa 3' adapter 
TTTTCGTATGCCGTCTTCTGCTTG 
>PE Adapters1  
GATCGGAAGAGCGGTTCAGCAGGAATGCCGAG  
>PE Adapters1_! 
ACACTCTTTCCCTACACGACGCTCTTCCGATCT  
>PE PCR Primers1   
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTC
CGATCT  
>PE PCR Primers1_1 
CAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGCTGAACCGCT
CTTCCGATCT  
>PE Sequencing Primer   
ACACTCTTTCCCTACACGACGCTCTTCCGATCT  
>PE Sequencing Primer_1 
CGGTCTCGGCATTCCTGCTGAACCGCTCTTCCGATCT 
>Gex Adapter 1              
GATCGTCGGACTGTAGAACTCTGAAC  
>Gex Adapter 1_2 
ACAGGTTCAGAGTTCTACAGTCCGAC  
>Gex Adapter 2   
CAAGCAGAAGACGGCATACGANN  
>Gex Adapter 2_2 
TCGTATGCCGTCTTCTGCTTG  
>Gex PCR Primer 1   
CAAGCAGAAGACGGCATACGA  
>Gex PCR Primer 2   
213
AATGATACGGCGACCACCGACAGGTTCAGAGTTCTACAGTCCGA  
>Gex Sequencing Primer   
CGACAGGTTCAGAGTTCTACAGTCCGACGATC  
>Adapters1   
GATCGGAAGAGCTCGTATGCCGTCTTCTGCTTG   
>Adapters1_1 
ACACTCTTTCCCTACACGACGCTCTTCCGATCT    
>PCR Primers1   
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTC
CGATCT  
>PCR Primers1_1 
CAAGCAGAAGACGGCATACGAGCTCTTCCGATCT    
>Genomic DNA Sequencing Primer   
ACACTCTTTCCCTACACGACGCTCTTCCGATCT  
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(b) QUALITY CONTROL DATA
CONTIGS
PDSD1 MTBNA-A0008 HP908 ECNA114 VPPCV08-7
Pipeline 1 4502 4345 2564 6830 7337
Pipeline 2 2684 2266 242 382 50
Pipeline 3 2675 2294 227 345 64
Pipeline 4 2674 2263 232 375 83
Pipeline 5 2705 2552 232 375 53
Pipeline 6 2758 4113 2567 6795 7129
TAH pipeline 3174 3015 69 100 69
MAX
PDSD1 MTBNA-A0008 HP908 ECNA114 VPPCV08-7
Pipeline 1 4154 4465 2264 4092 3877
Pipeline 2 40897 12372 37047 122365 1489867
Pipeline 3 40897 12874 47263 125596 819033
Pipeline 4 40897 12372 40952 192125 1297290
Pipeline 5 40897 12149 40952 192125 990781
Pipeline 6 40897 4363 2262 4004 4666
TAH pipeline 17891 10725 602993 4121844 1410318
PERCENTAGE OF READS USED
PDSD1 MTBNA-A0008 HP908 ECNA114 VPPCV08-7
Pipeline 1 84.6 87.3 78.9 86.3 92.1
Pipeline 2 86.8 90.7 94.8 92.9 95.8
Pipeline 3 88.1 92.8 96.1 93.5 97.8
Pipeline 4 86.7 90.6 96.0 93.4 95.8
Pipeline 5 87.8 93.1 96.0 93.4 98.1
Pipeline 6 85.5 89.0 78.3 83.9 95.2
TAH pipeline 87.3 93.6 96.1 96.3 98.8
230
(b) QUALITY CONTROL DATA
PDSD1
Hash Nodes N50 MAX Total Used reads Total % used CONTIGS
37 3511 1082 17891 2673937 1882230 2155489 87.32 3174
39 3411 1071 17889 2618123 1868383 2155489 86.68 3128
41 3608 1024 17887 2638927 1875828 2155489 87.03 3321
43 3578 991 17885 2564317 1851456 2155489 85.89 3261
45 3477 987 17883 2483743 1831432 2155489 84.97 3214
47 3706 909 17881 2506861 1840731 2155489 85.4 3461
49 3623 887 14478 2413069 1815469 2155489 84.23 3411
51 3982 803 14476 2428354 1820234 2155489 84.45 3714
53 3879 766 14474 2310173 1783080 2155489 82.72 3630
55 4363 681 14285 2312741 1785153 2155489 82.82 4053
57 4268 638 11560 2167367 1738973 2155489 80.68 4002
59 4135 590 10486 1975966 1667297 2155489 77.35 3897
61 4616 495 10484 1877333 1624526 2155489 75.37 4316
63 4321 421 5242 1563932 1476518 2155489 68.5 4074
65 4104 318 2823 1189727 1239235 2155489 57.49 3854
HP908
Hash Nodes N50 MAX Total Used reads Total % used CONTIGS
27 342 359004 511529 1502280 2606265 2714926 96 165
29 259 386201 572342 1527365 2595855 2714926 95.61 106
31 185 411830 602993 1551704 2611204 2714926 96.18 69
33 447 9486 32162 1539140 2592979 2714926 95.51 287
35 487 7273 23459 1510679 2559390 2714926 94.27 325
37 556 5980 20649 1500367 2532769 2714926 93.29 401
39 623 4679 18954 1458034 2502458 2714926 92.17 473
41 720 3392 12973 1389435 2455379 2714926 90.44 580
43 884 2359 11414 1296469 2392660 2714926 88.13 742
45 1311 1463 9300 1238688 2355772 2714926 86.77 1135
47 1813 945 8351 1111445 2220555 2714926 81.79 1511
49 2460 548 5082 886638 1931142 2714926 71.13 1729
51 1739 302 3078 421161 1183143 2714926 43.58 1019
53 65 251 829 13343 141997 2714926 5.23 38
MTBNA-A0008
Hash Nodes N50 MAX Total Used reads Total % used CONTIGS
37 3434 1336 10725 2995462 7388938 7888233 93.67 3015
39 3424 1313 10723 2994753 7369679 7888233 93.43 3052
41 3339 1293 8935 2974210 7357114 7888233 93.27 3086
43 3408 1254 8933 2961519 7350492 7888233 93.18 3195
45 3417 1194 10165 2907551 7303680 7888233 92.59 3232
47 3548 1133 10165 2895208 7283823 7888233 92.34 3346
49 3684 1057 10165 2864805 7267651 7888233 92.13 3496
51 3837 1004 10165 2838101 7233815 7888233 91.7 3655
53 3902 938 10165 2760753 7160457 7888233 90.77 3730
55 4096 866 10165 2719949 7127359 7888233 90.35 3926
57 4279 811 5853 2663169 7074364 7888233 89.68 4104
59 4505 737 5558 2594787 7009593 7888233 88.86 4333
61 4768 666 5556 2517819 6945524 7888233 88.05 4602
63 5029 598 5554 2419838 6844975 7888233 86.77 4863
65 5340 509 5543 2272695 6685880 7888233 84.76 5206
ECNA114
Hash Nodes N50 MAX Total Used reads Total % used CONTIGS
27 2365 9649 36631 4724859 36575849 38238190 95.65 993
29 789 1953528 2110120 4881444 36690082 38238190 95.95 124
31 678 4121844 4121844 4928019 36828395 38238190 96.31 100
33 1513 22945 84695 4914125 36606466 38238190 95.73 564
231
35 1390 22756 91593 4921399 36457047 38238190 95.34 545
37 1317 24242 91593 4934630 36131581 38238190 94.49 546
39 1249 24809 90152 4935886 36100872 38238190 94.41 567
41 1174 24046 90150 4935329 35936050 38238190 93.98 554
43 1167 23272 84434 4936986 35866947 38238190 93.8 562
45 429 562402 904051 4960745 35871087 38238190 93.81 131
47 376 750176 1557802 4953109 35404495 38238190 92.59 106
49 1369 11996 45149 4877312 35143862 38238190 91.91 881
51 1936 5490 27111 4751461 34728142 38238190 90.82 1455
53 10788 455 17051 3589485 28028320 38238190 73.3 8126
VPPCV08-7
Hash Nodes N50 MAX Total Used reads Total % used CONTIGS
51 593 93616 353866 5173283 2809503 2830497 99.26 216
53 577 89794 353868 5173506 2804795 2830497 99.09 210
55 524 92594 353870 5174326 2800459 2830497 98.94 204
57 266 1236609 1410318 5206616 2797610 2830497 98.84 69
59 196 1363224 2506561 5251991 2794268 2830497 98.72 37
61 488 73983 353876 5174614 2786182 2830497 98.43 207
63 189 2805973 2805973 5252562 2783302 2830497 98.33 41
65 249 506952 1106043 5201674 2777978 2830497 98.14 87
67 181 2824303 2824303 5198729 2772327 2830497 97.94 41
69 173 1217792 1835687 5264435 2766902 2830497 97.75 41
71 182 2810319 2810319 5263919 2762093 2830497 97.58 54
73 178 1871980 2490340 5190297 2755503 2830497 97.35 61
75 195 1809160 2225334 5191086 2749377 2830497 97.13 72
77 920 15796 78642 5171146 2740310 2830497 96.81 687
79 1167 10850 78640 5164125 2733156 2830497 96.56 966
81 1607 6940 57421 5155082 2725114 2830497 96.28 1418
83 2306 4364 57419 5124281 2712246 2830497 95.82 2143
85 3514 2406 31044 5038676 2682787 2830497 94.78 3380
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APPENDIX B 
(a) Genomic DNA isolation 
Qiagen DNeasy Blood & Tissue kit (Bacterial genomic DNA isolation protocol) 
Protocol: Pretreatment for Gram-Negative Bacteria 
This protocol is designed for purification of total DNA from Gram-negative bacteria, 
such as E. coli. The protocol describes the preliminary harvesting of bacteria before DNA 
purification. 
Procedure 
1. Harvest cells (maximum 2 x 109 cells) in a microcentrifuge tube by centrifuging for 
10 min at 5000 x g (7500 rpm). Discard supernatant. 
2. Resuspend pellet in 180 µl Buffer ATL. 
3. Continued by following the protocol for Purification of total DNA from Animal tissues 
(Spin-Column protocol). 
Purification of Total DNA from Animal Tissues (Spin-Column Protocol) 
4. Add 20 µl proteinase K. Mix thoroughly by vortexing, and incubate at 56°C until the 
tissue is completely lysed. Vortex occasionally during incubation to disperse the sample, 
or place in a thermomixer, shaking water bath, or on a rocking platform. Lysis time varies 
depending on the type of tissue processed. Lysis is usually complete in 1–3 hr or, for 
rodent tails, 6–8 hr. If it is more convenient, samples can be lysed overnight; this will not 
affect them adversely. After incubation the lysate may appear viscous, but should not be 
gelatinous as it may clog the DNeasy Mini spin column.  
Optional: If RNA-free genomic DNA is required, add 4 µl RNase A (100 mg/ml), mix by 
vortexing, and incubate for 2 min at room temperature before continuing with step 5. 
Transcriptionally active tissues such as liver and kidney contain high levels of RNA, 
which will copurify with genomic DNA. For tissues that contain low levels of RNA, such 
as rodent tails, or if residual RNA is not a concern, RNase A digestion is not necessary. 
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 5. Vortex for 15 sec. Add 200 µl Buffer AL to the sample, and mix thoroughly by 
vortexing. Then add 200 µl ethanol (96–100%), and mix again thoroughly by vortexing. 
It is essential that the sample, Buffer AL, and ethanol are mixed immediately and 
thoroughly by vortexing or pipetting to yield a homogeneous solution. Buffer AL and 
ethanol can be premixed and added together in one step to save time when processing 
multiple samples.  
A white precipitate may form on addition of Buffer AL and ethanol. This 
precipitate does not interfere with the DNeasy procedure. Some tissue types (e.g., spleen, 
lung) may form a gelatinous lysate after addition of Buffer AL and ethanol. In this case, 
vigorously shaking or vortexing the preparation is recommended. 
 
6. Pipet the mixture from step 3 (including any precipitate) into the DNeasy Mini spin 
column placed in a 2 ml collection tube (provided). Centrifuge at 6000 x g (8000 rpm) 
for 1 min. Discard flow-through and collection tube. 
 
7. Place the DNeasy Mini spin column in a new 2 ml collection tube (provided), add 500 
µl Buffer AW1, and centrifuge for 1 min at 6000 x g (8000 rpm). Discard flow-through 
and collection tube. 
 
8. Place the DNeasy Mini spin column in a new 2 ml collection tube (provided), add 500 
µl Buffer AW2, and centrifuge for 3 min at 20,000 x g (14,000 rpm) to dry the DNeasy 
membrane. Discard flow-through and collection tube. It is important to dry the membrane 
of the DNeasy Mini spin column, since residual ethanol may interfere with subsequent 
reactions.  
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This centrifugation step ensures that no residual ethanol will be carried over 
during the following elution. Following the centrifugation step, remove the DNeasy Mini 
spin column carefully so that the column does not come into contact with the flow-
through, since this will result in carryover of ethanol. If carryover of ethanol occurs, 
empty the collection tube, then reuse it in another centrifugation for 1 min at 20,000 x g 
(14,000 rpm). 
 
9. Place the DNeasy Mini spin column in a clean 1.5 ml or 2 ml microcentrifuge tube (not 
provided), and pipet 200 µl Buffer AE directly onto the DNeasy membrane. Incubate at 
room temperature for 1 min, and then centrifuge for 1 min at 6000 x g (8000 rpm) to 
elute. Elution with 100 µl (instead of 200 µl) increases the final DNA concentration in 
the eluate, but also decreases the overall DNA yield. 
 
10. Recommended: For maximum DNA yield, repeat elution once as described in step 9. 
This step leads to increased overall DNA yield. A new microcentrifuge tube can be used 
for the second elution step to prevent dilution of the first eluate. Alternatively, to combine 
the eluates, the microcentrifuge tube from step 9 can be reused for the second elution 
step. Note: Do not elute more than 200 µl into a 1.5 ml microcentrifuge tube because the 
DNeasy Mini spin column will come into contact with the eluate. 
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APPENDIX C 
(a) Plasmid DNA isolation 
High Copy number plasmid isolation protocol 
Harvesting 
1. Transfer 1.5 ml of bacterial culture to a microcentrifuge tube. 
2. Centrifuge for 1 min at full speed (14,000 rpm) in a microcentrifuge and discard the 
supernatant (If more than 1.5 ml of bacterial culture is used, repeat the Harvesting Step). 
Resuspension 
3. Add 200 μl of PD1 Buffer (RNase A added) to the tube and re-suspend the cell pellet 
by vortexing or pipetting. 
Lysis 
4. Add 200 μl of PD2 Buffer and mix gently by inverting the tube 10 times. Do not vortex, 
avoid shearing genomic DNA. 
5. Stand for 2 minutes at room temperature until lysate clears. 
Neutralization 
6. Add 300 μl of PD3 Buffer and mix immediately by inverting the tube 10 times. Do not 
vortex. 
7. Centrifuge for 3 minutes at full speed (14,000 rpm). 
DNA Binding 
8. Place a PD Column in a Collection Tube. 
9. Apply the clear lysate (supernatant) from Step 4 to the PD Column. 
10. Centrifuge at 6,000 x g (8,000 rpm) for 30 seconds. 
11. Discard the flow-through and place the PD Column back in the Collection Tube. 
Wash 
12. Add 400 μl of W1 Buffer in the PD column. 
13. Centrifuge at 6,000 x g (8,000 rpm) for 30 seconds. 
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14. Discard the flow-through and place the PD Column back in the Collection Tube. 
15. Add 600 μl of Wash Buffer (ethanol added) in the PD column. 
16. Centrifuge at 6,000 x g (8,000 rpm) for 30 seconds. 
17. Discard the flow-through and place the PD Column back in the Collection Tube. 
18. Centrifuge again for 2 minutes at full speed to dry the Column matrix. 
DNA Elution 
19. Transfer dried PD Column onto a clean micro centrifuge tube (Not provided). 
20. Add 50 μl of Elution Buffer or water into the centre of the column matrix. 
21. Stand for 2 minutes until Elution Buffer or water is absorbed by the matrix 
22. Centrifuge for 2 minutes at full speed to elute purified DNA. 
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Edena contig name Chromosome 1 Chromosome 2 Plasmid
plasmid171
plasmid288
plasmid318
plasmid312
plasmid182
plasmid113
plasmid43
plasmid267
plasmid181
plasmid32
plasmid394
plasmid319
plasmid121
plasmid78
plasmid30
plasmid1
plasmid260
plasmid109
plasmid244
plasmid275
plasmid119
plasmid98
plasmid238
plasmid408
plasmid28
plasmid76
plasmid274
plasmid59
plasmid134
plasmid250
plasmid330
plasmid164
plasmid338
plasmid168
plasmid27
plasmid246
plasmid281
plasmid39
plasmid174
plasmid322
plasmid188
plasmid90
plasmid162
plasmid137
plasmid320
plasmid130
plasmid370
plasmid115
plasmid73
plasmid22
plasmid200
plasmid148
plasmid329
plasmid209
plasmid47
plasmid153
plasmid19
241
plasmid6
plasmid10
plasmid310
plasmid155
plasmid67
plasmid380
plasmid217
plasmid194
plasmid86
plasmid135
plasmid351
plasmid85
plasmid46
plasmid136
plasmid149
plasmid95
plasmid127
plasmid391
plasmid237
plasmid3
plasmid139
plasmid63
plasmid176
plasmid21
plasmid205
plasmid14
plasmid192
plasmid70
plasmid276
plasmid74
plasmid140
plasmid114
plasmid34
plasmid18
plasmid395
plasmid247
plasmid229
plasmid104
plasmid103
plasmid360
plasmid235
plasmid379
plasmid375
plasmid296
plasmid286
plasmid249
plasmid83
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(e) ClustalW command-line parameters 
***MULTIPLE ALIGNMENT VIEW*** 
    1.  Do complete multiple alignment now Slow/Accurate 
    2.  Produce guide tree file only 
    3.  Do alignment using old guide tree file 
    4.  Toggle Slow/Fast pairwise alignments = SLOW 
    5.  Pairwise alignment parameters 
    6.  Multiple alignment parameters 
    7.  Reset gaps before alignment? = OFF 
    8.  Toggle screen display          = ON 
    9.  Output format options 
    I. Iteration = NONE 
    S.  Execute a system command 
    H.  HELP 
    or press [RETURN] to go back to main menu 
 ********* MULTIPLE ALIGNMENT PARAMETERS ********* 
     1. Gap Opening Penalty              :15.00 
     2. Gap Extension Penalty            :6.66 
     3. Delay divergent sequences      :30 % 
     4. DNA Transitions Weight         :0.50 
     5. Protein weight matrix              :Gonnet series 
     6. DNA weight matrix                 :IUB 
     7. Use negative matrix                 :OFF 
     8. Protein Gap Parameters 
     H. HELP 
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 ********* Format of Alignment Output ********* 
     F. Toggle FASTA format output       =  OFF 
     1. Toggle CLUSTAL format output     =  ON 
     2. Toggle NBRF/PIR format output    =  OFF 
     3. Toggle GCG/MSF format output     =  OFF 
     4. Toggle PHYLIP format output      =  ON 
     5. Toggle NEXUS format output       =  ON 
     6. Toggle GDE format output         =  OFF 
     7. Toggle GDE output case           =  LOWER 
     8. Toggle CLUSTALW sequence numbers =  OFF 
     9. Toggle output order              =  ALIGNED 
     0. Create alignment output file(s) now? 
     T. Toggle parameter output          = OFF 
     R. Toggle sequence range numbers =  OFF 
     H. HELP 
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(f) PCR sequencing results 
(Highlighted area represents matching sequence of the gene) 
gbpA – 1464bp 
Forward sequencing product 
CTGAGTGTCTTAGCACACGGTTACGTATCGGAATCCAACGATGGCGTCGCA
GCAAGTCGTGCAGCGCTGTGTAAGTACCCAACATCGGATACCAATGAAAGA
AACACTAACTGTGGCGCAATTCAATATGAACCACAAAGCGTGGAAGGCCCA
GATGGCTTCCCAGAGACAGGCCCTCGCGACGGGAAAATTGCCAGCGCAGAA
ACAGCTCGAGCAGCTGCACTAGACGAACAAACCGCCGACCGCTGGGTAAA
ACGTCCGATAAAATCTGGTACACAAACGTTTGAATGGACTTTTACAGCAAA
CCACGTGACTCGTGATTGGAAATACTACATCACAAAACCGAATTGGAACCC
GAACGCTTCATTGTCACGCGACTCGTTCGCTCTCAACCCTTTCTGTGTGGTT
GACGGCAATATGGTTCAACCACCAAAACAGATGAGCCACCAATGTAACGTG
CCTGAACGCGAAGGGTACCATGTCATCCTTGCGGTATGGGATGTGGGTGAT
ACCGCAGCATCATTCTACAACGTTATCGATGTCAAATTTGATGGTGACGACC
CTGTGATTCCTGAGTGGACTCAAGGTGGCCAAATCATCCCTACTATGAATCT
AAAGGTTGGCGATTCGGTTTACACTCGCGTGTTTGATCAATCTGGAGAGAA
CGTTGCATACCGCACTGAACTAGCAATTAGTAACGACGCACTCACTCAAGC
GAAAAACTGGTCTTACGCCTTGGCGAGTAAAGTCAACCAAGAGCAAACTAA
GCTTCAAGCTGGTCAATATTCGGAAGACAAGTTCACGCCAGTGTACGGCAC
GAACCCAATTTACCTGCAATCAAACAGTGGCCTTGAGCGTGTTGAAATTGG
CTACAATATTGAAACGCCAGTACCTGAGTATTCACTCACGGTTGATGGTCTT
GCCAGTGAGTACATAATTGCTACAGAACCAACCTCTTTAGACTCACTCTTAC
CGCAGAGGCGACTTAACCGCCGAGTACGGTTTACATCATCATCGCGACCAC
TAGCAGTGACGGTTCATTCAGATGTG 
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Reverse sequencing product 
CTGGTTGCACTCTCACTCCACTGTACGCAGTAGCCAGAGTAAGGGAATGGT
TTACATTGATAAATCGCGCCGTCGCTTGCTAACACTTTTGTACCTGCTGTGT
AGCTAGAAAGCCCCTCTGGGAATACAAAGTCGTATTCGCCTGATGGTGGTG
GGGTGACTTCCTCACTTTTTAGATGGAAATCCAGAGTTTGCTGATCGACAAG
GTTGCCATCGGTATCTTTAATGCGGGTTACTAACATGTGGTGCCCCGGTTCT
GATTTGCTCAGCGTGAGTTCTACTTGTTCGCTTGCACCATCTTGAATTGAAC
CCGTCCAACTTGCTAGTGGTTCGCGATGATGATTGTAAACCGTTAACTCGGC
GGTTAAGTCGCCCTCTGCGGTAAGAGTGAGGTCTAAAGAGGTTGGTTCTGT
AGCAATTATGTACTCACTGGCAAGACCATCAACCGTGAGTGAATACTCAGG
TACTGGCGTTTCAATATTGTAGCCAATTTCAACACGCTCAAGGCCACTGTTT
GATTGCAGGTAAATTGGGTTCGTGCCGTACACTGGCGTGAACTTGTCTTCCG
AATATTGACCAGCTTGAAGCTTAGTTTGCTCTTGGTTGACTTTACTCGCCAA
GGCGTAAGACCAGTTTTTCGCTTGAGTGAGTGCGTCGTTACTAATTGCTAGT
TCAGTGCGGTATGCAACGTTCTCTCCAGATTGATCAAACACGCGAGTGTAA
ACCGAATCGCCAACCTTTAGATTCATAGTAGGGATGATTTGGCCACCTTGAG
TCCACTCAGGAATCACAGGGTCGTCACCATCAAATTTGACATCGATAACGTT
GTAGAATGATGCTGCGGTATCACCCACATCCCATACCGCAAGGATGACATG
GTACCCTTCGCGTTCATGCACGTTACATTGGTGGCTCATCTGTTTTGGTGGTT
GACATATTGCGTCACACACAGAAAGGGTGAGAGCGACGAGTCGCGTGACAT
GAAGCGTCGGGTTCATTCGTTTTGTGATGTAGTATTTCATCACGAGTCACGT
GATTGCTGTAAAGGTCA 
 
 
 
 
256
dnaB – 1401bp 
Forward sequencing product 
ATAGGGTGGTCTGCGCTCGCAAGCGTGCCACCTCCCTCGGTAGAAGCACAG
GCTTCAGATGATTGGTGGTCTCTTACTGGACAATGAACGGAGGGATACCGT
TGCTGAGCGAGTTGTCGCCAGTGATTTCTATAGCCGTCCGCACCGTCTTATT
TTTGAAGGTGTGAAAACCATTCTTGAGTCGGGCAAACCGCTTGACCTTATCA
CTCTGTCTGAGCACCTAGAGCGACACGAGCAACTAGAAGATGTGGGTGGTT
TTGCTTACCTTGCTGACTTAGCGAAAAACACGCCCAGTGCTGCCAACATTAA
TGCCTACGCAGATATCGTGGCTGAACGTGCGATCGTCCGTGGTTTGATTGGT
GTTGCGAACGAAATTGCGGACGCGGGTTACGATCCTCAAGGTCGCAGTTCT
GAAGATTTGATAGACATGGCGGAGAGTAAAGTTTTTGCTATCGCCGAGTCT
CGCACCAGTGAAAACGAAGGTCCACAAAACGTCGACAACATCCTAGAAAA
GACGCTAGAACGTATCGAACTGCTGTACAAAACGCCGCAAGATGGCGTAAC
AGGTGTCGATACTGGTTTTACTGACCTCAACAAAAAGACCGCGGGTCTCCA
AGGTTCTGACTTAGTTATCGTGGCAGCGCGTCCATCGATGGGTAAAACCAC
CTTTGCGATGAACTTGTGTGAAAACGCGGCAATGCAGCAAGACAAACCCGT
TTTGATCTTCTCGCTAGAGATGCCGGCGGAACAGTTGATGATGCGTATGTTG
GCATCCTTGTCTCGCGTAGACCAAACCAAGATCCGTACGGGTCAGTTGGAT
GATGAAGACTGGGCACGTATTTCTTCTACCATGGGTATCCTGATGCAGAAG
AAAAATATGTACATCGATGACAGTTCAGGCTTAACGCCAACCGAAGTGCGT
TCACGTGCCCGTCGTGTTGCTCGTGAGCACGGAGGTCTATCAATGATCATGG
TCGACTACCTTCAGTTGATGCGCGTACCTTCGCTAACCGATAACCGTACTCT
TGAGATTGCCGAGATTTCTCGCTC 
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Reverse sequencing product 
GGGGCCCGTATTTCAAGCGCGAGTGTTGTCCTTGGAATGTTAAACGCACCG
AGCCAATAGGACCGTTACGTTGTTTACCGATTTCTATTTCCGCCGTGCCTTT
GTATGGGCTATCTGGGTGATAGACCTCATCACGGTAGATGAACATGATCAA
GTCGGCATCCTGCTCGATGGAACCCGATTCACGCAAGTCCGAGTTAACAGG
TCGTTTATCCGCTCGTTGCTCTAGAGAACGGTTTAGCTGCGATAGTGCAACG
ACAGGCACGTTCAACTCTTTCGCCAGTGCTTTAAGCGAGCGAGAAATCTCG
GCAATCTCAAGAGTACGGTTATCGGTTAGCGAAGGTACGCGCATCAACTGA
AGGTAGTCGACCATGATCATTGATAGACCTCCGTGCTCACGAGCAACACGA
CGGGCACGTGAACGCACTTCGGTTGGCGTTAAGCCTGAACTGTCATCGATG
TACATATTTTTCTTCTGCATCAGGATACCCATGGTAGAAGAAATACGTGCCC
AGTCTTCATCATCCAACTGACCCGTACGGATCTTGGTTTGGTCTACGCGAGA
CAAGGATGCCAACATACGCATCATCAACTGTTCCGCCGGCATCTCTAGCGA
GAAGATCAAAACGGGTTTGTCTTGCTGCATTGCCGCGTTTTCACACAAGTTC
ATCGCAAAGGTGGTTTTACCCATCGATGGACGCGCTGCCACGATAACTAAG
TCAGAACCTTGGAGACCCGCGGTCTTTTTGTTGAGGTCAGTAAAACCAGTAT
CGACACCTGTTACGCCATCTTGCGGCGTTTTGTACAGCAGTTCGATACGTTC
TAGCGTCTTTTCTAGGATGTTGTCGACGTTTTGTGGACCTTCGTTTTCACTGG
TGCGAGACTCGGCGATAGCAAAAACTTTACTCTCCGCCATGTCTATCAAATC
TTCAGAACTGCGACCTTGAGGATCGTAACCCGCGTCCGCAATTTCGTTCGCA
ACACCAATCAAACCACGGACGATCGCACGTTCAGCCACGATATCTGCGTAG
GCATTAATGTTGGCAGCAC 
 
 
 
 
258
deaD – 1930bp 
Forward sequencing product 
CTGATGAATCTATCCTTTCTGCTCTAGACGGAATGGGTTTCGTGTCACCAAA
CGGCCGTGGCCGTCGCACTCAAGACGCATAATTGGAAGGTGCTGACGCGCT
GGGTAAAGCACAGACGGGTACAGGTAAAACGGCAGCATTCTCTCTGCCTCT
TCTAAACAAGCTAGATCTTGATCAACGTAAACCACAAGCAATCGTTCTTGCT
CCAACTCGTGAGCTAGCGATCCAGGTTGCGGCTGAAATGAAAAACCTTGGT
AAAAACATCAAGGGTCTTAAAGTTCTAGAAATCTACGGTGGTGCATCTATC
GTAGATCAAATGCGTGCGCTTAAAAACGGTGCACACGTTGTTGTTGGTACTC
CTGGCCGTGTTCAAGACCTTATCAACCGTGAACGTCTACATCTTGACGAAGT
GAATACTTTCGTACTTGATGAAGCGGACGAAATGCTAAACATGGGTTTTGT
GGACGACGTAACTGCAATCATGGAGCACGCTCCTGAATCAGCACAACGCGT
TCTATTTTCTGCAACTATGCCACCAATGCTGAAAAACATTGTTGAGCGCTTC
CTACGTGATCCTGTAACTGTTGACGTTGCTGGTAAAAACCACACTGTAGACA
AAGTTCAACAACAGTTCTGGGTAGTGAAAGGTGTAGAGAAAGATGAAGCTA
TGTCTCGTCTTCTTGAAACTGAAGAAACTGACGCGTCAATCGTATTCGTACG
TACTCGTCAAGACACCGAGCGTCTAGCTGACTGGCTATCTGCACGTGGCTTC
AAAGCTGCTGCACTGCACGGTGACATTCCTCAGTCCCTACGTGAGCGTACTG
TTGATCACATCAAACAAGGTGTTATCGACATCCTAGTGGCAACTGACGTTGT
TGCTCGTGGTCTTGATGTTCCACGTATCACTCACGTATTTAACTACGACATC
CCATTCGATGTTGAGTCTTACATCCACCGTATCGGTCGTACTGGCCGTGCCG
GACGTAAAGGTAAAGCGATCCTTCTAGTTCGCACTAACCAATCCGTATGCTT
CGCACTATCGAGCGCGT 
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Reverse sequencing product 
TGGGTACGCAACCCATTCCGTCTAGAGCAGAAAGGATAGAATCATTCTGAG
ATAAATCGCTGAATTGAATAACAGAATCTTGCATAGTTGCCGTCACGGTTAC
CACGGAAGCCACCTTCACGACGACCGCCTTCACGACGCTCACCACCACGGT
TGCCACCTTCGCGGTTACCACGGAAACCACCTTCACGACGACCGCCATCGC
GACGACCACCGTCACGGCGACCACCACGAGACTCGCGGAAATCGTCGAAGT
CACATACTACAGCACCAACATCTTGTTGACGGATACGCAGTTTGCTTAGCTT
GCTCGCAGCTTCAGAAGTCATTGCTTTTGGTAGCTGAACGAATGTGTGACCT
TGCGCTAGCTTGATCGCACCGATAGAACCTTTACCTAGGCCTAGTTCGTTTG
CTAGAGCGCCAACGATATCTTTAACTTGAACGCCTTGCTCGCGACCAACTTG
AAGCTGGTAAGTATCCCAGTCTTGGTTGTTGAAGCTACGACCGCCTTCACGA
CCACCTTCACGGCGTTCTTTACGACGCTGCTTGTCACGCTCAATTGCTTCAA
CCATTGGGTCTTCGCCAATGTAGAACAGAGGACGTTTACCTTGTTGACGCTT
AAGAAGCATTGCAGCAAGCATCGCAGGGTCGATTTCTAGAGAAGTTTGTAG
TTTCTCTACTAGCTCTGCGAACTTGTCTAGTGCTTTGTGCTCTTTCTCAGCTT
CCAGTTCAGCCGCTAGCTTGTTTAGACGAGCTTCTGCAACTTGGTCACGTAG
AGGAAGTTGGATTTCTTCCATAGATGACTTAGTCACGCGCTCGATAGTGCGA
AGCATACGGATTTGGTTAGTGCGAACTAGAAAGATCGCTTTACCTTTACGTC
CGGCACGGCCAGTACGACCGATACGGTGGATGTAAGACTCAACATCGAATG
GGATGTCGTAGTTAAATACGTGAGTGATACGTGGAACATCAAGACCACGAG
CAACAACGTCAGTTGCCACTAGGATGTCGATAACACCTTGTTTGATGTGATC
AACAGTACGCTCACGT 
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Sequencing lengths corresponding to gene products used for Real Time PCR 
gbpA RT – 190bp 
Forward sequencing product 
GGGCATATGGGTTCACCACCAAAACAGATGAGCCACCAATGTAACGTGCCT
GAACGCGAAGGGTACCATGTCATCCTTGCGGTATGGGATGTGGGTGATACC
GCAGCATCATTCTACAACGTTATCGATGTCAAATTTGATGGTGACGACCCTG
TGA 
 
Reverse sequencing product 
TGCATGCTGCGGTATCACCCACATCCCATACCGCAAGGATGACATGGTACC
CTTCGCGTTCAGGCACGTTACATTGGTGGCTCATCTGTTTTGGTGGTTGAAC
CATATTGCCGTCAACCACACAGAAAGGGTTGAGAGCGAACGAGA 
 
dnaB RT – 196bp 
Forward sequencing product 
GACTTCGTTGATGCGCGTACCTTCGCTAACCGATAACCGTACTCTTGAGATT
GCCGAGATTTCTCGCTCGCTTAAAGCACTGGCGAAAGAGTTGAACGTGCCT
GTCGTTGCACTATCGCAGCTAAACCGTTCTCTAGAGCAACGAGCGGATAAA
CGAC 
 
Reverse sequencing product 
ATCAGAGGACGTGCACTCAGGCACGTTCAACTCTTTCGCCAGTGCTTTAAGC
GAGCGAGAAATCTCGGCAATCTCAAGAGTACGGTTATCGGTTAGCGAAGGT
ACGCGCATCAACTGAAGGTAGTCGACCATGATCATTGATAGACTCCCGTGC
TCACGAAG 
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deaD RT – 181bp 
Forward sequencing product 
ATACCTTATCACCGTGAACGTCTACATCTTGACGAAGTGAATACTTTCGTAC
TTGATGAAGCGGACGAAATGCTAAACATGGGTTTTGTGGACGACGTAACTG
CAATCATGGAGCACGCTCCTGAATCAGCACAACGCGTTCTTGA 
 
Reverse sequencing product 
TGTCGTCCACAAAACCCATGTTTAGCATTTCGTCCGCTTCATCAAGTACGAA
AGTATTCACTTCGTCAAGATGTAGACGTTCACGGTTGATAAGGTCTTGAACA
CGGCCAGGAGTACCAACAACAACGTGTGCAC 
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(g) pGEM T-easy vector system  
Ligation Protocol  
1. Briefly centrifuge the pGEM®-T or pGEM®-T Easy Vector and Control Insert DNA 
tubes to collect the contents at the bottom of the tubes.  
2. Set up ligation reactions as described below. Note: Use 0.5 ml tubes known to have 
low DNA-binding capacity. Vortex the 2X Rapid Ligation Buffer vigorously before 
each use.  
3. Mix the reactions by pipetting. Incubate the reactions for 1 hour at room temperature.  
Alternatively, if maximum number of transformants are required, incubate the reactions 
overnight at 4°C. 
 
4. An aliquot of the PCR reaction should be analysed on an agarose gel before use in 
the ligation reaction to verify that the reaction produced the desired product. The PCR 
product to be ligated can be gel-purified or purified directly from the PCR 
amplification. Clean-up of reactions prior to ligation is recommended to remove 
primer dimers or other undesired reaction products, and to improve ligation efficiency. 
Exposure of PCR products to shortwave ultraviolet light should be minimized in order 
to avoid the formation of pyrimidine dimers. 
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(h) Plasmid isolation sequencing results from 16 selected colonies 
The sequencing has been done using the primers for the complete gene stretch of gbpA 
(1464bp) (Highlighted area represents matching sequence of the gene) 
Colony 1 
Forward sequencing product 
AGACGGCCCGTGAATTGTAATACGACTCACTATAGGGCGAATTGGGCCCGA
CGTCGCATGCTCCCGGCCGCCATGGCGGCCGCGGGAATTCGATTTTAGTTCA
GTTTATCCCAAGCCATTTCCCAGTGTGAGCCTGTCGCTGGCTCAAATTGTGT
TGCACTCTCACTCCACTGTACGCAGTAGCCAGAGTAAGGGAATGGTTTACA
TTGATAAATCGCGCCGTCGCTTGCTAACACTTTTGTACCTGCTGTGTAGCTA
GAAAGCCCCTCTGGGAATACAAAGTCGTATTCGCCTGATGGTGGTGGGGTG
ACTTCCTCACTTTTTAGATGGAAATCCAGAGTTTGCTGATCGACAAGGTTGC
CATCGGTATCTTTAATGCGGGTTACTAACATGTGGTGCCCCGGTTCTGATTT
GCTCAGCGTGAGTTCTACTTGTTCGCTTGCACCATCTTGAATTGAACCCGTC
CAACTTGCTAGTGGTTCGCGATGATGATTGTAAACCGTTAACTCGGCGGTTA
AGTCGCCCTCTGCGGTAAGAGTGAGGTCTAAAGAGGTTGGTTCTGTAGCAA
TTATGTACTCACTGGCAAGACCATCAACCGTGAGTGAATACTCAGGTACTG
GCGTTTCAATATTGTAGCCAATTTCAACACGCTCAAGGCCACTGTTTGATTG
CAGGTAAATTGGGTTCGTGCCGTACACTGGCGTGAACTTGTCTTCCGAATAT
TGACCAGCTTGAAGCTTAGTTTGCTCTTGGTTGACTTTACTCGCCAAGGCGT
AAGACCAGTTTTTCGCTTGAGTGAGTGCGTCGTTACTAATTGCTAGTTCAGT
GCGGTATGCAACGTTCTCTCCAGATTGATCAAACACGCGAGTGTAAACCGA
ATCGCCAACCTTTAGATTCATAGTAGGGATGATTTGGCCACCTTGAGTCCAC
TCAGGAATCACAGGGTCGTCACCATCAATTTGACATCGATAACGTTGTAGA
ATGATGCTGCGGTATCACCCACATCCCATACCGCAAGGATGACATGGTACC
TTCGCGTTCAGGCCACGT 
264
Reverse sequencing product 
ATTTTTAGGTGACACTATAGAATACTCAAGCTATGCATCCAACGCGTTGGGA
GCTCTCCCATATGGTCGACCTGCAGGCGGCCGCGAATTCACTAGTGATTATG
AAATCATTCCCTAATAAATCGCTCGTTGCCCTTGCTATCGCAAGCATGAGCT
CTGGTGTCTTAGCACACGGTTACGTATCGGAATCCAACGATGGCGTCGCAG
CAAGTCGTGCAGCGCTGTGTAAGTACCCAACATCGGATACCAATGAAAGAA
ACACTAACTGTGGCGCAATTCAATATGAACCACAAAGCGTGGAAGGCCCAG
ATGGCTTCCCAGAGACAGGCCCTCGCGACGGGAAAATTGCCAGCGCAGAAA
CAGCTCGAGCAGCTGCACTAGACGAACAAACCGCCGACCGCTGGGTAAAAC
GTCCGATAAAATCTGGTACACAAACGTTTGAATGGACTTTTACAGCAAACC
ACGTGACTCGTGATTGGAAATACTACATCACAAAACCGAATTGGAACCCGA
ACGCTTCATTGTCACGCGACTCGTTCGCTCTCAACCCTTTCTGTGTGGTTGAC
GGCAATATGGTTCAACCACCAAAACAGATGAGCCACCAATGTAACGTGCCT
GAACGCGAAGGGTACCATGTCATCCTTGCGGTATGGGATGTGGGTGATACC
GCAGCATCATTCTACAACGTTATCGATGTCAAATTTGATGGTGACGACCCTG
TGATTCCTGAGTGGACTCAAGGTGGCCAAATCATCCCTACTATGAATCTAAA
GGTTGGCGATTCGGTTTACACTCGCGTGTTTGATCAATCTGGAGAGAACGTT
GCATACCGCACTGAACTAGCAATTAGTAACGACGCACTCACTCAAGCGAAA
AACTGGTCTTACGCCTTGGCGAGTAAAGTCAACCAAGAGCAAACTAAGCTT
CAAGCTGGTCAATATTCGGAAGACAAGTTCACGCCAGTGTACGGCACGAAC
CCAATTTACCTGCAATCAAACAGTGCCTTGAGCGTGTTGAAATTGGCTACAT
ATTGAACGCCAGTACCTGAGT 
 
Colony 2 
Forward sequencing product 
265
CGGCCCGTGATTGTTAATACGACTCACTATAGGGCGAATTGGGCCCGACGT
CGCATGCTCCCGGCCGCCATGGCGGCCGCGGGAATTCGATTTTAGTTCAGTT
TATCCCAAGCCATTTCCCAGTGTGAGCCTGTCGCTGGCTCAAATTCTGTTGC
ACTCTCACTCCACTGTACGCAGTAGCCAGAGTAAGGGAATGGTTTACATTG
ATAAATCGCGCCGTCGCTTGCTAACACTTTTGTACCTGCTGTGTAGCTAGAA
AGCCCCTCTGGGAATACAAAGTCGTATTCGCCTGATGGTGGTGGGGTGACT
TCCTCACTTTTTAGATGGAAATCCAGAGTTTGCTGATCGACAAGGTTGCCAT
CGGTATCTTTAATGCGGGTTACTAACATGTGGTGCCCCGGTTCTGATTTGCT
CAGCGTGAGTTCTACTTGTTCGCTTGCACCATCTTGAATTGAACCCGTCCAA
CTTGCTAGTGGTTCGCGATGATGATTGTAAACCGTTAACTCGGCGGTTAAGT
CGCCCTCTGCGGTAAGAGTGAGGTCTAAAGAGGTTGGTTCTGTAGCAATTA
TGTACTCACTGGCAAGACCATCAACCGTGAGTGAATACTCAGGTACTGGCG
TTTCAATATTGTAGCCAATTTCAACACGCTCAAGGCCACTGTTTGATTGCAG
GTAAATTGGGTTCGTGCCGTACACTGGCGTGAACTTGTCTTCCGAATATTGA
CCAGCTTGAAGCTTAGTTTGCTCTTGGTTGACTTTACTCGCCAAGGCGTAAG
ACCAGTTTTTCGCTTGAGTGAGTGCGTCGTTACTAATTGCTAGTTCAGTGCG
GTATGCAACGTTCTCTCCAGATTGATCAAACACGCGAGTGTAAACCGAATC
GCCAACCTTTAGATTCATAGTAGGGATGATTTGGCCACCTTTGAGTCCACTC
AGGAATCACAGGGTCGTCACCATCAAATTTGACATCGATAACGTTGTAGAA
TGATGCTGCGGTATCCCCCCACATCCCATACCGCAAGGATGACATGGTACC
CTTTCGCGTTCAGGCACG 
Reverse sequencing product 
CCACTGATTACGCCAAGCTATTTAGGTGACACTATAGAATACTCAAGCTATG
CATCCAACGCGTTGGGAGCTCTCCCATATGGTCGACCTGCAGGCGGCCGCG
AATTCACTAGTGATTATGAAATCATTCCCTAATAAATCGCTCGTTGCCCTTG
CTATCGCAAGCATGAGCTCTGGTGTCTTAGCACACGGTTACGTATCGGAATC
266
CAACGATGGCGTCGCAGCAAGTCGTGCAGCGCTGTGTAAGTACCCAACATC
GGATACCAATGAAAGAAACACTAACTGTGGCGCAATTCAATATGAACCACA
AAGCGTGGAAGGCCCAGATGGCTTCCCAGAGACAGGCCCTCGCGACGGGA
AAATTGCCAGCGCAGAAACAGCTCGAGCAGCTGCACTAGACGAACAAACC
GCCGACCGCTGGGTAAAACGTCCGATAAAATCTGGTACACAAACGTTTGAA
TGGACTTTTACAGCAAACCACGTGACTCGTGATTGGAAATACTACATCACA
AAACCGAATTGGAACCCGAACGCTTCATTGTCACGCGACTCGTTCGCTCTCA
ACCCTTTCTGTGTGGTTGACGGCAATATGGTTCAACCACCAAAACAGATGA
GCCACCAATGTAACGTGCCTGAACGCGAAGGGTACCATGTCATCCTTGCGG
TATGGGATGTGGGTGATACCGCAGCATCATTCTACAACGTTATCGATGTCAA
ATTTGATGGTGACGACCCTGTGATTCCTGAGTGGACTCAAGGTGGCCAAAT
CATCCCTACTATGAATCTAAAGGTTGGCGATTCGGTTTACACTCGCGTGTTT
GATCAATCTGGAGAGAACGTTGCATACCGCACTGAACTAGCAATTAGTAAC
GACGCACTCACTCAAGCGAAAAACTGGTCTTACGCCTTGGCGAGTAAAGTC
AACCAAGAGCAAACTAAGCTTCAAGCTGGTCAATATTCGGAAGACAAGTTC
ACGCCAGTGTACGGCACGAACCCAATTTACCTGCAATCAAACAGTGGCCTT
GAGCGTGTGAATTTGGCTACAATATT 
 
Colony 3 
Forward sequencing product 
TGGCCGTGATTTTGTAATACGACTCACTATAGGGCGAATTGGGCCCGACGTC
GCATGCTCCCGGCCGCCATGGCGGCCGCGGGAATTCGATTTTAGTTCAGTTT
ATCCCAAGCCATTTCCCAGTGTGAGCCTGTCGCTGGCTCAAATTGTGTTGCA
CTCTCACTCCACTGTACGCAGTAGCCAGAGTAAGGGAATGGTTTACATTGAT
AAATCGCGCCGTCGCTTGCTAACACTTTTGTACCTGCTGTGTAGCTAGAAAG
CCCCTCTGGGAATACAAAGTCGTATTCGCCTGATGGTGGTGGGGTGACTTCC
267
TCACTTTTTAGATGGAAATCCAGAGTTTGCTGATCGACAAGGTTGCCATCGG
TATCTTTAATGCGGGTTACTAACATGTGGTGCCCCGGTTCTGATTTGCTCAG
CGTGAGTTCTACTTGTTCGCTTGCACCATCTTGAATTGAACCCGTCCAACTT
GCTAGTGGTTCGCGATGATGATTGTAAACCGTTAACTCGGCGGTTAAGTCGC
CCTCTGCGGTAAGAGTGAGGTCTAAAGAGGTTGGTTCTGTAGCAATTATGT
ACTCACTGGCAAGACCATCAACCGTGAGTGAATACTCAGGTACTGGCGTTT
CAATATTGTAGCCAATTTCAACACGCTCAAGGCCACTGTTTGATTGCAGGTA
AATTGGGTTCGTGCCGTACACTGGCGTGAACTTGTCTTCCGAATATTGACCA
GCTTGAAGCTTAGTTTGCTCTTGGTTGACTTTTACTCGCCAAGGCGTAAGAC
CAGTTTTTCGCTTGAGTGAGTGCGTCGTTACTAATTGCTAGTTCAGTGCGGT
ATGCAACGTTCTCTCCAGATTGATCAAACACGCGAGTGTAAACCGAATCGC
CAACCTTTAGATTCATAGTAGGGATGATTTGGGCCACCTTGAGTCCACTCAG
GAATCACAGGGTCGTCACCATCAATTTGACATCGATAACGTTGTAGAATTG
ATGCTGCGGTATCCACCCAACAATCCCATACCGCAAGGAATGACATTGGTA
ACCCTTTCGCGTTCA 
Reverse sequencing product 
TTGACTTGATTCGCCAAGCTATTTAGGTGACACTATAGAATACTCAAGCTAT
GCATCCAACGCGTTGGGAGCTCTCCCATATGGTCGACCTGCAGGCGGCCGC
GAATTCACTAGTGATTATGAAATCATTCCCTAATAAATCGCTCGTTGCCCTT
GCTATCGCAAGCATGAGCTCTGGTGTCTTAGCACACGGTTACGTATCGGAAT
CCAACGATGGCGTCGCAGCAAGTCGTGCAGCGCTGTGTAAGTACCCAACAT
CGGATACCAATGAAAGAAACACTAACTGTGGCGCAATTCAATATGAACCAC
AAAGCGTGGAAGGCCCAGATGGCTTCCCAGAGACAGGCCCTCGCGACGGG
AAAATTGCCAGCGCAGAAACAGCTCGAGCAGCTGCACTAGACGAACAAAC
CGCCGACCGCTGGGTAAAACGTCCGATAAAATCTGGTACACAAACGTTTGA
ATGGACTTTTACAGCAAACCACGTGACTCGTGATTGGAAATACTACATCAC
268
AAAACCGAATTGGAACCCGAACGCTTCATTGTCACGCGACTCGTTCGCTCTC
AACCCTTTCTGTGTGGTTGACGGCAATATGGTTCAACCACCAAAACAGATG
AGCCACCAATGTAACGTGCCTGAACGCGAAGGGTACCATGTCATCCTTGCG
GTATGGGATGTGGGTGATACCGCAGCATCATTCTACAACGTTATCGATGTCA
AATTTGATGGTGACGACCCTGTGATTCCTGAGTGGACTCAAGGTGGCCAAA
TCATCCCTACTATGAATCTAAAGGTTGGCGATTCGGTTTACACTCGCGTGTT
TGATCAATCTGGAGAGAACGTTGCATACCGCACTGAACTAGCAATTAGTAA
CGACGCACTCACTCAAGCGAAAAACTGGTCTTACGCCTTGCCGAGTAAAGT
CAACCAAGAGCAAACTAGCTTCAAGCTGGTCAATATTCGGAAGACAAGTTC
ACGCCAGTGTACGGCACGAACCCAATTTACCTGCAATCAAACAGTGGGGTT
GAAGCGTGTTGAAATTGGCTAACAAT 
 
Colony 4 
Forward sequencing product 
CGTTCCGGTGGGAATTGTAATACGACTCACTATAGGGCGAATTGGGCCCGA
CGTCGCATGCTCCCGGCCGCCATGGCGGCCGCGGGAATTCGATTTTAGTTCA
GTTTATCCCAAGCCATTTCCCAGTGTGAGCCTGTCGCTGGCTCAAATTTTGT
TGCACTCTCACTCCACTGTACGCAGTAGCCAGAGTAAGGGAATGGTTTACA
TTGATAAATCGCGCCGTCGCTTGCTAACACTTTTGTACCTGCTGTGTAGCTA
GAAAGCCCCTCTGGGAATACAAAGTCGTATTCGCCTGATGGTGGTGGGGTG
ACTTCCTCACTTTTTAGATGGAAATCCAGAGTTTGCTGATCGACAAGGTTGC
CATCGGTATCTTTAATGCGGGTTACTAACATGTGGTGCCCCGGTTCTGATTT
GCTCAGCGTGAGTTCTACTTGTTCGCTTGCACCATCTTGAATTGAACCCGTC
CAACTTGCTAGTGGTTCGCGATGATGATTGTAAACCGTTAACTCGGCGGTTA
AGTCGCCCTCTGCGGTAAGAGTGAGGTCTAAAGAGGTTGGTTCTGTAGCAA
TTATGTACTCACTGGCAAGACCATCAACCGTGAGTGAATACTCAGGTACTG
269
GCGTTTCAATATTGTAGCCAATTTCAACACGCTCAAGGCCACTGTTTGATTG
CAGGTAAATTGGGTTCGTGCCGTACACTGGCGTGAACTTGTCTTCCGAATAT
TGACCAGCTTGAAGCTTAGTTTGCTCTTGGTTGACTTTACTCGCCAAGGCGT
AAGACCAGTTTTTCGCTTGAGTGAGTGCGTCGTTACTAATTGCTAGTTCAGT
GCGGTATGCAACGTTCTCTCCAGATTGATCAAACACGCGAGTGTAAACCGA
ATCGCCAACCTTTAGATTCATAGTAGGGATGATTTGGCCAACTTGAGTCCAC
TCAGGAATCACAGGGTCGTCACCATCAAATTGACATCCGATAACGTTGTAG
AATGATGCTGCGGTATCACCCACATCCCATACGCAGGGATGACATGGTAAC
CTTCGCGTTCAGGCACGT 
Reverse sequencing product 
CGCCCAAGGCTATTTTAGGTGACACTATAGAATACTCAAGCTATGCATCCA
ACGCGTTGGGAGCTCTCCCATATGGTCGACCTGCAGGCGGCCGCGAATTCA
CTAGTGATTATGAAATCATTCCCTAATAAATCGCTCGTTGCCCTTGCTATCG
CAAGCATGAGCTCTGGTGTCTTAGCACACGGTTACGTATCGGAATCCAACG
ATGGCGTCGCAGCAAGTCGTGCAGCGCTGTGTAAGTACCCAACATCGGATA
CCAATGAAAGAAACACTAACTGTGGCGCAATTCAATATGAACCACAAAGCG
TGGAAGGCCCAGATGGCTTCCCAGAGACAGGCCCTCGCGACGGGAAAATTG
CCAGCGCAGAAACAGCTCGAGCAGCTGCACTAGACGAACAAACCGCCGAC
CGCTGGGTAAAACGTCCGATAAAATCTGGTACACAAACGTTTGAATGGACT
TTTACAGCAAACCACGTGACTCGTGATTGGAAATACTACATCACAAAACCG
AATTGGAACCCGAACGCTTCATTGTCACGCGACTCGTTCGCTCTCAACCCTT
TCTGTGTGGTTGACGGCAATATGGTTCAACCACCAAAACAGATGAGCCACC
AATGTAACGTGCCTGAACGCGAAGGGTACCATGTCATCCTTGCGGTATGGG
ATGTGGGTGATACCGCAGCATCATTCTACAACGTTATCGATGTCAAATTTGA
TGGTGACGACCCTGTGATTCCTGAGTGGACTCAAGGTGGCCAAATCATCCCT
ACTATGAATCTAAAGGTTGGCGATTCGGTTTACACTCGCGTGTTTGATCAAT
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CTGGAGAGAACGTTTGCATACCGCACTGAACTAGCAATTAGTAACGACGCA
CTCACTCAAGCGAAAAACTGGTCTTACGCCTTGGCGAGTAAAGTCAACCAA
GAGCAAACTAAGCTTCAAGCTGGGTCAATATTTCGGAAGACAAGTTCACGC
CAGTGTACGGCACGTACCCCAATTTTACCTGCAATCAAACCAGTTGCCCTTG
AGCCGTGTTGAAATTTGGCTTACAA 
 
Colony 5 
Forward sequencing product 
ACGGCCAGGATTGTATACGACTCACTATAGGGCGAATTGGGCCCGACGTCG
CATGCTCCCGGCCGCCATGGCGGCCGCGGGAATTCGATTTAGTTCAGTTTAT
CCCAAGCCATTTCCCAGTGTGAGCCTGTCGCTGGCTCAAATTATGTTGCACT
CTCACTCCACTGTACGCAGTAGCCAGAGTAAGGGAATGGTTTACATTGATA
AATCGCGCCGTCGCTTGCTAACACTTTTGTACCTGCTGTGTAGCTAGAAAGC
CCCTCTGGGAATACAAAGTCGTATTCGCCTGATGGTGGTGGGGTGACTTCCT
CACTTTTTAGATGGAAATCCAGAGTTTGCTGATCGACAAGGTTGCCATCGGT
ATCTTTAATGCGGGTTACTAACATGTGGTGCCCCGGTTCTGATTTGCTCAGC
GTGAGTTCTACTTGTTCGCTTGCACCATCTTGAATTGAACCCGTCCAACTTG
CTAGTGGTTCGCGATGATGATTGTAAACCGTTAACTCGGCGGTTAAGTCGCC
CTCTGCGGTAAGAGTGAGGTCTAAAGAGGTTGGTTCTGTAGCAATTATGTA
CTCACTGGCAAGACCATCAACCGTGAGTGAATACTCAGGTACTGGCGTTTC
AATATTGTAGCCAATTTCAACACGCTCAAGGCCACTGTTTGATTGCAGGTAA
ATTGGGTTCGTGCCGTACACTGGCGTGAACTTGTCTTCCGAATATTGACCAG
CTTGAAGCTTAGTTTGCTCTTGGTTGACTTTACTCGCCAAGGCGTAAGACCA
GTTTTTCGCTTGAGTGAGTGCGTCGTTACTAATTGCTAGTTCAGTGCGGTAT
GCAACGTTCTCTCCAGATTGATCAAACACGCGAGTGTAAACCGAATCGCCA
ACCTTTAGATTCATAGTAGGGATGATTTGGGCCACCTTGAGTCCACTCAGGA
271
ATCACAGGGTCGTCACCATCAAATTTGACATCGATAACGTTGTAGATGATG
CTGCGGTATCACCCACATCCCATACCGCAAGGATGACAATGGTAACCCTTTC
GCGTTCAGCACGTTAC 
Reverse sequencing product 
ATTTTTAAGGTTGACACTATAGAATACTCAAGCTATGCATCCAACGCGTTGG
GAGCTCTCCCATATGGTCGACCTGCAGGCGGCCGCGAATTCACTAGTGATT
ATGAAATCATTCCCTAATAAATCGCTCGTTGCCCTTGCTATCGCAAGCATGA
GCTCTGGTGTCTTAGCACACGGTTACGTATCGGAATCCAACGATGGCGTCGC
AGCAAGTCGTGCAGCGCTGTGTAAGTACCCAACATCGGATACCAATGAAAG
AAACACTAACTGTGGCGCAATTCAATATGAACCACAAAGCGTGGAAGGCCC
AGATGGCTTCCCAGAGACAGGCCCTCGCGACGGGAAAATTGCCAGCGCAGA
AACAGCTCGAGCAGCTGCACTAGACGAACAAACCGCCGACCGCTGGGTAA
AACGTCCGATAAAATCTGGTACACAAACGTTTGAATGGACTTTTACAGCAA
ACCACGTGACTCGTGATTGGAAATACTACATCACAAAACCAAATTGGAACC
CGAACGCTTCATTGTCACGCGACTCGTTCGCTCTCAACCCTTTCTGTGTGGTT
GACGGCAATATGGTTCAACCACCAAAACAGATGAGCCACCAATGTAACGTG
CCTGAACGCGAAGGGTACCATGTCATCCTTGCGGTATGGGATGTGGGTGAT
ACCGCAGCATCATTCTACAACGTTATCGATGTCAAATTTGATGGTGACGACC
CTGTGATTCCTGAGTGGACTCAAGGTGGCCAAATCATCCCTACTATGAATCT
AAAGGTTGGCGATTCGGTTTACACTCGCGTGTTTGATCAATCTGGAGAGAA
CGTTGCATACCGCACTGAACTAGCAATTAGTAACGACGCACTCACTCAAGC
GAAAACTGGTCTTACGCCTTGGCGAGTAAAGTCAACCAAGAGCAAACTAAG
CTTCAAGCTGGTCAATATTCGGAAGACAAGTTCCACGCCAGTGTACGGCAC
GAACCCAAATTTACCCTGCAATCAAACAGTGGCCTTGAGCGTGTTGGAAAT
TGGGCTACAATATTGAAACGCCAG 
 
272
Colony 6 
Forward sequencing product 
ATGCCCGTGGATTTGTTATACGACTCACTATAGGGCGAATTGGGCCCGACGT
CGCATGCTCCCGGCCGCCATGGCGGCCGCGGGAATTCGATTATGAAATCAT
TCCCTAATAAATCGCTCGTTGCCCTTGCTATCGCAAGCATGAGCTCTGGTGT
CTTAGCACACGGTTACGTATCGGAATCCAACGATGGCGTCGCAGCAAGTCG
TGCAGCGCTGTGTAAGTACCCAACATCGGATACCAATGAAAGAAACACTAA
CTGTGGCGCAATTCAATATGAACCACAAAGCGTGGAAGGCCCAGATGGCTT
CCCAGAGACAGGCCCTCGCGACGGGAAAATTGCCAGCGCAGAAACAGCTC
GAGCAGCTGCACTAGACGAACAAACCGCCGACCGCTGGGTAAAACGTCCG
ATAAAATCTGGTACACAAACGTTTGAATGGACTTTTACAGCAAACCACGTG
ACTCGTGATTGGAAATACTACATCACAAAACCGAATTGGAACCCGAACGCT
TCATTGTCACGCGACTCGTTCGCTCTCAACCCTTTCTGTGTGGTTGACGGCA
ATATGGTTCAACCACCAAAACAGATGAGCCACCAATGTAACGTGCCTGAAC
GCGAAGGGTACCATGTCATCCTTGCGGTATGGGATGTGGGTGATACCGCAG
CATCATTCTACAACGTTATCGATGTCAAATTTGATGGTGACGACCCTGTGAT
TCCTGAGTGGACTCAAGGTGGCCAAATCATCCCTACTATGAATCTAAAGGTT
AGCGATTCGGTTTACACTCGCGTGTTTGATCAATCTGGAGAGAACGTTGCAT
ACCGCACTGAACTAGCAATTAGTAACGACGCACTCACTCAAGCGAAAAACT
GGTCTTACGCCTTGGCGAGTAAAGTCAACCAAGAGCAAACTAAGCTTCAAG
CTGGTCAATATTCGGAAGACAGTTCACGCCAGTGTACGGCACGAAACCCAA
TTTACCTGCAATCAAACAGTGGCCCTGAGCGTGTTGAAATTGGCTACAATTA
TTGAAACGCCAGTACCTGAGTATTC 
Reverse sequencing product 
AGGCCCCAAGGCTATTTTAGGTGACACTATAGAATACTCAAGCTATGCATC
CAACGCGTTGGGAGCTCTCCCATATGGTCGACCTGCAGGCGGCCGCGAATT
273
CACTAGTGATTTAGTTCAGTTTATCCCAAGCCATTTCCCAGTGTGAGCCTGT
CGCTGGCTCAAATTATGTTGCACTCTCACTCCACTGTACGCAGTAGCCAGAG
TAAGGGAATGGTTTACATTGATAAATCGCGCCGTCGCTTGCTAACACTTTTG
TACCTGCTGTGTAGCTAGAAAGCCCCTCTGGGAATACAAAGTCGTATTCGCC
TGATGGTGGTGGGGTGACTTCCTCACTTTTTAGATGGAAATCCAGAGTTTGC
TGATCGACAAGGTTGCCATCGGTATCTTTAATGCGGGTTACTAACATGTGGT
GCCCCGGTTCTGATTTGCTCAGCGTGAGTTCTACTTGTTCGCTTGCACCATCT
TGAATTGAACCCGTCCAACTTGCTAGTGGTTCGCGATGATGATTGTAAACCG
TTAACTCGGCGGTTAAGTCGCCCTCTGCGGTAAGAGTGAGGTCTAAAGAGG
TTGGTTCTGTAGCAATTATGTACTCACTGGCAAGACCATCAACCGTGAGTGA
ATACTCAGGTACTGGCGTTTCAATATTGTAGCCAATTTCAACACGCTCAAGG
CCACTGTTTGATTGCAGGTAAATTGGGTTCGTGCCGTACACTGGCGTGAACT
TGTCTTCCGAATATTGACCAGCTTGAAGCTTAGTTTGCTCTTGGTTGACTTTA
CTCGCCAAGGCGTAAGACCAGTTTTTCGCTTGAGTGAGTGCGTCGTTACTAA
TTGCTAGTTCAGTGCGGGTATGCAACGTTCTCTCCAGATTGATCAAACACGC
GAGTGTAAACCGGATCGCTAACCTTTAGATTCATAGTAGGGATGATTTGGG
CCACCTTGAGTCCACTCAGGAATCACAGGGTCGTCACCATCAATTTGACATC
GATAACGGTTGTAGATTGATGCTGCGGTATCCCCCCACATCCCATACCGCAG
GGATGACATTGC 
 
Colony 7 
Forward sequencing product 
GGGCCCGTGCATTGTATACGACTCACTATAGGGCGAATTGGGCCCGACGTC
GCATGCTCCCGGCCGCCATGGCGGCCGCGGGAATTCGATTATGAAATCATT
CCCTAATAAATCGCTCGTTGCCCTTGCTATCGCAAGCATGAGCTCTGGTGTC
TTAGCACACGGTTACGTATCGGAATCCAACGATGGCGTCGCAGCAAGTCGT
274
GCAGCGCTGTGTAAGTACCCAACATCGGATACCAATGAAAGAAACACTAAC
TGTGGCGCAATTCAATATGAACCACAAAGCGTGGAAGGCCCAGATGGCTTC
CCAGAGACAGGCCCTCGCGACGGGAAAATTGCCAGCGCAGAAACAGCTCG
AGCAGCTGCACTAGACGAACAAACCGCCGACCGCTGGGTAAAACGTCCGAT
AAAATCTGGTACACAAACGTTTGAATGGACTTTTACAGCAAACCACGTGAC
TCGTGATTGGAAATACTACATCACAAAACCGAATTGGAACCCGAACGCTTC
ATTGTCACGCGACTCGTTCGCTCTCAACCCTTTCTGTGTGGTTGACGGCAAT
ATGGTTCAACCACCAAAACAGATGAGCCACCAATGTAACGTGCCTGAACGC
GAAGGGTACCATGTCATCCTTGCGGTATGGGATGTGGGTGATACCGCAGCA
TCATTCTACAACGTTATCGATGTCAAATTTGATGGTGACGACCCTGTGATTC
CTGAGTGGACTCAAGGTGGCCAAATCATCCCTACTATGAATCTAAAGGTTG
GCGATTCGGTTTACACTCGCGTGTTTGATCAATCTGGAGAGAACGTTGCATA
CCGCACTGAACTAGCAATTAGTAACGACGCACTCACTCAAGCGAAAAACTG
GTCTTACGCCTTGGCGAGTAAAGTCAACCAAGAGCAAACTAAGCTTCAAGC
TGGTCAATATTCGGAAGACAGTTCACGCCAGTGTACGGCACGAACCCAATT
TACCTGCAATCAAACAGTGTCTTGAGCGTGTTGAAATTGGCTACATATTGAA
ACGCCAGTACCTGAGTATTCACCCCA 
Reverse sequencing product 
TAGGACATGATTTCCGCCAAGCTATTTAGGTGACACTATAGAATACTCAAG
CTATGCATCCAACGCGTTGGGAGCTCTCCCATATGGTCGACCTGCAGGCGG
CCGCGAATTCACTAGTGATTTAGTTCAGTTTATCCCAAGCCATTTCCCAGTG
TGAGCCTGTCGCTGGCTCAAATTGTGTTGCACTCTCACTCCACTGTACGCAG
TAGCCAGAGTAAGGGAATGGTTTACATTGATAAATCGCGCCGTCGCTTGCT
AACACTTTTGTACCTGCTGTGTAGCTAGAAAGCCCCTCTGGGAATACAAAGT
CGTATTCGCCTGATGGTGGTGGGGTGACTTCCTCACTTTTTAGATGGAAATC
CAGAGTTTGCTGATCGACAAGGTTGCCATCGGTATCTTTAATGCGGGTTACT
275
AACATGTGGTGCCCCGGTTCTGATTTGCTCAGCGTGAGTTCTACTTGTTCGC
TTGCACCATCTTGAATTGAACCCGTCCAACTTGCTAGTGGTTCGCGATGATG
ATTGTAAACCGTTAACTCGGCGGTTAAGTCGCCCTCTGCGGTAAGAGTGAG
GTCTAAAGAGGTTGGTTCTGTAGCAATTATGTACTCACTGGCAAGACCATCA
ACCGTGAGTGAATACTCAGGTACTGGCGTTTCAATATTGTAGCCAATTTCAA
CACGCTCAAGGCCACTGTTTGATTGCAGGTAAATTGGGTTCGTGCCGTACAC
TGGCGTGAACTTGTCTTCCGAATATTGACCAGCTTGAAGCTTAGTTTGCTCT
TGGTTGACTTTACTCGCCAAGGCGTAAGACCAGTTTTTCGCTTGAGTGAGTG
CGTCGTTACTAATTGCTAGTTCAGTGCGGTATGCAACGTTCTCTCCAGATTG
ATCAAACACGCGAGTGTAAACCGAATCGCCAACCTTTAGATTCATAGTAGG
GATGATTTGGCCACCTTGAGTCCACTCAAGAATCACAGGGTCGTCACCATC
AAATTTGACATCGATAACGTTGTAGAATGATGCTGCGGTATCACCAACATC
CCATACCGCAGATGACA 
 
Colony 8 
Forward sequencing product 
NNNNN 
Reverse sequencing product 
NNNNN 
 
Colony 9 
Forward sequencing product 
AGGCCCGGTGTTTTGGTAATACGACTCACTATAGGGGCGATTGGGCCCGAC
GTCGCATGCTCCCGGCCGCCATGGCGGCCGCGGGAATTCGATTATCCACAG
AATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAG
GCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGC
276
CCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAAC
CCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTG
CGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCC
TTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCG
GTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGC
CCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAG
ACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGC
GAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGG
CTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACC
TTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAAGCACCGCTG 
Reverse sequencing product 
CACTCAAAAACACCCATACCCCATTTAGAATAAGGCCCCATTGTTAATATTG
AAGCCAATGCCCTTCAGGTTCATCTTGTTCCCAATGCCCATCTTGCTCATATT
GCACCCAATCCCCTTCTTGCTCATCTTGCACCCAATCCCCATCATGCTCTCCA
TGCACCCAATGCCTTTCTTCTTCATCATGCACCCAATGCCCATCATGCTCTCC
ATGCCCTCAATGCCTATCATGCCCTTCATGCTCTCCATGCCCATCATGTTCAT
CATGCAATTAATCCCATTTTGCTCTTCATGCTTTTATTTCCTTCATGCTTATTT
TCTTCCTTTCCTCATCATGCTCATCATTTTTCTTATTCTTATTATGCTCATGAT
GCTTTCTTTGCACACGATGG 
 
Colony 10 
Forward sequencing product 
CGGGCCGGTGAATTGTAATACGACTCACTATAGGGCGAATTGGGCCCGACG
TCGCATGCTCCCGGCCGCCATGGCGGCCGCGGGAATTCGATTATGAAATCA
TTCCCTAATAAATCGCTCGTTGCCCTTGCTATCGCAAGCATGAGCTCTGGTG
TCTTAGCACACGGTTACGTATCGGAATCCAACGATGGCGTCGCAGCAAGTC
277
GTGCAGCGCTGTGTAAGTACCCAACATCGGATACCAATGAAAGAAACACTA
ACTGTGGCGCAATTCAATATGAACCACAAAGCGTGGAAGGCCCAGATGGCT
TCCCAGAGACAGGCCCTCGCGACGGGAAAATTGCCAGCGCAGAAACAGCTC
GAGCAGCTGCACTAGACGAACAAACCGCCGACCGCTGGGTAAAACGTCCG
ATAAAATCTGGTACACAAACGTTTGAATGGACTTTTACAGCAAACCACGTG
ACTCGTGATTGGAAATACTACATCACAAAACCGAATTGGAACCCGAACGCT
TCATTGTCACGCGACTCGTTCGCTCTCAACCCTTTCTGTGTGGTTGACGGCA
ATATGGTTCAACCACCAAAACAGATGAGCCACCAATGTAACGTGCCTGAAC
GCGAAGGGTACCATGTCATCCTTGCGGTATGGGATGTGGGTGATACCGCAG
CATCATTCTACAACGTTATCGATGTCAAATTTGATGGTGACGACCCTGTGAT
TCCTGAGTGGACTCAAGGTGGCCAAATCATCCCTACTATGAATCTAAAGGTT
GGCGATTCGGTTTACACTCGCGTGTTTGATCAATCTGGAGAGAACGTTGCAT
ACCGCACTGAACTAGCAATTAGTAACGACGCACTCACTCAAGCGAAAAACT
GGTCTTACGCCTTGGCGAGTAAAGTCAACCAAGAGCAAACTAAGCTTCAAG
CTGGTCAATATTCGGAAGACAAGTTCACGCCAGTGTACGGCACGAACCCAA
TTTACCTGCAATCAAACAGTGGCCTTGAGCGTGTTGAATTGGCTACATATTG
AACGCCAGTACCTGAGTATTCACTC 
Reverse sequencing product 
AGGATTCCGCCCAAGCTATTTAGGTGACACTATAGAATACTCAAGCTATGC
ATCCAACGCGTTGGGAGCTCTCCCATATGGTCGACCTGCAGGCGGCCGCGA
ATTCACTAGTGATTTTAGTTCAGTTTATCCCAAGCCATTTCCCAGTGTGAGC
CTGTCGCTGGCTCAAATTATGTTGCACTCTCACTCCACTGTACGCAGTAGCC
AGAGTAAGGGAATGGTTTACATTGATAAATCGCGCCGTCGCTTGCTAACAC
TTTTGTACCTGCTGTGTAGCTAGAAAGCCCCTCTGGGAATACAAAGTCGTAT
TCGCCTGATGGTGGTGGGGTGACTTCCTCACTTTTTAGATGGAAATCCAGAG
TTTGCTGATCGACAAGGTTGCCATCGGTATCTTTAATGCGGGTTACTAACAT
278
GTGGTGCCCCGGTTCTGATTTGCTCAGCGTGAGTTCTACTTGTTCGCTTGCA
CCATCTTGAATTGAACCCGTCCAACTTGCTAGTGGTTCGCGATGATGATTGT
AAACCGTTAACTCGGCGGTTAAGTCGCCCTCTGCGGTAAGAGTGAGGTCTA
AAGAGGTTGGTTCTGTAGCAATTATGTACTCACTGGCAAGACCATCAACCG
TGAGTGAATACTCAGGTACTGGCGTTTCAATATTGTAGCCAATTTCAACACG
CTCAAGGCCACTGTTTGATTGCAGGTAAATTGGGTTCGTGCCGTACACTGGC
GTGAACTTGTCTTCCGAATATTGACCAGCTTGAAGCTTAGTTTGCTCTTGGT
TGACTTTACTCGCCAAGGCGTAAGACCAGTTTTTCGCTTGAGTGAGTGCGTC
GTTACTAATTGCTAGTTCAGTGCGGTATGCAACGTTCTCTCCAGATTGATCA
AACACGCGAGTGTAAACCGAATCGCCAACCTTTAGATTCATAGTAGGTATG
ATTTGGCCACCTTGAGTCCACTCAGGAATCACCAGGGTCGTCACCATCAAAT
TTGACATCGATAACGTGTAGATGATGCTGCGGTATCCCCCACCATTCCCATA
CGCAAGGATGACATGG 
 
Colony 11 
Forward sequencing product 
GGGGCCAGTGAATTTGTAATACGACTCACTATAGGGCGAATTGGGCCCGAC
GTCGCATGCTCCCGGCCGCCATGGCGGCCGCGGGAATTCGATTATGAAATC
ATTCCCTAATAAATCGCTCGTTGCCCTTGCTATCGCAAGCATGAGCTCTGGT
GTCTTAGCACACGGTTACGTATCGGAATCCAACGATGGCGTCGCAGCAAGT
CGTGCAGCGCTGTGTAAGTACCCAACATCGGATACCAATGAAAGAAACACT
AACTGTGGCGCAATTCAATATGAACCACAAAGCGTGGAAGGCCCAGATGGC
TTCCCAGAGACAGGCCCTCGCGACGGGAAAATTGCCAGCGCAGAAACAGCT
CGAGCAGCTGCACTAGACGAACAAACCGCCGACCGCTGGGTAAAACGTCCG
ATAAAATCTGGTACACAAACGTTTGAATGGACTTTTACAGCAAACCACGTG
ACTCGTGATTGGAAATACTACATCACAAAACCGAATTGGAACCCGAACGCT
279
TCATTGTCACGCGACTCGTTCGCTCTCGACCCTTTCTGTGTGGTTGACGGCA
ATATGGTTCAACCACCAAAACAGATGAGCCACCAATGTAACGTGCCTGAAC
GCGAAGGGTACCATGTCATCCTTGCGGTATGGGATGTGGGTGATACCGCAG
CATCATTCTACAACGTTATCGATGTCAAATTTGATGGTGACGACCCTGTGAT
TCCTGAGTGGACTCAAGGTGGCCAAATCATCCCTACTATGAATCTAAAGGTT
GGCGATTCGGTTTACACTCGCGTGTTTGATCAATCTGGAGAGAACGTTGCAT
ACCGCACTGAACTAGCAATTAGTAACGACGCACTCACTCAAGCGAAAAACT
GGTCTTACGCCTTTGGCGAGTAAAGTCAAACAAAGAGCAAACTAAGCTTCA
AGCTGGTCAATATTCGGGAAGAACAAGTTCACGCCAGTGTACGGCACGAAC
CCAATTTTACCTGCAATCAAACAGTTGTCCTTGAGCGTGTTGAAATTGGGCT
TACAATATTGAAAACGCCAGTACC 
Reverse sequencing product 
AGACTGGATTACGCCAAGCTATTTAGGTGACACTATAGAATACTCAAGCTA
TGCATCCAACGCGTTGGGAGCTCTCCCATATGGTCGACCTGCAGGCGGCCG
CGAATTCACTAGTGATTTTAGTTCAGTTTATCCCAAGCCATTTCCCAGTGTG
AGCCTGTCGCTGGCTCAAATTTTGTTGCACTCTCACTCCACTGTACGCAGTA
GCCAGAGTAAGGGAATGGTTTACATTGATAAATCGCGCCGTCGCTTGCTAA
CACTTTTGTACCTGCTGTGTAGCTAGAAAGCCCCTCTGGGAATACAAAGTCG
TATTCGCCTGACGGTGGTGGGGTGACTTCCTCACTTTTTAGATGGAAATCCA
GAGTTTGCTGATCGACAAGGTTGCCATCGGTATCTTTAATGCGGGTTACTAA
CATGTGGTGCCCCGGTTCTGATTTGCTCAGCGTGAGTTCTACTTGTTCGCTTG
CACCATCTTGAATTGAACCCGTCCAACTTGCTAGTGGTTCGCGATGATGATT
GTAAACCGTTAACTCGGCGGTTAAGTCGCCCTCTGCGGTAAGAGTGAGGTC
TAAAGAGGTTGGTTCTGTAGCAATTATGTACTCACTGGCAAGACCATCAAC
CGTGAGTGAATACTCAGGTACTGGCGTTTCAATATTGTAGCCAATTTCAACA
CGCTCAAGGCCACTGTTTGATTGCAGGTAAATTGGGTTCGTGCCGTACACTG
280
GCGTGAACTTGTCTTCCGAATATTGACCAGCTTGAAGCTTAGTTTGCTCTTG
GTTGACTTTACTCGCCAAGGCGTAAGACCAGTTTTTCGCTTGAGTGAGTGCG
TCGTTACTAATTGCTAGTTCAGTGCGGTATGCAACGTTCTCTCAGATTGATC
AAACACGCGAGTGTAAACCGAATCGCCAACCTTTTAGATTCATAGTAGGGA
TGATTTGGCCACCTTGAGTCCACTCAAGAATCACAGGGTCGTCACCATCAA
ATTTTGACATCGATAACGTTGTAGAATGATGCTGCGGTATCACCCACATCCC
ATACCGCAAGGATGAC 
 
Colony 12 
Forward sequencing product 
NNNNN 
Reverse sequencing product 
NNNNN 
 
Colony 13 
Forward sequencing product 
CACGGGCCCGTTGTATTTGTTATACGACTCACTATAGGGCGAATTGGGCCCG
ACGTCGCATGCTCCCGGCCGCCATGGCGGCCGCGGGAATTCGATTTTAGTTC
AGTTTATCCCAAGCCATTTCCCAGTGTGAGCCTGTCGCTGGCTCAAATTTTG
TTGCACTCTCACTCCACTGTACGCAGTAGCCAGAGTAAGGGAATGGTTTAC
ATTGATAAATCGCGCCGTCGCTTGCTAACACTTTTGTACCTGCTGTGTAGCT
AGAAAGCCCCTCTGGGAATACAAAGTCGTATTCGCCTGATGGTGGTGGGGT
GACTTCCTCACTTTTTAGATGGAAATCCAGAGTTTGCTGATCGACAAGGTTG
CCATCGGTATCTTTAATGCGGGTTACTAACATGTGGTGCCCCGGTTCTGATT
TGCTCAGCGTGAGTTCTACTTGTTCGCTTGCACCATCTTGAATTGAACCCGT
CCAACTTGCTAGTGGTTCGCGATGATGATTGTAAACCGTTAACTCGGCGGTT
281
AAGTCGCCCTCTGCGGTAAGAGTGAGGTCTAAAGAGGTTGGTTCTGTAGCA
ATTATGTACTCACTGGCAAGACCATCAACCGTGAGTGAATACTCAGGTACT
GGCGTTTCAATATTGTAGCCAATTTCAACACGCTCAAGGCCACTGTTTGATT
GCAGGTAAATTGGGTTCGTGCCGTACACTGGCGTGAACTTGTCTTCCGAATA
TTGACCAGCTTGAAGCTTAGTTTGCTCTTGGTTGACTTTACTCGCCAAGGCG
TAAGACCAGTTTTTCGCTTGAGTGAGTGCGTCGTTACTAATTGCTAGTTCAG
TGCGGTATGCAACGTTCTCTCCAGATTGATCAAACACGCGAGTGTAAACCG
AATCGCCAACCTTTTAGATTCATAGTAAGGGATGATTTGGCCACCTTGAGTC
CACTCAGGAATCACAGGGTCGTCACCATCAAATTTGACATCGATTAACGTT
GTAGATTGATGCTGCGGTATCACCCACATCCCATACCGCAAGGATGACAAT
GTACCCTTCGCGTTCAG 
Reverse sequencing product 
TCCGGCCCAAGGCTATTTAGGGTGACACTATAGAATACTCAAGCTATGCAT
CCAACGCGTTGGGAGCTCTCCCATATGGTCGACCTGCAGGCGGCCGCGAAT
TCACTAGTGATTATGAAATCATTCCCTAATAAATCGCTCGTTGCCCTTGCTA
TCGCAGGCATGAGCTCTGGTGTCTTAGCACACGGTTACGTATCGGAATCCA
ACGATGGCGTCGCAGCAAGTCGTGCAGCGCTGTGTAAGTACCCAACATCGG
ATACCAATGAAAGAAACACTAACTGTGGCGCAATTCAATATGAACCACAAA
GCGTGGAAGGCCCAGATGGCTTCCCAGAGACAGGCCCTCGCGACGGGAAA
ATTGCCAGCGCAGAAACAGCTCGAGCAGCTGCACTAGACGAACAAACCGCC
GACCGCTGGGTAAAACGTCCGATAAAATCTGGTACACAAACGTTTGAATGG
ACTTTTACAGCAAACCACGTGACTCGTGATTGGAAATACTACATCACAAAA
CCGAATTGGAACCCGAACGCTTCATTGTCACGCGACTCGTTCGCTCTCAACC
CTTTCTGTGTGGTTGACGGCAATATGGTTCAACCACCAAAACAGATGAGCC
ACCAATGTAACGTGCCTGAACGCGAAGGGTACCATGTCATCCTTGCGGTAT
GGGATGTGGGTGATACCGCAGCATCATTCTACAACGTTATCGATGTCAAATT
282
TGATGGTGACGACCCTGTGATTCCTGAGTGGACTCAAGGTGGCCAAATCAT
CCCTACTATGAATCTAAAGGTTGGCGATTCGGTTTACACTCGCGTGTTTGAT
CAATCTGGAGAGAACGTTGCATACCGCACTGAACTAGCAATTAGTAACGAC
GCACTCACTCAAGCGAAAAACTGGTCTTACGCCTTGACGAGTAAAGTCAAC
CAAGAGCAAACTAAGCTTCAAGCTGGTCAATATTCGGGAAGAACAAGTTCA
CGCCAGTGTACGGCCACGAACCCCAATTTACCTGCAATCAAACAGTGCCTT
GAGCGTGTGAAATTGGCTAACAATTAT 
 
Colony 14 
Forward sequencing product 
CGCGGGCCGTTGAATTGTATACGACTCACTATAGGGCGAATTGGGCCCGAC
GTCGCATGCTCCCGGCCGCCATGGCGGCCGCGGGAATTCGATTTTAGTTCAG
TTTATCCCAAGCCATTTCCCAGTGTGAGCCTGTCGCTGGCTCAAATTGTGTT
GCACTCTCACTCCACTGTACGCAGTAGCCAGAGTAAGGGAATGGTTTACAT
TGATAAATCGCGCCGTCGCTTGCTAACACTTTTGTACCTGCTGTGTAGCTAG
AAAGCCCCTCTGGGAATACAAAGTCGTATTCGCCTGATGGTGGTGGGGTGA
CTTCCTCACTTTTTAGATGGAAATCCAGAGTTTGCTGATCGACAAGGTTGCC
ATCGGTATCTTTAATGCGGGTTACTAACATGTGGTGCCCCGGTTCTGATTTG
CTCAGCGTGAGTTCTACTTGTTCGCTTGCACCATCTTGAATTGAACCCGTCC
AACTTGCTAGTGGTTCGCGATGATGATTGTAAACCGTTAACTCGGCGGTTAA
GTCGCCCTCTGCGGTAAGAGTGAGGTCTAAAGAGGTTGGTTCTGTAGCAAT
TATGTACTCACTGGCAAGACCATCAACCGTGAGTGAATACTCAGGTACTGG
CGTTTCAATATTGTAGCCAATTTCAACACGCTCAAGGCCACTGTTTGATTGC
AGGTAAATTGGGTTCGTGCCGTACACTGGCGTGAACTTGTCTTCCGAATATT
GACCAGCTTGAAGCTTAGTTTGCTCTTGGTTGACTTTACTCGCCAAGGCGTA
AGACCAGTTTTTCGCTTGAGTGAGTGCGTCGTTACTAATTGCTAGTTCAGTG
283
CGGTATGCAACGTTCTCTCCAGATTGATCAAACACGCGAGTGTAAACCGAA
TCGCCAACCTTTAGATTCATAGTAGGGATGATTTGGGCCACCTTGAGTCCAC
TCAGGAATCACAGGGTCGTCACATCAAATTTGACATCGATACGTTGTAGAA
TGATGCTGCGGTATCACCCACATCCCATACCGCAAGGATGACATGGTACCC
TTCGCGTTCAGGCACGTT 
Reverse sequencing product 
ACCGCCCCAAGGCTTATTTTAGGTGACACTATAGAATACTCAAGCTATGCAT
CCAACGCGTTGGGAGCTCTCCCATATGGTCGACCTGCAGGCGGCCGCGAAT
TCACTAGTGATTATGAAATCATTCCCTAATAAATCGCTCGTTGCCCTTGCTA
TCGCAAGCATGAGCTCTGGTGTCTTAGCACACGGTTACGTATCGGAATCCA
ACGATGGCGTCGCAGCAAGTCGTGCAGCGCTGTGTAAGTACCCAACATCGG
ATACCAATGAAAGAAACACTAACTGTGGCGCAATTCAATATGAACCACAAA
GCGTGGAAGGCCCAGATGGCTTCCCAGAGACAGGCCCTCGCGACGGGAAA
ATTGCCAGCGCAGAAACAGCTCGAGCAGCTGCACTAGACGAACAAACCGCC
GACCGCTGGGTAAAACGTCCGATAAAATCTGGTACACAAACGTTTGAATGG
ACTTTTACAGCAAACCACGTGACTCGTGATTGGAAATACTACATCACAAAA
CCGAATTGGAACCCGAACGCTTCATTGTCACGCGACTCGTTCGCTCTCAACC
CTTTCTGTGTGGTTGACGGCAATATGGTTCAACCACCAAAACAGATGAGCC
ACCAATGTAACGTGCCTGAACGCGAAGGGTACCATGTCATCCTTGCGGTAT
GGGATGTGGGTGATACCGCAGCATCATTCTACAACGTTATCGATGTCAAATT
TGATGGTGACGACCCTGTGATTCCTGAGTGGACTCAAGGTGGCCAAATCAT
CCCTACTATGAATCTAAAGGTTGGCGATTCGGTTTACACTCGCGTGTTTGAT
CAATCTGGAGAGAACGTTGCATACCGCACTGAACTAGCAAATTAGTAACGA
CGCACTCACTCAAGCGAAAAACTGGTCTTACGCCTTGGCGAGTAAAGTCAA
CCAAGAGCAAACTAAGCTTCAAGCTGGTCAATATTCGGAAGACAAGTTCAC
284
GCCAGTGTACGGCACGAACCCAATTTACCTGCAATCAAAACAGTGGCCTTG
AGCGTGTTGAAATTGGCTACAATATT 
 
Colony 15 
Forward sequencing product 
CGGCCGTGGATTTGTAATACGACTCACTATAGGGCGAATTGGGCCCGACGT
CGCATGCTCCCGGCCGCCATGGCGGCCGCGGGAATTCGATTATGAAATCAT
TCCCTAATAAATCGCTCGTTGCCCTTGCTATCGCAAGCATGAGCTCTGGTGT
CTTAGCACACGGTTACGTATCGGAATCCAACGATGGCGTCGCAGCAAGTCG
TGCAGCGCTGTGTAAGTACCCAACATCGGATACCAATGAAAGAAACACTAA
CTGTGGCGCAATTCAATATGAACCACAAAGCGTGGAAGGCCCAGATGGCTT
CCCAGAGACAGGCCCTCGCGACGGGAAAATTGCCAGCGCAGAAACAGCTC
GAGCAGCTGCACTAGACGAACAAACCGCCGACCGCTGGGTAAAACGTCCG
ATAAAATCTGGTACACAAACGTTTGAATGGACTTTTACAGCAAACCACGTG
ACTCGTGATTGGAAATACTACATCACAAAACCGAATTGGAACCCGAACGCT
TCATTGTCACGCGACTCGTTCGCTCTCAACCCTTTCTGTGTGGTTGACGGCA
ATATGGTTCAACCACCAAAACAGATGAGCCACCAATGTAACGTGCCTGAAC
GCGAAGGGTACCATGTCATCCTTGCGGTATGGGATGTGGGTGATACCGCAG
CATCATTCTACAACGTTATCGATGTCAAATTTGATGGTGACGACCCTGTGAT
TCCTGAGTGGACTCAAGGTGGCCAAATCATCCCTACTATGAATCTAAAGGTT
GGCGATTCGGTTTACACTCGCGTGTTTGATCAATCTGGAGAGAACGTTGCAT
ACCGCACTGAACTAGCAATTAGTAACGACGCACTCACTCAAGCGAAAAACT
GGTCTTACGCCTTGGCGAGTAAAGTCAACCAAGAGCAAACTAAGCTTCAAG
CTGGTCAATATTCGGAAGACAAGTTCACGCCAGTGTACGGCACGAACCCAA
TTTACCTGCAATCAAACAGTGCCTTGAGCGTGTTTGAAATTGGCCTACAATA
TTGAAACCCCAGTACCTGAGTATTCA 
285
 Reverse sequencing product 
CGGCCCAAAGGCTTATTTTAGGTGACACTATAGAATACTCAAGCTATGCATC
CAACGCGTTGGGAGCTCTCCCATATGGTCGACCTGCAGGCGGCCGCGAATT
CACTAGTGATTTTAGTTCAGTTTATCCCAAGCCATTTCCCAGTGTGAGCCTG
TCGCTGGCTCAAATTTTGTTGCACTCTCACTCCACTGTACGCAGTAGCCAGA
GTAAGGGAATGGTTTACATTGATAAATCGCGCCGTCGCTTGCTAACACTTTT
GTACCTGCTGTGTAGCTAGAAAGCCCCTCTGGGAATACAAAGTCGTATTCG
CCTGATGGTGGTGGGGTGACTTCCTCACTTTTTAGATGGAAATCCAGAGTTT
GCTGATCGACAAGGTTGCCATCGGTATCTTTAATGCGGGTTACTAACATGTG
GTGCCCCGGTTCTGATTTGCTCAGCGTGAGTTCTACTTGTTCGCTTGCACCAT
CTTGAATTGAACCCGTCCAACTTGCTAGTGGTTCGCGATGATGATTGTAAAC
CGTTAACTCGGCGGTTAAGTCGCCCTCTGCGGTAAGAGTGAGGTCTAAAGA
GGTTGGTTCTGTAGCAATTATGTACTCACTGGCAAGACCATCAACCGTGAGT
GAATACTCAGGTACTGGCGTTTCAATATTGTAGCCAATTTCAACACGCTCAA
GGCCACTGTTTGATTGCAGGTAAATTGGGTTCGTGCCGTACACTGGCGTGAA
CTTGTCTTCCGAATATTGACCAGCTTGAAGCTTAGTTTGCTCTTGGTTGACTT
TACTCGCCAAGGCGTAAGACCAGTTTTTCGCTTGAGTGAGTGCGTCGTTACT
AATTGCTAGTTCAGTGCGGTATGCAACGTTCTCTCCAGATTGATCAAACACG
CGAGTGTAAACCGAATCGCCAACCTTTAGATTCATAGTAGGGATGATTTGG
CCACCTTGAGTCCACTCAGGATCACAGGGTCGTCACCATCAAATTTGACATC
GATAACGTTGTAGAATGATGCTGCGGTATCACCCACATCCCATACCGCAGA
TGACATGTACCCT 
 
Colony 16 
Forward sequencing product 
286
GCGGGCCCGGTTGAATTGTAATACGACTCACTATAGGGCGAATTGGGCCCG
ACGTCGCATGCTCCCGGCCGCCATGGCGGCCGCGGGAATTCGATTTTAGTTC
AGTTTATCCCAAGCCATTTCCCAGTGTGAGCCTGTCGCTGGCTCAAATTGTG
TTGCACTCTCACTCCACTGTACGCAGTAGCCAGAGTAAGGGAATGGTTTAC
ATTGATAAATCGCGCCGTCGCTTGCTAACACTTTTGTACCTGCTGTGTAGCT
AGAAAGCCCCTCTGGGAATACAAAGTCGTATTCGCCTGATGGTGGTGGGGT
GACTTCCTCACTTTTTAGATGGAAATCCAGAGTTTGCTGATCGACAAGGTTG
CCATCGGTATCTTTAATGCGGGTTACTAACATGTGGTGCCCCGGTTCTGATT
TGCTCAGCGTGAGTTCTACTTGTTCGCTTGCACCATCTTGAATTGAACCCGT
CCAACTTGCTAGTGGTTCGCGATGATGATTGTAAACCGTTAACTCGGCGGTT
AAGTCGCCCTCTGCGGTAAGAGTGAGGTCTAAAGAGGTTGGTTCTGTAGCA
ATTATGTACTCACTGGCAAGACCATCAACCGTGAGTGAATACTCAGGTACT
GGCGTTTCAATATTGTAGCCAATTTCAACACGCTCAAGGCCACTGTTTGATT
GCAGGTAAATTGGGTTCGTGCCGTACACTGGCGTGAACTTGTCTTCCGAATA
TTGACCAGCTTGAAGCTTAGTTTGCTCTTGGTTGACTTTACTCGCCAAGGCG
TAAGACCAGTTTTTCGCTTGAGTGAGTGCGTCGTTACTAATTGCTAGTTCAG
TGCGGTATGCAACGTTCTCTCCAGATTGATCAAACACGCGAGTGTAAACCG
AATCGCCAACCTTTAGATTCATAGTAGGGATGATTTGGGCCACCTTGAGTCC
ACTCAGGAATCACAGGGTCGTCACCATCAAATTTGACATCGATAACGTTGT
AGAATGATGCTGCGGTATCACCCCACATCCCATACCGCAAGGATGACATGG
TACCCTTCGCGTTCAGGC 
Reverse sequencing product 
TTAACTGGATTACGCCAAGCTATTTAGGTGACACTATAGAATACTCAAGCTA
TGCATCCAACGCGTTGGGAGCTCTCCCATATGGTCGACCTGCAGGCGGCCG
CGAATTCACTAGTGATTGTTCGCTCTCAACCCTTTCTGTGTGGTTGACGGCA
ATATGGTTCAACCACCAAAACAGATGAGCCACCAATGTAACGTGCCTGAAC
287
GCGAAGGGTACCATGTCATCCTTGCGGTATGGGATGTGGGTGATACCGCAG
CATCATTCTACAACGTTATCGATGTCAAATTTGATGGTGACGACCCTGTGAT
TCCTGAGTGGACTCAAGGTGGCCAAATCATCCCTACTATGAATCTAAAGGTT
GGCGATTCGGTTTACACTCGCGTGTTTGATCAATCTGGAGAGAACGTTGCAT
ACCGCACTGAACTAGCAATTAGTAACGACGCACTCACTCAAGCGAAAAACT
GGTCTTACGCCTTGGCGAGTAAAGTCAACCAAGAGCAAACTAAGCTTCAAG
CTGGTCAATATTCGGAAGACAAGTTCACGCCAGTGTACGGCACGAACCCAA
TTTACCTGCAATCAAACAGTGGCCTTGAGCGTGTTGAAATTGGCTACAATAT
TGAAACGCCAGTACCTGAGTATTCACTCACGGTTGATGGTCTTGCCAGTGAG
TACATAATTGCTACAGAACCAACCTCTTTAGACCTCACTCTTACCGCAGAGG
GCGACTTAACCGCCGAGTTAACGGTTTACAATCATCATCGCGAACCACTAG
CAAGTTGGACGGGTTCAATTCAAGATGGTGCAAGCGAACAAGTAGAACTCA
CGCTGAGCAAATCAGAACCGGGGCACCACATGTTAGTAACCCGCATTAAAG
ATACCGATGGCAACCTTGTCGATCAGCAAACTCTGGATTTCCATCTAAAGTG
AGGAAGTCACCCCACCACCATCAGGCGAATACGACTTTGTATCCCAGAGGG
GCTTTCTAGCTACACAGCAGTACAAAAGTGTTAGCAAGCGACGCGCGATTT
ATCATGTAACCATTCCTACTC 
288
  
(i) Vibrio parahaemolyticus PCV08-7 bacterial plate count 
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(j) Vibrio parahaemolyticus PCV08-7 RNA isolation and cDNA synthesis with      
Nanodrop quality readings 
 
 
AppTable1. Table representing concentration of RNA and cDNA isolations for 
different Magnesium concentrations in triplicates. 
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AppTable2. Table representing concentration of RNA and cDNA isolations for 
different Magnesium concentrations in triplicates in the presence of Chitin. 
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AppTable3. Table representing concentration of RNA and cDNA isolations for 
different Magnesium concentrations in triplicates in the presence of carapace. 
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(k) Absolute quantification
Absolute quantification Real Time PCR values
Well Sample Name Detector Task Ct StdDev Ct Average
E6 0.15_0.005 gbpA Unknown 34.82 1.133
F6 0.15_0.005 gbpA Unknown 33.24 1.133 33.56
G6 0.15_0.005 gbpA Unknown 32.62 1.133
B6 0.15_0.05 gbpA Unknown 33.12 1.005
C6 0.15_0.05 gbpA Unknown 33.02 1.005 32.49
D6 0.15_0.05 gbpA Unknown 31.33 1.005
A6 0.15_0.5 gbpA Unknown 30.4 0.329
G5 0.15_0.5 gbpA Unknown 29.74 0.329 30.0967
H5 0.15_0.5 gbpA Unknown 30.15 0.329
D5 0.15_5 gbpA Unknown 27.31 0.072
E5 0.15_5 gbpA Unknown 27.19 0.072 27.2267
F5 0.15_5 gbpA Unknown 27.18 0.072
A5 0.15_50 gbpA Unknown 23.17 0.023
B5 0.15_50 gbpA Unknown 23.13 0.023 23.1567
C5 0.15_50 gbpA Unknown 23.17 0.023
H6 0.15_BLANK gbpA Unknown 30.92
E4 0.3_0.005 gbpA Unknown 34.32 1.647
F4 0.3_0.005 gbpA Unknown 33.44 1.647 32.9633
G4 0.3_0.005 gbpA Unknown 31.13 1.647
B4 0.3_0.05 gbpA Unknown 34.61 0.781
C4 0.3_0.05 gbpA Unknown 34.42 0.781 34.0667
D4 0.3_0.05 gbpA Unknown 33.17 0.781
A4 0.3_0.5 gbpA Unknown 30.39 0.6
G3 0.3_0.5 gbpA Unknown 31.39 0.6 30.7
H3 0.3_0.5 gbpA Unknown 30.32 0.6
D3 0.3_5 gbpA Unknown 28.15 0.215
E3 0.3_5 gbpA Unknown 28.22 0.215 28.3067
F3 0.3_5 gbpA Unknown 28.55 0.215
A3 0.3_50 gbpA Unknown 23.93 0.204
B3 0.3_50 gbpA Unknown 23.79 0.204 23.97
C3 0.3_50 gbpA Unknown 24.19 0.204
H4 0.3_BLANK gbpA Unknown 31.21
E2 0.6_0.005 gbpA Unknown 33.14 1.88
F2 0.6_0.005 gbpA Unknown 31.88 1.88 32.65
G2 0.6_0.005 gbpA Unknown 32.93 1.88
B2 0.6_0.05 gbpA Unknown 31.5 1.231
C2 0.6_0.05 gbpA Unknown 32.92 1.231 32.79
D2 0.6_0.05 gbpA Unknown 33.95 1.231
A2 0.6_0.5 gbpA Unknown 30.23 0.112
G1 0.6_0.5 gbpA Unknown 30.4 0.112 30.2733
H1 0.6_0.5 gbpA Unknown 30.19 0.112
D1 0.6_5 gbpA Unknown 26.82 0.319
E1 0.6_5 gbpA Unknown 27.02 0.319 27.0967
F1 0.6_5 gbpA Unknown 27.45 0.319
A1 0.6_50 gbpA Unknown 22.68 0.742
B1 0.6_50 gbpA Unknown 24.13 0.742 23.3067
C1 0.6_50 gbpA Unknown 23.11 0.742
H2 0.6_BLANK gbpA Unknown 32.83
295
(l)
 R
el
a
tiv
e 
qu
a
n
tif
ic
a
tio
n
R
ea
l t
im
e 
v
al
u
es
 
in
 th
e 
pr
es
en
ce
 
o
f o
n
ly
 
M
ag
n
es
iu
m
 
su
lfa
te
 
he
pt
a 
hy
dr
at
e
Pl
at
e
W
el
l I
D
W
el
l
Sa
m
pl
e
D
et
ec
to
r
Ta
sk
Ct
Ct
 
st
d 
er
r
A
v
g 
Ct
Pl
at
e
W
el
l I
D
W
el
l
Sa
m
pl
e
D
et
ec
to
r
Ta
sk
Ct
Ct
 
st
d 
er
r
A
v
g 
Ct
R
EL
A
TI
V
E_
10
th
Se
pt
14
1
A
1
gb
pA
_
1
Cr
us
tin
EN
D
O
24
.6
39
0.
43
7
25
.2
89
R
EL
A
TI
V
E_
10
th
Se
pt
14
7
A
7
IC
_d
ea
D
_
1 C
ru
sti
n
EN
D
O
23
.6
9
0.
11
9
23
.7
85
R
EL
A
TI
V
E_
10
th
Se
pt
14
13
B
1
gb
pA
_
1
Cr
us
tin
EN
D
O
26
.1
2
0.
43
7
25
.2
89
R
EL
A
TI
V
E_
10
th
Se
pt
14
19
B
7
IC
_d
ea
D
_
1 C
ru
sti
n
EN
D
O
23
.6
43
0.
11
9
23
.7
85
R
EL
A
TI
V
E_
10
th
Se
pt
14
25
C1
gb
pA
_
1
Cr
us
tin
EN
D
O
25
.1
07
0.
43
7
25
.2
89
R
EL
A
TI
V
E_
10
th
Se
pt
14
31
C7
IC
_d
ea
D
_
1 C
ru
sti
n
EN
D
O
24
.0
21
0.
11
9
23
.7
85
R
EL
A
TI
V
E_
10
th
Se
pt
14
37
D
1
gb
pA
_
2
Cr
us
tin
EN
D
O
22
.1
86
0.
13
5
22
.4
13
R
EL
A
TI
V
E_
10
th
Se
pt
14
43
D
7
IC
_d
ea
D
_
2 C
ru
sti
n
EN
D
O
21
.4
56
0.
04
3
21
.4
22
R
EL
A
TI
V
E_
10
th
Se
pt
14
49
E1
gb
pA
_
2
Cr
us
tin
EN
D
O
22
.4
01
0.
13
5
22
.4
13
R
EL
A
TI
V
E_
10
th
Se
pt
14
55
E7
IC
_d
ea
D
_
2 C
ru
sti
n
EN
D
O
21
.3
37
0.
04
3
21
.4
22
R
EL
A
TI
V
E_
10
th
Se
pt
14
61
F1
gb
pA
_
2
Cr
us
tin
EN
D
O
22
.6
53
0.
13
5
22
.4
13
R
EL
A
TI
V
E_
10
th
Se
pt
14
67
F7
IC
_d
ea
D
_
2 C
ru
sti
n
EN
D
O
21
.4
72
0.
04
3
21
.4
22
R
EL
A
TI
V
E_
10
th
Se
pt
14
2
A
2
gb
pA
_
3
Cr
us
tin
EN
D
O
24
.7
02
0.
07
7
24
.8
24
R
EL
A
TI
V
E_
10
th
Se
pt
14
8
A
8
IC
_d
ea
D
_
3 C
ru
sti
n
EN
D
O
21
.4
46
0.
14
9
21
.6
7
R
EL
A
TI
V
E_
10
th
Se
pt
14
14
B
2
gb
pA
_
3
Cr
us
tin
EN
D
O
24
.8
05
0.
07
7
24
.8
24
R
EL
A
TI
V
E_
10
th
Se
pt
14
20
B
8
IC
_d
ea
D
_
3 C
ru
sti
n
EN
D
O
21
.6
12
0.
14
9
21
.6
7
R
EL
A
TI
V
E_
10
th
Se
pt
14
26
C2
gb
pA
_
3
Cr
us
tin
EN
D
O
24
.9
66
0.
07
7
24
.8
24
R
EL
A
TI
V
E_
10
th
Se
pt
14
32
C8
IC
_d
ea
D
_
3 C
ru
sti
n
EN
D
O
21
.9
51
0.
14
9
21
.6
7
R
EL
A
TI
V
E_
10
th
Se
pt
14
38
D
2
gb
pA
_
4
Cr
us
tin
EN
D
O
19
.3
99
0.
13
6
19
.6
58
R
EL
A
TI
V
E_
10
th
Se
pt
14
44
D
8
IC
_d
ea
D
_
4 C
ru
sti
n
EN
D
O
18
.7
94
0.
03
3
18
.8
47
R
EL
A
TI
V
E_
10
th
Se
pt
14
50
E2
gb
pA
_
4
Cr
us
tin
EN
D
O
19
.7
2
0.
13
6
19
.6
58
R
EL
A
TI
V
E_
10
th
Se
pt
14
56
E8
IC
_d
ea
D
_
4 C
ru
sti
n
EN
D
O
18
.8
38
0.
03
3
18
.8
47
R
EL
A
TI
V
E_
10
th
Se
pt
14
62
F2
gb
pA
_
4
Cr
us
tin
EN
D
O
19
.8
56
0.
13
6
19
.6
58
R
EL
A
TI
V
E_
10
th
Se
pt
14
68
F8
IC
_d
ea
D
_
4 C
ru
sti
n
EN
D
O
18
.9
08
0.
03
3
18
.8
47
R
EL
A
TI
V
E_
10
th
Se
pt
14
3
A
3
gb
pA
_
5
Cr
us
tin
EN
D
O
19
.4
57
0.
10
8
19
.5
86
R
EL
A
TI
V
E_
10
th
Se
pt
14
9
A
9
IC
_d
ea
D
_
5 C
ru
sti
n
EN
D
O
18
.8
22
0.
05
8
18
.8
05
R
EL
A
TI
V
E_
10
th
Se
pt
14
15
B
3
gb
pA
_
5
Cr
us
tin
EN
D
O
19
.5
02
0.
10
8
19
.5
86
R
EL
A
TI
V
E_
10
th
Se
pt
14
21
B
9
IC
_d
ea
D
_
5 C
ru
sti
n
EN
D
O
18
.6
97
0.
05
8
18
.8
05
R
EL
A
TI
V
E_
10
th
Se
pt
14
27
C3
gb
pA
_
5
Cr
us
tin
EN
D
O
19
.8
0.
10
8
19
.5
86
R
EL
A
TI
V
E_
10
th
Se
pt
14
33
C9
IC
_d
ea
D
_
5 C
ru
sti
n
EN
D
O
18
.8
95
0.
05
8
18
.8
05
R
EL
A
TI
V
E_
10
th
Se
pt
14
39
D
3
gb
pA
_
6
Cr
us
tin
EN
D
O
18
.7
71
0.
10
2
18
.9
6
R
EL
A
TI
V
E_
10
th
Se
pt
14
45
D
9
IC
_d
ea
D
_
6 C
ru
sti
n
EN
D
O
18
.1
0.
04
2
18
.1
47
R
EL
A
TI
V
E_
10
th
Se
pt
14
51
E3
gb
pA
_
6
Cr
us
tin
EN
D
O
18
.9
89
0.
10
2
18
.9
6
R
EL
A
TI
V
E_
10
th
Se
pt
14
57
E9
IC
_d
ea
D
_
6 C
ru
sti
n
EN
D
O
18
.1
12
0.
04
2
18
.1
47
R
EL
A
TI
V
E_
10
th
Se
pt
14
63
F3
gb
pA
_
6
Cr
us
tin
EN
D
O
19
.1
2
0.
10
2
18
.9
6
R
EL
A
TI
V
E_
10
th
Se
pt
14
69
F9
IC
_d
ea
D
_
6 C
ru
sti
n
EN
D
O
18
.2
3
0.
04
2
18
.1
47
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
1
A
1
gb
pA
_
7
Cr
us
tin
EN
D
O
20
.7
52
0.
40
3
21
.2
75
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
4
A
4
IC
_d
ea
D
_
7 C
ru
sti
n
EN
D
O
20
.4
21
0.
08
5
20
.5
81
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
13
B
1
gb
pA
_
7
Cr
us
tin
EN
D
O
22
.0
67
0.
40
3
21
.2
75
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
16
B
4
IC
_d
ea
D
_
7 C
ru
sti
n
EN
D
O
20
.6
09
0.
08
5
20
.5
81
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
25
C1
gb
pA
_
7
Cr
us
tin
EN
D
O
21
.0
07
0.
40
3
21
.2
75
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
28
C4
IC
_d
ea
D
_
7 C
ru
sti
n
EN
D
O
20
.7
12
0.
08
5
20
.5
81
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
37
D
1
gb
pA
_
8
Cr
us
tin
EN
D
O
21
.1
22
0.
02
5
21
.1
23
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
40
D
4
IC
_d
ea
D
_
8 C
ru
sti
n
EN
D
O
20
.4
73
0.
13
2
20
.7
35
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
49
E1
gb
pA
_
8
Cr
us
tin
EN
D
O
21
.1
68
0.
02
5
21
.1
23
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
52
E4
IC
_d
ea
D
_
8 C
ru
sti
n
EN
D
O
20
.8
88
0.
13
2
20
.7
35
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
61
F1
gb
pA
_
8
Cr
us
tin
EN
D
O
21
.0
8
0.
02
5
21
.1
23
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
64
F4
IC
_d
ea
D
_
8 C
ru
sti
n
EN
D
O
20
.8
45
0.
13
2
20
.7
35
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
2
A
2
gb
pA
_
9
Cr
us
tin
EN
D
O
19
.5
74
0.
12
6
19
.8
24
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
5
A
5
IC
_d
ea
D
_
9 C
ru
sti
n
EN
D
O
19
.3
33
0.
07
19
.4
46
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
14
B
2
gb
pA
_
9
Cr
us
tin
EN
D
O
19
.9
35
0.
12
6
19
.8
24
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
17
B
5
IC
_d
ea
D
_
9 C
ru
sti
n
EN
D
O
19
.4
29
0.
07
19
.4
46
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
26
C2
gb
pA
_
9
Cr
us
tin
EN
D
O
19
.9
65
0.
12
6
19
.8
24
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
29
C5
IC
_d
ea
D
_
9 C
ru
sti
n
EN
D
O
19
.5
75
0.
07
19
.4
46
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
1
A
1
gb
pA
_
10
gb
pA
EN
D
O
19
.7
24
0.
41
6
20
.2
56
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
44
D
8
gb
pA
_
IC
_1
0 gb
pA
EN
D
O
19
.7
02
0.
11
3
19
.9
28
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
13
B
1
gb
pA
_
10
gb
pA
EN
D
O
21
.0
76
0.
41
6
20
.2
56
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
56
E8
gb
pA
_
IC
_1
0 gb
pA
EN
D
O
20
.0
31
0.
11
3
19
.9
28
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
25
C1
gb
pA
_
10
gb
pA
EN
D
O
19
.9
67
0.
41
6
20
.2
56
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
68
F8
gb
pA
_
IC
_1
0 gb
pA
EN
D
O
20
.0
5
0.
11
3
19
.9
28
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
37
D
1
gb
pA
_
11
gb
pA
EN
D
O
22
.5
39
0.
17
22
.8
43
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
9
A
9
gb
pA
_
IC
_1
1 gb
pA
EN
D
O
21
.8
69
0.
10
3
22
.0
67
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
49
E1
gb
pA
_
11
gb
pA
EN
D
O
22
.8
6
0.
17
22
.8
43
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
21
B
9
gb
pA
_
IC
_1
1 gb
pA
EN
D
O
22
.1
14
0.
10
3
22
.0
67
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
61
F1
gb
pA
_
11
gb
pA
EN
D
O
23
.1
29
0.
17
22
.8
43
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
33
C9
gb
pA
_
IC
_1
1 gb
pA
EN
D
O
22
.2
17
0.
10
3
22
.0
67
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
2
A
2
gb
pA
_
12
gb
pA
EN
D
O
20
.4
37
0.
11
9
20
.5
97
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
45
D
9
gb
pA
_
IC
_1
2 gb
pA
EN
D
O
20
.2
7
0.
11
2
20
.4
86
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
14
B
2
gb
pA
_
12
gb
pA
EN
D
O
20
.5
26
0.
11
9
20
.5
97
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
57
E9
gb
pA
_
IC
_1
2 gb
pA
EN
D
O
20
.5
4
0.
11
2
20
.4
86
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
26
C2
gb
pA
_
12
gb
pA
EN
D
O
20
.8
3
0.
11
9
20
.5
97
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
69
F9
gb
pA
_
IC
_1
2 gb
pA
EN
D
O
20
.6
47
0.
11
2
20
.4
86
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
38
D
2
gb
pA
_
13
gb
pA
EN
D
O
19
.9
52
0.
15
2
20
.2
23
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
10
A
10
gb
pA
_
IC
_1
3 gb
pA
EN
D
O
19
.4
59
0.
13
19
.6
55
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
50
E2
gb
pA
_
13
gb
pA
EN
D
O
20
.2
39
0.
15
2
20
.2
23
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
22
B
10
gb
pA
_
IC
_1
3 gb
pA
EN
D
O
19
.6
04
0.
13
19
.6
55
296
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
62
F2
gb
pA
_
13
gb
pA
EN
D
O
20
.4
78
0.
15
2
20
.2
23
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
34
C1
0
gb
pA
_
IC
_1
3 gb
pA
EN
D
O
19
.9
02
0.
13
19
.6
55
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
3
A
3
gb
pA
_
14
gb
pA
EN
D
O
19
.2
69
0.
07
3
19
.3
85
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
46
D
10
gb
pA
_
IC
_1
4 gb
pA
EN
D
O
19
.2
52
0.
11
9
19
.4
64
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
15
B
3
gb
pA
_
14
gb
pA
EN
D
O
19
.3
64
0.
07
3
19
.3
85
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
58
E1
0
gb
pA
_
IC
_1
4 gb
pA
EN
D
O
19
.6
63
0.
11
9
19
.4
64
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
27
C3
gb
pA
_
14
gb
pA
EN
D
O
19
.5
21
0.
07
3
19
.3
85
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
70
F1
0
gb
pA
_
IC
_1
4 gb
pA
EN
D
O
19
.4
77
0.
11
9
19
.4
64
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
39
D
3
gb
pA
_
15
gb
pA
EN
D
O
20
.2
21
0.
56
7
20
.9
86
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
11
A
11
gb
pA
_
IC
_1
5 gb
pA
EN
D
O
19
.6
08
0.
09
9
19
.8
05
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
51
E3
gb
pA
_
15
gb
pA
EN
D
O
22
.0
94
0.
56
7
20
.9
86
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
23
B
11
gb
pA
_
IC
_1
5 gb
pA
EN
D
O
19
.8
83
0.
09
9
19
.8
05
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
63
F3
gb
pA
_
15
gb
pA
EN
D
O
20
.6
42
0.
56
7
20
.9
86
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
35
C1
1
gb
pA
_
IC
_1
5 gb
pA
EN
D
O
19
.9
23
0.
09
9
19
.8
05
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
4
A
4
gb
pA
_
16
gb
pA
EN
D
O
21
.7
02
0.
07
2
21
.8
45
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
47
D
11
gb
pA
_
IC
_1
6 gb
pA
EN
D
O
21
.3
91
0.
16
4
21
.4
87
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
16
B
4
gb
pA
_
16
gb
pA
EN
D
O
21
.9
09
0.
07
2
21
.8
45
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
59
E1
1
gb
pA
_
IC
_1
6 gb
pA
EN
D
O
21
.2
63
0.
16
4
21
.4
87
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
28
C4
gb
pA
_
16
gb
pA
EN
D
O
21
.9
25
0.
07
2
21
.8
45
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
71
F1
1
gb
pA
_
IC
_1
6 gb
pA
EN
D
O
21
.8
06
0.
16
4
21
.4
87
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
40
D
4
gb
pA
_
17
gb
pA
EN
D
O
21
.8
19
0.
09
3
21
.9
91
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
12
A
12
gb
pA
_
IC
_1
7 gb
pA
EN
D
O
21
.4
65
0.
02
6
21
.5
17
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
52
E4
gb
pA
_
17
gb
pA
EN
D
O
22
.0
12
0.
09
3
21
.9
91
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
24
B
12
gb
pA
_
IC
_1
7 gb
pA
EN
D
O
21
.5
4
0.
02
6
21
.5
17
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
64
F4
gb
pA
_
17
gb
pA
EN
D
O
22
.1
41
0.
09
3
21
.9
91
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
36
C1
2
gb
pA
_
IC
_1
7 gb
pA
EN
D
O
21
.5
47
0.
02
6
21
.5
17
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
5
A
5
gb
pA
_
18
gb
pA
EN
D
O
18
.9
74
0.
04
2
18
.9
45
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
48
D
12
gb
pA
_
IC
_1
8 gb
pA
EN
D
O
18
.7
0.
14
1
18
.9
76
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
17
B
5
gb
pA
_
18
gb
pA
EN
D
O
18
.9
98
0.
04
2
18
.9
45
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
60
E1
2
gb
pA
_
IC
_1
8 gb
pA
EN
D
O
19
.0
67
0.
14
1
18
.9
76
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
29
C5
gb
pA
_
18
gb
pA
EN
D
O
18
.8
63
0.
04
2
18
.9
45
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
72
F1
2
gb
pA
_
IC
_1
8 gb
pA
EN
D
O
19
.1
61
0.
14
1
18
.9
76
R
ea
l t
im
e 
v
al
u
es
 
in
 th
e 
pr
es
en
ce
 
o
f M
ag
n
es
iu
m
 
su
lfa
te
 
an
d 
ch
iti
n
Pl
at
e
W
el
l I
D
W
el
l
Sa
m
pl
e
D
et
ec
to
r
Ta
sk
Ct
Ct
 
st
d 
er
r
A
v
g 
Ct
Pl
at
e
W
el
l I
D
W
el
l
Sa
m
pl
e
D
et
ec
to
r
Ta
sk
Ct
Ct
 
st
d 
er
r
R
el
at
iv
e_
4t
h1
stO
ct
14
14
B
2
gb
pA
_
37
gb
pA
Ta
rg
et
26
.8
46
0.
29
3
27
.2
3
R
el
at
iv
e_
4t
h1
stO
ct
14
20
B
8
IC
_d
ea
D
_
37 d
ea
D
EN
D
O
21
.4
95
0.
00
2
R
el
at
iv
e_
4t
h1
stO
ct
14
26
C2
gb
pA
_
37
gb
pA
Ta
rg
et
27
.0
37
0.
29
3
27
.2
3
R
el
at
iv
e_
4t
h1
stO
ct
14
32
C8
IC
_d
ea
D
_
37 d
ea
D
EN
D
O
22
.2
18
0.
00
2
R
el
at
iv
e_
4t
h1
stO
ct
14
38
D
2
gb
pA
_
37
gb
pA
Ta
rg
et
27
.8
05
0.
29
3
27
.2
3
R
el
at
iv
e_
4t
h1
stO
ct
14
44
D
8
IC
_d
ea
D
_
37 d
ea
D
EN
D
O
22
.2
14
0.
00
2
R
el
at
iv
e_
4t
h1
stO
ct
14
50
E2
gb
pA
_
38
gb
pA
Ta
rg
et
27
.1
98
0.
24
9
27
.5
75
R
el
at
iv
e_
4t
h1
stO
ct
14
56
E8
IC
_d
ea
D
_
38 d
ea
D
EN
D
O
21
.8
59
0.
11
3
R
el
at
iv
e_
4t
h1
stO
ct
14
62
F2
gb
pA
_
38
gb
pA
Ta
rg
et
27
.4
82
0.
24
9
27
.5
75
R
el
at
iv
e_
4t
h1
stO
ct
14
68
F8
IC
_d
ea
D
_
38 d
ea
D
EN
D
O
22
.1
69
0.
11
3
R
el
at
iv
e_
4t
h1
stO
ct
14
74
G
2
gb
pA
_
38
gb
pA
Ta
rg
et
28
.0
45
0.
24
9
27
.5
75
R
el
at
iv
e_
4t
h1
stO
ct
14
80
G
8
IC
_d
ea
D
_
38 d
ea
D
EN
D
O
22
.2
24
0.
11
3
R
el
at
iv
e_
4t
h1
stO
ct
14
3
A
3
gb
pA
_
39
gb
pA
Ta
rg
et
26
.0
35
0.
75
2
27
.1
21
R
el
at
iv
e_
4t
h1
stO
ct
14
9
A
9
IC
_d
ea
D
_
39 d
ea
D
EN
D
O
21
.2
66
0.
00
5
R
el
at
iv
e_
4t
h1
stO
ct
14
15
B
3
gb
pA
_
39
gb
pA
Ta
rg
et
26
.7
61
0.
75
2
27
.1
21
R
el
at
iv
e_
4t
h1
stO
ct
14
21
B
9
IC
_d
ea
D
_
39 d
ea
D
EN
D
O
21
.2
56
0.
00
5
R
el
at
iv
e_
4t
h1
stO
ct
14
86
H
2
gb
pA
_
39
gb
pA
Ta
rg
et
28
.5
66
0.
75
2
27
.1
21
R
el
at
iv
e_
4t
h1
stO
ct
14
92
H
8
IC
_d
ea
D
_
39 d
ea
D
EN
D
O
21
.6
63
0.
00
5
R
el
at
iv
e_
4t
h1
stO
ct
14
27
C3
gb
pA
_
40
gb
pA
Ta
rg
et
27
.9
61
0.
31
9
28
.5
65
R
el
at
iv
e_
4t
h1
stO
ct
14
33
C9
IC
_d
ea
D
_
40 d
ea
D
EN
D
O
20
.7
35
0.
21
7
R
el
at
iv
e_
4t
h1
stO
ct
14
39
D
3
gb
pA
_
40
gb
pA
Ta
rg
et
28
.6
9
0.
31
9
28
.5
65
R
el
at
iv
e_
4t
h1
stO
ct
14
45
D
9
IC
_d
ea
D
_
40 d
ea
D
EN
D
O
21
.3
08
0.
21
7
R
el
at
iv
e_
4t
h1
stO
ct
14
51
E3
gb
pA
_
40
gb
pA
Ta
rg
et
29
.0
44
0.
31
9
28
.5
65
R
el
at
iv
e_
4t
h1
stO
ct
14
57
E9
IC
_d
ea
D
_
40 d
ea
D
EN
D
O
21
.4
42
0.
21
7
R
el
at
iv
e_
4t
h1
stO
ct
14
63
F3
gb
pA
_
41
gb
pA
Ta
rg
et
27
.5
54
0.
43
4
27
.8
75
R
el
at
iv
e_
4t
h1
stO
ct
14
69
F9
IC
_d
ea
D
_
41 d
ea
D
EN
D
O
21
.5
04
0.
10
3
R
el
at
iv
e_
4t
h1
stO
ct
14
75
G
3
gb
pA
_
41
gb
pA
Ta
rg
et
28
.7
34
0.
43
4
27
.8
75
R
el
at
iv
e_
4t
h1
stO
ct
14
81
G
9
IC
_d
ea
D
_
41 d
ea
D
EN
D
O
21
.4
17
0.
10
3
R
el
at
iv
e_
4t
h1
stO
ct
14
87
H
3
gb
pA
_
41
gb
pA
Ta
rg
et
27
.3
39
0.
43
4
27
.8
75
R
el
at
iv
e_
4t
h1
stO
ct
14
93
H
9
IC
_d
ea
D
_
41 d
ea
D
EN
D
O
21
.7
61
0.
10
3
R
el
at
iv
e_
4t
h1
stO
ct
14
4
A
4
gb
pA
_
42
gb
pA
Ta
rg
et
26
.4
81
0.
31
7
27
.0
04
R
el
at
iv
e_
4t
h1
stO
ct
14
10
A
10
IC
_d
ea
D
_
42 d
ea
D
EN
D
O
20
.2
97
0.
25
3
R
el
at
iv
e_
4t
h1
stO
ct
14
16
B
4
gb
pA
_
42
gb
pA
Ta
rg
et
27
.5
76
0.
31
7
27
.0
04
R
el
at
iv
e_
4t
h1
stO
ct
14
22
B
10
IC
_d
ea
D
_
42 d
ea
D
EN
D
O
20
.8
77
0.
25
3
R
el
at
iv
e_
4t
h1
stO
ct
14
28
C4
gb
pA
_
42
gb
pA
Ta
rg
et
26
.9
57
0.
31
7
27
.0
04
R
el
at
iv
e_
4t
h1
stO
ct
14
34
C1
0
IC
_d
ea
D
_
42 d
ea
D
EN
D
O
21
.1
54
0.
25
3
R
el
at
iv
e_
4t
h1
stO
ct
14
40
D
4
gb
pA
_
43
gb
pA
Ta
rg
et
28
.0
87
0.
00
2
28
.5
72
R
el
at
iv
e_
4t
h1
stO
ct
14
46
D
10
IC
_d
ea
D
_
43 d
ea
D
EN
D
O
21
.7
19
0.
09
5
R
el
at
iv
e_
4t
h1
stO
ct
14
52
E4
gb
pA
_
43
gb
pA
Ta
rg
et
28
.5
74
0.
00
2
28
.5
72
R
el
at
iv
e_
4t
h1
stO
ct
14
58
E1
0
IC
_d
ea
D
_
43 d
ea
D
EN
D
O
22
.0
47
0.
09
5
R
el
at
iv
e_
4t
h1
stO
ct
14
64
F4
gb
pA
_
43
gb
pA
Ta
rg
et
28
.5
7
0.
00
2
28
.5
72
R
el
at
iv
e_
4t
h1
stO
ct
14
70
F1
0
IC
_d
ea
D
_
43 d
ea
D
EN
D
O
21
.8
72
0.
09
5
R
el
at
iv
e_
4t
h1
stO
ct
14
5
A
5
gb
pA
_
44
gb
pA
Ta
rg
et
27
.4
23
0.
58
3
28
.5
82
R
el
at
iv
e_
4t
h1
stO
ct
14
11
A
11
IC
_d
ea
D
_
44 d
ea
D
EN
D
O
21
.3
28
0.
26
297
R
el
at
iv
e_
4t
h1
stO
ct
14
76
G
4
gb
pA
_
44
gb
pA
Ta
rg
et
29
.2
72
0.
58
3
28
.5
82
R
el
at
iv
e_
4t
h1
stO
ct
14
82
G
10
IC
_d
ea
D
_
44 d
ea
D
EN
D
O
21
.4
09
0.
26
R
el
at
iv
e_
4t
h1
stO
ct
14
88
H
4
gb
pA
_
44
gb
pA
Ta
rg
et
29
.0
49
0.
58
3
28
.5
82
R
el
at
iv
e_
4t
h1
stO
ct
14
94
H
10
IC
_d
ea
D
_
44 d
ea
D
EN
D
O
22
.1
45
0.
26
R
el
at
iv
e_
4t
h1
stO
ct
14
17
B
5
gb
pA
_
45
gb
pA
Ta
rg
et
27
.9
76
0.
21
5
27
.6
54
R
el
at
iv
e_
4t
h1
stO
ct
14
23
B
11
IC
_d
ea
D
_
45 d
ea
D
EN
D
O
20
.7
75
0.
20
9
R
el
at
iv
e_
4t
h1
stO
ct
14
29
C5
gb
pA
_
45
gb
pA
Ta
rg
et
27
.7
4
0.
21
5
27
.6
54
R
el
at
iv
e_
4t
h1
stO
ct
14
35
C1
1
IC
_d
ea
D
_
45 d
ea
D
EN
D
O
21
.1
27
0.
20
9
R
el
at
iv
e_
4t
h1
stO
ct
14
41
D
5
gb
pA
_
45
gb
pA
Ta
rg
et
27
.2
45
0.
21
5
27
.6
54
R
el
at
iv
e_
4t
h1
stO
ct
14
47
D
11
IC
_d
ea
D
_
45 d
ea
D
EN
D
O
21
.4
98
0.
20
9
R
el
at
iv
e_
4t
h1
stO
ct
14
53
E5
gb
pA
_
46
gb
pA
Ta
rg
et
27
.0
69
0.
11
3
27
.2
94
R
el
at
iv
e_
4t
h1
stO
ct
14
59
E1
1
IC
_d
ea
D
_
46 d
ea
D
EN
D
O
20
.8
95
0.
13
3
R
el
at
iv
e_
4t
h1
stO
ct
14
65
F5
gb
pA
_
46
gb
pA
Ta
rg
et
27
.4
27
0.
11
3
27
.2
94
R
el
at
iv
e_
4t
h1
stO
ct
14
71
F1
1
IC
_d
ea
D
_
46 d
ea
D
EN
D
O
21
.2
51
0.
13
3
R
el
at
iv
e_
4t
h1
stO
ct
14
77
G
5
gb
pA
_
46
gb
pA
Ta
rg
et
27
.3
86
0.
11
3
27
.2
94
R
el
at
iv
e_
4t
h1
stO
ct
14
83
G
11
IC
_d
ea
D
_
46 d
ea
D
EN
D
O
21
.3
28
0.
13
3
R
el
at
iv
e_
4t
h1
stO
ct
14
6
A
6
gb
pA
_
47
gb
pA
Ta
rg
et
27
.5
55
0.
28
3
27
.6
R
el
at
iv
e_
4t
h1
stO
ct
14
12
A
12
IC
_d
ea
D
_
47 d
ea
D
EN
D
O
21
.2
24
0.
20
3
R
el
at
iv
e_
4t
h1
stO
ct
14
18
B
6
gb
pA
_
47
gb
pA
Ta
rg
et
27
.1
34
0.
28
3
27
.6
R
el
at
iv
e_
4t
h1
stO
ct
14
24
B
12
IC
_d
ea
D
_
47 d
ea
D
EN
D
O
20
.5
67
0.
20
3
R
el
at
iv
e_
4t
h1
stO
ct
14
89
H
5
gb
pA
_
47
gb
pA
Ta
rg
et
28
.1
1
0.
28
3
27
.6
R
el
at
iv
e_
4t
h1
stO
ct
14
95
H
11
IC
_d
ea
D
_
47 d
ea
D
EN
D
O
21
.1
12
0.
20
3
R
el
at
iv
e_
4t
h1
stO
ct
14
30
C6
gb
pA
_
48
gb
pA
Ta
rg
et
27
.2
82
0.
18
8
27
.6
55
R
el
at
iv
e_
4t
h1
stO
ct
14
36
C1
2
IC
_d
ea
D
_
48 d
ea
D
EN
D
O
20
.6
39
0.
18
6
R
el
at
iv
e_
4t
h1
stO
ct
14
42
D
6
gb
pA
_
48
gb
pA
Ta
rg
et
27
.8
06
0.
18
8
27
.6
55
R
el
at
iv
e_
4t
h1
stO
ct
14
48
D
12
IC
_d
ea
D
_
48 d
ea
D
EN
D
O
20
.7
16
0.
18
6
R
el
at
iv
e_
4t
h1
stO
ct
14
54
E6
gb
pA
_
48
gb
pA
Ta
rg
et
27
.8
78
0.
18
8
27
.6
55
R
el
at
iv
e_
4t
h1
stO
ct
14
60
E1
2
IC
_d
ea
D
_
48 d
ea
D
EN
D
O
21
.2
3
0.
18
6
R
el
at
iv
e 
Q 
1
A
1
gb
pA
_
49
gb
pA
Ta
rg
et
28
.5
2
0.
12
4
28
.7
67
R
el
at
iv
e 
Q 
49
E1
IC
_d
ea
D
_
49 d
ea
D
m
ix
ed
22
.4
76
0.
01
6
R
el
at
iv
e 
Q 
2
A
2
gb
pA
_
49
gb
pA
Ta
rg
et
28
.9
11
0.
12
4
28
.7
67
R
el
at
iv
e 
Q 
50
E2
IC
_d
ea
D
_
49 d
ea
D
m
ix
ed
22
.4
24
0.
01
6
R
el
at
iv
e 
Q 
3
A
3
gb
pA
_
49
gb
pA
Ta
rg
et
28
.8
69
0.
12
4
28
.7
67
R
el
at
iv
e 
Q 
51
E3
IC
_d
ea
D
_
49 d
ea
D
m
ix
ed
22
.4
36
0.
01
6
R
el
at
iv
e 
Q 
4
A
4
gb
pA
_
50
gb
pA
Ta
rg
et
26
.8
9
0.
47
8
27
.8
13
R
el
at
iv
e 
Q 
52
E4
IC
_d
ea
D
_
50 d
ea
D
m
ix
ed
22
.0
96
0.
04
2
R
el
at
iv
e 
Q 
5
A
5
gb
pA
_
50
gb
pA
Ta
rg
et
28
.4
91
0.
47
8
27
.8
13
R
el
at
iv
e 
Q 
53
E5
IC
_d
ea
D
_
50 d
ea
D
m
ix
ed
22
.2
41
0.
04
2
R
el
at
iv
e 
Q 
6
A
6
gb
pA
_
50
gb
pA
Ta
rg
et
28
.0
57
0.
47
8
27
.8
13
R
el
at
iv
e 
Q 
54
E6
IC
_d
ea
D
_
50 d
ea
D
m
ix
ed
22
.1
65
0.
04
2
R
el
at
iv
e 
Q 
13
B
1
gb
pA
_
51
gb
pA
Ta
rg
et
30
.4
44
0.
52
8
29
.4
9
R
el
at
iv
e 
Q 
61
F1
IC
_d
ea
D
_
51 d
ea
D
m
ix
ed
22
.6
52
0.
05
6
R
el
at
iv
e 
Q 
14
B
2
gb
pA
_
51
gb
pA
Ta
rg
et
29
.4
05
0.
52
8
29
.4
9
R
el
at
iv
e 
Q 
62
F2
IC
_d
ea
D
_
51 d
ea
D
m
ix
ed
22
.8
44
0.
05
6
R
el
at
iv
e 
Q 
15
B
3
gb
pA
_
51
gb
pA
Ta
rg
et
28
.6
21
0.
52
8
29
.4
9
R
el
at
iv
e 
Q 
63
F3
IC
_d
ea
D
_
51 d
ea
D
m
ix
ed
22
.7
18
0.
05
6
R
el
at
iv
e 
Q 
16
B
4
gb
pA
_
52
gb
pA
Ta
rg
et
28
.1
92
0.
01
8
28
.2
01
R
el
at
iv
e 
Q 
64
F4
IC
_d
ea
D
_
52 d
ea
D
m
ix
ed
23
.2
64
0.
06
2
R
el
at
iv
e 
Q 
17
B
5
gb
pA
_
52
gb
pA
Ta
rg
et
28
.1
75
0.
01
8
28
.2
01
R
el
at
iv
e 
Q 
65
F5
IC
_d
ea
D
_
52 d
ea
D
m
ix
ed
23
.4
76
0.
06
2
R
el
at
iv
e 
Q 
18
B
6
gb
pA
_
52
gb
pA
Ta
rg
et
28
.2
36
0.
01
8
28
.2
01
R
el
at
iv
e 
Q 
66
F6
IC
_d
ea
D
_
52 d
ea
D
m
ix
ed
23
.3
31
0.
06
2
R
el
at
iv
e 
Q 
25
C1
gb
pA
_
53
gb
pA
Ta
rg
et
28
.1
41
0.
07
6
28
.2
67
R
el
at
iv
e 
Q 
73
G
1
IC
_d
ea
D
_
53 d
ea
D
m
ix
ed
23
.0
06
0.
02
R
el
at
iv
e 
Q 
26
C2
gb
pA
_
53
gb
pA
Ta
rg
et
28
.4
03
0.
07
6
28
.2
67
R
el
at
iv
e 
Q 
74
G
2
IC
_d
ea
D
_
53 d
ea
D
m
ix
ed
23
.0
53
0.
02
R
el
at
iv
e 
Q 
27
C3
gb
pA
_
53
gb
pA
Ta
rg
et
28
.2
56
0.
07
6
28
.2
67
R
el
at
iv
e 
Q 
75
G
3
IC
_d
ea
D
_
53 d
ea
D
m
ix
ed
23
.0
75
0.
02
R
el
at
iv
e 
Q 
28
C4
gb
pA
_
54
gb
pA
Ta
rg
et
28
.4
2
0.
21
6
28
.8
18
R
el
at
iv
e 
Q 
76
G
4
IC
_d
ea
D
_
54 d
ea
D
m
ix
ed
23
.3
99
0.
04
2
R
el
at
iv
e 
Q 
29
C5
gb
pA
_
54
gb
pA
Ta
rg
et
29
.1
62
0.
21
6
28
.8
18
R
el
at
iv
e 
Q 
77
G
5
IC
_d
ea
D
_
54 d
ea
D
m
ix
ed
23
.4
53
0.
04
2
R
el
at
iv
e 
Q 
30
C6
gb
pA
_
54
gb
pA
Ta
rg
et
28
.8
73
0.
21
6
28
.8
18
R
el
at
iv
e 
Q 
78
G
6
IC
_d
ea
D
_
54 d
ea
D
m
ix
ed
23
.5
44
0.
04
2
R
ea
l t
im
e 
v
al
u
es
 
in
 th
e 
pr
es
en
ce
 
o
f M
ag
n
es
iu
m
 
an
d 
ca
ra
pa
se
Pl
at
e
W
el
l I
D
W
el
l
Sa
m
pl
e
D
et
ec
to
r
Ta
sk
Ct
Ct
 
st
d 
er
r
A
v
g 
Ct
Pl
at
e
W
el
l I
D
W
el
l
Sa
m
pl
e
D
et
ec
to
r
Ta
sk
Ct
Ct
 
st
d 
er
r
R
EL
A
TI
V
E_
10
th
Se
pt
14
4
A
4
gb
pA
_
19
Cr
us
tin
EN
D
O
21
.2
59
0.
12
5
21
.0
09
R
EL
A
TI
V
E_
10
th
Se
pt
14
10
A
10
IC
_d
ea
D
_
19 C
ru
sti
n
EN
D
O
21
.1
52
0.
12
4
R
EL
A
TI
V
E_
10
th
Se
pt
14
16
B
4
gb
pA
_
19
Cr
us
tin
EN
D
O
20
.8
62
0.
12
5
21
.0
09
R
EL
A
TI
V
E_
10
th
Se
pt
14
22
B
10
IC
_d
ea
D
_
19 C
ru
sti
n
EN
D
O
20
.7
5
0.
12
4
R
EL
A
TI
V
E_
10
th
Se
pt
14
28
C4
gb
pA
_
19
Cr
us
tin
EN
D
O
20
.9
07
0.
12
5
21
.0
09
R
EL
A
TI
V
E_
10
th
Se
pt
14
34
C1
0
IC
_d
ea
D
_
19 C
ru
sti
n
EN
D
O
20
.8
18
0.
12
4
R
EL
A
TI
V
E_
10
th
Se
pt
14
40
D
4
gb
pA
_
20
Cr
us
tin
EN
D
O
19
.4
55
0.
17
4
19
.7
94
R
EL
A
TI
V
E_
10
th
Se
pt
14
46
D
10
IC
_d
ea
D
_
20 C
ru
sti
n
EN
D
O
19
.5
61
0.
24
6
R
EL
A
TI
V
E_
10
th
Se
pt
14
52
E4
gb
pA
_
20
Cr
us
tin
EN
D
O
20
.0
28
0.
17
4
19
.7
94
R
EL
A
TI
V
E_
10
th
Se
pt
14
58
E1
0
IC
_d
ea
D
_
20 C
ru
sti
n
EN
D
O
20
.4
08
0.
24
6
R
EL
A
TI
V
E_
10
th
Se
pt
14
64
F4
gb
pA
_
20
Cr
us
tin
EN
D
O
19
.8
99
0.
17
4
19
.7
94
R
EL
A
TI
V
E_
10
th
Se
pt
14
70
F1
0
IC
_d
ea
D
_
20 C
ru
sti
n
EN
D
O
20
.0
62
0.
24
6
298
R
EL
A
TI
V
E_
10
th
Se
pt
14
5
A
5
gb
pA
_
21
Cr
us
tin
EN
D
O
19
.6
56
0.
08
19
.8
14
R
EL
A
TI
V
E_
10
th
Se
pt
14
73
G
1
IC
_d
ea
D
_
21 C
ru
sti
n
EN
D
O
22
.1
11
0.
65
1
R
EL
A
TI
V
E_
10
th
Se
pt
14
17
B
5
gb
pA
_
21
Cr
us
tin
EN
D
O
19
.8
71
0.
08
19
.8
14
R
EL
A
TI
V
E_
10
th
Se
pt
14
74
G
2
IC
_d
ea
D
_
21 C
ru
sti
n
EN
D
O
20
.3
59
0.
65
1
R
EL
A
TI
V
E_
10
th
Se
pt
14
29
C5
gb
pA
_
21
Cr
us
tin
EN
D
O
19
.9
15
0.
08
19
.8
14
R
EL
A
TI
V
E_
10
th
Se
pt
14
75
G
3
IC
_d
ea
D
_
21 C
ru
sti
n
EN
D
O
20
.0
06
0.
65
1
R
EL
A
TI
V
E_
10
th
Se
pt
14
41
D
5
gb
pA
_
22
Cr
us
tin
EN
D
O
20
.8
44
0.
12
4
21
.0
7
R
EL
A
TI
V
E_
10
th
Se
pt
14
85
H
1
IC
_d
ea
D
_
22 C
ru
sti
n
EN
D
O
21
.1
38
0.
74
9
R
EL
A
TI
V
E_
10
th
Se
pt
14
53
E5
gb
pA
_
22
Cr
us
tin
EN
D
O
21
.0
93
0.
12
4
21
.0
7
R
EL
A
TI
V
E_
10
th
Se
pt
14
86
H
2
IC
_d
ea
D
_
22 C
ru
sti
n
EN
D
O
23
.4
95
0.
74
9
R
EL
A
TI
V
E_
10
th
Se
pt
14
65
F5
gb
pA
_
22
Cr
us
tin
EN
D
O
21
.2
72
0.
12
4
21
.0
7
R
EL
A
TI
V
E_
10
th
Se
pt
14
87
H
3
IC
_d
ea
D
_
22 C
ru
sti
n
EN
D
O
21
.3
79
0.
74
9
R
EL
A
TI
V
E_
10
th
Se
pt
14
6
A
6
gb
pA
_
23
Cr
us
tin
EN
D
O
20
.8
56
0.
07
20
.9
84
R
EL
A
TI
V
E_
10
th
Se
pt
14
76
G
4
IC
_d
ea
D
_
23 C
ru
sti
n
EN
D
O
21
.9
58
0.
42
7
R
EL
A
TI
V
E_
10
th
Se
pt
14
18
B
6
gb
pA
_
23
Cr
us
tin
EN
D
O
20
.9
97
0.
07
20
.9
84
R
EL
A
TI
V
E_
10
th
Se
pt
14
77
G
5
IC
_d
ea
D
_
23 C
ru
sti
n
EN
D
O
22
.6
33
0.
42
7
R
EL
A
TI
V
E_
10
th
Se
pt
14
30
C6
gb
pA
_
23
Cr
us
tin
EN
D
O
21
.0
99
0.
07
20
.9
84
R
EL
A
TI
V
E_
10
th
Se
pt
14
78
G
6
IC
_d
ea
D
_
23 C
ru
sti
n
EN
D
O
21
.1
55
0.
42
7
R
EL
A
TI
V
E_
10
th
Se
pt
14
42
D
6
gb
pA
_
24
Cr
us
tin
EN
D
O
20
.2
17
0.
19
3
20
.4
44
R
EL
A
TI
V
E_
10
th
Se
pt
14
88
H
4
IC
_d
ea
D
_
24 C
ru
sti
n
EN
D
O
21
.7
14
0.
48
R
EL
A
TI
V
E_
10
th
Se
pt
14
54
E6
gb
pA
_
24
Cr
us
tin
EN
D
O
20
.2
87
0.
19
3
20
.4
44
R
EL
A
TI
V
E_
10
th
Se
pt
14
89
H
5
IC
_d
ea
D
_
24 C
ru
sti
n
EN
D
O
20
.0
89
0.
48
R
EL
A
TI
V
E_
10
th
Se
pt
14
66
F6
gb
pA
_
24
Cr
us
tin
EN
D
O
20
.8
29
0.
19
3
20
.4
44
R
EL
A
TI
V
E_
10
th
Se
pt
14
90
H
6
IC
_d
ea
D
_
24 C
ru
sti
n
EN
D
O
20
.5
97
0.
48
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
38
D
2
gb
pA
_
25
Cr
us
tin
EN
D
O
21
.1
33
0.
20
1
21
.4
67
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
41
D
5
IC
_d
ea
D
_
25 C
ru
sti
n
EN
D
O
20
.8
13
0.
09
1
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
50
E2
gb
pA
_
25
Cr
us
tin
EN
D
O
21
.4
41
0.
20
1
21
.4
67
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
53
E5
IC
_d
ea
D
_
25 C
ru
sti
n
EN
D
O
21
.1
25
0.
09
1
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
62
F2
gb
pA
_
25
Cr
us
tin
EN
D
O
21
.8
28
0.
20
1
21
.4
67
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
65
F5
IC
_d
ea
D
_
25 C
ru
sti
n
EN
D
O
20
.9
98
0.
09
1
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
3
A
3
gb
pA
_
26
Cr
us
tin
EN
D
O
20
.1
77
0.
07
5
20
.3
24
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
6
A
6
IC
_d
ea
D
_
26 C
ru
sti
n
EN
D
O
19
.9
92
0.
05
4
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
15
B
3
gb
pA
_
26
Cr
us
tin
EN
D
O
20
.4
28
0.
07
5
20
.3
24
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
18
B
6
IC
_d
ea
D
_
26 C
ru
sti
n
EN
D
O
19
.9
66
0.
05
4
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
27
C3
gb
pA
_
26
Cr
us
tin
EN
D
O
20
.3
67
0.
07
5
20
.3
24
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
30
C6
IC
_d
ea
D
_
26 C
ru
sti
n
EN
D
O
20
.1
4
0.
05
4
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
39
D
3
gb
pA
_
27
Cr
us
tin
EN
D
O
20
.1
42
0.
07
3
20
.2
83
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
42
D
6
IC
_d
ea
D
_
27 C
ru
sti
n
EN
D
O
19
.7
28
0.
10
9
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
51
E3
gb
pA
_
27
Cr
us
tin
EN
D
O
20
.3
84
0.
07
3
20
.2
83
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
54
E6
IC
_d
ea
D
_
27 C
ru
sti
n
EN
D
O
20
.0
74
0.
10
9
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
63
F3
gb
pA
_
27
Cr
us
tin
EN
D
O
20
.3
23
0.
07
3
20
.2
83
R
el
at
iv
e2
_1
0t
hS
ep
t1
4
66
F6
IC
_d
ea
D
_
27 C
ru
sti
n
EN
D
O
20
.0
29
0.
10
9
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
41
D
5
gb
pA
_
28
gb
pA
EN
D
O
19
.4
38
0.
15
19
.7
36
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
73
G
1
gb
pA
_
IC
_2
8 gb
pA
EN
D
O
19
.4
57
0.
07
4
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
53
E5
gb
pA
_
28
gb
pA
EN
D
O
19
.8
58
0.
15
19
.7
36
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
74
G
2
gb
pA
_
IC
_2
8 gb
pA
EN
D
O
19
.6
79
0.
07
4
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
65
F5
gb
pA
_
28
gb
pA
EN
D
O
19
.9
11
0.
15
19
.7
36
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
75
G
3
gb
pA
_
IC
_2
8 gb
pA
EN
D
O
19
.4
6
0.
07
4
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
6
A
6
gb
pA
_
29
gb
pA
EN
D
O
20
.2
72
0.
18
20
.6
29
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
85
H
1
gb
pA
_
IC
_2
9 gb
pA
EN
D
O
20
.5
05
0.
05
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
18
B
6
gb
pA
_
29
gb
pA
EN
D
O
20
.8
44
0.
18
20
.6
29
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
86
H
2
gb
pA
_
IC
_2
9 gb
pA
EN
D
O
20
.6
74
0.
05
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
30
C6
gb
pA
_
29
gb
pA
EN
D
O
20
.7
71
0.
18
20
.6
29
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
87
H
3
gb
pA
_
IC
_2
9 gb
pA
EN
D
O
20
.5
58
0.
05
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
42
D
6
gb
pA
_
30
gb
pA
EN
D
O
19
.7
42
0.
1
19
.9
4
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
76
G
4
gb
pA
_
IC
_3
0 gb
pA
EN
D
O
19
.6
42
0.
04
7
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
54
E6
gb
pA
_
30
gb
pA
EN
D
O
20
.0
53
0.
1
19
.9
4
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
77
G
5
gb
pA
_
IC
_3
0 gb
pA
EN
D
O
19
.6
62
0.
04
7
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
66
F6
gb
pA
_
30
gb
pA
EN
D
O
20
.0
26
0.
1
19
.9
4
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
78
G
6
gb
pA
_
IC
_3
0 gb
pA
EN
D
O
19
.7
93
0.
04
7
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
7
A
7
gb
pA
_
31
gb
pA
EN
D
O
19
.7
05
0.
19
7
20
.0
27
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
88
H
4
gb
pA
_
IC
_3
1 gb
pA
EN
D
O
19
.9
66
0.
02
2
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
19
B
7
gb
pA
_
31
gb
pA
EN
D
O
19
.9
91
0.
19
7
20
.0
27
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
89
H
5
gb
pA
_
IC
_3
1 gb
pA
EN
D
O
20
.0
3
0.
02
2
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
31
C7
gb
pA
_
31
gb
pA
EN
D
O
20
.3
84
0.
19
7
20
.0
27
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
90
H
6
gb
pA
_
IC
_3
1 gb
pA
EN
D
O
20
.0
33
0.
02
2
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
43
D
7
gb
pA
_
32
gb
pA
EN
D
O
21
.3
51
0.
17
6
21
.6
65
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
79
G
7
gb
pA
_
IC
_3
2 gb
pA
EN
D
O
21
.4
44
0.
06
4
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
55
E7
gb
pA
_
32
gb
pA
EN
D
O
21
.6
83
0.
17
6
21
.6
65
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
80
G
8
gb
pA
_
IC
_3
2 gb
pA
EN
D
O
21
.5
48
0.
06
4
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
67
F7
gb
pA
_
32
gb
pA
EN
D
O
21
.9
59
0.
17
6
21
.6
65
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
81
G
9
gb
pA
_
IC
_3
2 gb
pA
EN
D
O
21
.3
25
0.
06
4
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
8
A
8
gb
pA
_
33
gb
pA
EN
D
O
20
.2
36
0.
17
6
20
.5
54
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
91
H
7
gb
pA
_
IC
_3
3 gb
pA
EN
D
O
20
.6
37
0.
02
8
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
20
B
8
gb
pA
_
33
gb
pA
EN
D
O
20
.5
84
0.
17
6
20
.5
54
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
92
H
8
gb
pA
_
IC
_3
3 gb
pA
EN
D
O
20
.5
48
0.
02
8
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
32
C8
gb
pA
_
33
gb
pA
EN
D
O
20
.8
43
0.
17
6
20
.5
54
R
el
at
iv
e_
3r
d3
0t
hS
ep
t1
4
93
H
9
gb
pA
_
IC
_3
3 gb
pA
EN
D
O
20
.6
23
0.
02
8
R
el
at
iv
e_
4t
h1
stO
ct
14
1
A
1
gb
pA
_
34
gb
pA
Ta
rg
et
19
.2
15
0.
60
9
20
.0
71
R
el
at
iv
e_
4t
h1
stO
ct
14
7
A
7
IC
_d
ea
D
_
34 d
ea
D
EN
D
O
18
.6
1
0.
21
7
R
el
at
iv
e_
4t
h1
stO
ct
14
13
B
1
gb
pA
_
34
gb
pA
Ta
rg
et
21
.2
49
0.
60
9
20
.0
71
R
el
at
iv
e_
4t
h1
stO
ct
14
19
B
7
IC
_d
ea
D
_
34 d
ea
D
EN
D
O
19
.1
03
0.
21
7
R
el
at
iv
e_
4t
h1
stO
ct
14
25
C1
gb
pA
_
34
gb
pA
Ta
rg
et
19
.7
49
0.
60
9
20
.0
71
R
el
at
iv
e_
4t
h1
stO
ct
14
31
C7
IC
_d
ea
D
_
34 d
ea
D
EN
D
O
19
.3
47
0.
21
7
299
R
el
at
iv
e_
4t
h1
stO
ct
14
37
D
1
gb
pA
_
35
gb
pA
Ta
rg
et
20
.6
03
0.
13
9
20
.8
74
R
el
at
iv
e_
4t
h1
stO
ct
14
43
D
7
IC
_d
ea
D
_
35 d
ea
D
EN
D
O
20
.2
77
0.
21
4
R
el
at
iv
e_
4t
h1
stO
ct
14
49
E1
gb
pA
_
35
gb
pA
Ta
rg
et
20
.9
54
0.
13
9
20
.8
74
R
el
at
iv
e_
4t
h1
stO
ct
14
55
E7
IC
_d
ea
D
_
35 d
ea
D
EN
D
O
20
.7
8
0.
21
4
R
el
at
iv
e_
4t
h1
stO
ct
14
61
F1
gb
pA
_
35
gb
pA
Ta
rg
et
21
.0
66
0.
13
9
20
.8
74
R
el
at
iv
e_
4t
h1
stO
ct
14
67
F7
IC
_d
ea
D
_
35 d
ea
D
EN
D
O
21
.0
01
0.
21
4
R
el
at
iv
e_
4t
h1
stO
ct
14
2
A
2
gb
pA
_
36
gb
pA
Ta
rg
et
20
.0
21
0.
21
6
20
.2
87
R
el
at
iv
e_
4t
h1
stO
ct
14
8
A
8
IC
_d
ea
D
_
36 d
ea
D
EN
D
O
19
.0
74
0.
17
1
R
el
at
iv
e_
4t
h1
stO
ct
14
73
G
1
gb
pA
_
36
gb
pA
Ta
rg
et
20
.1
24
0.
21
6
20
.2
87
R
el
at
iv
e_
4t
h1
stO
ct
14
79
G
7
IC
_d
ea
D
_
36 d
ea
D
EN
D
O
19
.2
84
0.
17
1
R
el
at
iv
e_
4t
h1
stO
ct
14
85
H
1
gb
pA
_
36
gb
pA
Ta
rg
et
20
.7
15
0.
21
6
20
.2
87
R
el
at
iv
e_
4t
h1
stO
ct
14
91
H
7
IC
_d
ea
D
_
36 d
ea
D
EN
D
O
19
.6
6
0.
17
1
300
(m) Phylogenetic tree representing the selected 52 V. parahaemolyticus genomes in 
relation with (i) Chitinase 1 (ii) Chitinase 2 (iii) Chitinase 3 (iv) Chitinase 4 (v) 
Chitinase 5 genes. Marked in RED are the three genomes VPPCV08-7, 
VPRIMD2210633 and VP01:K33 genomes. In GREEN are the three EMS strains 
from Thailand VPBAVF (Vibrio parahaemolyticus TUMST_DE1_S1), VPBAVG 
(Vibrio parahaemolyticus TUMSAT_DE2_S2) and VPBAVH (Vibrio 
parahaemolyticus TUMSAT_D06_S3) 
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